1	Thrombosis	NNP	O	Thrombosis	nn	2	SENT_1	[p1l834t81r975b103],
2	Research	NNP	O	Research	_	0	SENT_1	[p1l986t81r1093b103],
3	128	CD	NUMBER	128	number	4	SENT_1	[p1l1105t82r1147b103],
4	(	CD	NUMBER	(	dep	2	SENT_1	[p1l1160t81r1239b108],
5	2011	CD	DATE	2011	dep	4	SENT_1	[p1l1160t81r1239b108],
6	)	CD	NUMBER	)	num	7	SENT_1	[p1l1160t81r1239b108],
7	92-95	CD	DATE	92-95	dep	2	SENT_1	[p1l1251t82r1325b103],

1	Contents	NNS	O	contents	_	0	SENT_2	[p1l782t193r916b217],
2	lists	NNS	O	list	dep	1	SENT_2	[p1l931t193r988b217],
3	available	JJ	O	available	amod	2	SENT_2	[p1l1002t193r1130b217],
4	at	IN	O	at	_	0	SENT_2	[p1l1143t196r1170b217],
5	ScienceDirect	NNP	O	ScienceDirect	prep_at	3	SENT_2	[p1l1184t193r1389b217],

1	Thrombosis	NNP	O	Thrombosis	nn	4	SENT_3	[p1l804t289r1109b336],
2	Research	NNP	O	Research	nn	4	SENT_3	[p1l1133t289r1365b336],
3	journal	NN	O	journal	nn	4	SENT_3	[p1l580t424r704b453],
4	homepage	NN	O	homepage	_	0	SENT_3	[p1l723t424r918b453],
5	:	:	O	:	_	0	SENT_3	[p1l723t424r918b453],
6	www.elsevier.com/locate/thromres	NNS	O	www.elsevier.com/locate/thromres	dep	4	SENT_3	[p1l938t424r1588b449],

1	Letter	NN	O	letter	_	0	SENT_4	[p1l11t597r224b657],
2	to	TO	O	to	_	0	SENT_4	[p1l254t602r324b657],
3	the	DT	O	the	det	4	SENT_4	[p1l357t593r473b657],
4	Editors	NNP	O	Editors	prep_to	1	SENT_4	[p1l507t592r1102b657],
5	.	.	O	.	_	0	SENT_4	[p1l507t592r1102b657],

1	—	NN	O	—	_	0	SENT_5	[p1l507t592r1102b657],
2	.	.	O	.	_	0	SENT_5	[p1l507t592r1102b657],

1	in	IN	O	in	_	0	SENT_6	[p1l507t592r1102b657],
2	.	.	O	.	_	0	SENT_6	[p1l507t592r1102b657],

1	—	NN	O	—	_	0	SENT_7	[p1l507t592r1102b657],
2	.	.	O	.	_	0	SENT_7	[p1l507t592r1102b657],

1	Chief	NNP	O	Chief	_	0	SENT_8	[p1l507t592r1102b657],

1	High	JJ	O	high	amod	4	SENT_9	[p1l9t760r162b828],
2	on-clopidogrel	JJ	O	on-clopidogrel	amod	4	SENT_9	[p1l195t760r673b828],
3	platelet	NN	O	platelet	nn	4	SENT_9	[p1l707t760r954b828],
4	reactivity	NN	O	reactivity	_	0	SENT_9	[p1l987t760r1311b828],
5	:	:	O	:	_	0	SENT_9	[p1l987t760r1311b828],
6	Genotyping	NNP	O	Genotyping	dep	4	SENT_9	[p1l1347t760r1722b828],
7	Can	MD	O	can	aux	8	SENT_9	[p1l1754t762r1873b815],
8	help	VB	O	help	rcmod	6	SENT_9	[p1l1906t760r2047b828],
9	to	TO	O	to	aux	10	SENT_9	[p1l2080t767r2146b815],
10	optimize	VB	O	optimize	xcomp	8	SENT_9	[p1l9t849r296b918],
11	antiplatelet	JJ	O	antiplatelet	amod	12	SENT_9	[p1l319t849r695b918],
12	treatment	NN	O	treatment	dobj	10	SENT_9	[p1l719t856r1048b904],

1	Dear	NNP	O	Dear	_	0	SENT_10	[p1l7t1075r152b1126],
2	Editors	NNP	O	Editors	dep	1	SENT_10	[p1l172t1072r388b1134],
3	,	,	O	,	_	0	SENT_10	[p1l172t1072r388b1134],

1	Clopidogrel	NNP	MISC	Clopidogrel	nsubj	5	SENT_11	[p1l112t1263r463b1331],
2	is	VBZ	O	be	cop	5	SENT_11	[p1l496t1264r539b1318],
3	a	DT	O	a	det	5	SENT_11	[p1l572t1279r603b1318],
4	thienopyridine	NN	O	thienopyridine	nn	5	SENT_11	[p1l634t1263r1090b1331],
5	prodrug	NN	O	prodrug	_	0	SENT_11	[p1l1123t1263r1370b1331],
6	that	WDT	O	that	nsubjpass	9	SENT_11	[p1l1401t1263r1524b1318],
7	must	MD	O	must	aux	9	SENT_11	[p1l1554t1271r1708b1318],
8	be	VB	O	be	auxpass	9	SENT_11	[p1l1737t1263r1807b1318],
9	converted	VBN	O	convert	rcmod	5	SENT_11	[p1l1840t1263r2146b1318],
10	into	IN	O	into	_	0	SENT_11	[p1l10t1353r128b1407],
11	an	DT	O	a	det	13	SENT_11	[p1l159t1368r230b1407],
12	active	JJ	O	active	amod	13	SENT_11	[p1l261t1353r439b1407],
13	metabolite	NN	O	metabolite	prep_into	9	SENT_11	[p1l470t1352r799b1407],
14	to	TO	O	to	aux	15	SENT_11	[p1l829t1360r887b1407],
15	target	VB	O	target	xcomp	9	SENT_11	[p1l918t1360r1099b1420],
16	the	DT	O	the	det	20	SENT_11	[p1l1127t1352r1224b1407],
17	platelet	NN	O	platelet	nn	20	SENT_11	[p1l1255t1352r1486b1420],
18	ADP	NN	O	adp	nn	20	SENT_11	[p1l1512t1354r1642b1406],
19	P2Y12	NN	O	p2y12	nn	20	SENT_11	[p1l1672t1355r1843b1418],
20	receptor	NN	O	receptor	dobj	15	SENT_11	[p1l1875t1360r2146b1420],
21	.	.	O	.	_	0	SENT_11	[p1l1875t1360r2146b1420],

1	The	DT	O	the	det	3	SENT_12	[p1l7t1440r119b1495],
2	pharmacodynamic	JJ	O	pharmacodynamic	amod	3	SENT_12	[p1l145t1440r717b1509],
3	response	NN	O	response	nsubj	6	SENT_12	[p1l742t1456r1014b1509],
4	to	TO	O	to	_	0	SENT_12	[p1l1038t1448r1097b1495],
5	clopidogrel	NN	O	clopidogrel	prep_to	3	SENT_12	[p1l1123t1440r1465b1509],
6	exhibits	VBZ	O	exhibit	_	0	SENT_12	[p1l1492t1440r1733b1495],
7	considerable	JJ	O	considerable	amod	9	SENT_12	[p1l1759t1440r2146b1495],
8	interindividual	JJ	O	interindividual	amod	9	SENT_12	[p1l10t1529r465b1584],
9	variability	NN	O	variability	dobj	6	SENT_12	[p1l504t1529r829b1598],
10	,	,	O	,	_	0	SENT_12	[p1l504t1529r829b1598],
11	part	NN	O	part	nsubj	15	SENT_12	[p1l870t1537r995b1598],
12	of	IN	O	of	_	0	SENT_12	[p1l1033t1529r1097b1584],
13	which	WDT	O	which	prep_of	11	SENT_12	[p1l1128t1529r1317b1584],
14	is	VBZ	O	be	cop	15	SENT_12	[p1l1357t1530r1401b1584],
15	dependent	JJ	O	dependent	rcmod	9	SENT_12	[p1l1442t1529r1773b1598],
16	on	IN	O	on	_	0	SENT_12	[p1l1811t1545r1886b1584],
17	genetic	JJ	O	genetic	amod	18	SENT_12	[p1l1925t1530r2148b1598],
18	factors	NNS	O	factor	prep_on	15	SENT_12	[p1l10t1618r228b1674],
19	.	.	O	.	_	0	SENT_12	[p1l10t1618r228b1674],

1	About	RB	O	about	quantmod	2	SENT_13	[p1l254t1618r441b1673],
2	20	CD	PERCENT	20	num	3	SENT_13	[p1l466t1621r582b1673],
3	%	NN	PERCENT	%	nsubj	7	SENT_13	[p1l466t1621r582b1673],
4	of	IN	O	of	_	0	SENT_13	[p1l609t1618r672b1673],
5	patients	NNS	O	patient	prep_of	3	SENT_13	[p1l692t1619r937b1687],
6	have	VBP	O	have	aux	7	SENT_13	[p1l966t1618r1108b1673],
7	decreased	VBN	O	decrease	_	0	SENT_13	[p1l1136t1618r1441b1673],
8	biological	JJ	O	biological	amod	9	SENT_13	[p1l1468t1618r1762b1687],
9	responsiveness	NN	O	responsiveness	dobj	7	SENT_13	[p1l1790t1619r2145b1687, p1l10t1724r140b1763],
10	to	TO	O	to	_	0	SENT_13	[p1l165t1716r224b1763],
11	clopidogrel	NN	O	clopidogrel	prep_to	7	SENT_13	[p1l249t1708r591b1776],
12	with	IN	O	with	mark	19	SENT_13	[p1l615t1708r756b1763],
13	a	DT	O	a	det	15	SENT_13	[p1l780t1724r811b1763],
14	higher	JJR	O	higher	amod	15	SENT_13	[p1l836t1708r1035b1776],
15	risk	NN	O	risk	nsubj	19	SENT_13	[p1l1057t1708r1169b1763],
16	of	IN	O	of	_	0	SENT_13	[p1l1192t1708r1255b1763],
17	cardiovascular	JJ	O	cardiovascular	amod	18	SENT_13	[p1l1272t1708r1716b1763],
18	events	NNS	O	event	prep_of	15	SENT_13	[p1l1739t1716r1937b1763],
19	[	VBP	O	[	advcl	7	SENT_13	[p1l1965t1708r2059b1776],
20	1	CD	NUMBER	1	number	21	SENT_13	[p1l1965t1708r2059b1776],
21	]	CD	NUMBER	]	dobj	19	SENT_13	[p1l1965t1708r2059b1776],
22	.	.	O	.	_	0	SENT_13	[p1l1965t1708r2059b1776],

1	Two	CD	NUMBER	two	num	3	SENT_14	[p1l109t1800r241b1852],
2	genetic	JJ	O	genetic	amod	3	SENT_14	[p1l289t1798r515b1865],
3	factors	NNS	O	factor	nsubjpass	14	SENT_14	[p1l563t1797r770b1852],
4	that	WDT	O	that	nsubj	5	SENT_14	[p1l818t1797r943b1852],
5	contribute	VBP	O	contribute	rcmod	3	SENT_14	[p1l990t1797r1313b1852],
6	to	TO	O	to	aux	7	SENT_14	[p1l1361t1805r1419b1852],
7	limit	VB	O	limit	xcomp	5	SENT_14	[p1l1469t1797r1615b1852],
8	the	DT	O	the	det	9	SENT_14	[p1l1661t1797r1759b1852],
9	efﬁcacy	NN	O	efﬁcacy	dobj	7	SENT_14	[p1l1808t1797r2043b1865],
10	of	IN	O	of	_	0	SENT_14	[p1l2090t1797r2153b1852],
11	clopidogrel	NN	O	clopidogrel	prep_of	9	SENT_14	[p1l10t1885r353b1954],
12	have	VBP	O	have	aux	14	SENT_14	[p1l378t1885r521b1940],
13	been	VBN	O	be	auxpass	14	SENT_14	[p1l544t1885r692b1940],
14	identiﬁed	VBN	O	identiﬁed	_	0	SENT_14	[p1l716t1885r1009b1940],
15	in	IN	O	in	_	0	SENT_14	[p1l1035t1886r1091b1940],
16	healthy	JJ	O	healthy	amod	17	SENT_14	[p1l1116t1885r1346b1954],
17	volunteers	NNS	O	volunteer	prep_in	14	SENT_14	[p1l1367t1885r1708b1941],
18	.	.	O	.	_	0	SENT_14	[p1l1367t1885r1708b1941],

1	One	CD	NUMBER	one	nsubj	5	SENT_15	[p1l112t1977r231b2029],
2	is	VBZ	O	be	cop	5	SENT_15	[p1l254t1975r298b2029],
3	the	DT	O	the	det	5	SENT_15	[p1l320t1974r418b2029],
4	gain	NN	O	gain	nn	5	SENT_15	[p1l439t1974r941b2043],
5	—	NN	O	—	_	0	SENT_15	[p1l439t1974r941b2043],
6	of	IN	O	of	_	0	SENT_15	[p1l439t1974r941b2043],
7	—	CD	NUMBER	—	num	10	SENT_15	[p1l439t1974r941b2043],
8	function	NN	O	function	nn	10	SENT_15	[p1l439t1974r941b2043],
9	polymorphism	NN	O	polymorphism	nn	10	SENT_15	[p1l964t1974r1415b2043],
10	(	NN	O	(	prep_of	5	SENT_15	[p1l1441t1974r1550b2042],
11	H2	NN	O	h2	nn	13	SENT_15	[p1l1441t1974r1550b2042],
12	allele	NN	O	allele	nn	13	SENT_15	[p1l1574t1974r1759b2042],
13	)	NN	O	)	nsubj	32	SENT_15	[p1l1574t1974r1759b2042],
14	of	IN	O	of	_	0	SENT_15	[p1l1786t1974r1849b2029],
15	the	DT	O	the	det	17	SENT_15	[p1l1863t1974r1960b2029],
16	P2Y12	NN	O	p2y12	nn	17	SENT_15	[p1l1981t1977r2146b2040],
17	gene	NN	O	gene	prep_of	13	SENT_15	[p1l8t2079r168b2132],
18	,	,	O	,	_	0	SENT_15	[p1l8t2079r168b2132],
19	the	DT	O	the	det	23	SENT_15	[p1l196t2064r293b2119],
20	clopidogrel	NN	O	clopidogrel	nn	23	SENT_15	[p1l320t2064r662b2132],
21	active	JJ	O	active	amod	23	SENT_15	[p1l690t2065r868b2119],
22	metabolite	NN	O	metabolite	nn	23	SENT_15	[p1l896t2064r1224b2119],
23	target	NN	O	target	appos	13	SENT_15	[p1l1250t2072r1445b2132],
24	,	,	O	,	_	0	SENT_15	[p1l1250t2072r1445b2132],
25	which	WDT	O	which	nsubjpass	27	SENT_15	[p1l1471t2064r1660b2119],
26	was	VBD	O	be	auxpass	27	SENT_15	[p1l1686t2079r1804b2119],
27	associated	VBN	O	associate	rcmod	13	SENT_15	[p1l1832t2064r2146b2119],
28	with	IN	O	with	_	0	SENT_15	[p1l8t2153r149b2207],
29	increased	VBN	O	increase	amod	31	SENT_15	[p1l178t2152r468b2207],
30	ADP	NN	O	adp	nn	31	SENT_15	[p1l495t2152r899b2207],
31	—	NN	O	—	prep_with	27	SENT_15	[p1l495t2152r899b2207],
32	induced	VBD	O	induce	rcmod	10	SENT_15	[p1l495t2152r899b2207],
33	platelet	NN	O	platelet	nn	34	SENT_15	[p1l929t2152r1161b2221],
34	aggregation	NN	O	aggregation	dobj	32	SENT_15	[p1l1188t2153r1550b2221],
35	ex	FW	O	ex	nn	36	SENT_15	[p1l1579t2168r1649b2207],
36	vivo	FW	O	vivo	nsubj	40	SENT_15	[p1l1674t2153r1803b2207],
37	in	IN	O	in	_	0	SENT_15	[p1l1832t2153r1888b2207],
38	healthy	JJ	O	healthy	amod	39	SENT_15	[p1l1918t2152r2148b2221],
39	volunteers	NNS	O	volunteer	prep_in	36	SENT_15	[p1l8t2242r333b2297],
40	[	VBP	O	[	rcmod	34	SENT_15	[p1l357t2242r450b2310],
41	2	CD	NUMBER	2	number	42	SENT_15	[p1l357t2242r450b2310],
42	]	CD	NUMBER	]	dobj	40	SENT_15	[p1l357t2242r450b2310],
43	.	.	O	.	_	0	SENT_15	[p1l357t2242r450b2310],

1	Furthermore	RB	O	furthermore	advmod	7	SENT_16	[p1l472t2242r875b2305],
2	,	,	O	,	_	0	SENT_16	[p1l472t2242r875b2305],
3	the	DT	O	the	det	5	SENT_16	[p1l895t2242r992b2297],
4	H2	NN	O	h2	nn	5	SENT_16	[p1l1012t2245r1094b2296],
5	allele	NN	O	allele	nsubjpass	7	SENT_16	[p1l1116t2242r1276b2297],
6	was	VBD	O	be	auxpass	7	SENT_16	[p1l1294t2258r1413b2297],
7	found	VBN	O	find	_	0	SENT_16	[p1l1434t2242r1610b2297],
8	more	RBR	O	more	advmod	9	SENT_16	[p1l1631t2258r1789b2297],
9	frequent	JJ	O	frequent	acomp	7	SENT_16	[p1l1810t2242r2072b2310],
10	in	IN	O	in	_	0	SENT_16	[p1l2090t2243r2146b2296],
11	arteritic	JJ	O	arteritic	amod	12	SENT_16	[p1l9t2332r253b2386],
12	patients	NNS	O	patient	prep_in	7	SENT_16	[p1l276t2332r521b2399],
13	enrolled	VBN	O	enrol	partmod	12	SENT_16	[p1l547t2331r799b2386],
14	in	IN	O	in	_	0	SENT_16	[p1l825t2332r881b2385],
15	the	DT	O	the	det	17	SENT_16	[p1l905t2331r1002b2386],
16	PALLAS	NNP	ORGANIZATION	PALLAS	nn	17	SENT_16	[p1l1028t2333r1252b2386],
17	study	NN	O	study	prep_in	13	SENT_16	[p1l1279t2331r1447b2399],
18	compared	VBN	O	compare	_	0	SENT_16	[p1l1470t2331r1775b2399],
19	to	TO	O	to	prepc_compared_to	13	SENT_16	[p1l1800t2339r1859b2386],
20	controls	NNS	O	control	pobj	13	SENT_16	[p1l1885t2331r2146b2386],
21	.	.	O	.	_	0	SENT_16	[p1l1885t2331r2146b2386],

1	This	DT	O	this	det	2	SENT_17	[p1l7t2419r134b2474],
2	association	NN	O	association	nsubj	23	SENT_17	[p1l183t2420r526b2474],
3	remained	VBD	O	remain	cop	23	SENT_17	[p1l575t2419r869b2474],
4	signiﬁcant	JJ	O	signiﬁcant	amod	23	SENT_17	[p1l920t2419r1241b2488],
5	in	IN	O	in	_	0	SENT_17	[p1l1289t2420r1346b2474],
6	multivariate	JJ	O	multivariate	amod	8	SENT_17	[p1l1395t2419r1776b2474],
7	regression	NN	O	regression	nn	8	SENT_17	[p1l1825t2420r2146b2488],
8	analysis	NN	O	analysis	prep_in	4	SENT_17	[p1l9t2508r251b2577],
9	(	CD	NUMBER	(	num	10	SENT_17	[p1l298t2508r424b2576],
10	OR	NN	O	or	dep	8	SENT_17	[p1l298t2508r424b2576],
11	,	,	O	,	_	0	SENT_17	[p1l298t2508r424b2576],
12	2.3	CD	NUMBER	2.3	appos	10	SENT_17	[p1l468t2511r576b2572],
13	;	:	O	;	_	0	SENT_17	[p1l468t2511r576b2572],
14	CI	NNP	O	CI	dep	10	SENT_17	[p1l624t2511r695b2572],
15	,	,	O	,	_	0	SENT_17	[p1l624t2511r695b2572],
16	1.4	CD	NUMBER	1.4	number	18	SENT_17	[p1l742t2511r828b2564],
17	to	TO	O	to	dep	18	SENT_17	[p1l870t2516r928b2563],
18	3.9	CD	NUMBER	3.9	appos	14	SENT_17	[p1l971t2511r1079b2572],
19	;	:	O	;	_	0	SENT_17	[p1l971t2511r1079b2572],
20	P	NN	O	p	dep	10	SENT_17	[p1l1127t2508r1441b2576],
21	=	JJ	O	=	amod	20	SENT_17	[p1l1127t2508r1441b2576],
22	0.002	CD	NUMBER	0.002	tmod	21	SENT_17	[p1l1127t2508r1441b2576],
23	)	NN	O	)	dep	42	SENT_17	[p1l1127t2508r1441b2576],
24	after	IN	O	after	_	0	SENT_17	[p1l1489t2508r1630b2563],
25	adjustment	NN	O	adjustment	prep_after	23	SENT_17	[p1l1671t2508r2021b2577],
26	for	IN	O	for	_	0	SENT_17	[p1l2063t2508r2148b2563],
27	diabetes	NN	O	diabetes	nn	33	SENT_17	[p1l10t2598r278b2661],
28	,	,	O	,	_	0	SENT_17	[p1l10t2598r278b2661],
29	smoking	NN	O	smoking	dep	33	SENT_17	[p1l322t2598r597b2666],
30	,	,	O	,	_	0	SENT_17	[p1l322t2598r597b2666],
31	hypertension	NN	O	hypertension	dep	33	SENT_17	[p1l640t2598r1060b2666],
32	,	,	O	,	_	0	SENT_17	[p1l640t2598r1060b2666],
33	hypercholesterolemia	NN	O	hypercholesterolemia	prep_for	25	SENT_17	[p1l1104t2598r1787b2666],
34	,	,	O	,	_	0	SENT_17	[p1l1104t2598r1787b2666],
35	and	CC	O	and	_	0	SENT_17	[p1l1830t2598r1941b2653],
36	other	JJ	O	other	amod	39	SENT_17	[p1l1984t2598r2149b2653],
37	selected	VBN	O	select	amod	39	SENT_17	[p1l10t2686r257b2741],
38	platelet	NN	O	platelet	nn	39	SENT_17	[p1l285t2687r517b2755],
39	receptor	NN	O	receptor	prep_for	25	SENT_17	[p1l542t2695r800b2755],
40	gene	NN	O	gene	nn	41	SENT_17	[p1l824t2702r969b2755],
41	polymorphisms	NNS	O	polymorphism	nsubj	42	SENT_17	[p1l996t2686r1477b2755],
42	[	VBP	O	[	_	0	SENT_17	[p1l1508t2686r1602b2755],
43	3	CD	NUMBER	3	num	44	SENT_17	[p1l1508t2686r1602b2755],
44	]	NN	O	]	dobj	42	SENT_17	[p1l1508t2686r1602b2755],
45	.	.	O	.	_	0	SENT_17	[p1l1508t2686r1602b2755],

1	Finally	RB	O	finally	advmod	9	SENT_18	[p1l1630t2686r1846b2755],
2	,	,	O	,	_	0	SENT_18	[p1l1630t2686r1846b2755],
3	homozygosity	NN	O	homozygosity	nsubjpass	9	SENT_18	[p1l1874t2686r2146b2755, p1l8t2777r193b2844],
4	for	IN	O	for	_	0	SENT_18	[p1l233t2776r318b2831],
5	the	DT	O	the	det	7	SENT_18	[p1l357t2776r454b2831],
6	H2	NN	O	h2	nn	7	SENT_18	[p1l496t2779r579b2830],
7	allele	NN	O	allele	prep_for	3	SENT_18	[p1l622t2776r782b2831],
8	was	VBD	O	be	auxpass	9	SENT_18	[p1l822t2792r941b2831],
9	associated	VBN	O	associate	conj_and	9	SENT_18	[p1l984t2776r1298b2831],
10	with	IN	O	with	_	0	SENT_18	[p1l1338t2776r1479b2831],
11	a	DT	O	a	det	13	SENT_18	[p1l1519t2792r1551b2831],
12	poor	JJ	O	poor	amod	13	SENT_18	[p1l1592t2792r1734b2844],
13	response	NN	O	response	prep_with	9	SENT_18	[p1l1774t2792r2046b2844],
14	to	TO	O	to	_	0	SENT_18	[p1l2087t2784r2146b2831],
15	clopidogrel	NN	O	clopidogrel	prep_to	9	SENT_18	[p1l10t2865r353b2933],
16	in	IN	O	in	_	0	SENT_18	[p1l375t2866r432b2919],
17	a	DT	O	a	det	19	SENT_18	[p1l454t2881r485b2920],
18	small	JJ	O	small	amod	19	SENT_18	[p1l507t2865r668b2920],
19	subset	NN	O	subset	prep_in	15	SENT_18	[p1l691t2865r887b2920],
20	of	IN	O	of	_	0	SENT_18	[p1l907t2865r971b2920],
21	healthy	JJ	O	healthy	amod	22	SENT_18	[p1l986t2865r1216b2933],
22	volunteers	NNS	O	volunteer	prep_of	19	SENT_18	[p1l1235t2865r1560b2920],
23	[	VBP	O	[	rcmod	22	SENT_18	[p1l1586t2865r1662b2933],
24	4	CD	NUMBER	4	number	25	SENT_18	[p1l1586t2865r1662b2933],
25	]	CD	NUMBER	]	dobj	23	SENT_18	[p1l1586t2865r1662b2933],
26	and	CC	O	and	_	0	SENT_18	[p1l1687t2865r1799b2920],
27	in	IN	O	in	_	0	SENT_18	[p1l1822t2866r1878b2919],
28	patients	NNS	O	patient	prep_in	9	SENT_18	[p1l1901t2866r2146b2933],
29	treated	VBN	O	treat	partmod	28	SENT_18	[p1l9t2953r227b3008],
30	with	IN	O	with	_	0	SENT_18	[p1l268t2953r408b3008],
31	aspirin	NN	O	aspirin	prep_with	29	SENT_18	[p1l450t2954r659b3022],
32	and	CC	O	and	_	0	SENT_18	[p1l700t2953r811b3008],
33	clopidogrel	NN	O	clopidogrel	prep_with	29	SENT_18	[p1l853t2953r1196b3022],
34	after	IN	O	after	_	0	SENT_18	[p1l1237t2953r1380b3008],
35	percutaneous	JJ	O	percutaneous	amod	40	SENT_18	[p1l1419t2961r1833b3022],
36	coronary	JJ	O	coronary	amod	40	SENT_18	[p1l1875t2969r2149b3022],
37	intervention	NN	O	intervention	nn	40	SENT_18	[p1l10t3043r390b3097],
38	[	NN	O	[	nn	40	SENT_18	[p1l418t3042r512b3111],
39	5	CD	NUMBER	5	num	40	SENT_18	[p1l418t3042r512b3111],
40	]	NN	O	]	prep_after	29	SENT_18	[p1l418t3042r512b3111],
41	.	.	O	.	_	0	SENT_18	[p1l418t3042r512b3111],

1	The	DT	O	the	det	3	SENT_19	[p1l109t3132r221b3187],
2	other	JJ	O	other	amod	3	SENT_19	[p1l241t3132r405b3187],
3	factor	NN	O	factor	nsubj	7	SENT_19	[p1l423t3131r599b3187],
4	is	VBZ	O	be	cop	7	SENT_19	[p1l617t3133r661b3187],
5	a	DT	O	a	det	7	SENT_19	[p1l681t3147r712b3187],
6	loss	NN	O	loss	nn	7	SENT_19	[p1l732t3131r1218b3187],
7	—	NN	O	—	_	0	SENT_19	[p1l732t3131r1218b3187],
8	of	IN	O	of	_	0	SENT_19	[p1l732t3131r1218b3187],
9	—	CD	NUMBER	—	num	11	SENT_19	[p1l732t3131r1218b3187],
10	function	NN	O	function	nn	11	SENT_19	[p1l732t3131r1218b3187],
11	polymorphism	NN	O	polymorphism	prep_of	7	SENT_19	[p1l1237t3132r1689b3200],
12	of	IN	O	of	_	0	SENT_19	[p1l1708t3131r1772b3187],
13	cytochrome	NN	O	cytochrome	nn	14	SENT_19	[p1l1783t3132r2146b3200],
14	P450	NN	O	p450	prep_of	11	SENT_19	[p1l10t3223r160b3275],
15	2	CD	NUMBER	2	num	14	SENT_19	[p1l193t3223r226b3275],
16	C19	NN	O	c19	nn	19	SENT_19	[p1l249t3223r362b3275],
17	(	CD	NUMBER	(	num	19	SENT_19	[p1l401t3220r795b3289],
18	CYP2Cl9	NN	O	cyp2cl9	nn	19	SENT_19	[p1l401t3220r795b3289],
19	*	NN	O	*	dep	7	SENT_19	[p1l401t3220r795b3289],
20	2	CD	NUMBER	2	num	21	SENT_19	[p1l401t3220r795b3289],
21	)	NN	O	)	dep	19	SENT_19	[p1l401t3220r795b3289],
22	,	,	O	,	_	0	SENT_19	[p1l401t3220r795b3289],
23	involved	VBN	O	involve	partmod	7	SENT_19	[p1l830t3220r1092b3275],
24	in	IN	O	in	_	0	SENT_19	[p1l1126t3221r1182b3275],
25	the	DT	O	the	det	26	SENT_19	[p1l1215t3221r1312b3275],
26	conversion	NN	O	conversion	prep_in	23	SENT_19	[p1l1346t3221r1681b3275],
27	of	IN	O	of	_	0	SENT_19	[p1l1714t3220r1778b3275],
28	clopidogrel	NN	O	clopidogrel	prep_of	26	SENT_19	[p1l1804t3220r2146b3289],
29	into	IN	O	into	_	0	SENT_19	[p1l10t3311r128b3365],
30	its	PRP$	O	its	poss	36	SENT_19	[p1l147t3311r216b3365],
31	pharmacologically	RB	O	pharmacologically	advmod	32	SENT_19	[p1l235t3310r799b3378],
32	active	JJ	O	active	amod	36	SENT_19	[p1l815t3311r994b3365],
33	metabolite	NN	O	metabolite	nn	36	SENT_19	[p1l1013t3310r1341b3365],
34	[	NN	O	[	nn	36	SENT_19	[p1l1363t3310r1456b3378],
35	6	CD	NUMBER	6	num	36	SENT_19	[p1l1363t3310r1456b3378],
36	]	NN	O	]	prep_into	23	SENT_19	[p1l1363t3310r1456b3378],
37	.	.	O	.	_	0	SENT_19	[p1l1363t3310r1456b3378],

1	Carriers	NNS	O	carrier	_	0	SENT_20	[p1l1475t3311r1713b3365],
2	of	IN	O	of	_	0	SENT_20	[p1l1731t3310r1795b3365],
3	at	IN	O	at	quantmod	5	SENT_20	[p1l1805t3318r1862b3365],
4	least	JJS	O	least	mwe	3	SENT_20	[p1l1879t3310r2020b3365],
5	one	CD	NUMBER	one	prep_of	1	SENT_20	[p1l2036t3326r2146b3365],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_21	[p2l10t17r334b72],
2	*	NN	O	*	nsubj	22	SENT_21	[p2l10t17r334b72],
3	2	CD	NUMBER	2	num	4	SENT_21	[p2l10t17r334b72],
4	allele	NN	O	allele	dep	2	SENT_21	[p2l358t17r518b72],
5	have	VBP	O	have	_	0	SENT_21	[p2l543t17r686b72],
6	a	DT	O	a	det	12	SENT_21	[p2l710t33r741b72],
7	30	CD	PERCENT	30	number	11	SENT_21	[p2l764t20r881b72],
8	%	NN	PERCENT	%	dep	11	SENT_21	[p2l764t20r881b72],
9	to	TO	O	to	dep	11	SENT_21	[p2l905t25r963b72],
10	35	CD	PERCENT	35	number	11	SENT_21	[p2l987t20r1104b72],
11	%	NN	PERCENT	%	num	12	SENT_21	[p2l987t20r1104b72],
12	decrease	NN	O	decrease	dobj	5	SENT_21	[p2l1128t17r1393b72],
13	in	IN	O	in	_	0	SENT_21	[p2l1418t18r1475b71],
14	clopidogrel	NN	O	clopidogrel	nn	16	SENT_21	[p2l1499t17r1842b85],
15	exposure	NN	O	exposure	nn	16	SENT_21	[p2l1866t33r2146b85],
16	[	NN	O	[	prep_in	12	SENT_21	[p2l13t105r91b174],
17	7	CD	NUMBER	7	num	18	SENT_21	[p2l13t105r91b174],
18	]	NN	O	]	dep	16	SENT_21	[p2l13t105r91b174],
19	and	CC	O	and	_	0	SENT_21	[p2l145t105r258b160],
20	have	VBP	O	have	aux	22	SENT_21	[p2l310t105r456b160],
21	signiﬁcantly	RB	O	signiﬁcantly	advmod	22	SENT_21	[p2l507t105r895b174],
22	increased	VBN	O	increase	conj_and	5	SENT_21	[p2l944t105r1244b160],
23	rates	NNS	O	rate	dobj	22	SENT_21	[p2l1295t113r1448b160],
24	of	IN	O	of	_	0	SENT_21	[p2l1499t105r1563b160],
25	death	NN	O	death	prep_of	23	SENT_21	[p2l1605t105r1798b169],
26	,	,	O	,	_	0	SENT_21	[p2l1605t105r1798b169],
27	recurrent	JJ	O	recurrent	amod	28	SENT_21	[p2l1850t113r2148b160],
28	infarction	NN	O	infarction	prep_of	23	SENT_21	[p2l10t194r320b258],
29	,	,	O	,	_	0	SENT_21	[p2l10t194r320b258],
30	and	CC	O	and	_	0	SENT_21	[p2l346t194r456b249],
31	other	JJ	O	other	amod	33	SENT_21	[p2l482t194r647b249],
32	cardiac	JJ	O	cardiac	amod	33	SENT_21	[p2l669t194r886b249],
33	events	NNS	O	event	prep_of	23	SENT_21	[p2l909t202r1107b249],
34	such	JJ	O	such	_	0	SENT_21	[p2l1133t194r1271b249],
35	as	IN	O	as	_	0	SENT_21	[p2l1295t210r1354b249],
36	stent	JJ	O	stent	amod	38	SENT_21	[p2l1381t202r1533b249],
37	thrombosis	NN	O	thrombosis	nn	38	SENT_21	[p2l1555t194r1899b249],
38	[	NN	O	[	prep_such_as	33	SENT_21	[p2l1929t194r2100b263],
39	7	CD	NUMBER	7	number	40	SENT_21	[p2l1929t194r2100b263],
40	—	CD	NUMBER	—	dep	38	SENT_21	[p2l1929t194r2100b263],
41	9	CD	NUMBER	9	num	42	SENT_21	[p2l1929t194r2100b263],
42	]	NN	O	]	dep	40	SENT_21	[p2l1929t194r2100b263],
43	.	.	O	.	_	0	SENT_21	[p2l1929t194r2100b263],

1	Here	RB	O	here	advmod	4	SENT_22	[p2l112t287r270b347],
2	,	,	O	,	_	0	SENT_22	[p2l112t287r270b347],
3	we	PRP	O	we	nsubj	4	SENT_22	[p2l298t299r389b338],
4	describe	VBP	O	describe	_	0	SENT_22	[p2l418t283r672b338],
5	the	DT	O	the	det	7	SENT_22	[p2l701t284r798b338],
6	clinical	JJ	O	clinical	amod	7	SENT_22	[p2l827t283r1041b338],
7	management	NN	O	management	dobj	4	SENT_22	[p2l1070t292r1476b352],
8	of	IN	O	of	_	0	SENT_22	[p2l1502t283r1566b338],
9	two	CD	NUMBER	two	num	10	SENT_22	[p2l1587t292r1703b338],
10	patients	NNS	O	patient	prep_of	7	SENT_22	[p2l1732t284r1977b352],
11	with	IN	O	with	_	0	SENT_22	[p2l2005t283r2147b338],
12	suspected	VBN	O	suspect	amod	14	SENT_22	[p2l10t372r312b441],
13	genetic	JJ	O	genetic	amod	14	SENT_22	[p2l335t373r559b441],
14	resistance	NN	O	resistance	prep_with	4	SENT_22	[p2l583t373r886b427],
15	to	TO	O	to	_	0	SENT_22	[p2l911t380r970b427],
16	clopidogrel	NN	O	clopidogrel	prep_to	14	SENT_22	[p2l995t372r1352b441],
17	.	.	O	.	_	0	SENT_22	[p2l995t372r1352b441],

1	1	LS	NUMBER	1	_	0	SENT_23	[p2l11t598r61b650],
2	.	.	O	.	_	0	SENT_23	[p2l11t598r61b650],

1	Clinical	JJ	O	clinical	amod	2	SENT_24	[p2l87t595r326b649],
2	cases	NNS	O	case	_	0	SENT_24	[p2l351t610r515b649],

1	1.1	CD	NUMBER	1.1	_	0	SENT_25	[p2l16t775r107b828],
2	.	.	O	.	_	0	SENT_25	[p2l16t775r107b828],

1	Laboratory	NNP	O	Laboratory	nn	2	SENT_26	[p2l135t772r458b841],
2	procedures	NNS	O	procedure	_	0	SENT_26	[p2l480t772r806b841],

1	Aggregation	NN	O	aggregation	nn	2	SENT_27	[p2l109t952r483b1019],
2	studies	NNS	O	study	nsubjpass	4	SENT_27	[p2l515t951r730b1006],
3	were	VBD	O	be	auxpass	4	SENT_27	[p2l760t967r914b1006],
4	performed	VBN	O	perform	_	0	SENT_27	[p2l946t951r1269b1019],
5	within	IN	O	within	_	0	SENT_27	[p2l1300t951r1501b1006],
6	2	CD	DURATION	2	num	7	SENT_27	[p2l1533t954r1566b1005],
7	hours	NNS	NUMBER	hour	prep_within	4	SENT_27	[p2l1600t951r1771b1006],
8	after	IN	O	after	_	0	SENT_27	[p2l1804t951r1945b1006],
9	blood	NN	O	blood	nn	10	SENT_27	[p2l1975t951r2146b1006],
10	collection	NN	O	collection	prep_after	4	SENT_27	[p2l10t1040r306b1095],
11	as	IN	O	as	advmod	12	SENT_27	[p2l339t1056r398b1095],
12	described	VBN	O	describe	partmod	10	SENT_27	[p2l434t1040r728b1095],
13	elsewhere	RB	O	elsewhere	advmod	12	SENT_27	[p2l762t1040r1075b1095],
14	[	RB	O	[	advmod	16	SENT_27	[p2l1112t1040r1227b1108],
15	10	CD	NUMBER	10	num	16	SENT_27	[p2l1112t1040r1227b1108],
16	]	NN	O	]	dobj	12	SENT_27	[p2l1112t1040r1227b1108],
17	on	IN	O	on	_	0	SENT_27	[p2l1264t1056r1339b1095],
18	a	DT	O	a	det	20	SENT_27	[p2l1373t1056r1404b1095],
19	TA	NNP	O	TA	nn	20	SENT_27	[p2l1435t1042r1580b1095],
20	—	NN	O	—	prep_on	16	SENT_27	[p2l1435t1042r1580b1095],
21	8	CD	NUMBER	8	num	22	SENT_27	[p2l1435t1042r1580b1095],
22	V	NN	O	v	dep	28	SENT_27	[p2l1600t1043r1646b1094],
23	optical	JJ	O	optical	amod	24	SENT_27	[p2l1677t1040r1882b1108],
24	platelet	NN	O	platelet	dep	22	SENT_27	[p2l1916t1040r2148b1108],
25	aggregometer	NN	O	aggregometer	dep	28	SENT_27	[p2l9t1136r438b1197],
26	(	CD	NUMBER	(	num	25	SENT_27	[p2l481t1128r733b1197],
27	Soderel	NNP	ORGANIZATION	Soderel	nn	28	SENT_27	[p2l481t1128r733b1197],
28	Medical	NNP	ORGANIZATION	Medical	dep	16	SENT_27	[p2l775t1128r1029b1192],
29	,	,	O	,	_	0	SENT_27	[p2l775t1128r1029b1192],
30	Heillecourt	NNP	PERSON	Heillecourt	appos	28	SENT_27	[p2l1071t1128r1423b1192],
31	,	,	O	,	_	0	SENT_27	[p2l1071t1128r1423b1192],
32	France	NNP	LOCATION	France	appos	28	SENT_27	[p2l1465t1128r1709b1197],
33	)	CD	NUMBER	)	num	32	SENT_27	[p2l1465t1128r1709b1197],
34	.	.	O	.	_	0	SENT_27	[p2l1465t1128r1709b1197],

1	ADP	NN	O	adp	nsubj	34	SENT_28	[p2l1748t1131r1878b1183],
2	in	IN	O	in	_	0	SENT_28	[p2l1917t1129r1973b1183],
3	ﬁnal	JJ	O	ﬁnal	amod	4	SENT_28	[p2l2014t1128r2146b1183],
4	concentrations	NNS	O	concentration	prep_in	1	SENT_28	[p2l10t1218r489b1273],
5	of	IN	O	of	_	0	SENT_28	[p2l542t1217r608b1273],
6	5	CD	NUMBER	5	prep_of	4	SENT_28	[p2l652t1221r702b1281],
7	,	,	O	,	_	0	SENT_28	[p2l652t1221r702b1281],
8	10	CD	NUMBER	10	num	6	SENT_28	[p2l757t1220r846b1281],
9	,	,	O	,	_	0	SENT_28	[p2l757t1220r846b1281],
10	and	CC	NUMBER	and	_	0	SENT_28	[p2l898t1218r1013b1273],
11	20	CD	NUMBER	20	prep_of	4	SENT_28	[p2l1065t1220r1140b1273],
12	uM	NN	O	um	nsubjpass	14	SENT_28	[p2l1161t1221r1257b1288],
13	was	VBD	O	be	auxpass	14	SENT_28	[p2l1307t1233r1430b1273],
14	used	VBN	O	use	rcmod	6	SENT_28	[p2l1482t1218r1629b1273],
15	to	TO	O	to	aux	16	SENT_28	[p2l1680t1226r1741b1273],
16	investigate	VB	O	investigate	xcomp	14	SENT_28	[p2l1793t1218r2146b1286],
17	clopidogrel-induced	JJ	O	clopidogrel-induced	amod	18	SENT_28	[p2l10t1306r628b1375],
18	inhibition	NN	O	inhibition	dobj	16	SENT_28	[p2l654t1306r953b1361],
19	of	IN	O	of	_	0	SENT_28	[p2l977t1306r1040b1361],
20	the	DT	O	the	det	22	SENT_28	[p2l1056t1306r1152b1361],
21	P2Y12	NN	O	p2y12	nn	22	SENT_28	[p2l1178t1309r1349b1372],
22	receptor	NN	O	receptor	prep_of	18	SENT_28	[p2l1375t1315r1632b1375],
23	and	CC	O	and	_	0	SENT_28	[p2l1655t1307r1766b1362],
24	arachidonic	JJ	O	arachidonic	amod	25	SENT_28	[p2l1790t1307r2148b1362],
25	acid	NN	O	acid	prep_of	18	SENT_28	[p2l9t1395r146b1458],
26	,	,	O	,	_	0	SENT_28	[p2l9t1395r146b1458],
27	1.5	CD	NUMBER	1.5	num	28	SENT_28	[p2l177t1398r260b1451],
28	mM	NN	O	mm	appos	22	SENT_28	[p2l284t1398r419b1458],
29	,	,	O	,	_	0	SENT_28	[p2l284t1398r419b1458],
30	to	TO	O	to	aux	31	SENT_28	[p2l446t1403r504b1450],
31	evaluate	VB	O	evaluate	xcomp	16	SENT_28	[p2l531t1395r788b1450],
32	aspirin	NN	O	aspirin	nn	33	SENT_28	[p2l814t1395r1298b1464],
33	—	NN	O	—	dobj	31	SENT_28	[p2l814t1395r1298b1464],
34	induced	VBD	O	induce	_	0	SENT_28	[p2l814t1395r1298b1464],
35	inhibition	NN	O	inhibition	dobj	34	SENT_28	[p2l1325t1395r1624b1450],
36	of	IN	O	of	_	0	SENT_28	[p2l1650t1395r1713b1450],
37	thromboxane	NN	O	thromboxane	nn	39	SENT_28	[p2l1731t1395r2146b1450],
38	A2	NN	O	a2	nn	39	SENT_28	[p2l7t1487r87b1539],
39	generation	NN	O	generation	prep_of	35	SENT_28	[p2l110t1486r456b1553],
40	.	.	O	.	_	0	SENT_28	[p2l110t1486r456b1553],

1	We	PRP	O	we	nsubj	2	SENT_29	[p2l477t1488r581b1540],
2	recorded	VBD	O	record	_	0	SENT_29	[p2l605t1485r876b1540],
3	the	DT	O	the	det	9	SENT_29	[p2l898t1485r996b1540],
4	maximal	JJ	O	maximal	amod	9	SENT_29	[p2l1019t1485r1284b1540],
5	platelet	NN	O	platelet	nn	9	SENT_29	[p2l1308t1485r1540b1553],
6	aggregation	NN	O	aggregation	nn	9	SENT_29	[p2l1560t1486r1923b1553],
7	(	CD	NUMBER	(	num	9	SENT_29	[p2l1949t1485r2142b1553],
8	MPA	NN	ORGANIZATION	mpa	nn	9	SENT_29	[p2l1949t1485r2142b1553],
9	)	NN	O	)	dobj	2	SENT_29	[p2l1949t1485r2142b1553],
10	and	CC	O	and	_	0	SENT_29	[p2l9t1573r123b1628],
11	residual	JJ	O	residual	amod	13	SENT_29	[p2l174t1573r426b1628],
12	platelet	NN	O	platelet	nn	13	SENT_29	[p2l477t1573r718b1642],
13	aggregation	NN	O	aggregation	dobj	2	SENT_29	[p2l767t1574r1143b1642],
14	after	IN	O	after	_	0	SENT_29	[p2l1193t1573r1341b1628],
15	6	CD	DURATION	6	num	16	SENT_29	[p2l1390t1576r1424b1628],
16	minutes	NNS	NUMBER	minute	prep_after	2	SENT_29	[p2l1474t1574r1730b1628],
17	(	CD	NUMBER	(	num	19	SENT_29	[p2l1785t1573r1982b1642],
18	RPA	NN	O	rpa	nn	19	SENT_29	[p2l1785t1573r1982b1642],
19	)	NN	O	)	dep	16	SENT_29	[p2l1785t1573r1982b1642],
20	.	.	O	.	_	0	SENT_29	[p2l1785t1573r1982b1642],

1	The	DT	O	the	det	5	SENT_30	[p2l2031t1573r2146b1628],
2	laboratory	NN	O	laboratory	nn	5	SENT_30	[p2l10t1662r328b1731],
3	ADP10	NN	O	adp10	nn	5	SENT_30	[p2l361t1665r568b1717],
4	uM	NN	O	um	nn	5	SENT_30	[p2l604t1662r973b1733],
5	—	NN	O	—	nsubj	6	SENT_30	[p2l604t1662r973b1733],
6	induced	VBD	O	induce	_	0	SENT_30	[p2l604t1662r973b1733],
7	MPA	NNP	O	MPA	nn	8	SENT_30	[p2l1012t1665r1155b1717],
8	cutoff	NN	O	cutoff	nsubj	34	SENT_30	[p2l1191t1662r1373b1717],
9	for	IN	O	for	_	0	SENT_30	[p2l1404t1662r1488b1717],
10	distinguishing	VBG	O	distinguish	prepc_for	8	SENT_30	[p2l1524t1662r1961b1731],
11	good	JJ	O	good	amod	15	SENT_30	[p2l1996t1662r2146b1731],
12	and	CC	O	and	_	0	SENT_30	[p2l9t1752r121b1807],
13	poor	JJ	O	poor	amod	15	SENT_30	[p2l148t1767r289b1820],
14	clopidogrel	NN	O	clopidogrel	nn	15	SENT_30	[p2l313t1752r656b1820],
15	responders	NNS	O	responder	nsubj	18	SENT_30	[p2l683t1752r1022b1820],
16	was	VBD	O	be	cop	18	SENT_30	[p2l1048t1767r1166b1807],
17	50	CD	PERCENT	50	num	18	SENT_30	[p2l1195t1754r1323b1815],
18	%	NN	PERCENT	%	ccomp	10	SENT_30	[p2l1195t1754r1323b1815],
19	,	,	O	,	_	0	SENT_30	[p2l1195t1754r1323b1815],
20	which	WDT	O	which	nsubj	21	SENT_30	[p2l1348t1752r1538b1807],
21	corresponds	VBZ	O	correspond	rcmod	18	SENT_30	[p2l1563t1752r1938b1820],
22	to	TO	O	to	_	0	SENT_30	[p2l1964t1760r2023b1807],
23	the	DT	O	the	det	26	SENT_30	[p2l2049t1752r2146b1807],
24	fourth	JJ	ORDINAL	fourth	amod	26	SENT_30	[p2l10t1840r199b1895],
25	quartile	NN	O	quartile	nn	26	SENT_30	[p2l225t1841r462b1909],
26	(	NN	O	(	prep_to	21	SENT_30	[p2l493t1841r661b1909],
27	poor	JJ	O	poor	amod	28	SENT_30	[p2l493t1841r661b1909],
28	responders	NNS	O	responder	nsubj	29	SENT_30	[p2l686t1840r1051b1909],
29	)	VBP	O	)	rcmod	26	SENT_30	[p2l686t1840r1051b1909],
30	according	VBG	O	accord	_	0	SENT_30	[p2l1082t1840r1380b1909],
31	to	TO	O	to	prepc_according_to	29	SENT_30	[p2l1405t1849r1463b1895],
32	previous	JJ	O	previous	amod	33	SENT_30	[p2l1491t1841r1753b1909],
33	results	NNS	O	result	pobj	29	SENT_30	[p2l1780t1840r1982b1895],
34	[	VBP	O	[	ccomp	6	SENT_30	[p2l2013t1840r2145b1909],
35	10	CD	NUMBER	10	number	36	SENT_30	[p2l2013t1840r2145b1909],
36	]	CD	NUMBER	]	dobj	34	SENT_30	[p2l2013t1840r2145b1909],
37	.	.	O	.	_	0	SENT_30	[p2l2013t1840r2145b1909],

1	0049-3848	CD	DURATION	0049-3848	_	0	SENT_31	[p2l9t1995r324b2047],
2	/	:	O	/	punct	1	SENT_31	[p2l9t1995r324b2047],
3	$	$	MONEY	$	nsubj	5	SENT_31	[p2l9t1995r324b2047],
4	—	CD	MONEY	—	num	3	SENT_31	[p2l348t2022r374b2027],
5	see	VBP	O	see	dep	1	SENT_31	[p2l397t2009r473b2040],
6	front	JJ	O	front	amod	7	SENT_31	[p2l495t1996r615b2040],
7	matter	NN	O	matter	dobj	5	SENT_31	[p2l636t2003r801b2040],
8	©	CD	NUMBER	©	num	11	SENT_31	[p2l821t1999r861b2039],
9	2011	CD	DATE	2011	num	11	SENT_31	[p2l882t1998r997b2040],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	11	SENT_31	[p2l1025t1996r1218b2040],
11	Ltd.	NNP	ORGANIZATION	Ltd.	dep	7	SENT_31	[p2l1238t1996r1324b2040],
12	.	.	O	.	_	0	SENT_31	[p2l1238t1996r1324b2040],

1	All	DT	O	all	det	2	SENT_32	[p2l1344t1996r1410b2039],
2	rights	NNS	O	rights	nsubj	3	SENT_32	[p2l1433t1996r1572b2050],
3	reserved	VBN	O	reserve	_	0	SENT_32	[p2l1595t1996r1817b2040],
4	.	.	O	.	_	0	SENT_32	[p2l1595t1996r1817b2040],

1	doi	FW	O	doi	nsubj	19	SENT_33	[p2l9t2068r896b2122],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_33	[p2l9t2068r896b2122],
3	/	:	O	/	punct	5	SENT_33	[p2l9t2068r896b2122],
4	j.	NN	O	j.	nsubj	5	SENT_33	[p2l9t2068r896b2122],
5	thromres	VBZ	O	thromre	dep	1	SENT_33	[p2l9t2068r896b2122],
6	.2011.01.012	CD	NUMBER	.2011.01.012	num	9	SENT_33	[p2l9t2068r896b2122],
7	Good	JJ	O	good	amod	9	SENT_33	[p2l9t2145r172b2200],
8	aspirin	NN	O	aspirin	nn	9	SENT_33	[p2l223t2146r441b2214],
9	responders	NNS	O	responder	nsubjpass	11	SENT_33	[p2l492t2145r844b2214],
10	were	VBD	O	be	auxpass	11	SENT_33	[p2l894t2161r1052b2200],
11	deﬁned	VBN	O	deﬁned	ccomp	5	SENT_33	[p2l1103t2145r1339b2200],
12	as	IN	O	as	_	0	SENT_33	[p2l1390t2161r1451b2200],
13	patients	NNS	O	patient	prep_as	11	SENT_33	[p2l1503t2146r1758b2214],
14	having	VBG	O	have	partmod	13	SENT_33	[p2l1809t2146r2023b2214],
15	an	DT	O	a	det	18	SENT_33	[p2l2072t2161r2145b2200],
16	arachidonic	JJ	O	arachidonic	amod	18	SENT_33	[p2l9t2235r365b2290],
17	acid	NN	O	acid	nn	18	SENT_33	[p2l389t2235r786b2290],
18	—	NN	O	—	dobj	14	SENT_33	[p2l389t2235r786b2290],
19	induced	VBD	O	induce	_	0	SENT_33	[p2l389t2235r786b2290],
20	MPA	NN	ORGANIZATION	mpa	dobj	19	SENT_33	[p2l812t2237r956b2289],
21	below	IN	O	below	_	0	SENT_33	[p2l977t2235r1165b2290],
22	20	CD	PERCENT	20	num	23	SENT_33	[p2l1188t2238r1304b2290],
23	%	NN	PERCENT	%	prep_below	19	SENT_33	[p2l1188t2238r1304b2290],
24	[	CD	NUMBER	[	number	25	SENT_33	[p2l1331t2235r1463b2303],
25	11	CD	NUMBER	11	num	26	SENT_33	[p2l1331t2235r1463b2303],
26	]	NN	O	]	dep	19	SENT_33	[p2l1331t2235r1463b2303],
27	.	.	O	.	_	0	SENT_33	[p2l1331t2235r1463b2303],

1	Vasodilator	NN	O	vasodilator	nn	2	SENT_34	[p2l108t2324r816b2379],
2	—	NN	O	—	nsubj	3	SENT_34	[p2l108t2324r816b2379],
3	stimulated	VBD	O	stimulate	_	0	SENT_34	[p2l108t2324r816b2379],
4	phosphoprotein	NN	O	phosphoprotein	nn	7	SENT_34	[p2l846t2324r1337b2392],
5	(	CD	NUMBER	(	num	7	SENT_34	[p2l1369t2324r1579b2392],
6	VASP	NN	ORGANIZATION	vasp	nn	7	SENT_34	[p2l1369t2324r1579b2392],
7	)	NN	O	)	dobj	3	SENT_34	[p2l1369t2324r1579b2392],
8	was	VBD	O	be	auxpass	9	SENT_34	[p2l1611t2340r1730b2379],
9	measured	VBN	O	measure	rcmod	7	SENT_34	[p2l1760t2324r2059b2379],
10	in	IN	O	in	_	0	SENT_34	[p2l2089t2325r2145b2378],
11	whole	JJ	O	whole	amod	12	SENT_34	[p2l7t2412r197b2467],
12	blood	NN	O	blood	prep_in	9	SENT_34	[p2l215t2412r386b2467],
13	using	VBG	O	use	xcomp	9	SENT_34	[p2l406t2413r570b2481],
14	a	DT	O	a	det	19	SENT_34	[p2l588t2428r619b2467],
15	commercial	JJ	O	commercial	amod	19	SENT_34	[p2l638t2412r997b2467],
16	kit	NN	O	kit	nn	19	SENT_34	[p2l1016t2412r1095b2467],
17	(	CD	NUMBER	(	num	19	SENT_34	[p2l1117t2412r1373b2480],
18	Platelet	NN	O	platelet	nn	19	SENT_34	[p2l1117t2412r1373b2480],
19	VASP	NN	ORGANIZATION	vasp	dobj	13	SENT_34	[p2l1387t2415r1567b2476],
20	;	:	O	;	_	0	SENT_34	[p2l1387t2415r1567b2476],
21	Diagnostica	NNP	PERSON	Diagnostica	nn	22	SENT_34	[p2l1591t2413r1946b2481],
22	Stago	NNP	PERSON	Stago	dep	37	SENT_34	[p2l1965t2415r2144b2481],
23	,	,	O	,	_	0	SENT_34	[p2l1965t2415r2144b2481],
24	Biocytex	NNP	PERSON	Biocytex	conj_and	22	SENT_34	[p2l9t2502r283b2570],
25	,	,	O	,	_	0	SENT_34	[p2l9t2502r283b2570],
26	Asniéres	NNP	PERSON	Asniéres	conj_and	22	SENT_34	[p2l316t2500r592b2565],
27	,	,	O	,	_	0	SENT_34	[p2l316t2500r592b2565],
28	France	NNP	LOCATION	France	nn	29	SENT_34	[p2l627t2501r853b2570],
29	)	NNP	O	)	dep	37	SENT_34	[p2l627t2501r853b2570],
30	and	CC	O	and	_	0	SENT_34	[p2l891t2501r1002b2556],
31	a	DT	O	a	det	33	SENT_34	[p2l1037t2517r1068b2556],
32	FACScan	NN	MISC	facscan	nn	33	SENT_34	[p2l1102t2504r1359b2556],
33	ﬂow	NN	O	ﬂow	conj_and	22	SENT_34	[p2l1394t2501r1528b2556],
34	cytometer	NN	O	cytometer	dep	37	SENT_34	[p2l1562t2509r1876b2570],
35	(	CD	NUMBER	(	num	34	SENT_34	[p2l1912t2501r2146b2570],
36	Becton	NNP	PERSON	Becton	nn	37	SENT_34	[p2l1912t2501r2146b2570],
37	Dickinson	NNP	PERSON	Dickinson	dep	45	SENT_34	[p2l9t2591r326b2654],
38	,	,	O	,	_	0	SENT_34	[p2l9t2591r326b2654],
39	Le	NNP	PERSON	Le	nn	42	SENT_34	[p2l347t2594r409b2646],
40	Pont	NNP	PERSON	Pont	nn	42	SENT_34	[p2l429t2594r569b2646],
41	de	IN	PERSON	de	amod	42	SENT_34	[p2l586t2591r656b2646],
42	Claix	NNP	PERSON	Claix	appos	37	SENT_34	[p2l677t2591r838b2654],
43	,	,	O	,	_	0	SENT_34	[p2l677t2591r838b2654],
44	France	NNP	LOCATION	France	appos	37	SENT_34	[p2l859t2591r1103b2659],
45	)	CD	NUMBER	)	dep	3	SENT_34	[p2l859t2591r1103b2659],
46	.	.	O	.	_	0	SENT_34	[p2l859t2591r1103b2659],

1	The	DT	O	the	det	2	SENT_35	[p2l1120t2591r1232b2646],
2	results	NNS	O	result	nsubjpass	4	SENT_35	[p2l1252t2591r1453b2646],
3	were	VBD	O	be	auxpass	4	SENT_35	[p2l1471t2606r1625b2646],
4	expressed	VBN	O	express	_	0	SENT_35	[p2l1644t2591r1950b2659],
5	as	IN	O	as	_	0	SENT_35	[p2l1969t2606r2028b2646],
6	the	DT	O	the	det	9	SENT_35	[p2l2048t2591r2145b2646],
7	platelet	NN	O	platelet	nn	9	SENT_35	[p2l9t2679r241b2748],
8	reactivity	NN	O	reactivity	nn	9	SENT_35	[p2l269t2680r557b2748],
9	index	NN	O	index	prep_as	4	SENT_35	[p2l584t2679r755b2734],
10	(	CD	NUMBER	(	num	11	SENT_35	[p2l787t2679r923b2748],
11	PR1	NN	O	pr1	tmod	4	SENT_35	[p2l787t2679r923b2748],
12	,	,	O	,	_	0	SENT_35	[p2l787t2679r923b2748],
13	%	NN	O	%	appos	11	SENT_35	[p2l952t2680r1015b2748],
14	)	CD	NUMBER	)	num	13	SENT_35	[p2l952t2680r1015b2748],
15	calculated	VBN	O	calculate	partmod	13	SENT_35	[p2l1049t2679r1357b2734],
16	as	IN	O	as	mark	17	SENT_35	[p2l1386t2695r1445b2734],
17	recommended	VBN	O	recommend	advcl	15	SENT_35	[p2l1475t2679r1919b2734],
18	by	IN	O	by	_	0	SENT_35	[p2l1948t2679r2021b2748],
19	the	DT	O	the	det	20	SENT_35	[p2l2048t2679r2145b2734],
20	manufacturer	NN	O	manufacturer	prep_by	17	SENT_35	[p2l9t2769r440b2824],
21	.	.	O	.	_	0	SENT_35	[p2l9t2769r440b2824],

1	According	VBG	O	accord	_	0	SENT_36	[p2l458t2769r770b2837],
2	to	TO	O	to	prepc_according_to	12	SENT_36	[p2l787t2777r845b2824],
3	previous	JJ	O	previous	amod	4	SENT_36	[p2l866t2770r1128b2837],
4	results	NNS	O	result	pobj	12	SENT_36	[p2l1149t2769r1366b2832],
5	,	,	O	,	_	0	SENT_36	[p2l1149t2769r1366b2832],
6	PR1	NN	O	pr1	nn	7	SENT_36	[p2l1386t2772r1481b2823],
7	values	NNS	O	value	nsubjpass	12	SENT_36	[p2l1499t2769r1693b2824],
8	below	IN	O	below	_	0	SENT_36	[p2l1712t2769r1900b2824],
9	60	CD	PERCENT	60	num	10	SENT_36	[p2l1918t2772r2033b2824],
10	%	NN	PERCENT	%	prep_below	7	SENT_36	[p2l1918t2772r2033b2824],
11	are	VBP	O	be	auxpass	12	SENT_36	[p2l2052t2785r2145b2824],
12	expected	VBN	O	expect	_	0	SENT_36	[p2l9t2858r285b2926],
13	in	IN	O	in	_	0	SENT_36	[p2l310t2859r366b2912],
14	good	JJ	O	good	amod	16	SENT_36	[p2l389t2858r538b2926],
15	clopidogrel	NN	O	clopidogrel	nn	16	SENT_36	[p2l565t2858r907b2926],
16	responders	NNS	O	responder	prep_in	12	SENT_36	[p2l932t2858r1271b2926],
17	[	VBP	O	[	rcmod	16	SENT_36	[p2l1300t2858r1433b2926],
18	10	CD	NUMBER	10	number	19	SENT_36	[p2l1300t2858r1433b2926],
19	]	CD	NUMBER	]	dobj	17	SENT_36	[p2l1300t2858r1433b2926],
20	.	.	O	.	_	0	SENT_36	[p2l1300t2858r1433b2926],

1	1.1.1	CD	NUMBER	1.1.1	_	0	SENT_37	[p2l15t3080r159b3133],
2	.	.	O	.	_	0	SENT_37	[p2l15t3080r159b3133],

1	Genotyping	VBG	O	genotype	_	0	SENT_38	[p2l189t3078r528b3146],

1	Blood	NN	O	blood	nn	2	SENT_39	[p2l111t3167r283b3222],
2	samples	NNS	O	sample	nsubjpass	4	SENT_39	[p2l333t3167r581b3235],
3	were	VBD	O	be	auxpass	4	SENT_39	[p2l629t3182r784b3222],
4	taken	VBN	O	take	_	0	SENT_39	[p2l832t3167r1003b3222],
5	after	IN	O	after	_	0	SENT_39	[p2l1051t3166r1195b3222],
6	obtaining	VBG	O	obtain	prepc_after	4	SENT_39	[p2l1241t3167r1536b3235],
7	written	VBN	O	write	amod	9	SENT_39	[p2l1581t3167r1811b3222],
8	informed	VBN	O	inform	amod	9	SENT_39	[p2l1861t3166r2144b3222],
9	consent	NN	O	consent	dobj	6	SENT_39	[p2l9t3264r248b3311],
10	from	IN	O	from	_	0	SENT_39	[p2l273t3255r419b3311],
11	each	DT	O	each	det	12	SENT_39	[p2l444t3256r582b3311],
12	patient	NN	O	patient	prep_from	6	SENT_39	[p2l609t3256r839b3324],
13	.	.	O	.	_	0	SENT_39	[p2l609t3256r839b3324],

1	Genomic	JJ	O	genomic	amod	2	SENT_40	[p2l867t3256r1139b3311],
2	DNA	NN	O	dna	nsubjpass	4	SENT_40	[p2l1164t3258r1304b3310],
3	was	VBD	O	be	auxpass	4	SENT_40	[p2l1326t3271r1445b3311],
4	extracted	VBN	O	extract	_	0	SENT_40	[p2l1472t3256r1759b3311],
5	from	IN	O	from	_	0	SENT_40	[p2l1786t3255r1932b3311],
6	whole	JJ	O	whole	amod	7	SENT_40	[p2l1956t3256r2145b3311],
7	blood	NN	O	blood	prep_from	4	SENT_40	[p2l8t3344r181b3399],
8	using	VBG	O	use	partmod	7	SENT_40	[p2l230t3345r397b3413],
9	the	DT	O	the	det	12	SENT_40	[p2l444t3344r541b3399],
10	QiAamp	NNP	O	QiAamp	nn	12	SENT_40	[p2l591t3345r837b3413],
11	Mini	NNP	MISC	Mini	nn	12	SENT_40	[p2l887t3345r1027b3398],
12	Kit	NN	MISC	kit	dobj	8	SENT_40	[p2l1076t3345r1162b3399],
13	(	CD	NUMBER	(	num	12	SENT_40	[p2l1214t3344r1469b3413],
14	Qiagen	NNP	ORGANIZATION	Qiagen	nn	20	SENT_40	[p2l1214t3344r1469b3413],
15	,	,	O	,	_	0	SENT_40	[p2l1214t3344r1469b3413],
16	Valencia	NNP	LOCATION	Valencia	appos	20	SENT_40	[p2l1516t3344r1795b3407],
17	,	,	O	,	_	0	SENT_40	[p2l1516t3344r1795b3407],
18	CA	NNP	LOCATION	CA	appos	20	SENT_40	[p2l1845t3347r1940b3408],
19	,	,	O	,	_	0	SENT_40	[p2l1845t3347r1940b3408],
20	USA	NNP	LOCATION	USA	dep	12	SENT_40	[p2l1990t3344r2140b3412],
21	)	CD	NUMBER	)	num	20	SENT_40	[p2l1990t3344r2140b3412],
22	according	VBG	O	accord	_	0	SENT_40	[p2l9t3433r307b3502],
23	to	TO	O	to	prepc_according_to	8	SENT_40	[p2l330t3441r389b3488],
24	the	DT	O	the	det	25	SENT_40	[p2l413t3433r511b3488],
25	manufacturer	NN	O	manufacturer	poss	27	SENT_40	[p2l536t3433r997b3488],
26	's	POS	O	's	_	0	SENT_40	[p2l536t3433r997b3488],
27	instructions	NNS	O	instruction	pobj	8	SENT_40	[p2l1023t3434r1400b3489],
28	.	.	O	.	_	0	SENT_40	[p2l1023t3434r1400b3489],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_41	[p2l111t3522r434b3577],
2	*	NN	O	*	nsubjpass	14	SENT_41	[p2l111t3522r434b3577],
3	2	CD	NUMBER	2	number	4	SENT_41	[p2l111t3522r434b3577],
4	(	CD	NUMBER	(	num	6	SENT_41	[p2l476t3522r852b3591],
5	rs4244285	NN	O	rs4244285	nn	6	SENT_41	[p2l476t3522r852b3591],
6	)	NN	O	)	dep	2	SENT_41	[p2l476t3522r852b3591],
7	and	CC	O	and	_	0	SENT_41	[p2l893t3522r1004b3577],
8	P2Y12	NN	O	p2y12	nn	9	SENT_41	[p2l1040t3525r1206b3588],
9	H2	NN	O	h2	dep	2	SENT_41	[p2l1240t3525r1323b3577],
10	(	CD	NUMBER	(	num	12	SENT_41	[p2l1365t3523r1741b3591],
11	rs2046934	NN	O	rs2046934	nn	12	SENT_41	[p2l1365t3523r1741b3591],
12	)	NN	O	)	dep	2	SENT_41	[p2l1365t3523r1741b3591],
13	were	VBD	O	be	auxpass	14	SENT_41	[p2l1780t3538r1934b3577],
14	genotyped	VBN	O	genotype	_	0	SENT_41	[p2l1970t3538r2145b3591, p2l8t3611r181b3680],
15	by	IN	O	by	_	0	SENT_41	[p2l214t3611r288b3680],
16	allelic	JJ	O	allelic	amod	17	SENT_41	[p2l319t3611r496b3666],
17	discrimination	NN	O	discrimination	agent	14	SENT_41	[p2l528t3611r974b3666],
18	using	VBG	O	use	xcomp	14	SENT_41	[p2l1007t3612r1171b3680],
19	TaqMan	NNP	O	TaqMan	nn	22	SENT_41	[p2l1200t3615r1449b3680],
20	Validated	NNP	O	Validated	nn	22	SENT_41	[p2l1478t3611r1770b3666],
21	SNP	NN	O	snp	nn	22	SENT_41	[p2l1804t3614r1923b3666],
22	assays	NNS	O	assay	dobj	18	SENT_41	[p2l1954t3627r2145b3680],
23	with	IN	O	with	_	0	SENT_41	[p3l7t17r148b72],
24	the	DT	O	the	det	27	SENT_41	[p3l182t17r279b72],
25	790OHT	NN	O	790oht	nn	27	SENT_41	[p3l315t20r555b72],
26	sequence	NN	O	sequence	nn	27	SENT_41	[p3l587t33r870b85],
27	Detection	NN	O	detection	prep_with	18	SENT_41	[p3l905t18r1199b72],
28	System	NNP	O	System	nn	31	SENT_41	[p3l1234t20r1454b85],
29	(	NNP	O	(	nn	31	SENT_41	[p3l1492t17r1753b85],
30	Applied	NNP	O	Applied	nn	31	SENT_41	[p3l1492t17r1753b85],
31	Biosystems	NNP	O	Biosystems	tmod	18	SENT_41	[p3l1788t18r2145b85],
32	,	,	O	,	_	0	SENT_41	[p3l1788t18r2145b85],
33	Courtaboeuf	NNP	PERSON	Courtaboeuf	nn	35	SENT_41	[p3l9t105r399b169],
34	,	,	O	,	_	0	SENT_41	[p3l9t105r399b169],
35	France	NNP	LOCATION	France	appos	31	SENT_41	[p3l425t106r669b174],
36	)	CD	NUMBER	)	num	35	SENT_41	[p3l425t106r669b174],
37	.	.	O	.	_	0	SENT_41	[p3l425t106r669b174],

1	1.2	CD	NUMBER	1.2	_	0	SENT_42	[p3l15t328r106b381],
2	.	.	O	.	_	0	SENT_42	[p3l15t328r106b381],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_43	[p3l137t325r468b394],
2	response	NN	O	response	dep	1	SENT_43	[p3l494t341r749b394],
3	in	IN	O	in	_	0	SENT_43	[p3l775t326r828b380],
4	the	DT	O	the	det	6	SENT_43	[p3l858t325r946b380],
5	two	CD	NUMBER	two	num	6	SENT_43	[p3l974t333r1081b380],
6	patients	NNS	O	patient	prep_in	2	SENT_43	[p3l1104t326r1344b394],
7	and	CC	O	and	_	0	SENT_43	[p3l1370t325r1479b380],
8	management	NN	O	management	prep_in	2	SENT_43	[p3l1505t333r1893b394],

1	1.2	CD	NUMBER	1.2	nsubj	3	SENT_44	[p3l15t506r159b558],
2	.	.	O	.	_	0	SENT_44	[p3l15t506r159b558],
3	]	SYM	O	]	_	0	SENT_44	[p3l15t506r159b558],

1	.	.	O	.	_	0	SENT_45	[p3l15t506r159b558],

1	Patient	NN	O	patient	_	0	SENT_46	[p3l186t505r397b558],
2	1	CD	NUMBER	1	num	1	SENT_46	[p3l426t506r445b557],

1	Patient	NN	O	patient	nsubj	6	SENT_47	[p3l111t593r327b647],
2	1	CD	NUMBER	1	num	1	SENT_47	[p3l350t595r373b646],
3	was	VBD	O	be	cop	6	SENT_47	[p3l402t608r521b647],
4	a	DT	O	a	det	6	SENT_47	[p3l544t608r575b647],
5	58	CD	DURATION	58	num	6	SENT_47	[p3l597t595r668b647],
6	year	NN	NUMBER	year	_	0	SENT_47	[p3l689t592r946b660],
7	—	CD	NUMBER	—	num	9	SENT_47	[p3l689t592r946b660],
8	old	JJ	O	old	amod	9	SENT_47	[p3l689t592r946b660],
9	man	NN	O	man	nsubj	10	SENT_47	[p3l970t608r1103b647],
10	admitted	VBN	O	admit	rcmod	6	SENT_47	[p3l1124t592r1402b647],
11	in	IN	O	in	_	0	SENT_47	[p3l1425t593r1481b646],
12	our	PRP$	O	we	poss	13	SENT_47	[p3l1503t608r1607b647],
13	institution	NN	O	institution	prep_in	10	SENT_47	[p3l1628t593r1946b647],
14	for	IN	O	for	_	0	SENT_47	[p3l1969t592r2054b647],
15	an	DT	O	a	det	24	SENT_47	[p3l2074t608r2146b647],
16	inferior	JJ	O	inferior	amod	24	SENT_47	[p3l9t681r237b736],
17	STEMI	NN	O	stemus	dep	16	SENT_47	[p3l265t684r453b736],
18	(	CD	NUMBER	(	num	17	SENT_47	[p3l487t681r584b749],
19	ST	JJ	O	st	amod	24	SENT_47	[p3l487t681r584b749],
20	segment	NN	O	segment	nn	24	SENT_47	[p3l611t689r872b749],
21	elevation	NN	O	elevation	nn	24	SENT_47	[p3l899t681r1180b736],
22	myocardial	JJ	O	myocardial	amod	24	SENT_47	[p3l1209t681r1549b749],
23	infarction	NN	O	infarction	nn	24	SENT_47	[p3l1579t681r1899b749],
24	)	NN	O	)	prep_for	13	SENT_47	[p3l1579t681r1899b749],
25	related	JJ	O	related	amod	24	SENT_47	[p3l1933t681r2145b736],
26	to	TO	O	to	_	0	SENT_47	[p3l8t777r67b824],
27	de	FW	O	de	nn	29	SENT_47	[p3l113t769r184b824],
28	novo	FW	O	novo	nn	29	SENT_47	[p3l230t785r379b824],
29	occlusion	NN	O	occlusion	prep_to	25	SENT_47	[p3l424t769r710b824],
30	of	IN	O	of	_	0	SENT_47	[p3l755t769r819b824],
31	the	DT	O	the	det	34	SENT_47	[p3l856t769r953b824],
32	right	JJ	O	right	amod	34	SENT_47	[p3l999t769r1146b838],
33	coronary	JJ	O	coronary	amod	34	SENT_47	[p3l1189t785r1462b838],
34	artery	NN	O	artery	prep_of	29	SENT_47	[p3l1505t777r1703b838],
35	,	,	O	,	_	0	SENT_47	[p3l1505t777r1703b838],
36	despite	IN	O	despite	_	0	SENT_47	[p3l1749t769r1969b838],
37	dual	JJ	O	dual	amod	41	SENT_47	[p3l2015t769r2145b824],
38	antiplatelet	JJ	O	antiplatelet	amod	41	SENT_47	[p3l9t858r361b927],
39	therapy	NN	O	therapy	nn	41	SENT_47	[p3l385t858r624b927],
40	(	NN	O	(	nn	41	SENT_47	[p3l653t858r887b927],
41	aspirin	NN	O	aspirin	prep_despite	25	SENT_47	[p3l653t858r887b927],
42	75	CD	NUMBER	75	num	43	SENT_47	[p3l915t862r985b913],
43	mg/day	NN	O	mg/day	dobj	10	SENT_47	[p3l1009t858r1241b927],
44	and	CC	O	and	_	0	SENT_47	[p3l1266t858r1377b913],
45	clopidogrel	NN	O	clopidogrel	nn	48	SENT_47	[p3l1405t858r1748b927],
46	75	CD	NUMBER	75	num	48	SENT_47	[p3l1776t862r1846b913],
47	mg/day	NN	O	mg/day	nn	48	SENT_47	[p3l1870t858r2145b927],
48	)	NN	O	)	conj_and	43	SENT_47	[p3l1870t858r2145b927],
49	.	.	O	.	_	0	SENT_47	[p3l1870t858r2145b927],

1	The	DT	O	the	det	2	SENT_48	[p3l6t948r118b1003],
2	lesion	NN	O	lesion	nsubjpass	5	SENT_48	[p3l151t948r330b1003],
3	was	VBD	O	be	auxpass	5	SENT_48	[p3l360t963r479b1003],
4	successfully	RB	O	successfully	advmod	5	SENT_48	[p3l512t947r876b1016],
5	treated	VBN	O	treat	_	0	SENT_48	[p3l905t948r1124b1003],
6	by	IN	O	by	_	0	SENT_48	[p3l1155t948r1229b1016],
7	primary	JJ	O	primary	amod	8	SENT_48	[p3l1260t948r1506b1016],
8	angioplasty	NN	O	angioplasty	agent	5	SENT_48	[p3l1536t948r1890b1016],
9	using	VBG	O	use	xcomp	5	SENT_48	[p3l1920t949r2085b1016],
10	a	DT	O	a	det	12	SENT_48	[p3l2115t963r2146b1003],
11	drug	NN	O	drug	nn	12	SENT_48	[p3l9t1036r395b1105],
12	—	NN	O	—	dobj	9	SENT_48	[p3l9t1036r395b1105],
13	eluting	VBG	O	elute	xcomp	9	SENT_48	[p3l9t1036r395b1105],
14	stent	NN	O	stent	dobj	13	SENT_48	[p3l426t1045r591b1092],
15	.	.	O	.	_	0	SENT_48	[p3l426t1045r591b1092],

1	Interestingly	RB	O	interestingly	advmod	14	SENT_49	[p3l624t1036r1026b1105],
2	,	,	O	,	_	0	SENT_49	[p3l624t1036r1026b1105],
3	this	DT	O	this	det	4	SENT_49	[p3l1059t1036r1170b1091],
4	patient	NN	O	patient	nsubj	14	SENT_49	[p3l1202t1037r1419b1105],
5	with	IN	O	with	_	0	SENT_49	[p3l1448t1037r1589b1091],
6	a	DT	O	a	det	8	SENT_49	[p3l1620t1052r1651b1091],
7	long	JJ	O	long	amod	8	SENT_49	[p3l1682t1037r1814b1105],
8	history	NN	O	history	prep_with	4	SENT_49	[p3l1846t1036r2060b1105],
9	of	IN	O	of	_	0	SENT_49	[p3l2090t1036r2153b1091],
10	coronary	JJ	O	coronary	amod	13	SENT_49	[p3l9t1142r282b1194],
11	artery	NN	O	artery	nn	13	SENT_49	[p3l309t1134r493b1194],
12	disease	NN	O	disease	nn	13	SENT_49	[p3l521t1126r741b1181],
13	(	NN	O	(	prep_of	8	SENT_49	[p3l774t1126r1111b1194],
14	diagnosed	VBD	O	diagnose	_	0	SENT_49	[p3l774t1126r1111b1194],
15	more	JJR	DATE	more	mwe	16	SENT_49	[p3l1142t1142r1300b1181],
16	than	IN	DATE	than	quantmod	17	SENT_49	[p3l1329t1126r1467b1181],
17	10	CD	DATE	10	num	18	SENT_49	[p3l1499t1129r1569b1181],
18	years	NNS	DATE	year	npadvmod	19	SENT_49	[p3l1588t1142r1749b1194],
19	earlier	RBR	DATE	earlier	advmod	14	SENT_49	[p3l1779t1126r2000b1194],
20	)	RB	O	)	advmod	14	SENT_49	[p3l1779t1126r2000b1194],
21	and	CC	O	and	_	0	SENT_49	[p3l2033t1126r2144b1181],
22	revascularization	NN	O	revascularization	nsubj	28	SENT_49	[p3l9t1215r533b1270],
23	with	IN	O	with	_	0	SENT_49	[p3l572t1215r713b1270],
24	multiple	JJ	O	multiple	amod	26	SENT_49	[p3l753t1215r1010b1283],
25	angioplasty	NN	O	angioplasty	nn	26	SENT_49	[p3l1051t1215r1404b1283],
26	procedures	NNS	O	procedure	prep_with	22	SENT_49	[p3l1443t1215r1799b1283],
27	,	,	O	,	_	0	SENT_49	[p3l1443t1215r1799b1283],
28	had	VBD	O	have	conj_and	14	SENT_49	[p3l1841t1215r1951b1270],
29	eight	CD	DATE	eight	num	30	SENT_49	[p3l1992t1215r2147b1283],
30	months	NNS	DATE	month	npadvmod	31	SENT_49	[p3l9t1303r241b1358],
31	earlier	RBR	DATE	earlier	advmod	33	SENT_49	[p3l260t1303r457b1358],
32	an	DT	O	a	det	33	SENT_49	[p3l473t1319r544b1358],
33	angiogram	NN	O	angiogram	dobj	28	SENT_49	[p3l563t1304r890b1372],
34	showing	VBG	O	show	partmod	33	SENT_49	[p3l908t1303r1169b1372],
35	no	DT	O	no	det	37	SENT_49	[p3l1186t1319r1260b1358],
36	signiﬁcant	JJ	O	signiﬁcant	amod	37	SENT_49	[p3l1280t1303r1597b1372],
37	lesion	NN	O	lesion	dobj	34	SENT_49	[p3l1614t1303r1793b1358],
38	of	IN	O	of	_	0	SENT_49	[p3l1811t1303r1875b1358],
39	the	DT	O	the	det	42	SENT_49	[p3l1885t1303r1981b1358],
40	right	JJ	O	right	amod	42	SENT_49	[p3l2000t1303r2147b1372],
41	coronary	JJ	O	coronary	amod	42	SENT_49	[p3l9t1408r282b1461],
42	artery	NN	O	artery	prep_of	37	SENT_49	[p3l299t1400r496b1461],
43	,	,	O	,	_	0	SENT_49	[p3l299t1400r496b1461],
44	conﬁrming	VBG	O	conﬁrming	partmod	34	SENT_49	[p3l516t1392r853b1461],
45	that	IN	O	that	complm	56	SENT_49	[p3l871t1392r994b1447],
46	occlusion	NN	O	occlusion	nsubj	59	SENT_49	[p3l1011t1392r1298b1447],
47	of	IN	O	of	_	0	SENT_49	[p3l1317t1392r1380b1447],
48	the	DT	O	the	det	51	SENT_49	[p3l1391t1392r1488b1447],
49	right	JJ	O	right	amod	51	SENT_49	[p3l1508t1392r1655b1461],
50	coronary	JJ	O	coronary	amod	51	SENT_49	[p3l1673t1408r1946b1461],
51	artery	NN	O	artery	prep_of	46	SENT_49	[p3l1963t1400r2148b1461],
52	was	VBD	O	be	cop	56	SENT_49	[p3l7t1497r126b1537],
53	an	DT	O	a	det	56	SENT_49	[p3l152t1497r223b1537],
54	acute	JJ	O	acute	amod	56	SENT_49	[p3l248t1490r410b1537],
55	thrombotic	JJ	O	thrombotic	amod	56	SENT_49	[p3l436t1482r780b1537],
56	event	NN	O	event	ccomp	44	SENT_49	[p3l804t1490r974b1537],
57	and	CC	O	and	_	0	SENT_49	[p3l998t1482r1109b1537],
58	not	RB	O	not	neg	59	SENT_49	[p3l1136t1490r1236b1537],
59	related	JJ	O	related	ccomp	44	SENT_49	[p3l1260t1482r1473b1537],
60	to	TO	O	to	_	0	SENT_49	[p3l1498t1490r1557b1537],
61	the	DT	O	the	det	62	SENT_49	[p3l1582t1482r1679b1537],
62	progression	NN	O	progression	prep_to	59	SENT_49	[p3l1705t1482r2064b1550],
63	of	IN	O	of	_	0	SENT_49	[p3l2090t1481r2153b1537],
64	the	DT	O	the	det	67	SENT_49	[p3l8t1570r105b1625],
65	coronary	JJ	O	coronary	amod	67	SENT_49	[p3l135t1586r408b1639],
66	artery	NN	O	artery	nn	67	SENT_49	[p3l435t1579r619b1639],
67	disease	NN	O	disease	prep_of	62	SENT_49	[p3l646t1571r881b1626],
68	.	.	O	.	_	0	SENT_49	[p3l646t1571r881b1626],

1	Therefore	RB	O	therefore	advmod	13	SENT_50	[p3l909t1570r1222b1634],
2	,	,	O	,	_	0	SENT_50	[p3l909t1570r1222b1634],
3	the	DT	O	the	det	4	SENT_50	[p3l1251t1570r1348b1625],
4	appearance	NN	O	appearance	nsubj	13	SENT_50	[p3l1377t1586r1729b1639],
5	of	IN	O	of	_	0	SENT_50	[p3l1758t1570r1822b1625],
6	this	DT	O	this	det	8	SENT_50	[p3l1843t1570r1953b1625],
7	acute	JJ	O	acute	amod	8	SENT_50	[p3l1983t1579r2145b1625],
8	event	NN	O	event	prep_of	4	SENT_50	[p3l9t1668r180b1715],
9	despite	IN	O	despite	_	0	SENT_50	[p3l227t1660r449b1728],
10	dual	JJ	O	dual	amod	12	SENT_50	[p3l498t1660r629b1715],
11	antiplatelet	JJ	O	antiplatelet	amod	12	SENT_50	[p3l677t1660r1033b1728],
12	therapy	NN	O	therapy	prep_despite	13	SENT_50	[p3l1078t1660r1319b1728],
13	suggested	VBD	O	suggest	_	0	SENT_50	[p3l1366t1660r1671b1728],
14	a	DT	O	a	det	16	SENT_50	[p3l1720t1676r1751b1715],
15	clopidogrel	NN	O	clopidogrel	nn	16	SENT_50	[p3l1799t1660r2145b1728],
16	resistance	NN	O	resistance	dobj	13	SENT_50	[p3l9t1733r328b1786],
17	.	.	O	.	_	0	SENT_50	[p3l9t1733r328b1786],

1	The	DT	O	the	det	5	SENT_51	[p3l108t1819r220b1874],
2	initial	JJ	O	initial	amod	5	SENT_51	[p3l258t1819r432b1874],
3	platelet	NN	O	platelet	nn	5	SENT_51	[p3l469t1819r701b1888],
4	function	NN	O	function	nn	5	SENT_51	[p3l736t1819r991b1874],
5	evaluation	NN	O	evaluation	nsubj	6	SENT_51	[p3l1027t1819r1348b1874],
6	showed	VBD	O	show	_	0	SENT_51	[p3l1385t1819r1622b1874],
7	an	DT	O	a	det	11	SENT_51	[p3l1659t1835r1731b1874],
8	ADP	NN	O	adp	nn	11	SENT_51	[p3l1765t1822r1895b1874],
9	10	CD	NUMBER	10	num	11	SENT_51	[p3l1934t1822r2004b1874],
10	Minduced	JJ	ORGANIZATION	minduced	amod	11	SENT_51	[p3l2024t1823r2145b1890, p3l9t1908r253b1963],
11	MPA	NN	ORGANIZATION	mpa	dobj	6	SENT_51	[p3l285t1910r429b1962],
12	of	IN	O	of	_	0	SENT_51	[p3l458t1908r522b1963],
13	75	CD	PERCENT	75	num	14	SENT_51	[p3l548t1911r676b1971],
14	%	NN	PERCENT	%	prep_of	11	SENT_51	[p3l548t1911r676b1971],
15	,	,	O	,	_	0	SENT_51	[p3l548t1911r676b1971],
16	indicating	VBG	O	indicate	partmod	6	SENT_51	[p3l709t1908r1015b1977],
17	high	JJ	O	high	advmod	16	SENT_51	[p3l1046t1908r1180b1977],
18	on	IN	O	on	_	0	SENT_51	[p3l1212t1908r1661b1977],
19	—	CD	NUMBER	—	num	20	SENT_51	[p3l1212t1908r1661b1977],
20	clopidogrel	NN	O	clopidogrel	prep_on	17	SENT_51	[p3l1212t1908r1661b1977],
21	75	CD	NUMBER	75	num	24	SENT_51	[p3l1695t1911r1765b1963],
22	mg	NN	O	mg	nn	24	SENT_51	[p3l1789t1924r1884b1977],
23	platelet	NN	O	platelet	nn	24	SENT_51	[p3l1915t1908r2147b1977],
24	reactivity	NN	O	reactivity	dobj	16	SENT_51	[p3l9t1998r311b2066],
25	.	.	O	.	_	0	SENT_51	[p3l9t1998r311b2066],

1	Accordingly	RB	O	accordingly	advmod	7	SENT_52	[p3l337t1997r718b2066],
2	,	,	O	,	_	0	SENT_52	[p3l337t1997r718b2066],
3	the	DT	O	the	det	4	SENT_52	[p3l747t1998r844b2052],
4	PR1	NN	O	pr1	nsubj	7	SENT_52	[p3l873t2001r968b2052],
5	was	VBD	O	be	cop	7	SENT_52	[p3l996t2013r1115b2052],
6	76	CD	PERCENT	76	num	7	SENT_52	[p3l1145t2000r1274b2053],
7	%	NN	PERCENT	%	_	0	SENT_52	[p3l1145t2000r1274b2053],
8	.	.	O	.	_	0	SENT_52	[p3l1145t2000r1274b2053],

1	A	DT	O	a	det	3	SENT_53	[p3l1300t2000r1346b2052],
2	good	JJ	O	good	amod	3	SENT_53	[p3l1370t1997r1520b2066],
3	response	NN	O	response	nsubj	15	SENT_53	[p3l1550t2013r1822b2066],
4	to	TO	O	to	_	0	SENT_53	[p3l1849t2006r1908b2052],
5	aspirin	NN	O	aspirin	prep_to	3	SENT_53	[p3l1937t1998r2145b2066],
6	75	CD	NUMBER	75	num	7	SENT_53	[p3l10t2090r80b2141],
7	mg/day	NN	O	mg/day	nsubjpass	9	SENT_53	[p3l104t2086r337b2155],
8	was	VBD	O	be	auxpass	9	SENT_53	[p3l351t2102r470b2141],
9	observed	VBN	O	observe	rcmod	5	SENT_53	[p3l489t2086r765b2141],
10	with	IN	O	with	_	0	SENT_53	[p3l782t2086r923b2141],
11	an	DT	O	a	det	14	SENT_53	[p3l941t2102r1012b2141],
12	arachidonic	JJ	O	arachidonic	amod	14	SENT_53	[p3l1030t2086r1387b2141],
13	acid	NN	O	acid	nn	14	SENT_53	[p3l1404t2086r1801b2141],
14	—	NN	O	—	prep_with	9	SENT_53	[p3l1404t2086r1801b2141],
15	induced	VBD	O	induce	_	0	SENT_53	[p3l1404t2086r1801b2141],
16	MPA	NN	O	mpa	dobj	15	SENT_53	[p3l1821t2089r1964b2141],
17	of	IN	O	of	_	0	SENT_53	[p3l1980t2086r2044b2141],
18	4	CD	PERCENT	4	num	19	SENT_53	[p3l2051t2089r2144b2150],
19	%	NN	PERCENT	%	prep_of	16	SENT_53	[p3l2051t2089r2144b2150],
20	,	,	O	,	_	0	SENT_53	[p3l2051t2089r2144b2150],
21	supporting	VBG	O	support	partmod	15	SENT_53	[p3l10t2177r344b2244],
22	good	JJ	O	good	amod	24	SENT_53	[p3l366t2176r515b2244],
23	patient	NN	O	patient	nn	24	SENT_53	[p3l541t2177r759b2244],
24	adherence	NN	O	adherence	dobj	21	SENT_53	[p3l781t2176r1099b2231],
25	to	TO	O	to	_	0	SENT_53	[p3l1123t2184r1182b2231],
26	the	DT	O	the	det	28	SENT_53	[p3l1206t2176r1303b2231],
27	medication	NN	O	medication	nn	28	SENT_53	[p3l1329t2176r1672b2231],
28	regimen	NN	O	regimen	prep_to	21	SENT_53	[p3l1696t2177r1964b2244],
29	.	.	O	.	_	0	SENT_53	[p3l1696t2177r1964b2244],

1	The	DT	O	the	det	3	SENT_54	[p3l108t2265r220b2320],
2	clopidogrel	NN	O	clopidogrel	nn	3	SENT_54	[p3l253t2265r596b2333],
3	dosage	NN	O	dosage	nsubjpass	5	SENT_54	[p3l630t2265r840b2333],
4	was	VBD	O	be	auxpass	5	SENT_54	[p3l872t2281r991b2320],
5	doubled	VBN	O	double	_	0	SENT_54	[p3l1025t2265r1273b2320],
6	and	CC	O	and	_	0	SENT_54	[p3l1307t2265r1418b2320],
7	1	CD	DATE	1	num	8	SENT_54	[p3l1455t2268r1478b2319],
8	week	NN	DATE	week	npadvmod	9	SENT_54	[p3l1506t2265r1671b2320],
9	later	RB	DATE	later	advmod	5	SENT_54	[p3l1703t2265r1854b2328],
10	,	,	O	,	_	0	SENT_54	[p3l1703t2265r1854b2328],
11	the	DT	O	the	det	15	SENT_54	[p3l1888t2265r1985b2320],
12	ADP	NN	O	adp	nn	15	SENT_54	[p3l2017t2267r2147b2319],
13	10	CD	NUMBER	10	num	15	SENT_54	[p3l12t2356r82b2408],
14	uM	NN	O	um	nn	15	SENT_54	[p3l102t2353r471b2424],
15	—	NN	O	—	nsubj	16	SENT_54	[p3l102t2353r471b2424],
16	induced	VBD	O	induce	conj_and	5	SENT_54	[p3l102t2353r471b2424],
17	MPA	NNP	ORGANIZATION	MPA	nsubj	20	SENT_54	[p3l508t2356r651b2408],
18	was	VBD	O	be	cop	20	SENT_54	[p3l682t2369r801b2408],
19	54	CD	PERCENT	54	num	20	SENT_54	[p3l839t2356r953b2408],
20	%	NN	PERCENT	%	ccomp	16	SENT_54	[p3l839t2356r953b2408],
21	and	CC	O	and	_	0	SENT_54	[p3l987t2353r1099b2408],
22	the	DT	O	the	det	23	SENT_54	[p3l1135t2353r1231b2408],
23	PR1	NN	O	pr1	nsubj	26	SENT_54	[p3l1268t2357r1363b2408],
24	was	VBD	O	be	cop	26	SENT_54	[p3l1397t2369r1516b2408],
25	73	CD	PERCENT	73	num	26	SENT_54	[p3l1553t2356r1682b2409],
26	%	NN	PERCENT	%	conj_and	5	SENT_54	[p3l1553t2356r1682b2409],
27	.	.	O	.	_	0	SENT_54	[p3l1553t2356r1682b2409],

1	These	DT	O	these	det	3	SENT_55	[p3l1715t2353r1892b2408],
2	limited	JJ	O	limited	amod	3	SENT_55	[p3l1928t2353r2144b2408],
3	improvements	NNS	O	improvement	nsubj	4	SENT_55	[p3l9t2443r456b2511],
4	prompted	VBD	O	prompt	_	0	SENT_55	[p3l492t2443r795b2511],
5	a	DT	O	a	det	8	SENT_55	[p3l830t2458r861b2498],
6	further	JJ	O	further	amod	8	SENT_55	[p3l895t2442r1110b2498],
7	dosage	NN	O	dosage	nn	8	SENT_55	[p3l1143t2443r1353b2511],
8	increase	NN	O	increase	dobj	4	SENT_55	[p3l1388t2443r1638b2498],
9	to	TO	O	to	_	0	SENT_55	[p3l1672t2451r1731b2498],
10	225	CD	NUMBER	225	num	11	SENT_55	[p3l1766t2445r1876b2498],
11	mg/day	NN	O	mg/day	prep_to	4	SENT_55	[p3l1900t2443r2145b2511],
12	,	,	O	,	_	0	SENT_55	[p3l1900t2443r2145b2511],
13	which	WDT	O	which	nsubj	14	SENT_55	[p3l7t2531r196b2586],
14	failed	VBD	O	fail	rcmod	11	SENT_55	[p3l230t2531r396b2586],
15	to	TO	O	to	_	0	SENT_55	[p3l430t2540r489b2586],
16	further	JJ	O	further	amod	17	SENT_55	[p3l524t2531r739b2586],
17	increase	NN	O	increase	prep_to	14	SENT_55	[p3l771t2532r1021b2586],
18	the	DT	O	the	det	24	SENT_55	[p3l1055t2531r1151b2586],
19	response	NN	O	response	nn	24	SENT_55	[p3l1186t2547r1458b2600],
20	(	CD	NUMBER	(	num	24	SENT_55	[p3l1496t2532r1650b2600],
21	ADP	NN	O	adp	nn	24	SENT_55	[p3l1496t2532r1650b2600],
22	10	CD	NUMBER	10	num	24	SENT_55	[p3l1685t2534r1755b2586],
23	u1Vl	NN	O	u1vl	nn	24	SENT_55	[p3l1775t2531r2145b2602],
24	—	NN	O	—	nsubj	25	SENT_55	[p3l1775t2531r2145b2602],
25	induced	VBD	O	induce	ccomp	14	SENT_55	[p3l1775t2531r2145b2602],
26	MPA	NNP	ORGANIZATION	MPA	dobj	25	SENT_55	[p3l9t2623r165b2684],
27	,	,	O	,	_	0	SENT_55	[p3l9t2623r165b2684],
28	56	CD	PERCENT	56	num	29	SENT_55	[p3l191t2624r324b2684],
29	%	NN	PERCENT	%	appos	26	SENT_55	[p3l191t2624r324b2684],
30	;	:	O	;	_	0	SENT_55	[p3l191t2624r324b2684],
31	and	CC	O	and	_	0	SENT_55	[p3l353t2621r464b2676],
32	PR1	NN	O	pr1	dobj	25	SENT_55	[p3l490t2624r600b2684],
33	,	,	O	,	_	0	SENT_55	[p3l490t2624r600b2684],
34	67	CD	PERCENT	67	num	35	SENT_55	[p3l626t2621r766b2689],
35	%	NN	PERCENT	%	appos	32	SENT_55	[p3l626t2621r766b2689],
36	)	CD	NUMBER	)	number	37	SENT_55	[p3l626t2621r766b2689],
37	(	CD	NUMBER	(	num	38	SENT_55	[p3l799t2621r926b2689],
38	Fig	NN	O	fig	dep	35	SENT_55	[p3l799t2621r926b2689],
39	.	.	O	.	_	0	SENT_55	[p3l799t2621r926b2689],

1	1A	NN	O	1a	_	0	SENT_56	[p3l955t2621r1075b2689],
2	)	NN	O	)	dep	1	SENT_56	[p3l955t2621r1075b2689],
3	.	.	O	.	_	0	SENT_56	[p3l955t2621r1075b2689],

1	Genotyping	NN	O	genotyping	nsubj	2	SENT_57	[p3l111t2711r486b2778],
2	showed	VBD	O	show	_	0	SENT_57	[p3l537t2710r784b2765],
3	homozygosity	NN	O	homozygosity	nsubj	22	SENT_57	[p3l836t2710r1290b2778],
4	for	IN	O	for	prep	3	SENT_57	[p3l1339t2710r1428b2765],
5	the	DT	O	the	det	7	SENT_57	[p3l1477t2710r1578b2765],
6	loss	NN	O	loss	nn	7	SENT_57	[p3l1630t2710r2145b2765],
7	—	NN	O	—	dep	17	SENT_57	[p3l1630t2710r2145b2765],
8	of	IN	O	of	_	0	SENT_57	[p3l1630t2710r2145b2765],
9	—	CD	NUMBER	—	num	11	SENT_57	[p3l1630t2710r2145b2765],
10	function	NN	O	function	nn	11	SENT_57	[p3l1630t2710r2145b2765],
11	CYP2C19	NN	O	cyp2c19	prep_of	7	SENT_57	[p3l10t2798r332b2853],
12	*	NN	O	*	dep	17	SENT_57	[p3l10t2798r332b2853],
13	2	CD	NUMBER	2	num	12	SENT_57	[p3l10t2798r332b2853],
14	allele	NN	O	allele	nn	17	SENT_57	[p3l355t2798r516b2853],
15	(	CD	NUMBER	(	num	17	SENT_57	[p3l543t2798r1023b2866],
16	CYP2C19	NN	O	cyp2c19	nn	17	SENT_57	[p3l543t2798r1023b2866],
17	*	NN	O	*	dep	21	SENT_57	[p3l543t2798r1023b2866],
18	2	CD	NUMBER	2	dep	17	SENT_57	[p3l543t2798r1023b2866],
19	/	:	O	/	punct	21	SENT_57	[p3l543t2798r1023b2866],
20	*	CD	NUMBER	*	num	21	SENT_57	[p3l543t2798r1023b2866],
21	2	CD	NUMBER	2	dep	4	SENT_57	[p3l543t2798r1023b2866],
22	)	NN	O	)	xcomp	2	SENT_57	[p3l543t2798r1023b2866],
23	,	,	O	,	_	0	SENT_57	[p3l543t2798r1023b2866],
24	likely	JJ	O	likely	acomp	2	SENT_57	[p3l1048t2798r1214b2867],
25	to	TO	O	to	aux	26	SENT_57	[p3l1234t2806r1293b2853],
26	explain	VB	O	explain	xcomp	24	SENT_57	[p3l1316t2798r1540b2867],
27	a	DT	O	a	det	28	SENT_57	[p3l1562t2814r1593b2853],
28	failure	NN	O	failure	dobj	26	SENT_57	[p3l1616t2798r1810b2853],
29	to	TO	O	to	aux	30	SENT_57	[p3l1832t2806r1891b2853],
30	convert	VB	O	convert	infmod	28	SENT_57	[p3l1915t2806r2148b2853],
31	clopidogrel	NN	O	clopidogrel	dobj	30	SENT_57	[p3l9t2887r351b2956],
32	to	TO	O	to	_	0	SENT_57	[p3l391t2895r449b2942],
33	its	PRP$	O	its	poss	35	SENT_57	[p3l490t2888r558b2942],
34	active	JJ	O	active	amod	35	SENT_57	[p3l597t2888r776b2942],
35	metabolite	NN	O	metabolite	prep_to	30	SENT_57	[p3l816t2887r1159b2943],
36	.	.	O	.	_	0	SENT_57	[p3l816t2887r1159b2943],

1	Therefore	RB	O	therefore	advmod	9	SENT_58	[p3l1197t2887r1510b2951],
2	,	,	O	,	_	0	SENT_58	[p3l1197t2887r1510b2951],
3	further	JJ	O	further	amod	6	SENT_58	[p3l1550t2887r1765b2942],
4	clopidogrel	NN	O	clopidogrel	nn	6	SENT_58	[p3l1803t2887r2145b2956],
5	dosage	NN	O	dosage	nn	6	SENT_58	[p3l9t2977r219b3045],
6	increases	NNS	O	increase	nsubjpass	9	SENT_58	[p3l252t2977r532b3032],
7	were	VBD	O	be	auxpass	9	SENT_58	[p3l564t2992r717b3032],
8	not	RB	O	not	neg	9	SENT_58	[p3l751t2985r851b3032],
9	expected	VBN	O	expect	_	0	SENT_58	[p3l883t2977r1158b3045],
10	to	TO	O	to	aux	11	SENT_58	[p3l1191t2985r1250b3032],
11	improve	VB	O	improve	xcomp	9	SENT_58	[p3l1283t2977r1538b3045],
12	the	DT	O	the	det	13	SENT_58	[p3l1571t2977r1668b3032],
13	response	NN	O	response	dobj	11	SENT_58	[p3l1701t2992r1988b3045],
14	.	.	O	.	_	0	SENT_58	[p3l1701t2992r1988b3045],

1	This	DT	O	this	det	2	SENT_59	[p3l2019t2977r2145b3032],
2	patient	NN	O	patient	nsubj	3	SENT_59	[p3l9t3066r227b3134],
3	had	VBD	O	have	_	0	SENT_59	[p3l244t3065r354b3120],
4	no	DT	O	no	det	7	SENT_59	[p3l374t3081r448b3120],
5	clinical	JJ	O	clinical	amod	7	SENT_59	[p3l467t3065r680b3120],
6	risk	NN	O	risk	nn	7	SENT_59	[p3l700t3065r811b3120],
7	factors	NNS	O	factor	dobj	3	SENT_59	[p3l829t3065r1031b3120],
8	known	VBN	O	know	partmod	7	SENT_59	[p3l1051t3065r1262b3120],
9	to	TO	O	to	aux	11	SENT_59	[p3l1279t3074r1338b3120],
10	be	VB	O	be	auxpass	11	SENT_59	[p3l1357t3065r1427b3120],
11	involved	VBN	O	involve	xcomp	8	SENT_59	[p3l1446t3065r1708b3120],
12	in	IN	O	in	_	0	SENT_59	[p3l1728t3066r1784b3120],
13	clopidogrel	NN	O	clopidogrel	prep_in	11	SENT_59	[p3l1803t3065r2145b3134],

1	Letter	NN	O	letter	_	0	SENT_60	[p4l781t45r848b66],
2	to	TO	O	to	_	0	SENT_60	[p4l857t47r878b66],
3	the	DT	O	the	det	4	SENT_60	[p4l889t44r924b66],
4	Editor5	NN	O	editor5	prep_to	1	SENT_60	[p4l934t44r1121b71],
5	.	.	O	.	_	0	SENT_60	[p4l934t44r1121b71],

1	—	NN	O	—	_	0	SENT_61	[p4l934t44r1121b71],
2	.	.	O	.	_	0	SENT_61	[p4l934t44r1121b71],

1	in	IN	O	in	_	0	SENT_62	[p4l934t44r1121b71],
2	.	.	O	.	_	0	SENT_62	[p4l934t44r1121b71],

1	—	NN	O	—	_	0	SENT_63	[p4l934t44r1121b71],
2	.	.	O	.	_	0	SENT_63	[p4l934t44r1121b71],

1	Chief	NNP	O	Chief	_	0	SENT_64	[p4l934t44r1121b71],
2	93	CD	NUMBER	93	dep	1	SENT_64	[p4l2000t45r2028b66],

1	%	NN	O	%	nn	2	SENT_65	[p4l961t328r1004b331],
2	G	NN	O	g	_	0	SENT_65	[p4l961t328r1004b331],
3	*	CD	NUMBER	*	num	5	SENT_65	[p4l961t328r1004b331],
4	ADP	NN	O	adp	nn	5	SENT_65	[p4l1402t338r1452b358],
5	mm	NN	O	mm	dep	2	SENT_65	[p4l1461t338r1521b363],
6	us	PRP	O	we	dep	5	SENT_65	[p4l1618t352r1683b372],
7	?	.	O	?	_	0	SENT_65	[p4l1618t352r1683b372],

1	MPAC	NNP	ORGANIZATION	MPAC	nsubj	2	SENT_66	[p4l1347t403r1445b427],
2	‘	VBD	O	‘	_	0	SENT_66	[p4l1347t403r1445b427],
3	/	:	O	/	punct	6	SENT_66	[p4l1347t403r1445b427],
4	o	NN	O	o	nn	6	SENT_66	[p4l1347t403r1445b427],
5	)	CD	NUMBER	)	num	6	SENT_66	[p4l1347t403r1445b427],
6	RPA	NN	ORGANIZATION	rpa	parataxis	2	SENT_66	[p4l1482t403r1575b427],
7	(	CD	PERCENT	(	num	8	SENT_66	[p4l1482t403r1575b427],
8	%	NN	PERCENT	%	dep	6	SENT_66	[p4l1482t403r1575b427],
9	)	CD	NUMBER	)	num	10	SENT_66	[p4l1482t403r1575b427],
10	Pm	NN	O	pm	dep	6	SENT_66	[p4l1612t389r1689b412],
11	“	CD	NUMBER	“	number	12	SENT_66	[p4l1612t389r1689b412],
12	)	CD	NUMBER	)	num	13	SENT_66	[p4l1612t389r1689b412],
13	E	NN	O	e	dep	10	SENT_66	[p4l1027t445r1708b506],
14	i	FW	O	i	npadvmod	15	SENT_66	[p4l945t523r947b526],
15	If	IN	O	if	dep	6	SENT_66	[p4l1027t510r1708b571],
16	‘	CD	NUMBER	‘	pobj	15	SENT_66	[p4l1006t587r1010b589],
17	HERE	RB	O	here	advmod	18	SENT_66	[p4l1027t574r1708b634],
18	“	CD	NUMBER	“	rcmod	16	SENT_66	[p4l884t643r897b651],
19	El	NNP	O	El	dep	18	SENT_66	[p4l1027t637r1708b696],
20	511	CD	NUMBER	511	num	19	SENT_66	[p4l1027t700r1708b761],

1	mp	NN	O	mp	_	0	SENT_67	[p4l1566t1193r1629b1212],

1	Treatment	NN	O	treatment	_	0	SENT_68	[p4l1106t1210r1208b1230],

1	.	.	O	.	_	0	SENT_69	[p4l953t1258r962b1266],

1	—	NN	O	—	nn	2	SENT_70	[p4l989t1257r1000b1259],
2	M1	NN	O	m1	dep	9	SENT_70	[p4l1305t1243r1400b1266],
3	>	JJR	O	>	dep	2	SENT_70	[p4l1305t1243r1400b1266],
4	A	DT	O	a	det	6	SENT_70	[p4l1305t1243r1400b1266],
5	(	CD	PERCENT	(	num	6	SENT_70	[p4l1305t1243r1400b1266],
6	%	NN	PERCENT	%	dep	3	SENT_70	[p4l1305t1243r1400b1266],
7	)	CD	NUMBER	)	num	8	SENT_70	[p4l1305t1243r1400b1266],
8	R1	NN	O	r1	dep	9	SENT_70	[p4l1435t1243r1526b1266],
9	>	JJR	O	>	dep	14	SENT_70	[p4l1435t1243r1526b1266],
10	A	DT	O	a	det	12	SENT_70	[p4l1435t1243r1526b1266],
11	(	CD	PERCENT	(	num	12	SENT_70	[p4l1435t1243r1526b1266],
12	%	NN	PERCENT	%	dep	9	SENT_70	[p4l1435t1243r1526b1266],
13	)	CD	NUMBER	)	num	14	SENT_70	[p4l1435t1243r1526b1266],
14	PW	NN	O	pw	dep	17	SENT_70	[p4l1560t1229r1635b1252],
15	’	NN	O	’	dep	14	SENT_70	[p4l1560t1229r1635b1252],
16	'	''	O	'	_	0	SENT_70	[p4l974t1280r987b1298],
17	1	CD	NUMBER	1	_	0	SENT_70	[p4l974t1280r987b1298],

1	I	PRP	O	I	nn	10	SENT_71	[p4l1027t1353r1061b1415],
2	:	:	O	:	_	0	SENT_71	[p4l1027t1353r1061b1415],
3	-	:	O	-	_	0	SENT_71	[p4l1079t1375r1273b1398],
4	G	NN	O	g	nsubj	9	SENT_71	[p4l1079t1375r1273b1398],
5	*	CD	NUMBER	*	num	6	SENT_71	[p4l1079t1375r1273b1398],
6	nun	NN	O	nun	dep	4	SENT_71	[p4l1292t1353r1653b1415],
7	s	VBZ	O	s	cop	9	SENT_71	[p4l1001t1444r1007b1446],
8	a	DT	O	a	det	9	SENT_71	[p4l1027t1418r1061b1480],
9	ma	NN	O	ma	dep	10	SENT_71	[p4l1079t1440r1273b1463],
10	nun	NN	O	nun	_	0	SENT_71	[p4l1292t1418r1653b1480],

1	Fig	NN	O	fig	_	0	SENT_72	[p4l131t1689r174b1716],
2	.	.	O	.	_	0	SENT_72	[p4l131t1689r174b1716],

1	1	LS	NUMBER	1	_	0	SENT_73	[p4l184t1690r204b1711],
2	.	.	O	.	_	0	SENT_73	[p4l184t1690r204b1711],

1	Effects	NNS	O	effect	_	0	SENT_74	[p4l214t1689r291b1711],
2	of	IN	O	of	_	0	SENT_74	[p4l301t1689r326b1711],
3	different	JJ	O	different	amod	4	SENT_74	[p4l333t1689r437b1711],
4	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_74	[p4l446t1689r580b1716],
5	and	CC	O	and	_	0	SENT_74	[p4l590t1689r633b1711],
6	prasugrel	NN	O	prasugrel	nn	7	SENT_74	[p4l643t1689r756b1716],
7	dosages	NNS	O	dosage	prep_of	1	SENT_74	[p4l766t1689r859b1716],
8	on	IN	O	on	_	0	SENT_74	[p4l869t1695r899b1711],
9	pharmacodynamic	JJ	O	pharmacodynamic	amod	10	SENT_74	[p4l909t1689r1133b1716],
10	results	NNS	O	result	prep_on	4	SENT_74	[p4l1143t1689r1222b1711],
11	in	IN	O	in	_	0	SENT_74	[p4l1232t1689r1254b1710],
12	patient	NN	O	patient	prep_in	10	SENT_74	[p4l1263t1689r1349b1716],
13	1	CD	NUMBER	1	number	14	SENT_74	[p4l1359t1690r1368b1710],
14	(	CD	NUMBER	(	dep	1	SENT_74	[p4l1382t1689r1432b1716],
15	Fig	NN	O	fig	dep	14	SENT_74	[p4l1382t1689r1432b1716],
16	.	.	O	.	_	0	SENT_74	[p4l1382t1689r1432b1716],

1	1A	NN	O	1a	nn	2	SENT_75	[p4l1444t1689r1483b1716],
2	)	NN	O	)	_	0	SENT_75	[p4l1444t1689r1483b1716],
3	and	CC	O	and	_	0	SENT_75	[p4l1494t1689r1538b1711],
4	patient	NN	O	patient	conj_and	2	SENT_75	[p4l1548t1689r1633b1716],
5	2	CD	NUMBER	2	number	6	SENT_75	[p4l1642t1690r1655b1710],
6	(	CD	NUMBER	(	dep	2	SENT_75	[p4l1667t1689r1717b1716],
7	Fig	NN	O	fig	dep	6	SENT_75	[p4l1667t1689r1717b1716],
8	.	.	O	.	_	0	SENT_75	[p4l1667t1689r1717b1716],

1	1B	NN	O	1b	_	0	SENT_76	[p4l1728t1689r1774b1716],
2	)	NN	O	)	dep	1	SENT_76	[p4l1728t1689r1774b1716],
3	.	.	O	.	_	0	SENT_76	[p4l1728t1689r1774b1716],

1	response	NN	O	response	dep	12	SENT_77	[p4l7t1886r280b1938],
2	[	CD	NUMBER	[	num	1	SENT_77	[p4l315t1870r448b1938],
3	12	CD	NUMBER	12	num	4	SENT_77	[p4l315t1870r448b1938],
4	]	NN	O	]	dep	1	SENT_77	[p4l315t1870r448b1938],
5	,	,	O	,	_	0	SENT_77	[p4l315t1870r448b1938],
6	and	CC	O	and	_	0	SENT_77	[p4l481t1870r592b1925],
7	in	IN	O	in	conj_and	1	SENT_77	[p4l626t1871r682b1924],
8	particular	JJ	O	particular	pobj	7	SENT_77	[p4l714t1870r1013b1938],
9	he	PRP	O	he	nsubj	12	SENT_77	[p4l1043t1870r1115b1925],
10	had	VBD	O	have	aux	12	SENT_77	[p4l1148t1870r1259b1925],
11	not	RB	O	not	neg	12	SENT_77	[p4l1291t1878r1392b1925],
12	advanced	VBN	O	advance	_	0	SENT_77	[p4l1422t1870r1713b1925],
13	age	NN	O	age	dobj	12	SENT_77	[p4l1745t1886r1863b1938],
14	,	,	O	,	_	0	SENT_77	[p4l1745t1886r1863b1938],
15	diabetes	NN	O	diabetes	nn	16	SENT_77	[p4l1896t1870r2150b1925],
16	mellitus	NN	O	mellitus	appos	13	SENT_77	[p4l7t1958r270b2022],
17	,	,	O	,	_	0	SENT_77	[p4l7t1958r270b2022],
18	nor	CC	O	nor	_	0	SENT_77	[p4l295t1974r400b2013],
19	an	DT	O	a	det	23	SENT_77	[p4l422t1974r494b2013],
20	elevated	JJ	O	elevated	amod	23	SENT_77	[p4l518t1958r776b2013],
21	body	NN	O	body	nn	23	SENT_77	[p4l801t1958r954b2027],
22	mass	NN	O	mass	nn	23	SENT_77	[p4l977t1974r1128b2013],
23	index	NN	O	index	dobj	12	SENT_77	[p4l1154t1958r1338b2014],
24	.	.	O	.	_	0	SENT_77	[p4l1154t1958r1338b2014],

1	An	DT	O	a	det	2	SENT_78	[p4l107t2049r192b2101],
2	authorization	NN	O	authorization	nsubjpass	30	SENT_78	[p4l243t2047r678b2102],
3	for	IN	O	for	_	0	SENT_78	[p4l729t2047r818b2102],
4	temporary	JJ	O	temporary	amod	5	SENT_78	[p4l866t2055r1205b2116],
5	use	NN	O	use	prep_for	2	SENT_78	[p4l1255t2063r1358b2102],
6	of	IN	O	of	_	0	SENT_78	[p4l1410t2047r1476b2102],
7	the	DT	O	the	det	9	SENT_78	[p4l1518t2047r1618b2102],
8	thienopyridine	NN	O	thienopyridine	nn	9	SENT_78	[p4l1669t2047r2150b2116],
9	prasugrel	NN	O	prasugrel	prep_of	5	SENT_78	[p4l7t2136r295b2205],
10	was	VBD	O	be	auxpass	11	SENT_78	[p4l341t2152r460b2191],
11	requested	VBN	O	request	_	0	SENT_78	[p4l508t2136r811b2205],
12	from	IN	O	from	_	0	SENT_78	[p4l860t2136r1006b2191],
13	the	DT	O	the	det	16	SENT_78	[p4l1052t2136r1149b2191],
14	French	JJ	MISC	french	amod	16	SENT_78	[p4l1198t2136r1404b2191],
15	drug	NN	O	drug	nn	16	SENT_78	[p4l1452t2136r1594b2205],
16	agency	NN	O	agency	prep_from	11	SENT_78	[p4l1639t2152r1854b2205],
17	(	CD	NUMBER	(	num	19	SENT_78	[p4l1903t2136r2151b2205],
18	Agence	NNP	O	Agence	nn	19	SENT_78	[p4l1903t2136r2151b2205],
19	Francaise	NNP	O	Francaise	dobj	11	SENT_78	[p4l7t2225r292b2295],
20	de	IN	O	de	_	0	SENT_78	[p4l338t2224r409b2279],
21	Sécurité	NNP	O	Sécurité	nn	22	SENT_78	[p4l456t2223r702b2279],
22	Sanitaire	NNP	O	Sanitaire	nn	27	SENT_78	[p4l749t2225r1018b2279],
23	des	NNP	O	des	nn	27	SENT_78	[p4l1064t2224r1164b2279],
24	Produits	NNP	O	Produits	nn	27	SENT_78	[p4l1212t2224r1466b2279],
25	de	IN	O	de	amod	27	SENT_78	[p4l1513t2224r1584b2279],
26	Santé	NNP	O	Santé	nn	27	SENT_78	[p4l1631t2223r1824b2293],
27	)	NN	O	)	prep_de	19	SENT_78	[p4l1631t2223r1824b2293],
28	and	CC	O	and	_	0	SENT_78	[p4l1874t2224r1985b2279],
29	was	VBD	O	be	auxpass	30	SENT_78	[p4l2030t2240r2150b2279],
30	obtained	VBN	O	obtain	conj_and	11	SENT_78	[p4l7t2314r275b2369],
31	2	CD	DATE	2	num	32	SENT_78	[p4l309t2317r342b2368],
32	weeks	NNS	DATE	week	tmod	30	SENT_78	[p4l363t2314r557b2369],
33	later	RB	DATE	later	advmod	32	SENT_78	[p4l591t2314r743b2369],
34	.	.	O	.	_	0	SENT_78	[p4l591t2314r743b2369],

1	During	IN	O	during	_	0	SENT_79	[p4l777t2315r988b2382],
2	these	DT	O	these	det	4	SENT_79	[p4l1019t2314r1182b2369],
3	2	CD	DURATION	2	num	4	SENT_79	[p4l1215t2317r1248b2368],
4	weeks	NNS	NUMBER	week	prep_during	8	SENT_79	[p4l1270t2314r1478b2377],
5	,	,	O	,	_	0	SENT_79	[p4l1270t2314r1478b2377],
6	the	DT	O	the	det	7	SENT_79	[p4l1511t2314r1609b2369],
7	patient	NN	O	patient	nsubj	8	SENT_79	[p4l1642t2315r1861b2382],
8	received	VBD	O	receive	_	0	SENT_79	[p4l1892t2314r2150b2369],
9	ticlopidine	NN	O	ticlopidine	nn	11	SENT_79	[p4l6t2403r334b2471],
10	250	CD	NUMBER	250	num	11	SENT_79	[p4l368t2406r481b2458],
11	mg	NN	O	mg	dobj	8	SENT_79	[p4l503t2419r599b2471],
12	twice	RB	O	twice	advmod	14	SENT_79	[p4l632t2404r798b2458],
13	a	DT	DURATION	a	det	14	SENT_79	[p4l833t2419r864b2458],
14	day	NN	DURATION	day	tmod	8	SENT_79	[p4l898t2403r1020b2471],
15	,	,	O	,	_	0	SENT_79	[p4l898t2403r1020b2471],
16	which	WDT	O	which	nsubj	17	SENT_79	[p4l1054t2403r1244b2458],
17	produced	VBD	O	produce	dep	8	SENT_79	[p4l1279t2403r1569b2471],
18	adequate	JJ	O	adequate	amod	20	SENT_79	[p4l1603t2403r1885b2471],
19	platelet	NN	O	platelet	nn	20	SENT_79	[p4l1920t2403r2152b2471],
20	inhibition	NN	O	inhibition	dobj	17	SENT_79	[p4l7t2491r322b2547],
21	.	.	O	.	_	0	SENT_79	[p4l7t2491r322b2547],

1	Given	VBN	O	give	prep	14	SENT_80	[p4l346t2492r522b2546],
2	the	DT	O	the	det	4	SENT_80	[p4l544t2491r642b2546],
3	potential	JJ	O	potential	amod	4	SENT_80	[p4l665t2491r939b2560],
4	risk	NN	O	risk	dep	1	SENT_80	[p4l962t2491r1074b2546],
5	of	IN	O	of	_	0	SENT_80	[p4l1095t2491r1159b2546],
6	serious	JJ	O	serious	amod	7	SENT_80	[p4l1174t2492r1390b2546],
7	neutropenia	NN	O	neutropenia	prep_of	4	SENT_80	[p4l1414t2492r1790b2560],
8	induced	VBN	O	induce	partmod	7	SENT_80	[p4l1812t2491r2055b2546],
9	by	IN	O	by	_	0	SENT_80	[p4l2078t2491r2152b2560],
10	ticlopidine	NN	O	ticlopidine	agent	8	SENT_80	[p4l6t2580r348b2649],
11	,	,	O	,	_	0	SENT_80	[p4l6t2580r348b2649],
12	prasugrel	NN	O	prasugrel	nsubjpass	14	SENT_80	[p4l387t2580r675b2649],
13	was	VBD	O	be	auxpass	14	SENT_80	[p4l711t2596r830b2635],
14	initiated	VBN	O	initiate	_	0	SENT_80	[p4l869t2580r1124b2635],
15	at	IN	O	at	_	0	SENT_80	[p4l1162t2588r1219b2635],
16	10	CD	NUMBER	10	num	17	SENT_80	[p4l1258t2583r1328b2635],
17	mg/day	NN	O	mg/day	prep_at	14	SENT_80	[p4l1350t2580r1597b2649],
18	,	,	O	,	_	0	SENT_80	[p4l1350t2580r1597b2649],
19	with	IN	O	with	_	0	SENT_80	[p4l1632t2580r1774b2635],
20	no	DT	O	no	det	22	SENT_80	[p4l1812t2596r1886b2635],
21	loading	NN	O	loading	nn	22	SENT_80	[p4l1924t2580r2152b2649],
22	dose	NN	O	dose	prep_with	14	SENT_80	[p4l7t2669r161b2725],
23	.	.	O	.	_	0	SENT_80	[p4l7t2669r161b2725],

1	An	DT	O	a	det	4	SENT_81	[p4l193t2672r277b2724],
2	evaluation	NN	O	evaluation	nn	4	SENT_81	[p4l312t2669r634b2724],
3	1	CD	DURATION	1	num	4	SENT_81	[p4l671t2672r694b2724],
4	week	NN	NUMBER	week	nsubj	14	SENT_81	[p4l722t2669r888b2724],
5	(	CD	NUMBER	(	num	6	SENT_81	[p4l924t2669r1081b2738],
6	data	NNS	O	datum	npadvmod	7	SENT_81	[p4l924t2669r1081b2738],
7	not	RB	O	not	neg	8	SENT_81	[p4l1115t2677r1216b2724],
8	shown	VBN	O	show	partmod	4	SENT_81	[p4l1250t2669r1479b2738],
9	)	NN	O	)	dobj	8	SENT_81	[p4l1250t2669r1479b2738],
10	then	RB	O	then	advmod	12	SENT_81	[p4l1516t2669r1655b2724],
11	2	CD	DATE	2	num	12	SENT_81	[p4l1689t2672r1722b2724],
12	months	NNS	DATE	month	npadvmod	13	SENT_81	[p4l1746t2669r1978b2724],
13	later	RB	DATE	later	advmod	14	SENT_81	[p4l2013t2669r2153b2724],
14	showed	VBD	O	show	_	0	SENT_81	[p4l8t2758r245b2813],
15	an	DT	O	a	det	17	SENT_81	[p4l263t2774r335b2813],
16	optimal	JJ	O	optimal	amod	17	SENT_81	[p4l353t2758r588b2827],
17	response	NN	O	response	dobj	14	SENT_81	[p4l607t2774r880b2827],
18	with	IN	O	with	_	0	SENT_81	[p4l896t2758r1038b2813],
19	an	DT	O	a	det	22	SENT_81	[p4l1055t2774r1127b2813],
20	ADP	NN	O	adp	nn	22	SENT_81	[p4l1142t2761r1273b2813],
21	10	CD	NUMBER	10	num	22	SENT_81	[p4l1293t2761r1363b2813],
22	ulVl	NN	O	ulvl	prep_with	14	SENT_81	[p4l1383t2761r1653b2829],
23	.	.	O	.	_	0	SENT_81	[p4l1383t2761r1653b2829],

1	—	NN	O	—	_	0	SENT_82	[p4l1383t2761r1653b2829],
2	.	.	O	.	_	0	SENT_82	[p4l1383t2761r1653b2829],

1	MPA	NN	O	mpa	_	0	SENT_83	[p4l1383t2761r1653b2829],
2	of	IN	O	of	_	0	SENT_83	[p4l1669t2758r1732b2813],
3	34	CD	PERCENT	34	num	4	SENT_83	[p4l1742t2761r1859b2813],
4	%	NN	PERCENT	%	prep_of	1	SENT_83	[p4l1742t2761r1859b2813],
5	and	CC	O	and	_	0	SENT_83	[p4l1876t2758r1987b2813],
6	a	DT	O	a	det	7	SENT_83	[p4l2006t2774r2037b2813],
7	PR1	NN	O	pr1	prep_of	1	SENT_83	[p4l2055t2762r2150b2813],
8	of	IN	O	of	_	0	SENT_83	[p4l7t2848r71b2903],
9	16	CD	PERCENT	16	num	10	SENT_83	[p4l93t2851r206b2903],
10	%	NN	PERCENT	%	prep_of	1	SENT_83	[p4l93t2851r206b2903],
11	(	CD	NUMBER	(	num	12	SENT_83	[p4l237t2848r364b2916],
12	Fig	NN	O	fig	dep	10	SENT_83	[p4l237t2848r364b2916],
13	.	.	O	.	_	0	SENT_83	[p4l237t2848r364b2916],

1	1A	NN	O	1a	nn	2	SENT_84	[p4l396t2848r516b2916],
2	)	NN	O	)	nsubj	8	SENT_84	[p4l396t2848r516b2916],
3	,	,	O	,	_	0	SENT_84	[p4l396t2848r516b2916],
4	with	IN	O	with	_	0	SENT_84	[p4l543t2848r684b2903],
5	no	DT	O	no	det	7	SENT_84	[p4l711t2864r786b2903],
6	bleeding	NN	O	bleeding	nn	7	SENT_84	[p4l813t2848r1078b2916],
7	event	NN	O	event	prep_with	2	SENT_84	[p4l1105t2856r1275b2903],
8	reported	VBD	O	report	_	0	SENT_84	[p4l1302t2848r1566b2916],
9	so	RB	O	so	advmod	10	SENT_84	[p4l1595t2864r1657b2903],
10	far	RB	O	far	advmod	8	SENT_84	[p4l1685t2848r1767b2903],
11	(	CD	NUMBER	(	number	12	SENT_84	[p4l1796t2848r1894b2916],
12	15	CD	DURATION	15	num	13	SENT_84	[p4l1796t2848r1894b2916],
13	months	NNS	NUMBER	month	npadvmod	8	SENT_84	[p4l1918t2848r2150b2903],
14	after	IN	O	after	_	0	SENT_84	[p4l7t2937r149b2992],
15	prasugrel	NN	O	prasugrel	prep_after	8	SENT_84	[p4l177t2937r465b3005],
16	initiating	VBG	O	initiate	partmod	15	SENT_84	[p4l495t2937r818b3005],
17	)	NN	O	)	dobj	16	SENT_84	[p4l495t2937r818b3005],
18	.	.	O	.	_	0	SENT_84	[p4l495t2937r818b3005],

1	On	IN	O	on	_	0	SENT_85	[p4l849t2940r933b2992],
2	discharge	NN	O	discharge	prep_on	6	SENT_85	[p4l963t2937r1271b3005],
3	,	,	O	,	_	0	SENT_85	[p4l963t2937r1271b3005],
4	he	PRP	O	he	nsubj	6	SENT_85	[p4l1302t2937r1374b2992],
5	was	VBD	O	be	aux	6	SENT_85	[p4l1402t2953r1522b2992],
6	receiving	VBG	O	receive	_	0	SENT_85	[p4l1552t2938r1834b3005],
7	prasugrel	NN	O	prasugrel	nn	8	SENT_85	[p4l1862t2937r2150b3005],
8	10mg/day	NN	O	10mg/day	dobj	6	SENT_85	[p4l10t3025r348b3094],
9	,	,	O	,	_	0	SENT_85	[p4l10t3025r348b3094],
10	aspirin	NN	O	aspirin	nn	12	SENT_85	[p4l396t3026r605b3094],
11	75	CD	NUMBER	75	num	12	SENT_85	[p4l653t3029r723b3080],
12	mg/day	NN	O	mg/day	dobj	6	SENT_85	[p4l747t3025r993b3094],
13	,	,	O	,	_	0	SENT_85	[p4l747t3025r993b3094],
14	esomeprazole	NN	O	esomeprazole	nn	16	SENT_85	[p4l1041t3025r1466b3094],
15	40	CD	NUMBER	40	num	16	SENT_85	[p4l1511t3028r1587b3080],
16	mg/day	NN	O	mg/day	dobj	6	SENT_85	[p4l1609t3025r1855b3094],
17	,	,	O	,	_	0	SENT_85	[p4l1609t3025r1855b3094],
18	atenolol	NN	O	atenolol	nn	20	SENT_85	[p4l1902t3025r2150b3080],
19	50	CD	NUMBER	50	num	20	SENT_85	[p4l8t3117r80b3169],
20	mg/day	NN	O	mg/day	conj_and	8	SENT_85	[p4l102t3114r348b3183],
21	,	,	O	,	_	0	SENT_85	[p4l102t3114r348b3183],
22	amlopidin	NN	O	amlopidin	nn	24	SENT_85	[p4l383t3114r696b3183],
23	5	CD	NUMBER	5	num	24	SENT_85	[p4l730t3117r761b3169],
24	mg/day	NN	O	mg/day	conj_and	8	SENT_85	[p4l785t3114r1031b3183],
25	,	,	O	,	_	0	SENT_85	[p4l785t3114r1031b3183],
26	perindopril	NN	O	perindopril	nn	28	SENT_85	[p4l1066t3114r1412b3183],
27	4	CD	NUMBER	4	num	28	SENT_85	[p4l1444t3117r1481b3168],
28	mg/day	NN	O	mg/day	conj_and	8	SENT_85	[p4l1502t3114r1748b3183],
29	,	,	O	,	_	0	SENT_85	[p4l1502t3114r1748b3183],
30	molsidomin	NN	O	molsidomin	nn	32	SENT_85	[p4l1783t3114r2151b3169],
31	6	CD	NUMBER	6	num	32	SENT_85	[p4l7t3206r41b3258],
32	mg/day	NN	O	mg/day	conj_and	8	SENT_85	[p4l63t3203r296b3272],
33	and	CC	O	and	_	0	SENT_85	[p4l319t3203r430b3258],
34	simvastatin	NN	O	simvastatin	nn	36	SENT_85	[p4l457t3204r810b3258],
35	40	CD	NUMBER	40	num	36	SENT_85	[p4l833t3206r908b3258],
36	mg/day	NN	O	mg/day	conj_and	8	SENT_85	[p4l930t3203r1176b3272],
37	.	.	O	.	_	0	SENT_85	[p4l930t3203r1176b3272],

1	1.2.2	CD	NUMBER	1.2.2	_	0	SENT_86	[p4l13t3427r157b3479],
2	.	.	O	.	_	0	SENT_86	[p4l13t3427r157b3479],

1	Patient	NN	O	patient	_	0	SENT_87	[p4l184t3426r396b3479],
2	2	CD	NUMBER	2	num	1	SENT_87	[p4l415t3427r452b3478],

1	This	DT	DATE	this	det	6	SENT_88	[p5l106t23r232b78],
2	49	CD	DATE	49	num	6	SENT_88	[p5l278t26r353b78],
3	year	NN	DATE	year	nn	6	SENT_88	[p5l373t23r630b92],
4	—	CD	NUMBER	—	num	6	SENT_88	[p5l373t23r630b92],
5	old	JJ	O	old	amod	6	SENT_88	[p5l373t23r630b92],
6	lady	NN	O	lady	nsubj	14	SENT_88	[p5l678t23r820b92],
7	,	,	O	,	_	0	SENT_88	[p5l678t23r820b92],
8	without	IN	O	without	_	0	SENT_88	[p5l866t23r1112b78],
9	any	DT	O	any	det	12	SENT_88	[p5l1157t39r1267b92],
10	cardiovascular	JJ	O	cardiovascular	amod	12	SENT_88	[p5l1312t23r1758b78],
11	risk	NN	O	risk	nn	12	SENT_88	[p5l1804t23r1915b78],
12	factor	NN	O	factor	prep_without	14	SENT_88	[p5l1961t23r2150b86],
13	,	,	O	,	_	0	SENT_88	[p5l1961t23r2150b86],
14	presented	VBN	O	present	_	0	SENT_88	[p5l7t112r315b181],
15	with	IN	O	with	_	0	SENT_88	[p5l362t112r504b167],
16	an	DT	O	a	det	18	SENT_88	[p5l552t128r624b167],
17	anterior	JJ	O	anterior	amod	18	SENT_88	[p5l672t113r921b167],
18	STEMI	NN	O	stemus	prep_with	14	SENT_88	[p5l969t115r1159b167],
19	9	CD	DATE	9	num	20	SENT_88	[p5l1208t115r1242b167],
20	months	NNS	DATE	month	npadvmod	21	SENT_88	[p5l1265t112r1498b167],
21	ago	RB	DATE	ago	advmod	18	SENT_88	[p5l1547t128r1668b181],
22	.	.	O	.	_	0	SENT_88	[p5l1547t128r1668b181],

1	The	DT	O	the	det	3	SENT_89	[p5l1715t112r1827b167],
2	coronary	JJ	O	coronary	amod	3	SENT_89	[p5l1877t128r2152b181],
3	angiography	NN	O	angiography	nsubj	4	SENT_89	[p5l7t201r392b270],
4	revealed	VBD	O	reveal	_	0	SENT_89	[p5l428t201r689b256],
5	an	DT	O	a	det	6	SENT_89	[p5l726t217r798b256],
6	occlusion	NN	O	occlusion	dobj	4	SENT_89	[p5l835t201r1122b256],
7	of	IN	O	of	_	0	SENT_89	[p5l1159t201r1223b256],
8	the	DT	O	the	det	12	SENT_89	[p5l1251t201r1348b256],
9	left	JJ	O	left	amod	12	SENT_89	[p5l1386t201r1485b256],
10	anterior	JJ	O	anterior	amod	12	SENT_89	[p5l1520t202r1768b256],
11	descending	VBG	O	descend	amod	12	SENT_89	[p5l1803t201r2152b270],
12	artery	NN	O	artery	prep_of	6	SENT_89	[p5l7t298r192b359],
13	successfully	RB	O	successfully	advmod	14	SENT_89	[p5l216t290r581b359],
14	treated	VBN	O	treat	partmod	12	SENT_89	[p5l604t290r823b345],
15	by	IN	O	by	_	0	SENT_89	[p5l849t290r923b359],
16	primary	JJ	O	primary	amod	17	SENT_89	[p5l947t291r1194b359],
17	angioplasty	NN	O	angioplasty	agent	14	SENT_89	[p5l1218t290r1573b359],
18	with	IN	O	with	_	0	SENT_89	[p5l1595t290r1737b345],
19	a	DT	O	a	det	22	SENT_89	[p5l1763t306r1794b345],
20	bare	JJ	O	bare	amod	22	SENT_89	[p5l1818t290r1951b345],
21	metal	NN	O	metal	nn	22	SENT_89	[p5l1978t290r2150b345],
22	stent	NN	O	stent	prep_with	17	SENT_89	[p5l8t388r173b435],
23	.	.	O	.	_	0	SENT_89	[p5l8t388r173b435],

1	She	PRP	O	she	nsubjpass	3	SENT_90	[p5l222t380r329b435],
2	was	VBD	O	be	auxpass	3	SENT_90	[p5l375t396r494b435],
3	prescribed	VBN	O	prescribe	_	0	SENT_90	[p5l544t380r866b448],
4	long	RB	O	long	advmod	7	SENT_90	[p5l914t380r1225b448],
5	—	RB	O	—	advmod	7	SENT_90	[p5l914t380r1225b448],
6	term	NN	O	term	nn	7	SENT_90	[p5l914t380r1225b448],
7	clopidogrel	NN	O	clopidogrel	dobj	3	SENT_90	[p5l1271t380r1615b448],
8	75	CD	NUMBER	75	num	9	SENT_90	[p5l1665t383r1735b435],
9	mg/day	NN	O	mg/day	dep	7	SENT_90	[p5l1759t380r1993b448],
10	and	CC	O	and	_	0	SENT_90	[p5l2038t380r2150b435],
11	aspirin	NN	O	aspirin	dobj	3	SENT_90	[p5l7t469r223b537],
12	75	CD	NUMBER	75	num	13	SENT_90	[p5l274t472r346b524],
13	mg/day	NN	O	mg/day	dep	11	SENT_90	[p5l371t469r625b537],
14	.	.	O	.	_	0	SENT_90	[p5l371t469r625b537],

1	She	PRP	O	she	nsubj	4	SENT_91	[p5l676t469r786b524],
2	was	VBD	O	be	cop	4	SENT_91	[p5l834t484r956b524],
3	re	JJ	O	re	amod	4	SENT_91	[p5l1007t468r1387b524],
4	—	NN	O	—	_	0	SENT_91	[p5l1007t468r1387b524],
5	admitted	VBN	O	admit	partmod	4	SENT_91	[p5l1007t468r1387b524],
6	for	IN	O	for	_	0	SENT_91	[p5l1438t468r1526b524],
7	silent	JJ	O	silent	amod	9	SENT_91	[p5l1575t469r1748b524],
8	myocardial	JJ	O	myocardial	amod	9	SENT_91	[p5l1797t469r2150b537],
9	ischaemia	NN	O	ischaemia	prep_for	5	SENT_91	[p5l7t557r327b613],
10	.	.	O	.	_	0	SENT_91	[p5l7t557r327b613],

1	The	DT	O	the	det	2	SENT_92	[p5l350t557r462b612],
2	angiogram	NN	O	angiogram	nsubj	3	SENT_92	[p5l486t558r815b626],
3	demonstrated	VBD	O	demonstrate	_	0	SENT_92	[p5l839t557r1268b612],
4	a	DT	O	a	det	5	SENT_92	[p5l1293t573r1325b612],
5	diffuse	NN	O	diffuse	dobj	3	SENT_92	[p5l1349t557r1554b612],
6	in	IN	O	in	_	0	SENT_92	[p5l1579t558r1821b612],
7	—	NN	O	—	nn	9	SENT_92	[p5l1579t558r1821b612],
8	stent	NN	O	stent	nn	9	SENT_92	[p5l1579t558r1821b612],
9	restenosis	NN	O	restenosis	prep_in	5	SENT_92	[p5l1844t558r2150b612],
10	treated	VBN	O	treat	partmod	9	SENT_92	[p5l6t646r225b701],
11	successfully	RB	O	successfully	advmod	10	SENT_92	[p5l251t646r616b715],
12	by	IN	O	by	_	0	SENT_92	[p5l638t646r712b715],
13	a	DT	O	a	det	16	SENT_92	[p5l735t662r766b701],
14	drug	NN	O	drug	nn	16	SENT_92	[p5l790t646r932b715],
15	eluting	VBG	O	elute	amod	16	SENT_92	[p5l956t646r1171b715],
16	stent	NN	O	stent	agent	10	SENT_92	[p5l1195t654r1361b702],
17	.	.	O	.	_	0	SENT_92	[p5l1195t654r1361b702],

1	She	PRP	O	she	nsubjpass	4	SENT_93	[p5l111t736r218b791],
2	was	VBD	O	be	auxpass	4	SENT_93	[p5l255t752r375b791],
3	then	RB	O	then	advmod	4	SENT_93	[p5l414t736r553b791],
4	referred	VBN	O	refer	_	0	SENT_93	[p5l593t736r839b791],
5	to	TO	O	to	_	0	SENT_93	[p5l879t744r937b791],
6	our	PRP$	O	we	poss	7	SENT_93	[p5l977t752r1081b791],
7	laboratory	NN	O	laboratory	prep_to	4	SENT_93	[p5l1119t736r1439b804],
8	for	IN	O	for	_	0	SENT_93	[p5l1476t736r1561b791],
9	evaluation	NN	O	evaluation	prep_for	7	SENT_93	[p5l1598t736r1920b791],
10	of	IN	O	of	_	0	SENT_93	[p5l1960t736r2024b791],
11	the	DT	O	the	det	12	SENT_93	[p5l2054t736r2151b791],
12	response	NN	O	response	prep_of	9	SENT_93	[p5l8t840r281b893],
13	to	TO	O	to	_	0	SENT_93	[p5l305t832r364b879],
14	antiplatelet	JJ	O	antiplatelet	amod	15	SENT_93	[p5l390t824r742b893],
15	treatment	NN	O	treatment	prep_to	4	SENT_93	[p5l765t832r1087b880],
16	.	.	O	.	_	0	SENT_93	[p5l765t832r1087b880],

1	Pharmacodynamic	JJ	O	pharmacodynamic	amod	2	SENT_94	[p5l111t913r695b982],
2	tests	NNS	O	test	nsubj	3	SENT_94	[p5l740t921r884b968],
3	showed	VBD	O	show	_	0	SENT_94	[p5l932t913r1174b968],
4	high	JJ	O	high	amod	9	SENT_94	[p5l1222t913r1358b982],
5	on	IN	O	on	_	0	SENT_94	[p5l1406t913r1867b982],
6	—	CD	NUMBER	—	num	7	SENT_94	[p5l1406t913r1867b982],
7	clopidogrel	NN	O	clopidogrel	prep_on	4	SENT_94	[p5l1406t913r1867b982],
8	platelet	NN	O	platelet	nn	9	SENT_94	[p5l1915t913r2153b982],
9	reactivity	NN	O	reactivity	dobj	3	SENT_94	[p5l8t1003r304b1071],
10	with	IN	O	with	_	0	SENT_94	[p5l341t1002r485b1057],
11	a	DT	O	a	det	13	SENT_94	[p5l523t1018r554b1057],
12	good	JJ	O	good	amod	13	SENT_94	[p5l592t1002r745b1071],
13	response	NN	O	response	prep_with	3	SENT_94	[p5l786t1018r1063b1071],
14	to	TO	O	to	_	0	SENT_94	[p5l1103t1010r1161b1057],
15	aspirin	NN	O	aspirin	prep_to	3	SENT_94	[p5l1202t1003r1435b1071],
16	:	:	O	:	_	0	SENT_94	[p5l1202t1003r1435b1071],
17	the	DT	O	the	det	19	SENT_94	[p5l1479t1002r1577b1057],
18	ADP	NN	O	adp	nn	19	SENT_94	[p5l1615t1005r1747b1057],
19	10uM	NN	O	10um	dep	15	SENT_94	[p5l1788t1005r2153b1073],
20	.	.	O	.	_	0	SENT_94	[p5l1788t1005r2153b1073],

1	—	NN	O	—	_	0	SENT_95	[p5l1788t1005r2153b1073],
2	.	.	O	.	_	0	SENT_95	[p5l1788t1005r2153b1073],

1	MPA	NN	ORGANIZATION	mpa	nsubj	4	SENT_96	[p5l1788t1005r2153b1073],
2	was	VBD	O	be	cop	4	SENT_96	[p5l6t1107r127b1146],
3	66	CD	PERCENT	66	num	4	SENT_96	[p5l146t1094r264b1146],
4	%	NN	PERCENT	%	_	0	SENT_96	[p5l146t1094r264b1146],
5	and	CC	O	and	_	0	SENT_96	[p5l280t1091r393b1146],
6	the	DT	O	the	det	7	SENT_96	[p5l411t1091r510b1146],
7	PR1	NN	O	pr1	nsubj	10	SENT_96	[p5l529t1095r625b1146],
8	was	VBD	O	be	cop	10	SENT_96	[p5l642t1107r763b1146],
9	71	CD	PERCENT	71	num	10	SENT_96	[p5l783t1094r914b1155],
10	%	NN	PERCENT	%	conj_and	4	SENT_96	[p5l783t1094r914b1155],
11	,	,	O	,	_	0	SENT_96	[p5l783t1094r914b1155],
12	whereas	IN	O	whereas	mark	15	SENT_96	[p5l931t1091r1195b1146],
13	the	DT	O	the	det	15	SENT_96	[p5l1213t1091r1312b1146],
14	arachidonic	JJ	O	arachidonic	amod	15	SENT_96	[p5l1329t1091r1695b1146],
15	acid	NN	O	acid	advcl	10	SENT_96	[p5l1712t1091r2016b1146],
16	.	.	O	.	_	0	SENT_96	[p5l1712t1091r2016b1146],

1	—	NN	O	—	_	0	SENT_97	[p5l1712t1091r2016b1146],
2	.	.	O	.	_	0	SENT_97	[p5l1712t1091r2016b1146],

1	MPA	NN	ORGANIZATION	mpa	nsubj	4	SENT_98	[p5l1712t1091r2016b1146],
2	was	VBD	O	be	cop	4	SENT_98	[p5l2030t1107r2151b1146],
3	13	CD	PERCENT	13	num	4	SENT_98	[p5l11t1184r142b1236],
4	%	NN	PERCENT	%	_	0	SENT_98	[p5l11t1184r142b1236],
5	.	.	O	.	_	0	SENT_98	[p5l11t1184r142b1236],

1	The	DT	O	the	det	3	SENT_99	[p5l189t1181r303b1236],
2	genetic	JJ	O	genetic	amod	3	SENT_99	[p5l351t1182r582b1249],
3	study	NN	O	study	nsubj	4	SENT_99	[p5l630t1181r804b1249],
4	showed	VBD	O	show	_	0	SENT_99	[p5l851t1181r1095b1236],
5	wild	JJ	O	wild	amod	8	SENT_99	[p5l1142t1181r1454b1249],
6	—	NN	O	—	nn	8	SENT_99	[p5l1142t1181r1454b1249],
7	type	NN	O	type	nn	8	SENT_99	[p5l1142t1181r1454b1249],
8	alleles	NNS	O	allele	dobj	4	SENT_99	[p5l1502t1181r1700b1236],
9	for	IN	O	for	_	0	SENT_99	[p5l1749t1181r1837b1236],
10	CYP2C19	NN	O	cyp2c19	nn	13	SENT_99	[p5l1884t1184r2152b1236],
11	(	CD	NUMBER	(	num	13	SENT_99	[p5l12t1269r496b1338],
12	CYP2C19	NN	O	cyp2c19	nn	13	SENT_99	[p5l12t1269r496b1338],
13	*	NN	O	*	prep_for	4	SENT_99	[p5l12t1269r496b1338],
14	1	CD	NUMBER	1	dep	13	SENT_99	[p5l12t1269r496b1338],
15	/	:	O	/	punct	29	SENT_99	[p5l12t1269r496b1338],
16	*	CD	NUMBER	*	number	17	SENT_99	[p5l12t1269r496b1338],
17	1	CD	NUMBER	1	num	18	SENT_99	[p5l12t1269r496b1338],
18	)	NN	O	)	dep	29	SENT_99	[p5l12t1269r496b1338],
19	but	CC	O	but	prep	18	SENT_99	[p5l548t1270r653b1325],
20	homozygosity	NN	O	homozygosity	dep	19	SENT_99	[p5l700t1270r1151b1338],
21	for	IN	O	for	_	0	SENT_99	[p5l1198t1269r1286b1325],
22	the	DT	O	the	det	25	SENT_99	[p5l1332t1270r1432b1325],
23	P2Y12	NN	O	p2y12	nn	25	SENT_99	[p5l1479t1272r1652b1336],
24	H2	NN	O	h2	nn	25	SENT_99	[p5l1698t1273r1783b1324],
25	haplotype	NN	O	haplotype	prep_for	20	SENT_99	[p5l1832t1270r2151b1338],
26	(	CD	NUMBER	(	num	29	SENT_99	[p5l12t1358r206b1426],
27	P2Y12	NN	O	p2y12	nn	29	SENT_99	[p5l12t1358r206b1426],
28	H2/H2	NN	O	h2/h2	nn	29	SENT_99	[p5l228t1358r468b1427],
29	)	NN	O	)	parataxis	4	SENT_99	[p5l228t1358r468b1427],
30	.	.	O	.	_	0	SENT_99	[p5l228t1358r468b1427],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_100	[p5l111t1447r462b1516],
2	dosage	NN	O	dosage	nsubjpass	4	SENT_100	[p5l491t1447r702b1516],
3	was	VBD	O	be	auxpass	4	SENT_100	[p5l729t1463r848b1502],
4	increased	VBN	O	increase	_	0	SENT_100	[p5l878t1447r1169b1502],
5	to	TO	O	to	_	0	SENT_100	[p5l1196t1455r1255b1502],
6	150	CD	NUMBER	150	num	7	SENT_100	[p5l1287t1450r1396b1502],
7	mg/day	NN	O	mg/day	prep_to	4	SENT_100	[p5l1419t1447r1665b1516],
8	,	,	O	,	_	0	SENT_100	[p5l1419t1447r1665b1516],
9	resulting	VBG	O	result	xcomp	4	SENT_100	[p5l1694t1447r1966b1516],
10	to	TO	O	to	_	0	SENT_100	[p5l1992t1455r2051b1502],
11	an	DT	O	a	det	12	SENT_100	[p5l2080t1463r2152b1502],
12	improvement	NN	O	improvement	prep_to	9	SENT_100	[p5l8t1537r440b1605],
13	of	IN	O	of	_	0	SENT_100	[p5l487t1536r552b1591],
14	the	DT	O	the	det	16	SENT_100	[p5l593t1536r692b1591],
15	antiplatelet	JJ	O	antiplatelet	amod	16	SENT_100	[p5l742t1536r1106b1605],
16	effect	NN	O	effect	prep_of	12	SENT_100	[p5l1154t1536r1328b1591],
17	one	CD	DATE	one	num	18	SENT_100	[p5l1376t1552r1487b1591],
18	week	NN	DATE	week	npadvmod	19	SENT_100	[p5l1535t1536r1704b1591],
19	later	RB	DATE	later	advmod	16	SENT_100	[p5l1752t1536r1910b1600],
20	,	,	O	,	_	0	SENT_100	[p5l1752t1536r1910b1600],
21	which	WDT	O	which	nsubj	24	SENT_100	[p5l1959t1536r2152b1591],
22	remained	VBD	O	remain	cop	24	SENT_100	[p5l8t1625r299b1680],
23	however	RB	O	however	advmod	24	SENT_100	[p5l328t1625r599b1680],
24	inadequate	JJ	O	inadequate	rcmod	12	SENT_100	[p5l624t1625r981b1694],
25	.	.	O	.	_	0	SENT_100	[p5l624t1625r981b1694],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_101	[p5l1009t1625r1361b1694],
2	dosage	NN	O	dosage	nsubjpass	4	SENT_101	[p5l1390t1625r1601b1694],
3	was	VBD	O	be	auxpass	4	SENT_101	[p5l1626t1641r1745b1680],
4	increased	VBN	O	increase	_	0	SENT_101	[p5l1774t1625r2065b1680],
5	to	TO	O	to	_	0	SENT_101	[p5l2092t1634r2151b1680],
6	300	CD	NUMBER	300	num	7	SENT_101	[p5l7t1719r120b1771],
7	mg/day	NN	O	mg/day	prep_to	4	SENT_101	[p5l142t1716r388b1784],
8	,	,	O	,	_	0	SENT_101	[p5l142t1716r388b1784],
9	leading	VBG	O	lead	xcomp	4	SENT_101	[p5l418t1716r642b1784],
10	to	TO	O	to	_	0	SENT_101	[p5l668t1724r727b1771],
11	a	DT	O	a	det	13	SENT_101	[p5l755t1732r786b1771],
12	good	JJ	O	good	amod	13	SENT_101	[p5l813t1716r963b1784],
13	response	NN	O	response	prep_to	9	SENT_101	[p5l992t1732r1265b1784],
14	to	TO	O	to	_	0	SENT_101	[p5l1292t1724r1351b1771],
15	clopidogrel	NN	O	clopidogrel	nn	17	SENT_101	[p5l1379t1716r1723b1784],
16	(	CD	NUMBER	(	num	17	SENT_101	[p5l1755t1716r1910b1784],
17	ADP	NN	O	adp	prep_to	13	SENT_101	[p5l1755t1716r1910b1784],
18	10	CD	NUMBER	10	num	17	SENT_101	[p5l1939t1719r2009b1771],
19	ulVl	NN	O	ulvl	nn	21	SENT_101	[p5l2030t1719r2151b1786],
20	—	CD	NUMBER	—	num	21	SENT_101	[p5l2030t1719r2151b1786],
21	MPA	NNP	ORGANIZATION	MPA	dobj	9	SENT_101	[p5l8t1806r164b1867],
22	,	,	O	,	_	0	SENT_101	[p5l8t1806r164b1867],
23	46	CD	PERCENT	46	num	24	SENT_101	[p5l192t1807r327b1867],
24	%	NN	PERCENT	%	appos	21	SENT_101	[p5l192t1807r327b1867],
25	;	:	O	;	_	0	SENT_101	[p5l192t1807r327b1867],
26	and	CC	O	and	_	0	SENT_101	[p5l361t1804r472b1859],
27	PR1	NN	O	pr1	dobj	9	SENT_101	[p5l501t1807r612b1867],
28	,	,	O	,	_	0	SENT_101	[p5l501t1807r612b1867],
29	32	CD	PERCENT	32	num	30	SENT_101	[p5l640t1804r782b1872],
30	%	NN	PERCENT	%	appos	27	SENT_101	[p5l640t1804r782b1872],
31	)	CD	NUMBER	)	number	32	SENT_101	[p5l640t1804r782b1872],
32	(	CD	NUMBER	(	num	33	SENT_101	[p5l818t1804r946b1872],
33	Fig	NN	O	fig	dep	30	SENT_101	[p5l818t1804r946b1872],
34	.	.	O	.	_	0	SENT_101	[p5l818t1804r946b1872],

1	1B	NN	O	1b	nn	2	SENT_102	[p5l978t1804r1095b1872],
2	)	NN	O	)	_	0	SENT_102	[p5l978t1804r1095b1872],
3	,	,	O	,	_	0	SENT_102	[p5l978t1804r1095b1872],
4	with	IN	O	with	dep	2	SENT_102	[p5l1122t1804r1264b1859],
5	no	DT	O	no	det	8	SENT_102	[p5l1292t1820r1366b1859],
6	reported	VBN	O	report	amod	8	SENT_102	[p5l1395t1804r1660b1872],
7	adverse	JJ	O	adverse	amod	8	SENT_102	[p5l1688t1804r1924b1859],
8	events	NNS	O	event	pobj	4	SENT_102	[p5l1953t1812r2151b1859],
9	after	IN	O	after	_	0	SENT_102	[p5l8t1892r150b1947],
10	9	CD	DURATION	9	num	11	SENT_102	[p5l166t1895r200b1947],
11	months	NNS	NUMBER	month	prep_after	8	SENT_102	[p5l223t1892r454b1947],
12	of	IN	O	of	_	0	SENT_102	[p5l473t1892r537b1947],
13	treatment	NN	O	treatment	prep_of	11	SENT_102	[p5l547t1900r869b1948],
14	.	.	O	.	_	0	SENT_102	[p5l547t1900r869b1948],

1	Treatment	NN	O	treatment	nsubjpass	7	SENT_103	[p5l885t1896r1209b1947],
2	with	IN	O	with	_	0	SENT_103	[p5l1224t1892r1365b1947],
3	prasugrel	NN	O	prasugrel	nn	5	SENT_103	[p5l1383t1892r1671b1961],
4	10	CD	NUMBER	10	num	5	SENT_103	[p5l1692t1895r1762b1947],
5	mg/day	NN	O	mg/day	prep_with	1	SENT_103	[p5l1784t1892r2018b1961],
6	was	VBD	O	be	auxpass	7	SENT_103	[p5l2032t1908r2151b1947],
7	considered	VBN	O	consider	_	0	SENT_103	[p5l8t1981r344b2036],
8	but	CC	O	but	_	0	SENT_103	[p5l369t1981r471b2036],
9	was	VBD	O	be	auxpass	11	SENT_103	[p5l493t1997r613b2036],
10	not	RB	O	not	neg	11	SENT_103	[p5l639t1989r741b2036],
11	given	VBN	O	give	conj_but	7	SENT_103	[p5l764t1982r931b2050],
12	because	IN	O	because	mark	15	SENT_103	[p5l956t1981r1198b2036],
13	the	DT	O	the	det	14	SENT_103	[p5l1224t1981r1321b2036],
14	patient	NN	O	patient	nsubj	15	SENT_103	[p5l1347t1982r1566b2050],
15	weighed	VBD	O	weigh	advcl	11	SENT_103	[p5l1588t1981r1852b2050],
16	less	JJR	O	less	mwe	17	SENT_103	[p5l1878t1981r1988b2036],
17	than	IN	O	than	quantmod	18	SENT_103	[p5l2014t1981r2152b2036],
18	60	CD	NUMBER	60	num	19	SENT_103	[p5l8t2073r81b2125],
19	kg	NN	O	kg	dobj	15	SENT_103	[p5l103t2070r188b2139],
20	,	,	O	,	_	0	SENT_103	[p5l103t2070r188b2139],
21	and	CC	O	and	_	0	SENT_103	[p5l213t2070r325b2125],
22	the	DT	O	the	det	25	SENT_103	[p5l350t2070r448b2125],
23	5	CD	NUMBER	5	num	25	SENT_103	[p5l474t2074r506b2125],
24	mg	NN	O	mg	nn	25	SENT_103	[p5l529t2086r625b2139],
25	dosage	NN	O	dosage	nsubjpass	29	SENT_103	[p5l649t2070r860b2139],
26	is	VBZ	O	be	auxpass	29	SENT_103	[p5l886t2071r929b2125],
27	not	RB	O	not	neg	29	SENT_103	[p5l956t2079r1058b2125],
28	currently	RB	DATE	currently	advmod	29	SENT_103	[p5l1081t2070r1364b2139],
29	authorized	VBN	O	authorize	conj_and	7	SENT_103	[p5l1387t2070r1718b2125],
30	in	IN	O	in	_	0	SENT_103	[p5l1744t2071r1801b2125],
31	France	NNP	LOCATION	France	prep_in	29	SENT_103	[p5l1826t2074r2041b2126],
32	.	.	O	.	_	0	SENT_103	[p5l1826t2074r2041b2126],

1	On	IN	O	on	_	0	SENT_104	[p5l2067t2073r2152b2125],
2	discharge	NN	O	discharge	prep_on	5	SENT_104	[p5l8t2159r301b2228],
3	she	PRP	O	she	nsubjpass	5	SENT_104	[p5l325t2159r426b2214],
4	was	VBD	O	be	auxpass	5	SENT_104	[p5l447t2175r566b2214],
5	prescribed	VBN	O	prescribe	_	0	SENT_104	[p5l589t2159r912b2228],
6	clopidogrel	NN	O	clopidogrel	nn	8	SENT_104	[p5l935t2159r1278b2228],
7	300	CD	NUMBER	300	num	8	SENT_104	[p5l1301t2162r1414b2214],
8	mg/day	NN	O	mg/day	dobj	5	SENT_104	[p5l1436t2159r1682b2228],
9	,	,	O	,	_	0	SENT_104	[p5l1436t2159r1682b2228],
10	aspirin	NN	O	aspirin	dep	5	SENT_104	[p5l1705t2160r1915b2228],
11	75	CD	NUMBER	75	num	12	SENT_104	[p5l1938t2163r2008b2214],
12	mg	NN	O	mg	dep	10	SENT_104	[p5l2032t2162r2154b2228],
13	/	:	O	/	punct	10	SENT_104	[p5l2032t2162r2154b2228],
14	day	NN	DURATION	day	dep	10	SENT_104	[p5l8t2249r130b2317],
15	,	,	O	,	_	0	SENT_104	[p5l8t2249r130b2317],
16	esomeprazole	NN	O	esomeprazole	nn	18	SENT_104	[p5l169t2249r595b2317],
17	20	CD	NUMBER	20	num	18	SENT_104	[p5l633t2252r706b2304],
18	mg/day	NN	O	mg/day	conj_and	14	SENT_104	[p5l729t2249r975b2317],
19	,	,	O	,	_	0	SENT_104	[p5l729t2249r975b2317],
20	rosuvastatine	NN	O	rosuvastatine	nn	22	SENT_104	[p5l1014t2250r1427b2304],
21	10	CD	NUMBER	10	num	22	SENT_104	[p5l1468t2252r1538b2304],
22	mg/day	NN	O	mg/day	conj_and	14	SENT_104	[p5l1560t2249r1806b2317],
23	,	,	O	,	_	0	SENT_104	[p5l1560t2249r1806b2317],
24	bisoprolol	NN	O	bisoprolol	nn	26	SENT_104	[p5l1845t2249r2152b2317],
25	5	CD	NUMBER	5	num	26	SENT_104	[p5l9t2341r40b2393],
26	mg	NN	O	mg	conj_and	14	SENT_104	[p5l64t2354r173b2406],
27	,	,	O	,	_	0	SENT_104	[p5l64t2354r173b2406],
28	and	CC	O	and	_	0	SENT_104	[p5l199t2338r310b2393],
29	ramipril	NN	O	ramipril	nn	31	SENT_104	[p5l336t2338r584b2406],
30	2.5	CD	NUMBER	2.5	num	31	SENT_104	[p5l609t2341r696b2393],
31	mg/day	NN	O	mg/day	conj_and	14	SENT_104	[p5l720t2338r966b2406],
32	.	.	O	.	_	0	SENT_104	[p5l720t2338r966b2406],

1	2	LS	NUMBER	2	_	0	SENT_105	[p5l7t2519r60b2571],
2	.	.	O	.	_	0	SENT_105	[p5l7t2519r60b2571],

1	Discussion	NN	O	discussion	_	0	SENT_106	[p5l86t2517r430b2571],

1	Functional	JJ	O	functional	amod	2	SENT_107	[p5l111t2695r420b2750],
2	tests	NNS	O	test	nsubj	3	SENT_107	[p5l439t2703r574b2750],
3	developed	VBD	O	develop	ccomp	31	SENT_107	[p5l594t2695r902b2763],
4	to	TO	O	to	aux	5	SENT_107	[p5l922t2703r979b2750],
5	evaluate	VB	O	evaluate	xcomp	3	SENT_107	[p5l999t2695r1247b2750],
6	clopidogrel	NN	O	clopidogrel	nn	7	SENT_107	[p5l1268t2695r1599b2763],
7	pharmacodynam	NN	O	pharmacodynam	dobj	5	SENT_107	[p5l1619t2695r2151b2763],
8	—	CD	NUMBER	—	num	9	SENT_107	[p5l1619t2695r2151b2763],
9	ics	NNS	O	ic	nsubj	10	SENT_107	[p5l8t2785r83b2839],
10	include	VBP	O	include	rcmod	7	SENT_107	[p5l129t2784r348b2839],
11	light	JJ	O	light	amod	14	SENT_107	[p5l394t2784r944b2852],
12	—	JJ	O	—	amod	14	SENT_107	[p5l394t2784r944b2852],
13	transmission	NN	O	transmission	nn	14	SENT_107	[p5l394t2784r944b2852],
14	aggregometry	NN	O	aggregometry	dobj	10	SENT_107	[p5l989t2792r1423b2852],
15	,	,	O	,	_	0	SENT_107	[p5l989t2792r1423b2852],
16	VASP	NN	ORGANIZATION	vasp	nn	19	SENT_107	[p5l1466t2784r2152b2852],
17	—	NN	O	—	nn	19	SENT_107	[p5l1466t2784r2152b2852],
18	phosphorylation	NN	O	phosphorylation	nn	19	SENT_107	[p5l1466t2784r2152b2852],
19	assay	NN	O	assay	conj_and	14	SENT_107	[p5l8t2888r177b2941],
20	,	,	O	,	_	0	SENT_107	[p5l8t2888r177b2941],
21	and	CC	O	and	_	0	SENT_107	[p5l200t2872r308b2927],
22	whole	JJ	O	whole	amod	24	SENT_107	[p5l328t2872r708b2927],
23	—	JJ	O	—	amod	24	SENT_107	[p5l328t2872r708b2927],
24	blood	NN	O	blood	conj_and	14	SENT_107	[p5l328t2872r708b2927],
25	impedance	NN	O	impedance	nn	26	SENT_107	[p5l731t2872r1057b2941],
26	aggregometry	NN	O	aggregometry	dep	24	SENT_107	[p5l1079t2880r1508b2941],
27	,	,	O	,	_	0	SENT_107	[p5l1079t2880r1508b2941],
28	However	RB	O	however	advmod	24	SENT_107	[p5l1531t2876r1813b2936],
29	,	,	O	,	_	0	SENT_107	[p5l1531t2876r1813b2936],
30	there	EX	O	there	expl	31	SENT_107	[p5l1836t2872r1991b2927],
31	is	VBZ	O	be	_	0	SENT_107	[p5l2013t2873r2055b2927],
32	no	DT	O	no	det	33	SENT_107	[p5l2078t2888r2151b2927],
33	consensus	NN	O	consensus	nsubj	31	SENT_107	[p5l8t2977r309b3016],
34	regarding	VBG	O	regard	_	0	SENT_107	[p5l326t2961r614b3030],
35	the	DT	O	the	det	39	SENT_107	[p5l626t2961r721b3016],
36	optimal	JJ	O	optimal	amod	39	SENT_107	[p5l736t2961r963b3030],
37	drug	NN	O	drug	nn	39	SENT_107	[p5l979t2961r1117b3030],
38	monitoring	NN	O	monitoring	nn	39	SENT_107	[p5l1131t2962r1466b3030],
39	strategy	NN	O	strategy	prep_regarding	33	SENT_107	[p5l1481t2969r1731b3030],
40	.	.	O	.	_	0	SENT_107	[p5l1481t2969r1731b3030],

1	In	IN	O	in	_	0	SENT_108	[p5l1748t2964r1804b3015],
2	the	DT	O	the	det	4	SENT_108	[p5l1819t2961r1913b3016],
3	present	JJ	DATE	present	amod	4	SENT_108	[p5l1929t2969r2153b3030],
4	work	NN	O	work	prep_in	9	SENT_108	[p5l6t3050r175b3114],
5	,	,	O	,	_	0	SENT_108	[p5l6t3050r175b3114],
6	pharmacodynamic	JJ	O	pharmacodynamic	amod	7	SENT_108	[p5l201t3050r757b3119],
7	tests	NNS	O	test	nsubjpass	9	SENT_108	[p5l779t3058r914b3105],
8	were	VBD	O	be	auxpass	9	SENT_108	[p5l937t3066r1087b3105],
9	used	VBN	O	use	_	0	SENT_108	[p5l1112t3050r1250b3105],
10	to	TO	O	to	aux	11	SENT_108	[p5l1274t3058r1332b3105],
11	detect	VB	O	detect	xcomp	9	SENT_108	[p5l1356t3050r1541b3105],
12	high	JJ	O	high	acomp	11	SENT_108	[p5l1563t3050r1693b3119],
13	on	IN	O	on	_	0	SENT_108	[p5l1717t3050r2151b3119],
14	—	CD	NUMBER	—	num	15	SENT_108	[p5l1717t3050r2151b3119],
15	clopidogrel	NN	O	clopidogrel	prep_on	11	SENT_108	[p5l1717t3050r2151b3119],

1	94	CD	NUMBER	94	num	2	SENT_109	[p5l453t3195r482b3216],
2	Letter	NN	O	letter	_	0	SENT_109	[p5l1366t3196r1433b3216],
3	to	TO	O	to	_	0	SENT_109	[p5l1443t3197r1463b3216],
4	the	DT	O	the	det	5	SENT_109	[p5l1475t3194r1509b3216],
5	Editors	NNP	O	Editors	prep_to	2	SENT_109	[p5l1519t3194r1706b3221],
6	.	.	O	.	_	0	SENT_109	[p5l1519t3194r1706b3221],

1	—	NN	O	—	_	0	SENT_110	[p5l1519t3194r1706b3221],
2	.	.	O	.	_	0	SENT_110	[p5l1519t3194r1706b3221],

1	in	IN	O	in	_	0	SENT_111	[p5l1519t3194r1706b3221],
2	.	.	O	.	_	0	SENT_111	[p5l1519t3194r1706b3221],

1	—	NN	O	—	_	0	SENT_112	[p5l1519t3194r1706b3221],
2	.	.	O	.	_	0	SENT_112	[p5l1519t3194r1706b3221],

1	Chief	NNP	O	Chief	nn	3	SENT_113	[p5l1519t3194r1706b3221],
2	platelet	NN	O	platelet	nn	3	SENT_113	[p5l9t3333r231b3402],
3	reactivity	NN	O	reactivity	nsubj	16	SENT_113	[p5l256t3334r544b3402],
4	,	,	O	,	_	0	SENT_113	[p5l256t3334r544b3402],
5	which	WDT	O	which	nsubjpass	8	SENT_113	[p5l568t3333r752b3388],
6	has	VBZ	O	have	aux	8	SENT_113	[p5l778t3333r875b3388],
7	been	VBN	O	be	auxpass	8	SENT_113	[p5l900t3333r1044b3388],
8	associated	VBN	O	associate	rcmod	3	SENT_113	[p5l1069t3333r1371b3388],
9	with	IN	O	with	_	0	SENT_113	[p5l1395t3333r1533b3388],
10	an	DT	O	a	det	12	SENT_113	[p5l1558t3349r1628b3388],
11	increased	VBN	O	increase	amod	12	SENT_113	[p5l1654t3333r1933b3388],
12	risk	NN	O	risk	prep_with	8	SENT_113	[p5l1959t3333r2067b3388],
13	of	IN	O	of	_	0	SENT_113	[p5l2090t3333r2153b3388],
14	cardiovascular	JJ	O	cardiovascular	amod	15	SENT_113	[p5l9t3422r436b3477],
15	events	NNS	O	event	prep_of	12	SENT_113	[p5l463t3430r654b3477],
16	[	VBP	O	[	_	0	SENT_113	[p5l686t3422r777b3491],
17	1	CD	NUMBER	1	number	18	SENT_113	[p5l686t3422r777b3491],
18	]	CD	NUMBER	]	dobj	16	SENT_113	[p5l686t3422r777b3491],
19	.	.	O	.	_	0	SENT_113	[p5l686t3422r777b3491],

1	On	IN	O	on	_	0	SENT_114	[p5l805t3425r889b3477],
2	the	DT	O	the	det	4	SENT_114	[p5l917t3422r1011b3477],
3	other	JJ	O	other	amod	4	SENT_114	[p5l1039t3422r1199b3477],
4	hand	NN	O	hand	prep_on	8	SENT_114	[p5l1226t3422r1387b3485],
5	,	,	O	,	_	0	SENT_114	[p5l1226t3422r1387b3485],
6	genotyping	VBG	O	genotype	nsubjpass	8	SENT_114	[p5l1415t3423r1752b3491],
7	was	VBD	O	be	auxpass	8	SENT_114	[p5l1777t3438r1893b3477],
8	used	VBN	O	use	_	0	SENT_114	[p5l1922t3422r2059b3477],
9	to	TO	O	to	aux	10	SENT_114	[p5l2087t3430r2144b3477],
10	identify	VB	O	identify	ccomp	8	SENT_114	[p5l9t3511r236b3580],
11	a	DT	O	a	det	15	SENT_114	[p5l252t3527r283b3566],
12	genotype	NN	O	genotype	nn	15	SENT_114	[p5l300t3511r923b3580],
13	—	NN	O	—	nn	15	SENT_114	[p5l300t3511r923b3580],
14	phenotype	NN	O	phenotype	nn	15	SENT_114	[p5l300t3511r923b3580],
15	relationship	NN	O	relationship	dobj	10	SENT_114	[p5l942t3511r1294b3580],
16	and	CC	O	and	_	0	SENT_114	[p5l1312t3511r1420b3566],
17	to	TO	O	to	aux	18	SENT_114	[p5l1439t3520r1496b3566],
18	guide	VB	O	guide	conj_and	10	SENT_114	[p5l1513t3511r1676b3580],
19	the	DT	O	the	det	21	SENT_114	[p5l1694t3511r1789b3566],
20	therapeutic	JJ	O	therapeutic	amod	21	SENT_114	[p5l1806t3511r2146b3580],
21	management	NN	O	management	dobj	18	SENT_114	[p5l9t3608r402b3669],
22	to	TO	O	to	aux	23	SENT_114	[p5l426t3608r483b3655],
23	ensure	VB	O	ensure	xcomp	18	SENT_114	[p5l510t3616r708b3655],
24	a	DT	O	a	det	26	SENT_114	[p5l735t3616r766b3655],
25	rapid	JJ	O	rapid	amod	26	SENT_114	[p5l792t3600r944b3669],
26	achievement	NN	O	achievement	dobj	23	SENT_114	[p5l971t3600r1353b3655],
27	of	IN	O	of	_	0	SENT_114	[p5l1378t3600r1440b3655],
28	an	DT	O	a	det	31	SENT_114	[p5l1459t3616r1529b3655],
29	optimal	JJ	O	optimal	amod	31	SENT_114	[p5l1555t3600r1782b3669],
30	antiplatelet	JJ	O	antiplatelet	amod	31	SENT_114	[p5l1808t3600r2147b3669],
31	effect	NN	O	effect	prep_of	26	SENT_114	[p5l9t3690r182b3745],
32	.	.	O	.	_	0	SENT_114	[p5l9t3690r182b3745],

1	We	PRP	O	we	nsubj	2	SENT_115	[p6l108t27r212b79],
2	describe	VBP	O	describe	_	0	SENT_115	[p6l254t24r508b79],
3	the	DT	O	the	det	4	SENT_115	[p6l549t24r647b79],
4	management	NN	O	management	dobj	2	SENT_115	[p6l689t32r1094b92],
5	of	IN	O	of	_	0	SENT_115	[p6l1134t23r1198b79],
6	two	CD	NUMBER	two	num	7	SENT_115	[p6l1231t32r1348b79],
7	patients	NNS	O	patient	prep_of	4	SENT_115	[p6l1390t24r1635b92],
8	with	IN	O	with	_	0	SENT_115	[p6l1676t24r1817b79],
9	a	DT	O	a	det	11	SENT_115	[p6l1859t39r1890b79],
10	clinical	JJ	O	clinical	amod	11	SENT_115	[p6l1931t24r2145b79],
11	suspicion	NN	O	suspicion	prep_with	7	SENT_115	[p6l9t113r295b181],
12	of	IN	O	of	_	0	SENT_115	[p6l335t112r398b167],
13	clopidogrel	NN	O	clopidogrel	nn	14	SENT_115	[p6l431t112r774b181],
14	resistance	NN	O	resistance	prep_of	11	SENT_115	[p6l815t113r1134b168],
15	.	.	O	.	_	0	SENT_115	[p6l815t113r1134b168],

1	No	DT	O	no	det	5	SENT_116	[p6l1176t115r1259b167],
2	drug	NN	O	drug	nn	5	SENT_116	[p6l1299t112r1614b181],
3	—	NN	O	—	nn	5	SENT_116	[p6l1299t112r1614b181],
4	drug	NN	O	drug	nn	5	SENT_116	[p6l1299t112r1614b181],
5	interaction	NN	O	interaction	nsubjpass	7	SENT_116	[p6l1653t113r1987b167],
6	was	VBD	O	be	auxpass	7	SENT_116	[p6l2025t128r2144b167],
7	suspected	VBN	O	suspect	_	0	SENT_116	[p6l9t201r326b270],
8	.	.	O	.	_	0	SENT_116	[p6l9t201r326b270],

1	Both	DT	O	both	det	2	SENT_117	[p6l358t201r498b256],
2	patients	NNS	O	patient	nsubj	4	SENT_117	[p6l529t202r774b270],
3	were	VBD	O	be	aux	4	SENT_117	[p6l803t217r957b256],
4	taking	VBG	O	take	_	0	SENT_117	[p6l986t201r1179b270],
5	esomeprazole	NN	O	esomeprazole	dobj	4	SENT_117	[p6l1208t201r1647b270],
6	,	,	O	,	_	0	SENT_117	[p6l1208t201r1647b270],
7	which	WDT	O	which	nsubjpass	10	SENT_117	[p6l1677t201r1866b256],
8	was	VBD	O	be	auxpass	10	SENT_117	[p6l1895t217r2014b256],
9	not	RB	O	not	neg	10	SENT_117	[p6l2046t210r2147b256],
10	reported	VBN	O	report	rcmod	5	SENT_117	[p6l9t290r273b359],
11	to	TO	O	to	aux	12	SENT_117	[p6l301t298r359b345],
12	interfere	VB	O	interfere	xcomp	10	SENT_117	[p6l389t290r653b345],
13	with	IN	O	with	_	0	SENT_117	[p6l679t290r821b345],
14	clopidogrel	NN	O	clopidogrel	nn	15	SENT_117	[p6l849t290r1191b359],
15	metabolism	NN	O	metabolism	prep_with	12	SENT_117	[p6l1221t290r1582b345],
16	at	IN	O	at	_	0	SENT_117	[p6l1609t299r1666b345],
17	that	DT	O	that	det	18	SENT_117	[p6l1692t290r1815b345],
18	time	NN	O	time	prep_at	12	SENT_117	[p6l1842t291r1980b345],
19	[	CD	NUMBER	[	number	20	SENT_117	[p6l2012t290r2144b359],
20	13	CD	NUMBER	13	num	21	SENT_117	[p6l2012t290r2144b359],
21	]	NN	O	]	dep	12	SENT_117	[p6l2012t290r2144b359],
22	.	.	O	.	_	0	SENT_117	[p6l2012t290r2144b359],

1	However	RB	O	however	advmod	14	SENT_118	[p6l9t383r300b443],
2	,	,	O	,	_	0	SENT_118	[p6l9t383r300b443],
3	the	DT	O	the	det	4	SENT_118	[p6l330t380r427b435],
4	possibility	NN	O	possibility	nsubjpass	14	SENT_118	[p6l457t380r772b448],
5	of	IN	O	of	_	0	SENT_118	[p6l799t380r863b435],
6	a	DT	O	a	det	10	SENT_118	[p6l884t396r915b435],
7	drug	NN	O	drug	nn	10	SENT_118	[p6l944t380r1259b448],
8	—	NN	O	—	nn	10	SENT_118	[p6l944t380r1259b448],
9	drug	NN	O	drug	nn	10	SENT_118	[p6l944t380r1259b448],
10	interaction	NN	O	interaction	prep_of	4	SENT_118	[p6l1287t381r1621b435],
11	can	MD	O	can	aux	14	SENT_118	[p6l1650t388r1859b435],
12	not	RB	O	not	neg	14	SENT_118	[p6l1650t388r1859b435],
13	be	VB	O	be	auxpass	14	SENT_118	[p6l1886t380r1956b435],
14	ruled	VBN	O	rule	_	0	SENT_118	[p6l1987t380r2145b435],
15	out	RP	O	out	prt	14	SENT_118	[p6l9t477r109b524],
16	regarding	VBG	O	regard	_	0	SENT_118	[p6l135t469r431b537],
17	more	RBR	O	more	advmod	19	SENT_118	[p6l457t484r615b524],
18	recent	JJ	O	recent	amod	19	SENT_118	[p6l642t477r835b524],
19	data	NNS	O	datum	prep_regarding	14	SENT_118	[p6l860t469r991b524],
20	reporting	VBG	O	report	partmod	19	SENT_118	[p6l1017t469r1305b537],
21	an	DT	O	a	det	23	SENT_118	[p6l1330t484r1402b524],
22	increased	VBN	O	increase	amod	23	SENT_118	[p6l1429t469r1719b524],
23	risk	NN	O	risk	dobj	20	SENT_118	[p6l1747t469r1858b524],
24	of	IN	O	of	_	0	SENT_118	[p6l1884t468r1947b524],
25	major	JJ	O	major	amod	28	SENT_118	[p6l1967t469r2147b537],
26	adverse	JJ	O	adverse	amod	28	SENT_118	[p6l8t557r245b612],
27	cardiovascular	JJ	O	cardiovascular	amod	28	SENT_118	[p6l292t557r739b612],
28	events	NNS	O	event	prep_of	23	SENT_118	[p6l785t565r984b612],
29	in	IN	O	in	_	0	SENT_118	[p6l1032t558r1089b611],
30	patients	NNS	O	patient	prep_in	28	SENT_118	[p6l1137t558r1383b626],
31	receiving	VBG	O	receive	partmod	30	SENT_118	[p6l1431t558r1713b626],
32	concomitant	JJ	O	concomitant	amod	38	SENT_118	[p6l1760t558r2147b612],
33	clopidogrel	NN	O	clopidogrel	nn	38	SENT_118	[p6l9t646r589b715],
34	—	NN	O	—	nn	38	SENT_118	[p6l9t646r589b715],
35	proton	NN	O	proton	nn	38	SENT_118	[p6l9t646r589b715],
36	pump	NN	O	pump	nn	38	SENT_118	[p6l616t662r794b715],
37	inhibitor	NN	O	inhibitor	nn	38	SENT_118	[p6l821t646r1089b701],
38	therapy	NN	O	therapy	dobj	31	SENT_118	[p6l1113t646r1364b715],
39	,	,	O	,	_	0	SENT_118	[p6l1113t646r1364b715],
40	including	VBG	O	include	_	0	SENT_118	[p6l1392t646r1679b715],
41	esomeprazole	NN	O	esomeprazole	prep_including	38	SENT_118	[p6l1705t646r2144b715],
42	,	,	O	,	_	0	SENT_118	[p6l1705t646r2144b715],
43	compared	VBN	O	compare	_	0	SENT_118	[p6l9t735r318b804],
44	with	IN	O	with	prepc_compared_with	14	SENT_118	[p6l366t735r509b790],
45	clopidogrel	NN	O	clopidogrel	pobj	14	SENT_118	[p6l557t735r907b804],
46	alone	RB	O	alone	advmod	45	SENT_118	[p6l955t735r1123b790],
47	[	RB	O	[	advmod	49	SENT_118	[p6l1175t735r1310b804],
48	14	CD	NUMBER	14	num	49	SENT_118	[p6l1175t735r1310b804],
49	]	NN	O	]	rcmod	45	SENT_118	[p6l1175t735r1310b804],
50	.	.	O	.	_	0	SENT_118	[p6l1175t735r1310b804],

1	Statin	NN	O	statin	nn	2	SENT_119	[p6l1360t736r1539b790],
2	therapy	NN	O	therapy	nsubjpass	5	SENT_119	[p6l1587t735r1830b804],
3	was	VBD	O	be	auxpass	5	SENT_119	[p6l1874t751r1995b790],
4	not	RB	O	not	neg	5	SENT_119	[p6l2045t743r2146b790],
5	discontinuated	VBN	O	discontinuate	_	0	SENT_119	[p6l9t824r465b879],
6	given	VBN	O	give	prep	5	SENT_119	[p6l507t825r673b893],
7	the	DT	O	the	det	8	SENT_119	[p6l715t824r812b879],
8	lack	NN	O	lack	dep	6	SENT_119	[p6l855t824r976b879],
9	of	IN	O	of	_	0	SENT_119	[p6l1017t824r1081b879],
10	evidence	NN	O	evidence	prep_of	8	SENT_119	[p6l1115t824r1387b879],
11	of	IN	O	of	_	0	SENT_119	[p6l1429t824r1493b879],
12	a	DT	O	a	det	16	SENT_119	[p6l1527t840r1558b879],
13	clopidogrel	NN	O	clopidogrel	nn	16	SENT_119	[p6l1600t824r2145b893],
14	—	NN	O	—	nn	16	SENT_119	[p6l1600t824r2145b893],
15	statin	NN	O	statin	nn	16	SENT_119	[p6l1600t824r2145b893],
16	interaction	NN	O	interaction	prep_of	10	SENT_119	[p6l9t915r343b969],
17	reported	VBN	O	report	partmod	16	SENT_119	[p6l368t914r631b982],
18	in	IN	O	in	_	0	SENT_119	[p6l657t915r713b968],
19	the	DT	O	the	det	21	SENT_119	[p6l737t914r834b969],
20	CHARISMA	NN	O	charisma	nn	21	SENT_119	[p6l859t916r1196b969],
21	trial	NN	O	trial	prep_in	17	SENT_119	[p6l1218t914r1340b969],
22	[	CD	NUMBER	[	number	23	SENT_119	[p6l1369t914r1502b982],
23	15	CD	NUMBER	15	num	24	SENT_119	[p6l1369t914r1502b982],
24	]	NN	O	]	dep	17	SENT_119	[p6l1369t914r1502b982],
25	.	.	O	.	_	0	SENT_119	[p6l1369t914r1502b982],

1	The	DT	O	the	det	2	SENT_120	[p6l108t1003r218b1058],
2	results	NNS	O	result	nsubj	3	SENT_120	[p6l244t1003r441b1058],
3	suggested	VBD	O	suggest	_	0	SENT_120	[p6l468t1002r764b1071],
4	a	DT	O	a	det	6	SENT_120	[p6l790t1018r821b1058],
5	pharmacokinetic	JJ	O	pharmacokinetic	amod	6	SENT_120	[p6l846t1003r1351b1071],
6	origin	NN	O	origin	dobj	3	SENT_120	[p6l1375t1003r1550b1071],
7	in	IN	O	in	_	0	SENT_120	[p6l1576t1003r1631b1057],
8	the	DT	O	the	det	10	SENT_120	[p6l1656t1003r1751b1058],
9	ﬁrst	JJ	O	ﬁrst	amod	10	SENT_120	[p6l1777t1002r1896b1058],
10	patient	NN	O	patient	prep_in	3	SENT_120	[p6l1919t1003r2144b1071],
11	,	,	O	,	_	0	SENT_120	[p6l1919t1003r2144b1071],
12	who	WP	O	who	nsubj	13	SENT_120	[p6l7t1091r140b1146],
13	had	VBD	O	have	rcmod	10	SENT_120	[p6l159t1091r268b1146],
14	two	CD	NUMBER	two	num	16	SENT_120	[p6l287t1099r401b1146],
15	loss	NN	O	loss	nn	16	SENT_120	[p6l421t1091r897b1146],
16	—	NN	O	—	dobj	13	SENT_120	[p6l421t1091r897b1146],
17	of	IN	O	of	_	0	SENT_120	[p6l421t1091r897b1146],
18	—	CD	NUMBER	—	num	19	SENT_120	[p6l421t1091r897b1146],
19	function	NN	O	function	prep_of	16	SENT_120	[p6l421t1091r897b1146],
20	2	CD	NUMBER	2	num	22	SENT_120	[p6l911t1094r948b1145],
21	C19	NN	O	c19	nn	22	SENT_120	[p6l969t1091r1140b1146],
22	*	NN	O	*	dep	19	SENT_120	[p6l969t1091r1140b1146],
23	2	CD	NUMBER	2	num	24	SENT_120	[p6l969t1091r1140b1146],
24	alleles	NNS	O	allele	dep	22	SENT_120	[p6l1158t1091r1358b1147],
25	.	.	O	.	_	0	SENT_120	[p6l1158t1091r1358b1147],

1	Recently	RB	DATE	recently	advmod	4	SENT_121	[p6l1377t1091r1647b1160],
2	,	,	O	,	_	0	SENT_121	[p6l1377t1091r1647b1160],
3	we	PRP	O	we	nsubj	4	SENT_121	[p6l1665t1107r1755b1146],
4	showed	VBD	O	show	_	0	SENT_121	[p6l1774t1091r2007b1146],
5	that	IN	O	that	complm	25	SENT_121	[p6l2026t1091r2148b1146],
6	the	DT	O	the	det	9	SENT_121	[p6l8t1180r103b1235],
7	negative	JJ	O	negative	amod	9	SENT_121	[p6l133t1181r387b1249],
8	pharmacokinetic	JJ	O	pharmacokinetic	amod	9	SENT_121	[p6l416t1180r922b1249],
9	impact	NN	O	impact	dep	14	SENT_121	[p6l950t1181r1156b1249],
10	of	IN	O	of	_	0	SENT_121	[p6l1184t1180r1246b1235],
11	one	CD	NUMBER	one	prep_of	9	SENT_121	[p6l1268t1196r1377b1235],
12	*	NN	O	*	dep	14	SENT_121	[p6l1406t1180r1466b1234],
13	2	CD	NUMBER	2	num	12	SENT_121	[p6l1406t1180r1466b1234],
14	allele	NN	O	allele	dep	21	SENT_121	[p6l1497t1180r1653b1235],
15	of	IN	O	of	_	0	SENT_121	[p6l1682t1180r1745b1235],
16	the	DT	O	the	det	19	SENT_121	[p6l1765t1180r1861b1235],
17	CYP2C	NN	O	cyp2c	nn	19	SENT_121	[p6l1891t1183r2077b1235],
18	19	CD	NUMBER	19	num	19	SENT_121	[p6l2083t1183r2146b1235],
19	gene	NN	O	gene	prep_of	14	SENT_121	[p6l7t1285r150b1338],
20	(	CD	NUMBER	(	num	21	SENT_121	[p6l175t1269r626b1338],
21	CYP2C19	NN	O	cyp2c19	dep	22	SENT_121	[p6l175t1269r626b1338],
22	*	NN	O	*	dep	25	SENT_121	[p6l175t1269r626b1338],
23	1	CD	NUMBER	1	num	22	SENT_121	[p6l175t1269r626b1338],
24	/	:	O	/	punct	25	SENT_121	[p6l175t1269r626b1338],
25	*	CD	NUMBER	*	dep	4	SENT_121	[p6l175t1269r626b1338],
26	2	CD	NUMBER	2	num	27	SENT_121	[p6l175t1269r626b1338],
27	)	NN	O	)	dep	25	SENT_121	[p6l175t1269r626b1338],
28	on	IN	O	on	_	0	SENT_121	[p6l652t1285r726b1324],
29	the	DT	O	the	det	31	SENT_121	[p6l746t1269r842b1324],
30	pharmacodynamic	JJ	O	pharmacodynamic	amod	31	SENT_121	[p6l862t1269r1424b1338],
31	response	NN	O	response	prep_on	27	SENT_121	[p6l1444t1285r1711b1338],
32	to	TO	O	to	_	0	SENT_121	[p6l1730t1278r1789b1324],
33	clopidogrel	NN	O	clopidogrel	prep_to	27	SENT_121	[p6l1810t1269r2145b1338],
34	could	MD	O	could	aux	36	SENT_121	[p6l9t1358r170b1413],
35	be	VB	O	be	auxpass	36	SENT_121	[p6l197t1358r267b1413],
36	reversed	VBN	O	reverse	dep	25	SENT_121	[p6l294t1358r551b1413],
37	in	IN	O	in	_	0	SENT_121	[p6l578t1359r633b1413],
38	healthy	JJ	O	healthy	amod	39	SENT_121	[p6l660t1358r885b1427],
39	volunteers	NNS	O	volunteer	prep_in	36	SENT_121	[p6l908t1358r1227b1413],
40	by	IN	O	by	_	0	SENT_121	[p6l1253t1358r1327b1427],
41	using	VBG	O	use	agent	36	SENT_121	[p6l1350t1359r1512b1427],
42	higher	JJR	O	higher	amod	44	SENT_121	[p6l1537t1358r1732b1427],
43	maintenance	NN	O	maintenance	nn	44	SENT_121	[p6l1757t1359r2146b1413],
44	doses	NNS	O	dose	dobj	41	SENT_121	[p6l9t1448r173b1503],
45	of	IN	O	of	_	0	SENT_121	[p6l212t1448r276b1503],
46	clopidogrel	NN	O	clopidogrel	prep_of	44	SENT_121	[p6l306t1448r641b1516],
47	[	CD	NUMBER	[	number	48	SENT_121	[p6l682t1448r812b1516],
48	10	CD	NUMBER	10	num	49	SENT_121	[p6l682t1448r812b1516],
49	]	NN	O	]	dep	46	SENT_121	[p6l682t1448r812b1516],
50	.	.	O	.	_	0	SENT_121	[p6l682t1448r812b1516],

1	However	RB	O	however	advmod	5	SENT_122	[p6l851t1451r1136b1511],
2	,	,	O	,	_	0	SENT_122	[p6l851t1451r1136b1511],
3	this	DT	O	this	det	4	SENT_122	[p6l1175t1448r1283b1503],
4	strategy	NN	O	strategy	nsubj	5	SENT_122	[p6l1323t1456r1565b1516],
5	is	VBZ	O	be	_	0	SENT_122	[p6l1601t1449r1645b1503],
6	far	RB	O	far	_	0	SENT_122	[p6l1684t1448r1764b1503],
7	from	IN	O	from	_	0	SENT_122	[p6l1800t1448r1943b1503],
8	being	VBG	O	be	cop	9	SENT_122	[p6l1981t1448r2147b1516],
9	effective	JJ	O	effective	prepc_far_from	5	SENT_122	[p6l9t1536r261b1592],
10	in	IN	O	in	_	0	SENT_122	[p6l281t1537r336b1591],
11	all	DT	O	all	det	14	SENT_122	[p6l355t1536r423b1592],
12	poor	JJ	O	poor	amod	14	SENT_122	[p6l443t1537r1010b1605],
13	—	NN	O	—	nn	14	SENT_122	[p6l443t1537r1010b1605],
14	metabolizers	NNS	O	metabolizer	prep_in	9	SENT_122	[p6l443t1537r1010b1605],
15	,	,	O	,	_	0	SENT_122	[p6l443t1537r1010b1605],
16	as	RB	O	as	advmod	17	SENT_122	[p6l1031t1552r1090b1592],
17	recently	RB	DATE	recently	advmod	18	SENT_122	[p6l1110t1537r1354b1605],
18	published	VBN	O	publish	partmod	14	SENT_122	[p6l1372t1537r1666b1605],
19	[	NN	O	[	nn	21	SENT_122	[p6l1688t1536r1818b1605],
20	16	CD	NUMBER	16	num	21	SENT_122	[p6l1688t1536r1818b1605],
21	]	NN	O	]	dobj	18	SENT_122	[p6l1688t1536r1818b1605],
22	.	.	O	.	_	0	SENT_122	[p6l1688t1536r1818b1605],

1	Moreover	RB	O	moreover	advmod	20	SENT_123	[p6l1839t1540r2144b1600],
2	,	,	O	,	_	0	SENT_123	[p6l1839t1540r2144b1600],
3	in	IN	O	in	mark	5	SENT_123	[p6l9t1626r64b1679],
4	CYP2C19	NN	O	cyp2c19	nn	5	SENT_123	[p6l95t1625r496b1689],
5	*	NN	O	*	advcl	20	SENT_123	[p6l95t1625r496b1689],
6	2	CD	NUMBER	2	dep	5	SENT_123	[p6l95t1625r496b1689],
7	/	:	O	/	punct	5	SENT_123	[p6l95t1625r496b1689],
8	*	CD	NUMBER	*	num	10	SENT_123	[p6l95t1625r496b1689],
9	2	CD	NUMBER	2	num	10	SENT_123	[p6l95t1625r496b1689],
10	patients	NNS	O	patient	dep	5	SENT_123	[p6l527t1626r766b1694],
11	with	IN	O	with	_	0	SENT_123	[p6l795t1625r934b1680],
12	high	JJ	O	high	amod	16	SENT_123	[p6l964t1625r1096b1694],
13	on	IN	O	on	_	0	SENT_123	[p6l1125t1641r1199b1680],
14	clopidogrel	NN	O	clopidogrel	nn	15	SENT_123	[p6l1230t1625r1564b1694],
15	platelet	NN	O	platelet	prep_on	12	SENT_123	[p6l1596t1625r1822b1694],
16	reactivity	NN	O	reactivity	prep_with	10	SENT_123	[p6l1851t1626r2144b1694],
17	,	,	O	,	_	0	SENT_123	[p6l1851t1626r2144b1694],
18	CYP2C19	NN	O	cyp2c19	nsubj	20	SENT_123	[p6l9t1717r276b1769],
19	is	VBZ	O	be	cop	20	SENT_123	[p6l301t1715r344b1769],
20	inactive	JJ	O	inactive	_	0	SENT_123	[p6l370t1715r603b1769],
21	and	CC	O	and	_	0	SENT_123	[p6l627t1714r736b1769],
22	increasing	VBG	O	increase	csubj	28	SENT_123	[p6l762t1715r1069b1783],
23	the	DT	O	the	det	25	SENT_123	[p6l1091t1714r1186b1769],
24	clopidogrel	NN	O	clopidogrel	nn	25	SENT_123	[p6l1210t1714r1545b1783],
25	dosage	NN	O	dosage	dobj	22	SENT_123	[p6l1570t1714r1776b1783],
26	is	VBZ	O	be	cop	28	SENT_123	[p6l1801t1715r1845b1769],
27	therefore	RB	O	therefore	advmod	28	SENT_123	[p6l1868t1714r2145b1769],
28	likely	JJ	O	likely	conj_and	20	SENT_123	[p6l9t1803r171b1872],
29	to	TO	O	to	aux	30	SENT_123	[p6l186t1812r245b1858],
30	fail	VB	O	fail	xcomp	28	SENT_123	[p6l262t1803r365b1859],
31	.	.	O	.	_	0	SENT_123	[p6l262t1803r365b1859],

1	CY	NN	O	cy	nn	2	SENT_124	[p6l384t1806r463b1858],
2	P2C1	NN	O	p2c1	nsubj	30	SENT_124	[p6l465t1806r606b1858],
3	9	CD	NUMBER	9	num	5	SENT_124	[p6l617t1806r651b1858],
4	loss	NN	O	loss	nn	5	SENT_124	[p6l669t1803r1144b1858],
5	—	NN	O	—	nsubj	10	SENT_124	[p6l669t1803r1144b1858],
6	of	IN	O	of	_	0	SENT_124	[p6l669t1803r1144b1858],
7	—	CD	NUMBER	—	num	8	SENT_124	[p6l669t1803r1144b1858],
8	function	NN	O	function	prep_of	5	SENT_124	[p6l669t1803r1144b1858],
9	variant	JJ	O	variant	amod	8	SENT_124	[p6l1159t1804r1373b1858],
10	explains	VBZ	O	explain	rcmod	2	SENT_124	[p6l1389t1803r1637b1872],
11	only	RB	O	only	quantmod	13	SENT_124	[p6l1654t1803r1785b1872],
12	around	RB	O	around	quantmod	13	SENT_124	[p6l1801t1803r2013b1858],
13	10	CD	PERCENT	10	num	14	SENT_124	[p6l2035t1806r2147b1858],
14	%	NN	PERCENT	%	dobj	10	SENT_124	[p6l2035t1806r2147b1858],
15	of	IN	O	of	_	0	SENT_124	[p6l9t1892r71b1947],
16	the	DT	O	the	det	17	SENT_124	[p6l82t1892r178b1947],
17	variability	NN	O	variability	prep_of	14	SENT_124	[p6l194t1892r500b1961],
18	in	IN	O	in	_	0	SENT_124	[p6l517t1893r572b1947],
19	antiplatelet	JJ	O	antiplatelet	amod	20	SENT_124	[p6l590t1892r934b1961],
20	effect	NN	O	effect	prep_in	17	SENT_124	[p6l951t1892r1128b1956],
21	,	,	O	,	_	0	SENT_124	[p6l951t1892r1128b1956],
22	and	CC	O	and	_	0	SENT_124	[p6l1147t1892r1257b1947],
23	a	DT	O	a	det	25	SENT_124	[p6l1276t1908r1307b1947],
24	recent	JJ	O	recent	amod	25	SENT_124	[p6l1326t1901r1516b1947],
25	study	NN	O	study	conj_and	14	SENT_124	[p6l1533t1892r1698b1961],
26	from	IN	O	from	_	0	SENT_124	[p6l1715t1892r1859b1947],
27	Barker	NNP	PERSON	Barker	prep_from	25	SENT_124	[p6l1877t1892r2073b1947],
28	et	FW	O	et	nn	29	SENT_124	[p6l2090t1900r2147b1947],
29	al.	FW	O	al.	dep	25	SENT_124	[p6l8t1982r72b2037],
30	suggested	VBD	O	suggest	_	0	SENT_124	[p6l94t1982r391b2050],
31	that	IN	O	that	complm	40	SENT_124	[p6l411t1982r531b2037],
32	carriage	NN	O	carriage	nsubj	40	SENT_124	[p6l550t1983r788b2050],
33	of	IN	O	of	_	0	SENT_124	[p6l808t1982r871b2037],
34	one	CD	NUMBER	one	num	35	SENT_124	[p6l883t1998r992b2037],
35	*	NN	O	*	prep_of	32	SENT_124	[p6l1013t1982r1073b2036],
36	2	CD	NUMBER	2	num	37	SENT_124	[p6l1013t1982r1073b2036],
37	allele	NN	O	allele	dep	35	SENT_124	[p6l1094t1982r1250b2037],
38	did	VBD	O	do	aux	40	SENT_124	[p6l1271t1982r1364b2037],
39	not	RB	O	not	neg	40	SENT_124	[p6l1386t1990r1486b2037],
40	seem	VB	O	seem	ccomp	30	SENT_124	[p6l1505t1998r1661b2037],
41	to	TO	O	to	aux	42	SENT_124	[p6l1679t1990r1738b2037],
42	have	VB	O	have	xcomp	40	SENT_124	[p6l1758t1982r1899b2037],
43	a	DT	O	a	det	45	SENT_124	[p6l1919t1998r1950b2037],
44	major	JJ	O	major	amod	45	SENT_124	[p6l1970t1983r2147b2050],
45	inﬂuence	NN	O	inﬂuence	dobj	42	SENT_124	[p6l9t2070r284b2126],
46	on	IN	O	on	_	0	SENT_124	[p6l317t2086r392b2126],
47	dose	NN	O	dose	nn	48	SENT_124	[p6l423t2071r561b2126],
48	effect	NN	O	effect	prep_on	45	SENT_124	[p6l593t2070r769b2126],
49	.	.	O	.	_	0	SENT_124	[p6l593t2070r769b2126],

1	Interestingly	RB	O	interestingly	advmod	17	SENT_125	[p6l803t2071r1195b2139],
2	,	,	O	,	_	0	SENT_125	[p6l803t2071r1195b2139],
3	a	DT	O	a	det	4	SENT_125	[p6l1228t2086r1259b2126],
4	lack	NN	O	lack	nsubjpass	17	SENT_125	[p6l1291t2071r1411b2126],
5	of	IN	O	of	_	0	SENT_125	[p6l1440t2070r1503b2126],
6	effect	NN	O	effect	prep_of	4	SENT_125	[p6l1528t2070r1692b2126],
7	of	IN	O	of	_	0	SENT_125	[p6l1723t2070r1785b2126],
8	clopidogrel	NN	O	clopidogrel	prep_of	6	SENT_125	[p6l1810t2071r2145b2139],
9	increasing	VBG	O	increase	partmod	8	SENT_125	[p6l9t2160r316b2228],
10	dose	NN	O	dose	nn	11	SENT_125	[p6l347t2159r484b2214],
11	(	NN	O	(	dobj	9	SENT_125	[p6l519t2159r601b2227],
12	at	IN	O	at	_	0	SENT_125	[p6l519t2159r601b2227],
13	150	CD	NUMBER	150	num	15	SENT_125	[p6l634t2162r741b2214],
14	mg	NN	O	mg	nn	15	SENT_125	[p6l763t2159r880b2228],
15	)	NN	O	)	prep_at	9	SENT_125	[p6l763t2159r880b2228],
16	was	VBD	O	be	auxpass	17	SENT_125	[p6l915t2175r1033b2214],
17	reported	VBN	O	report	_	0	SENT_125	[p6l1066t2159r1324b2228],
18	by	IN	O	by	prep	17	SENT_125	[p6l1356t2159r1430b2228],
19	in	IN	O	in	dep	27	SENT_125	[p6l1460t2160r1515b2213],
20	the	DT	O	the	det	22	SENT_125	[p6l1546t2159r1642b2214],
21	small	JJ	O	small	amod	22	SENT_125	[p6l1675t2159r1833b2214],
22	cohort	NN	O	cohort	pobj	19	SENT_125	[p6l1865t2159r2060b2214],
23	of	IN	O	of	_	0	SENT_125	[p6l2090t2159r2153b2214],
24	2	CD	NUMBER	2	num	26	SENT_125	[p6l9t2251r41b2302],
25	C19	NN	O	c19	nn	26	SENT_125	[p6l64t2248r329b2312],
26	*	NN	O	*	prep_of	22	SENT_125	[p6l64t2248r329b2312],
27	2	CD	NUMBER	2	dep	18	SENT_125	[p6l64t2248r329b2312],
28	/	:	O	/	punct	27	SENT_125	[p6l64t2248r329b2312],
29	*	CD	NUMBER	*	number	30	SENT_125	[p6l64t2248r329b2312],
30	2	CD	NUMBER	2	num	31	SENT_125	[p6l64t2248r329b2312],
31	patients	NNS	O	patient	tmod	17	SENT_125	[p6l357t2249r596b2317],
32	enrolled	VBN	O	enrol	partmod	31	SENT_125	[p6l623t2248r869b2303],
33	in	IN	O	in	_	0	SENT_125	[p6l896t2249r952b2302],
34	this	DT	O	this	det	36	SENT_125	[p6l976t2248r1085b2303],
35	study	NN	O	study	nn	36	SENT_125	[p6l1112t2248r1277b2317],
36	[	NN	O	[	prep_in	32	SENT_125	[p6l1305t2248r1435b2317],
37	17	CD	NUMBER	17	num	38	SENT_125	[p6l1305t2248r1435b2317],
38	]	NN	O	]	dep	31	SENT_125	[p6l1305t2248r1435b2317],
39	.	.	O	.	_	0	SENT_125	[p6l1305t2248r1435b2317],

1	In	IN	O	in	_	0	SENT_126	[p6l1461t2251r1518b2303],
2	such	JJ	O	such	amod	3	SENT_126	[p6l1544t2248r1680b2303],
3	patients	NNS	O	patient	prep_in	19	SENT_126	[p6l1705t2249r1960b2317],
4	,	,	O	,	_	0	SENT_126	[p6l1705t2249r1960b2317],
5	other	JJ	O	other	amod	6	SENT_126	[p6l1986t2248r2147b2303],
6	isoenzymes	NNS	O	isoenzyme	nsubj	19	SENT_126	[p6l9t2338r357b2406],
7	including	VBG	O	include	_	0	SENT_126	[p6l396t2337r677b2406],
8	CYP2C9	NN	O	cyp2c9	prep_including	6	SENT_126	[p6l712t2340r956b2401],
9	,	,	O	,	_	0	SENT_126	[p6l712t2340r956b2401],
10	3A4	NN	O	3a4	appos	8	SENT_126	[p6l993t2340r1125b2401],
11	,	,	O	,	_	0	SENT_126	[p6l993t2340r1125b2401],
12	3A5	NN	O	3a5	conj_and	10	SENT_126	[p6l1161t2340r1293b2401],
13	,	,	O	,	_	0	SENT_126	[p6l1161t2340r1293b2401],
14	and	CC	O	and	_	0	SENT_126	[p6l1330t2337r1440b2392],
15	2B6	NN	O	2b6	appos	8	SENT_126	[p6l1478t2340r1590b2392],
16	were	VBD	O	be	cop	19	SENT_126	[p6l1625t2353r1776b2392],
17	clearly	RB	O	clearly	advmod	19	SENT_126	[p6l1813t2337r2012b2406],
18	not	RB	O	not	neg	19	SENT_126	[p6l2048t2346r2147b2392],
19	sufﬁcient	JJ	O	sufﬁcient	_	0	SENT_126	[p6l9t2426r286b2481],
20	to	TO	O	to	aux	21	SENT_126	[p6l309t2435r366b2481],
21	convert	VB	O	convert	xcomp	19	SENT_126	[p6l392t2434r619b2481],
22	clopidogrel	NN	O	clopidogrel	dobj	21	SENT_126	[p6l643t2426r978b2495],
23	to	TO	O	to	_	0	SENT_126	[p6l1003t2434r1060b2481],
24	its	PRP$	O	its	poss	26	SENT_126	[p6l1087t2427r1154b2481],
25	active	JJ	O	active	amod	26	SENT_126	[p6l1179t2427r1354b2481],
26	metabolite	NN	O	metabolite	prep_to	21	SENT_126	[p6l1380t2426r1715b2482],
27	.	.	O	.	_	0	SENT_126	[p6l1380t2426r1715b2482],

1	The	DT	O	the	det	2	SENT_127	[p6l1738t2426r1848b2481],
2	biotrans	NNS	O	biotran	nsubj	3	SENT_127	[p6l1873t2426r2145b2481],
3	—	VBP	O	—	_	0	SENT_127	[p6l1873t2426r2145b2481],
4	formation	NN	O	formation	nn	5	SENT_127	[p6l9t2516r306b2571],
5	pathway	NN	O	pathway	nsubj	8	SENT_127	[p6l333t2516r596b2584],
6	of	IN	O	of	_	0	SENT_127	[p6l620t2516r684b2571],
7	ticlopidine	NN	O	ticlopidine	prep_of	5	SENT_127	[p6l701t2516r1021b2584],
8	differs	VBZ	O	differ	ccomp	3	SENT_127	[p6l1047t2516r1234b2571],
9	from	IN	O	from	_	0	SENT_127	[p6l1262t2516r1405b2571],
10	that	DT	O	that	prep_from	8	SENT_127	[p6l1431t2516r1551b2571],
11	of	IN	O	of	_	0	SENT_127	[p6l1577t2516r1639b2571],
12	clopidogrel	NN	O	clopidogrel	prep_of	10	SENT_127	[p6l1658t2516r2007b2584],
13	,	,	O	,	_	0	SENT_127	[p6l1658t2516r2007b2584],
14	and	CC	O	and	_	0	SENT_127	[p6l2035t2516r2145b2571],
15	this	DT	O	this	det	16	SENT_127	[p6l8t2605r116b2660],
16	drug	NN	O	drug	nsubjpass	19	SENT_127	[p6l139t2605r278b2673],
17	has	VBZ	O	have	aux	19	SENT_127	[p6l300t2605r398b2660],
18	been	VBN	O	be	auxpass	19	SENT_127	[p6l419t2605r564b2660],
19	used	VBN	O	use	conj_and	3	SENT_127	[p6l586t2605r724b2660],
20	to	TO	O	to	aux	21	SENT_127	[p6l746t2613r804b2660],
21	achieve	VB	O	achieve	xcomp	19	SENT_127	[p6l826t2605r1052b2660],
22	adequate	JJ	O	adequate	amod	24	SENT_127	[p6l1073t2605r1348b2673],
23	platelet	NN	O	platelet	nn	24	SENT_127	[p6l1371t2605r1597b2673],
24	inhibition	NN	O	inhibition	nsubj	27	SENT_127	[p6l1618t2605r1910b2660],
25	[	CD	NUMBER	[	number	26	SENT_127	[p6l1934t2604r2064b2673],
26	18	CD	NUMBER	18	num	27	SENT_127	[p6l1934t2604r2064b2673],
27	]	NN	O	]	xcomp	21	SENT_127	[p6l1934t2604r2064b2673],
28	.	.	O	.	_	0	SENT_127	[p6l1934t2604r2064b2673],

1	New	NNP	O	New	amod	2	SENT_128	[p6l111t2696r251b2748],
2	antiplatelet	JJ	O	antiplatelet	amod	3	SENT_128	[p6l274t2693r626b2762],
3	agents	NNS	O	agent	nsubj	22	SENT_128	[p6l650t2701r863b2762],
4	,	,	O	,	_	0	SENT_128	[p6l650t2701r863b2762],
5	such	JJ	O	such	_	0	SENT_128	[p6l890t2693r1028b2748],
6	as	IN	O	as	_	0	SENT_128	[p6l1054t2709r1113b2748],
7	prasugrel	NN	O	prasugrel	prep_such_as	19	SENT_128	[p6l1140t2693r1427b2762],
8	[	CD	NUMBER	[	number	9	SENT_128	[p6l1456t2693r1687b2762],
9	19	CD	NUMBER	19	num	10	SENT_128	[p6l1456t2693r1687b2762],
10	—	NN	O	—	dep	7	SENT_128	[p6l1456t2693r1687b2762],
11	21	CD	NUMBER	21	num	12	SENT_128	[p6l1456t2693r1687b2762],
12	]	NN	O	]	dep	7	SENT_128	[p6l1456t2693r1687b2762],
13	and	CC	O	and	_	0	SENT_128	[p6l1716t2693r1827b2748],
14	ticagrelor	NN	O	ticagrelor	prep_such_as	19	SENT_128	[p6l1853t2693r2147b2762],
15	[	CD	NUMBER	[	number	16	SENT_128	[p6l12t2782r261b2851],
16	22	CD	NUMBER	22	num	17	SENT_128	[p6l12t2782r261b2851],
17	—	NN	O	—	dep	14	SENT_128	[p6l12t2782r261b2851],
18	25	CD	NUMBER	25	num	19	SENT_128	[p6l12t2782r261b2851],
19	]	NN	O	]	rcmod	3	SENT_128	[p6l12t2782r261b2851],
20	,	,	O	,	_	0	SENT_128	[p6l12t2782r261b2851],
21	have	VBP	O	have	aux	22	SENT_128	[p6l306t2782r448b2837],
22	proved	VBN	O	prove	_	0	SENT_128	[p6l492t2782r705b2851],
23	clinical	JJ	O	clinical	amod	24	SENT_128	[p6l749t2782r962b2837],
24	efﬁcacy	NN	O	efﬁcacy	dobj	22	SENT_128	[p6l1006t2782r1237b2851],
25	with	IN	O	with	_	0	SENT_128	[p6l1277t2782r1418b2837],
26	a	DT	O	a	det	29	SENT_128	[p6l1461t2798r1492b2837],
27	low	JJ	O	low	amod	29	SENT_128	[p6l1535t2782r1648b2837],
28	interindividual	JJ	O	interindividual	amod	29	SENT_128	[p6l1689t2782r2145b2837],
29	variability	NN	O	variability	prep_with	22	SENT_128	[p6l7t2871r328b2940],
30	in	IN	O	in	_	0	SENT_128	[p6l376t2872r434b2926],
31	antiplatelet	JJ	O	antiplatelet	amod	32	SENT_128	[p6l483t2871r845b2940],
32	effect	NN	O	effect	prep_in	29	SENT_128	[p6l893t2871r1066b2926],
33	compared	VBN	O	compare	_	0	SENT_128	[p6l1113t2871r1425b2940],
34	to	TO	O	to	prepc_compared_to	32	SENT_128	[p6l1474t2880r1534b2926],
35	clopidogrel	NN	O	clopidogrel	pobj	32	SENT_128	[p6l1584t2871r1953b2940],
36	,	,	O	,	_	0	SENT_128	[p6l1584t2871r1953b2940],
37	with	IN	O	with	_	0	SENT_128	[p6l2001t2871r2145b2926],
38	however	RB	O	however	advmod	22	SENT_128	[p6l9t2960r278b3015],
39	an	DT	O	a	det	41	SENT_128	[p6l319t2976r391b3015],
40	increased	VBN	O	increase	amod	41	SENT_128	[p6l435t2960r725b3015],
41	risk	NN	O	risk	prep_with	22	SENT_128	[p6l768t2960r880b3015],
42	of	IN	O	of	_	0	SENT_128	[p6l922t2960r985b3015],
43	bleeding	VBG	O	bleed	prepc_of	41	SENT_128	[p6l1020t2960r1284b3029],
44	with	IN	O	with	_	0	SENT_128	[p6l1325t2960r1466b3015],
45	prasugrel	NN	O	prasugrel	prep_with	43	SENT_128	[p6l1509t2960r1796b3029],
46	compared	VBN	O	compare	_	0	SENT_128	[p6l1840t2960r2145b3029],
47	with	IN	O	with	prepc_compared_with	43	SENT_128	[p6l7t3050r148b3105],
48	clopidogrel	NN	O	clopidogrel	pobj	43	SENT_128	[p6l192t3050r534b3118],
49	[	CD	NUMBER	[	num	48	SENT_128	[p6l583t3049r715b3118],
50	19	CD	NUMBER	19	num	51	SENT_128	[p6l583t3049r715b3118],
51	]	NN	O	]	dep	48	SENT_128	[p6l583t3049r715b3118],
52	,	,	O	,	_	0	SENT_128	[p6l583t3049r715b3118],
53	especially	RB	O	especially	advmod	48	SENT_128	[p6l761t3050r1062b3118],
54	in	IN	O	in	_	0	SENT_128	[p6l1105t3050r1161b3104],
55	elderly	JJ	O	elderly	amod	58	SENT_128	[p6l1205t3050r1417b3118],
56	and	CC	O	and	_	0	SENT_128	[p6l1460t3050r1571b3105],
57	thin	JJ	O	thin	conj_and	55	SENT_128	[p6l1615t3050r1738b3105],
58	patients	NNS	O	patient	prep_in	48	SENT_128	[p6l1782t3050r2043b3118],
59	.	.	O	.	_	0	SENT_128	[p6l1782t3050r2043b3118],

1	In	IN	O	in	_	0	SENT_129	[p6l2088t3053r2145b3104],
2	healthy	JJ	O	healthy	amod	3	SENT_129	[p6l9t3138r239b3207],
3	individuals	NNS	O	individual	prep_in	17	SENT_129	[p6l276t3138r612b3193],
4	as	RB	O	as	_	0	SENT_129	[p6l650t3154r709b3193],
5	well	RB	O	well	_	0	SENT_129	[p6l746t3138r876b3193],
6	as	IN	O	as	_	0	SENT_129	[p6l914t3154r973b3193],
7	in	IN	O	in	amod	9	SENT_129	[p6l1012t3139r1068b3192],
8	cardiovascular	JJ	O	cardiovascular	amod	9	SENT_129	[p6l1106t3138r1550b3193],
9	patients	NNS	O	patient	conj_and	3	SENT_129	[p6l1587t3139r1847b3207],
10	,	,	O	,	_	0	SENT_129	[p6l1587t3139r1847b3207],
11	CYP2C19	NN	O	cyp2c19	nn	13	SENT_129	[p6l1886t3141r2146b3193],
12	genetic	JJ	O	genetic	amod	13	SENT_129	[p6l7t3228r230b3296],
13	polymorphisms	NNS	O	polymorphism	nsubj	17	SENT_129	[p6l260t3227r740b3296],
14	do	VBP	O	do	aux	17	SENT_129	[p6l771t3227r845b3282],
15	not	RB	O	not	neg	17	SENT_129	[p6l877t3235r978b3282],
16	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_129	[p6l1008t3227r1382b3296],
17	affect	VB	O	affect	_	0	SENT_129	[p6l1410t3227r1578b3282],
18	the	DT	O	the	det	19	SENT_129	[p6l1607t3227r1704b3282],
19	pharmacodynamics	NNS	O	pharmacodynamic	dobj	17	SENT_129	[p6l1735t3227r2144b3296, p6l9t3317r223b3371],
20	and	CC	O	and	_	0	SENT_129	[p6l243t3316r354b3371],
21	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	19	SENT_129	[p6l375t3316r919b3385],
22	of	IN	O	of	_	0	SENT_129	[p6l940t3316r1003b3371],
23	either	CC	O	either	dep	24	SENT_129	[p6l1016t3316r1197b3371],
24	prasugrel	NN	O	prasugrel	prep_of	19	SENT_129	[p6l1215t3316r1502b3385],
25	[	CD	NUMBER	[	number	26	SENT_129	[p6l1526t3316r1751b3385],
26	26,27	CD	NUMBER	26,27	num	27	SENT_129	[p6l1526t3316r1751b3385],
27	]	NN	O	]	dep	24	SENT_129	[p6l1526t3316r1751b3385],
28	,	,	O	,	_	0	SENT_129	[p6l1526t3316r1751b3385],
29	or	CC	O	or	_	0	SENT_129	[p6l1772t3332r1836b3371],
30	ticagrelor	NN	O	ticagrelor	conj_or	24	SENT_129	[p6l1853t3316r2147b3385],
31	[	CD	NUMBER	[	number	32	SENT_129	[p6l12t3405r144b3474],
32	25	CD	NUMBER	25	num	33	SENT_129	[p6l12t3405r144b3474],
33	]	NN	O	]	dep	30	SENT_129	[p6l12t3405r144b3474],
34	.	.	O	.	_	0	SENT_129	[p6l12t3405r144b3474],

1	Further	JJ	O	further	amod	2	SENT_130	[p6l172t3405r400b3460],
2	studies	NNS	O	study	nsubjpass	4	SENT_130	[p6l425t3405r639b3460],
3	are	VBP	O	be	auxpass	4	SENT_130	[p6l665t3421r758b3460],
4	needed	VBN	O	need	dep	22	SENT_130	[p6l786t3405r1008b3460],
5	to	TO	O	to	aux	6	SENT_130	[p6l1033t3413r1092b3460],
6	evaluate	VB	O	evaluate	xcomp	4	SENT_130	[p6l1119t3405r1376b3460],
7	the	DT	O	the	det	10	SENT_130	[p6l1402t3405r1498b3460],
8	long	JJ	O	long	amod	10	SENT_130	[p6l1526t3405r1658b3474],
9	term	NN	O	term	nn	10	SENT_130	[p6l1682t3413r1829b3460],
10	impact	NN	O	impact	dobj	6	SENT_130	[p6l1855t3406r2064b3474],
11	of	IN	O	of	_	0	SENT_130	[p6l2089t3405r2153b3460],
12	these	DT	O	these	det	13	SENT_130	[p7l8t17r173b72],
13	molecules	NNS	O	molecule	prep_of	10	SENT_130	[p7l223t17r553b80],
14	,	,	O	,	_	0	SENT_130	[p7l223t17r553b80],
15	especially	RB	O	especially	advmod	4	SENT_130	[p7l602t17r910b85],
16	about	IN	O	about	_	0	SENT_130	[p7l958t17r1135b72],
17	the	DT	O	the	det	19	SENT_130	[p7l1181t17r1280b72],
18	increased	VBN	O	increase	amod	19	SENT_130	[p7l1330t17r1626b72],
19	risk	NN	O	risk	prep_about	4	SENT_130	[p7l1677t17r1790b72],
20	of	IN	O	of	_	0	SENT_130	[p7l1838t17r1902b72],
21	cancer	NN	O	cancer	prep_of	19	SENT_130	[p7l1944t33r2147b72],
22	highlighted	VBD	O	highlight	_	0	SENT_130	[p7l9t105r360b174],
23	for	IN	O	for	_	0	SENT_130	[p7l385t105r470b161],
24	prasugrel	NN	O	prasugrel	prep_for	22	SENT_130	[p7l493t106r780b174],
25	[	CD	NUMBER	[	num	24	SENT_130	[p7l808t105r940b174],
26	28	CD	NUMBER	28	num	27	SENT_130	[p7l808t105r940b174],
27	]	NN	O	]	nsubj	22	SENT_130	[p7l808t105r940b174],
28	.	.	O	.	_	0	SENT_130	[p7l808t105r940b174],

1	In	IN	O	in	_	0	SENT_131	[p7l111t197r168b248],
2	the	DT	O	the	det	4	SENT_131	[p7l186t194r283b249],
3	second	JJ	ORDINAL	second	amod	4	SENT_131	[p7l303t194r514b249],
4	patient	NN	O	patient	prep_in	15	SENT_131	[p7l534t195r764b263],
5	,	,	O	,	_	0	SENT_131	[p7l534t195r764b263],
6	a	DT	O	a	det	8	SENT_131	[p7l784t210r815b249],
7	pharmacodynamic	JJ	O	pharmacodynamic	amod	8	SENT_131	[p7l834t194r1407b263],
8	cause	NN	O	cause	nsubjpass	15	SENT_131	[p7l1425t210r1592b249],
9	for	IN	O	for	_	0	SENT_131	[p7l1611t194r1697b249],
10	poor	JJ	O	poor	amod	11	SENT_131	[p7l1714t210r1855b263],
11	response	NN	O	response	prep_for	8	SENT_131	[p7l1873t210r2145b263],
12	to	TO	O	to	_	0	SENT_131	[p7l8t291r68b338],
13	clopidogrel	NN	O	clopidogrel	prep_to	11	SENT_131	[p7l117t283r470b352],
14	was	VBD	O	be	auxpass	15	SENT_131	[p7l518t299r638b338],
15	suspected	VBN	O	suspect	_	0	SENT_131	[p7l689t283r1014b352],
16	.	.	O	.	_	0	SENT_131	[p7l689t283r1014b352],

1	An	DT	O	a	det	2	SENT_132	[p7l1063t285r1148b337],
2	association	NN	O	association	nsubjpass	12	SENT_132	[p7l1196t284r1543b338],
3	between	IN	O	between	_	0	SENT_132	[p7l1592t283r1862b338],
4	the	DT	O	the	det	6	SENT_132	[p7l1911t283r2010b338],
5	H2	NN	O	h2	nn	6	SENT_132	[p7l2060t286r2143b337],
6	haplotype	NN	O	haplotype	prep_between	2	SENT_132	[p7l9t372r314b441],
7	and	CC	O	and	_	0	SENT_132	[p7l344t372r455b427],
8	clopidogrel	NN	O	clopidogrel	nn	9	SENT_132	[p7l485t372r827b441],
9	resistance	NN	O	resistance	prep_between	2	SENT_132	[p7l857t373r1162b427],
10	has	VBZ	O	have	aux	12	SENT_132	[p7l1191t372r1291b427],
11	been	VBN	O	be	auxpass	12	SENT_132	[p7l1320t372r1467b427],
12	reported	VBN	O	report	_	0	SENT_132	[p7l1497t372r1760b441],
13	only	RB	O	only	advmod	14	SENT_132	[p7l1790t372r1923b441],
14	in	IN	O	in	prep	12	SENT_132	[p7l1950t373r2007b427],
15	H2	NN	O	h2	dep	14	SENT_132	[p7l2036t375r2148b437],
16	/	:	O	/	punct	15	SENT_132	[p7l2036t375r2148b437],
17	H2	NN	O	h2	nn	18	SENT_132	[p7l9t464r91b516],
18	homozygotes	NNS	O	homozygote	nsubj	19	SENT_132	[p7l123t461r532b530],
19	[	VBP	O	[	dep	15	SENT_132	[p7l565t461r713b530],
20	4,5	CD	NUMBER	4,5	number	21	SENT_132	[p7l565t461r713b530],
21	]	CD	NUMBER	]	dobj	19	SENT_132	[p7l565t461r713b530],
22	,	,	O	,	_	0	SENT_132	[p7l565t461r713b530],
23	who	WP	O	who	nsubj	24	SENT_132	[p7l742t461r876b516],
24	represent	VBP	O	represent	rcmod	21	SENT_132	[p7l907t469r1201b530],
25	less	JJR	O	less	mwe	26	SENT_132	[p7l1228t461r1337b516],
26	than	IN	O	than	quantmod	27	SENT_132	[p7l1367t461r1505b516],
27	3	CD	PERCENT	3	num	28	SENT_132	[p7l1533t464r1611b516],
28	%	NN	PERCENT	%	dobj	24	SENT_132	[p7l1533t464r1611b516],
29	of	IN	O	of	_	0	SENT_132	[p7l1640t461r1703b516],
30	the	DT	O	the	det	32	SENT_132	[p7l1725t461r1822b516],
31	Caucasian	JJ	MISC	caucasian	amod	32	SENT_132	[p7l1852t462r2145b516],
32	population	NN	O	population	prep_of	28	SENT_132	[p7l9t551r356b619],
33	.	.	O	.	_	0	SENT_132	[p7l9t551r356b619],

1	Our	PRP$	O	we	poss	2	SENT_133	[p7l385t554r498b606],
2	hypothesis	NN	O	hypothesis	nsubj	3	SENT_133	[p7l525t551r856b619],
3	is	VBZ	O	be	_	0	SENT_133	[p7l885t552r929b606],
4	that	IN	O	that	complm	11	SENT_133	[p7l957t551r1081b606],
5	the	DT	O	the	det	6	SENT_133	[p7l1106t551r1203b606],
6	number	NN	O	number	nsubjpass	11	SENT_133	[p7l1232t551r1475b606],
7	of	IN	O	of	_	0	SENT_133	[p7l1501t551r1565b606],
8	P2Y12	NN	O	p2y12	nn	9	SENT_133	[p7l1586t554r1756b616],
9	receptors	NNS	O	receptor	prep_of	6	SENT_133	[p7l1786t559r2071b619],
10	is	VBZ	O	be	auxpass	11	SENT_133	[p7l2101t552r2144b606],
11	increased	VBN	O	increase	ccomp	3	SENT_133	[p7l9t640r299b695],
12	in	IN	O	in	_	0	SENT_133	[p7l347t641r403b694],
13	H2/H2	NN	O	h2/h2	nn	14	SENT_133	[p7l451t642r648b704],
14	homozygotes	NNS	O	homozygote	prep_in	11	SENT_133	[p7l697t640r1121b708],
15	,	,	O	,	_	0	SENT_133	[p7l697t640r1121b708],
16	who	WP	O	who	nsubj	18	SENT_133	[p7l1167t640r1302b695],
17	therefore	RB	O	therefore	advmod	18	SENT_133	[p7l1349t640r1632b695],
18	require	VBP	O	require	rcmod	14	SENT_133	[p7l1680t641r1900b708],
19	higher	JJR	O	higher	amod	20	SENT_133	[p7l1948t640r2147b708],
20	concentrations	NNS	O	concentration	nsubj	26	SENT_133	[p7l9t729r469b782],
21	of	IN	O	of	_	0	SENT_133	[p7l518t728r581b782],
22	the	DT	O	the	det	24	SENT_133	[p7l622t728r719b782],
23	active	JJ	O	active	amod	24	SENT_133	[p7l768t729r948b782],
24	metabolite	NN	O	metabolite	prep_of	20	SENT_133	[p7l998t728r1330b782],
25	to	TO	O	to	aux	26	SENT_133	[p7l1378t736r1437b782],
26	inhibit	VB	O	inhibit	xcomp	18	SENT_133	[p7l1487t728r1691b782],
27	ADP-induced	JJ	MISC	adp-induced	amod	29	SENT_133	[p7l1735t728r2144b782],
28	platelet	NN	O	platelet	nn	29	SENT_133	[p7l9t816r241b885],
29	aggregation	NN	O	aggregation	dobj	26	SENT_133	[p7l262t817r638b885],
30	.	.	O	.	_	0	SENT_133	[p7l262t817r638b885],

1	In	IN	O	in	_	0	SENT_134	[p7l664t819r720b870],
2	keeping	VBG	O	keep	prepc_in	9	SENT_134	[p7l744t816r987b885],
3	with	IN	O	with	_	0	SENT_134	[p7l1008t816r1149b871],
4	this	DT	O	this	det	5	SENT_134	[p7l1171t816r1282b871],
5	hypothesis	NN	O	hypothesis	prep_with	2	SENT_134	[p7l1307t816r1653b885],
6	,	,	O	,	_	0	SENT_134	[p7l1307t816r1653b885],
7	H2/H2	NN	O	h2/h2	nn	8	SENT_134	[p7l1678t819r1874b880],
8	patients	NNS	O	patient	nsubj	9	SENT_134	[p7l1900t817r2145b885],
9	responded	VBD	O	respond	_	0	SENT_134	[p7l9t905r331b974],
10	normally	RB	O	normally	advmod	9	SENT_134	[p7l356t905r633b974],
11	to	TO	O	to	_	0	SENT_134	[p7l654t913r713b960],
12	clopidogrel	NN	O	clopidogrel	nn	14	SENT_134	[p7l737t905r1080b974],
13	loading	NN	O	loading	nn	14	SENT_134	[p7l1104t905r1331b974],
14	doses	NNS	O	dose	prep_to	9	SENT_134	[p7l1354t905r1522b960],
15	[	VBP	O	[	dep	14	SENT_134	[p7l1550t905r1682b974],
16	29	CD	NUMBER	29	num	17	SENT_134	[p7l1550t905r1682b974],
17	]	CD	NUMBER	]	dobj	15	SENT_134	[p7l1550t905r1682b974],
18	.	.	O	.	_	0	SENT_134	[p7l1550t905r1682b974],

1	In	IN	O	in	_	0	SENT_135	[p7l1707t909r1764b960],
2	our	PRP$	O	we	poss	3	SENT_135	[p7l1788t921r1892b960],
3	patient	NN	O	patient	prep_in	12	SENT_135	[p7l1914t906r2144b974],
4	,	,	O	,	_	0	SENT_135	[p7l1914t906r2144b974],
5	increasing	VBG	O	increase	csubj	12	SENT_135	[p7l9t995r323b1063],
6	the	DT	O	the	det	8	SENT_135	[p7l365t994r462b1049],
7	clopidogrel	NN	O	clopidogrel	nn	8	SENT_135	[p7l506t994r849b1063],
8	dosage	NN	O	dosage	dobj	5	SENT_135	[p7l894t994r1104b1063],
9	to	TO	O	to	_	0	SENT_135	[p7l1148t1002r1206b1049],
10	300	CD	NUMBER	300	num	11	SENT_135	[p7l1250t997r1363b1049],
11	mg/d	NN	O	mg/d	prep_to	5	SENT_135	[p7l1385t994r1543b1063],
12	produced	VBD	O	produce	_	0	SENT_135	[p7l1588t994r1877b1063],
13	a	DT	O	a	det	16	SENT_135	[p7l1922t1010r1952b1049],
14	good	JJ	O	good	amod	16	SENT_135	[p7l1995t994r2144b1063],
15	antiplatelet	JJ	O	antiplatelet	amod	16	SENT_135	[p7l8t1084r361b1152],
16	effect	NN	O	effect	dobj	12	SENT_135	[p7l386t1084r567b1139],
17	.	.	O	.	_	0	SENT_135	[p7l386t1084r567b1139],

1	We	PRP	O	we	nsubj	4	SENT_136	[p7l592t1087r696b1139],
2	were	VBD	O	be	cop	4	SENT_136	[p7l722t1100r875b1139],
3	not	RB	O	not	neg	4	SENT_136	[p7l902t1092r1003b1139],
4	able	JJ	O	able	_	0	SENT_136	[p7l1028t1084r1152b1139],
5	to	TO	O	to	aux	6	SENT_136	[p7l1179t1092r1238b1139],
6	use	VB	O	use	xcomp	4	SENT_136	[p7l1266t1100r1366b1139],
7	prasugrel	NN	O	prasugrel	nsubjpass	15	SENT_136	[p7l1394t1084r1681b1152],
8	in	IN	O	in	_	0	SENT_136	[p7l1709t1085r1764b1138],
9	this	DT	O	this	det	10	SENT_136	[p7l1791t1084r1901b1139],
10	patient	NN	O	patient	prep_in	7	SENT_136	[p7l1930t1085r2147b1152],
11	and	CC	O	and	_	0	SENT_136	[p7l8t1173r120b1228],
12	further	JJ	O	further	amod	13	SENT_136	[p7l167t1173r382b1228],
13	investigations	NNS	O	investigation	conj_and	10	SENT_136	[p7l427t1174r852b1241],
14	are	VBP	O	be	auxpass	15	SENT_136	[p7l899t1189r992b1228],
15	needed	VBN	O	need	ccomp	6	SENT_136	[p7l1039t1173r1261b1228],
16	to	TO	O	to	aux	17	SENT_136	[p7l1307t1181r1366b1228],
17	evaluate	VB	O	evaluate	xcomp	15	SENT_136	[p7l1412t1173r1669b1228],
18	the	DT	O	the	det	20	SENT_136	[p7l1715t1173r1811b1228],
19	prasugrel	NN	O	prasugrel	nn	20	SENT_136	[p7l1858t1173r2145b1241],
20	response	NN	O	response	dobj	17	SENT_136	[p7l9t1277r281b1330],
21	in	IN	O	in	_	0	SENT_136	[p7l307t1262r362b1316],
22	P2Y12	NN	O	p2y12	nn	24	SENT_136	[p7l384t1264r550b1327],
23	H2/H2	NN	O	h2/h2	nn	24	SENT_136	[p7l573t1264r763b1325],
24	homozygotes	NNS	O	homozygote	prep_in	17	SENT_136	[p7l788t1261r1212b1330],
25	,	,	O	,	_	0	SENT_136	[p7l788t1261r1212b1330],

1	Consistent	JJ	O	consistent	nsubj	18	SENT_137	[p7l111t1351r433b1405],
2	with	IN	O	with	_	0	SENT_137	[p7l467t1350r609b1405],
3	the	DT	O	the	det	5	SENT_137	[p7l646t1350r744b1405],
4	limited	JJ	O	limited	amod	5	SENT_137	[p7l784t1350r1000b1405],
5	number	NN	O	number	prep_with	1	SENT_137	[p7l1040t1350r1282b1405],
6	of	IN	O	of	_	0	SENT_137	[p7l1319t1350r1382b1405],
7	cases	NNS	O	case	prep_of	5	SENT_137	[p7l1413t1366r1570b1405],
8	presented	VBN	O	present	partmod	7	SENT_137	[p7l1609t1350r1914b1419],
9	in	IN	O	in	_	0	SENT_137	[p7l1953t1351r2010b1404],
10	the	DT	O	the	det	12	SENT_137	[p7l2048t1350r2145b1405],
11	present	JJ	DATE	present	amod	12	SENT_137	[p7l9t1447r240b1508],
12	study	NN	O	study	prep_in	8	SENT_137	[p7l265t1439r446b1508],
13	,	,	O	,	_	0	SENT_137	[p7l265t1439r446b1508],
14	and	CC	O	and	_	0	SENT_137	[p7l473t1439r584b1494],
15	with	IN	O	with	_	0	SENT_137	[p7l610t1439r751b1494],
16	recent	JJ	O	recent	amod	17	SENT_137	[p7l777t1448r970b1494],
17	ﬁndings	NNS	O	ﬁndings	prep_with	1	SENT_137	[p7l995t1439r1239b1508],
18	[	VBP	O	[	ccomp	28	SENT_137	[p7l1270t1439r1403b1508],
19	30	CD	NUMBER	30	num	20	SENT_137	[p7l1270t1439r1403b1508],
20	]	CD	NUMBER	]	dobj	18	SENT_137	[p7l1270t1439r1403b1508],
21	,	,	O	,	_	0	SENT_137	[p7l1270t1439r1403b1508],
22	2C19	NN	O	2c19	nn	23	SENT_137	[p7l1429t1442r1581b1494],
23	genotyping	NN	O	genotyping	nsubjpass	28	SENT_137	[p7l1607t1440r1955b1508],
24	alone	RB	O	alone	advmod	28	SENT_137	[p7l1980t1439r2145b1494],
25	should	MD	O	should	aux	28	SENT_137	[p7l9t1528r213b1583],
26	not	RB	O	not	neg	28	SENT_137	[p7l233t1536r334b1583],
27	be	VB	O	be	auxpass	28	SENT_137	[p7l351t1528r421b1583],
28	proposed	VBN	O	propose	_	0	SENT_137	[p7l442t1528r726b1597],
29	to	TO	O	to	aux	30	SENT_137	[p7l745t1536r804b1583],
30	replace	VB	O	replace	ccomp	28	SENT_137	[p7l825t1528r1044b1597],
31	platelet	NN	O	platelet	nn	32	SENT_137	[p7l1064t1528r1296b1597],
32	function	NN	O	function	dobj	30	SENT_137	[p7l1314t1528r1582b1592],
33	,	,	O	,	_	0	SENT_137	[p7l1314t1528r1582b1592],
34	but	CC	O	but	_	0	SENT_137	[p7l1602t1528r1704b1583],
35	to	TO	O	to	aux	36	SENT_137	[p7l1721t1537r1780b1583],
36	ﬁgure	VB	O	ﬁgure	ccomp	28	SENT_137	[p7l1800t1528r1977b1597],
37	out	RP	O	out	prt	36	SENT_137	[p7l1996t1536r2097b1583],
38	a	DT	O	a	det	40	SENT_137	[p7l2115t1544r2146b1583],
39	pharmacological	JJ	O	pharmacological	amod	40	SENT_137	[p7l9t1618r514b1686],
40	cause	NN	O	cause	dobj	36	SENT_137	[p7l546t1634r713b1673],
41	to	TO	O	to	_	0	SENT_137	[p7l743t1626r802b1673],
42	the	DT	O	the	det	45	SENT_137	[p7l833t1618r930b1673],
43	observed	VBN	O	observe	amod	45	SENT_137	[p7l961t1618r1238b1673],
44	high	JJ	O	high	amod	45	SENT_137	[p7l1270t1618r1510b1686],
45	—	NN	O	—	prep_to	36	SENT_137	[p7l1270t1618r1510b1686],
46	on	IN	O	on	_	0	SENT_137	[p7l1270t1618r1510b1686],
47	clopidogrel	NN	O	clopidogrel	nn	49	SENT_137	[p7l1541t1618r1884b1686],
48	platelet	NN	O	platelet	nn	49	SENT_137	[p7l1915t1618r2147b1686],
49	reactivity	NN	O	reactivity	prep_on	45	SENT_137	[p7l9t1708r298b1775],
50	in	IN	O	in	_	0	SENT_137	[p7l319t1708r375b1761],
51	patients	NNS	O	patient	prep_in	49	SENT_137	[p7l398t1708r643b1775],
52	with	IN	O	with	_	0	SENT_137	[p7l665t1707r806b1762],
53	no	DT	O	no	det	57	SENT_137	[p7l829t1723r902b1762],
54	major	JJ	O	major	amod	57	SENT_137	[p7l926t1708r1106b1775],
55	clinical	JJ	O	clinical	amod	57	SENT_137	[p7l1127t1707r1341b1762],
56	risk	NN	O	risk	nn	57	SENT_137	[p7l1364t1707r1476b1762],
57	factors	NNS	O	factor	prep_with	51	SENT_137	[p7l1497t1707r1700b1762],
58	of	IN	O	of	_	0	SENT_137	[p7l1723t1707r1787b1762],
59	clopidogrel	NN	O	clopidogrel	nn	60	SENT_137	[p7l1802t1707r2145b1775],
60	resistance	NN	O	resistance	prep_of	57	SENT_137	[p7l9t1796r328b1851],
61	.	.	O	.	_	0	SENT_137	[p7l9t1796r328b1851],

1	Indeed	RB	O	indeed	advmod	16	SENT_138	[p7l351t1795r573b1859],
2	,	,	O	,	_	0	SENT_138	[p7l351t1795r573b1859],
3	carriage	NN	O	carriage	nsubj	16	SENT_138	[p7l595t1796r838b1864],
4	of	IN	O	of	_	0	SENT_138	[p7l859t1795r923b1850],
5	one	CD	NUMBER	one	prep_of	3	SENT_138	[p7l936t1811r1046b1850],
6	or	CC	O	or	_	0	SENT_138	[p7l1068t1811r1131b1850],
7	two	CD	NUMBER	two	num	9	SENT_138	[p7l1149t1803r1266b1850],
8	loss	NN	O	loss	nn	9	SENT_138	[p7l1288t1795r1774b1850],
9	—	NN	O	—	conj_or	3	SENT_138	[p7l1288t1795r1774b1850],
10	of	IN	O	of	_	0	SENT_138	[p7l1288t1795r1774b1850],
11	—	CD	NUMBER	—	num	13	SENT_138	[p7l1288t1795r1774b1850],
12	function	NN	O	function	nn	13	SENT_138	[p7l1288t1795r1774b1850],
13	alleles	NNS	O	allele	prep_of	9	SENT_138	[p7l1795t1795r1984b1850],
14	does	VBZ	O	do	aux	16	SENT_138	[p7l2006t1795r2145b1850],
15	not	RB	O	not	neg	16	SENT_138	[p7l9t1892r110b1939],
16	imply	VB	O	imply	dep	39	SENT_138	[p7l132t1884r307b1953],
17	a	DT	O	a	det	18	SENT_138	[p7l328t1900r359b1939],
18	biological	JJ	O	biological	dobj	16	SENT_138	[p7l380t1884r674b1953],
19	or	CC	O	or	_	0	SENT_138	[p7l697t1900r760b1939],
20	a	DT	O	a	det	22	SENT_138	[p7l781t1900r812b1939],
21	clinical	JJ	O	clinical	amod	22	SENT_138	[p7l835t1884r1048b1939],
22	resistance	NN	O	resistance	dobj	16	SENT_138	[p7l1072t1885r1391b1947],
23	,	,	O	,	_	0	SENT_138	[p7l1072t1885r1391b1947],
24	and	CC	O	and	_	0	SENT_138	[p7l1414t1884r1525b1939],
25	in	IN	O	in	conj_and	18	SENT_138	[p7l1549t1885r1605b1938],
26	about	IN	O	about	pcomp	25	SENT_138	[p7l1628t1884r1802b1939],
27	one	CD	NUMBER	one	pobj	26	SENT_138	[p7l1823t1900r1933b1939],
28	fourth	JJ	ORDINAL	fourth	quantmod	27	SENT_138	[p7l1956t1884r2146b1939],
29	of	IN	O	of	_	0	SENT_138	[p7l11t1973r75b2028],
30	such	JJ	O	such	amod	31	SENT_138	[p7l87t1973r225b2028],
31	patients	NNS	O	patient	prep_of	27	SENT_138	[p7l243t1974r489b2042],
32	an	DT	O	a	det	34	SENT_138	[p7l508t1989r580b2028],
33	adequate	JJ	O	adequate	amod	34	SENT_138	[p7l599t1973r880b2042],
34	inhibition	NN	O	inhibition	dep	18	SENT_138	[p7l899t1973r1199b2028],
35	of	IN	O	of	_	0	SENT_138	[p7l1217t1973r1281b2028],
36	platelet	NN	O	platelet	nn	37	SENT_138	[p7l1293t1973r1525b2042],
37	function	NN	O	function	prep_of	34	SENT_138	[p7l1542t1973r1797b2028],
38	is	VBZ	O	be	auxpass	39	SENT_138	[p7l1816t1974r1860b2028],
39	achieved	VBN	O	achieve	_	0	SENT_138	[p7l1879t1973r2150b2028],
40	probably	RB	O	probably	advmod	39	SENT_138	[p7l11t2062r284b2131],
41	via	IN	O	via	_	0	SENT_138	[p7l320t2063r409b2117],
42	other	JJ	O	other	amod	44	SENT_138	[p7l449t2062r613b2117],
43	metabolization	NN	O	metabolization	nn	44	SENT_138	[p7l652t2062r1112b2117],
44	pathways	NNS	O	pathway	prep_via	39	SENT_138	[p7l1153t2062r1447b2131],
45	in	IN	O	in	_	0	SENT_138	[p7l1489t2063r1545b2116],
46	patients	NNS	O	patient	prep_in	39	SENT_138	[p7l1585t2063r1830b2131],
47	receiving	VBG	O	receive	dep	46	SENT_138	[p7l1871t2063r2152b2131],
48	clopidogrel	NN	O	clopidogrel	nn	51	SENT_138	[p7l11t2151r370b2220],
49	maintenance	NN	O	maintenance	nn	51	SENT_138	[p7l421t2152r834b2206],
50	dose	NN	O	dose	nn	51	SENT_138	[p7l885t2151r1029b2206],
51	[	NN	O	[	dobj	47	SENT_138	[p7l1083t2151r1358b2220],
52	9,31,32	CD	NUMBER	9,31,32	num	53	SENT_138	[p7l1083t2151r1358b2220],
53	]	CD	NUMBER	]	dep	51	SENT_138	[p7l1083t2151r1358b2220],
54	or	CC	O	or	_	0	SENT_138	[p7l1412t2167r1478b2206],
55	loading	VBG	O	load	dep	46	SENT_138	[p7l1527t2151r1763b2220],
56	dose	NN	O	dose	nn	57	SENT_138	[p7l1813t2151r1956b2206],
57	[	NN	O	[	dobj	55	SENT_138	[p7l2010t2151r2149b2220],
58	33	CD	NUMBER	33	num	59	SENT_138	[p7l2010t2151r2149b2220],
59	]	NN	O	]	nsubjpass	39	SENT_138	[p7l2010t2151r2149b2220],
60	.	.	O	.	_	0	SENT_138	[p7l2010t2151r2149b2220],

1	Furthermore	RB	O	furthermore	advmod	6	SENT_139	[p7l11t2240r415b2304],
2	,	,	O	,	_	0	SENT_139	[p7l11t2240r415b2304],
3	2	CD	NUMBER	2	num	5	SENT_139	[p7l434t2243r467b2295],
4	C19	NN	O	c19	nn	5	SENT_139	[p7l491t2243r604b2295],
5	polymorphisms	NNS	O	polymorphism	nsubj	6	SENT_139	[p7l624t2240r1104b2309],
6	account	VBP	O	account	_	0	SENT_139	[p7l1123t2248r1364b2295],
7	for	IN	O	for	_	0	SENT_139	[p7l1381t2240r1466b2295],
8	only	RB	O	only	quantmod	9	SENT_139	[p7l1483t2240r1616b2309],
9	12	CD	PERCENT	12	num	10	SENT_139	[p7l1636t2243r1748b2295],
10	%	NN	PERCENT	%	prep_for	6	SENT_139	[p7l1636t2243r1748b2295],
11	of	IN	O	of	_	0	SENT_139	[p7l1767t2240r1830b2295],
12	variability	NN	O	variability	prep_of	10	SENT_139	[p7l1839t2240r2152b2309],
13	in	IN	O	in	_	0	SENT_139	[p7l11t2330r68b2384],
14	platelet	NN	O	platelet	nn	15	SENT_139	[p7l95t2330r327b2398],
15	response	NN	O	response	prep_in	12	SENT_139	[p7l353t2345r626b2398],
16	to	TO	O	to	_	0	SENT_139	[p7l653t2338r711b2385],
17	clopidogrel	NN	O	clopidogrel	prep_to	6	SENT_139	[p7l739t2330r1082b2398],
18	and	CC	O	and	_	0	SENT_139	[p7l1110t2330r1221b2385],
19	has	VBZ	O	have	aux	26	SENT_139	[p7l1250t2330r1350b2385],
20	a	DT	O	a	det	25	SENT_139	[p7l1378t2345r1409b2385],
21	low	JJ	O	low	amod	22	SENT_139	[p7l1436t2330r1549b2385],
22	positive	JJ	O	positive	amod	25	SENT_139	[p7l1575t2330r1815b2398],
23	predictive	JJ	O	predictive	amod	25	SENT_139	[p7l1843t2330r2150b2398],
24	value	NN	O	value	nn	25	SENT_139	[p7l9t2419r173b2474],
25	(	NN	O	(	dobj	26	SENT_139	[p7l202t2419r414b2487],
26	<	JJR	O	<	conj_and	6	SENT_139	[p7l202t2419r414b2487],
27	20	CD	PERCENT	20	num	28	SENT_139	[p7l202t2419r414b2487],
28	%	NN	PERCENT	%	dep	26	SENT_139	[p7l202t2419r414b2487],
29	)	CD	NUMBER	)	tmod	26	SENT_139	[p7l202t2419r414b2487],
30	for	IN	O	for	mark	33	SENT_139	[p7l443t2418r528b2474],
31	cardiovascular	JJ	O	cardiovascular	amod	32	SENT_139	[p7l551t2418r996b2474],
32	events	NNS	O	event	nsubj	33	SENT_139	[p7l1019t2427r1217b2474],
33	[	VBP	O	[	ccomp	26	SENT_139	[p7l1245t2418r1339b2487],
34	9	CD	NUMBER	9	num	35	SENT_139	[p7l1245t2418r1339b2487],
35	]	NN	O	]	dobj	33	SENT_139	[p7l1245t2418r1339b2487],
36	.	.	O	.	_	0	SENT_139	[p7l1245t2418r1339b2487],

1	The	DT	O	the	det	3	SENT_140	[p7l1362t2419r1474b2474],
2	CYP2C19	NN	O	cyp2c19	nn	3	SENT_140	[p7l1499t2418r1909b2483],
3	*	NN	O	*	_	0	SENT_140	[p7l1499t2418r1909b2483],
4	2	CD	NUMBER	2	dep	3	SENT_140	[p7l1499t2418r1909b2483],
5	/	:	O	/	punct	3	SENT_140	[p7l1499t2418r1909b2483],
6	*	CD	NUMBER	*	number	7	SENT_140	[p7l1499t2418r1909b2483],
7	2	CD	NUMBER	2	num	8	SENT_140	[p7l1499t2418r1909b2483],
8	patient	NN	O	patient	nsubj	13	SENT_140	[p7l1934t2419r2152b2487],
9	presented	VBN	O	present	partmod	8	SENT_140	[p7l11t2507r316b2576],
10	here	RB	O	here	advmod	9	SENT_140	[p7l340t2507r475b2562],
11	had	VBD	O	have	aux	13	SENT_140	[p7l499t2507r610b2562],
12	successfully	RB	O	successfully	advmod	13	SENT_140	[p7l635t2507r999b2576],
13	responded	VBN	O	respond	dep	3	SENT_140	[p7l1021t2507r1344b2576],
14	to	TO	O	to	_	0	SENT_140	[p7l1368t2515r1427b2562],
15	prasugrel	NN	O	prasugrel	prep_to	13	SENT_140	[p7l1451t2507r1739b2576],
16	as	IN	O	as	_	0	SENT_140	[p7l1762t2523r1822b2562],
17	substitute	NN	O	substitute	prep_as	13	SENT_140	[p7l1847t2507r2150b2562],
18	for	IN	O	for	_	0	SENT_140	[p7l11t2596r96b2651],
19	clopidogrel	NN	O	clopidogrel	prep_for	17	SENT_140	[p7l129t2596r487b2665],
20	.	.	O	.	_	0	SENT_140	[p7l129t2596r487b2665],

1	Increasing	VBG	O	increase	dep	17	SENT_141	[p7l523t2597r838b2665],
2	the	DT	O	the	det	4	SENT_141	[p7l871t2596r968b2651],
3	clopidogrel	NN	O	clopidogrel	nn	4	SENT_141	[p7l1003t2596r1346b2665],
4	dosage	NN	O	dosage	nsubj	9	SENT_141	[p7l1381t2596r1591b2665],
5	may	MD	O	may	aux	9	SENT_141	[p7l1626t2612r1757b2665],
6	be	VB	O	be	cop	9	SENT_141	[p7l1789t2596r1860b2651],
7	the	DT	O	the	det	9	SENT_141	[p7l1894t2596r1991b2651],
8	best	JJS	O	best	amod	9	SENT_141	[p7l2025t2596r2152b2651],
9	strategy	NN	O	strategy	ccomp	1	SENT_141	[p7l12t2693r259b2754],
10	in	IN	O	in	_	0	SENT_141	[p7l281t2686r337b2740],
11	CYP2C19	NN	O	cyp2c19	nn	12	SENT_141	[p7l362t2685r771b2750],
12	*	NN	O	*	prep_in	9	SENT_141	[p7l362t2685r771b2750],
13	1	CD	NUMBER	1	num	12	SENT_141	[p7l362t2685r771b2750],
14	/	:	O	/	punct	17	SENT_141	[p7l362t2685r771b2750],
15	*	CD	NUMBER	*	num	17	SENT_141	[p7l362t2685r771b2750],
16	2	CD	NUMBER	2	num	17	SENT_141	[p7l362t2685r771b2750],
17	patients	NNS	O	patient	_	0	SENT_141	[p7l796t2686r1056b2754],
18	,	,	O	,	_	0	SENT_141	[p7l796t2686r1056b2754],
19	most	RBS	O	most	advmod	20	SENT_141	[p7l1081t2694r1233b2740],
20	notably	RB	O	notably	advmod	21	SENT_141	[p7l1255t2685r1487b2754],
21	those	DT	O	those	appos	17	SENT_141	[p7l1507t2685r1672b2740],
22	at	IN	O	at	_	0	SENT_141	[p7l1696t2693r1753b2740],
23	high	JJ	O	high	amod	24	SENT_141	[p7l1776t2685r1910b2754],
24	risk	NN	O	risk	prep_at	21	SENT_141	[p7l1933t2685r2045b2740],
25	for	IN	O	for	_	0	SENT_141	[p7l2068t2685r2152b2740],
26	bleeding	VBG	O	bleed	prepc_for	24	SENT_141	[p7l10t2775r275b2843],
27	(	JJ	O	(	amod	28	SENT_141	[p7l314t2775r556b2843],
28	history	NN	O	history	dobj	26	SENT_141	[p7l314t2775r556b2843],
29	of	IN	O	of	_	0	SENT_141	[p7l590t2775r654b2830],
30	transient	JJ	O	transient	amod	32	SENT_141	[p7l681t2776r958b2830],
31	ischemic	JJ	O	ischemic	amod	32	SENT_141	[p7l992t2775r1260b2830],
32	attack	NN	O	attack	prep_of	28	SENT_141	[p7l1295t2775r1481b2830],
33	or	CC	O	or	_	0	SENT_141	[p7l1515t2791r1579b2830],
34	stroke	NN	O	stroke	conj_or	21	SENT_141	[p7l1613t2775r1816b2838],
35	,	,	O	,	_	0	SENT_141	[p7l1613t2775r1816b2838],
36	low	JJ	O	low	amod	38	SENT_141	[p7l1854t2775r1967b2830],
37	body	NN	O	body	nn	38	SENT_141	[p7l2000t2775r2152b2843],
38	weight	NN	O	weight	conj_or	21	SENT_141	[p7l9t2864r237b2932],
39	,	,	O	,	_	0	SENT_141	[p7l9t2864r237b2932],
40	or	CC	O	or	_	0	SENT_141	[p7l269t2879r333b2919],
41	advanced	JJ	O	advanced	amod	43	SENT_141	[p7l362t2864r653b2919],
42	age	NN	O	age	nn	43	SENT_141	[p7l684t2864r831b2932],
43	)	NN	O	)	conj_or	21	SENT_141	[p7l684t2864r831b2932],
44	.	.	O	.	_	0	SENT_141	[p7l684t2864r831b2932],

1	Interestingly	RB	O	interestingly	advmod	6	SENT_142	[p7l864t2864r1267b2932],
2	,	,	O	,	_	0	SENT_142	[p7l864t2864r1267b2932],
3	a	DT	O	a	det	5	SENT_142	[p7l1299t2879r1330b2919],
4	recent	JJ	O	recent	amod	5	SENT_142	[p7l1362t2872r1555b2919],
5	study	NN	O	study	nsubj	6	SENT_142	[p7l1586t2864r1754b2932],
6	showed	VBD	O	show	_	0	SENT_142	[p7l1785t2864r2022b2919],
7	the	DT	O	the	det	9	SENT_142	[p7l2053t2864r2150b2919],
8	biological	JJ	O	biological	amod	9	SENT_142	[p7l10t2952r313b3021],
9	impact	NN	O	impact	dobj	6	SENT_142	[p7l364t2953r579b3021],
10	of	IN	O	of	_	0	SENT_142	[p7l627t2952r691b3007],
11	repeated	VBN	O	repeat	prep_of	9	SENT_142	[p7l734t2952r1010b3021],
12	loading	VBG	O	load	partmod	11	SENT_142	[p7l1060t2952r1293b3021],
13	doses	NNS	O	dose	dobj	12	SENT_142	[p7l1342t2952r1514b3007],
14	of	IN	O	of	_	0	SENT_142	[p7l1564t2952r1629b3007],
15	clopidogrel	NN	O	clopidogrel	prep_of	13	SENT_142	[p7l1670t2952r2024b3021],
16	on	IN	O	on	_	0	SENT_142	[p7l2074t2968r2150b3007],
17	CYP2C19	NN	O	cyp2c19	nn	20	SENT_142	[p7l11t3041r348b3096],
18	*	NN	O	*	nn	20	SENT_142	[p7l11t3041r348b3096],
19	2	CD	NUMBER	2	num	20	SENT_142	[p7l11t3041r348b3096],
20	carriers	NNS	O	carrier	prep_on	12	SENT_142	[p7l378t3042r607b3096],
21	undergoing	VBG	O	undergo	partmod	20	SENT_142	[p7l634t3041r988b3110],
22	percutaneous	JJ	O	percutaneous	amod	24	SENT_142	[p7l1014t3049r1428b3110],
23	coronary	JJ	O	coronary	amod	24	SENT_142	[p7l1456t3057r1729b3110],
24	intervention	NN	O	intervention	dobj	21	SENT_142	[p7l1754t3042r2149b3105],
25	,	,	O	,	_	0	SENT_142	[p7l1754t3042r2149b3105],
26	as	IN	O	as	mark	27	SENT_142	[p7l11t3146r70b3185],
27	measured	VBN	O	measure	advcl	21	SENT_142	[p7l98t3130r398b3185],
28	with	IN	O	with	_	0	SENT_142	[p7l424t3130r565b3185],
29	the	DT	O	the	det	31	SENT_142	[p7l590t3130r688b3185],
30	VASP	NN	ORGANIZATION	vasp	nn	31	SENT_142	[p7l712t3133r874b3185],
31	assay	NN	O	assay	prep_with	27	SENT_142	[p7l899t3146r1075b3199],
32	.	.	O	.	_	0	SENT_142	[p7l899t3146r1075b3199],

1	The	DT	O	the	det	2	SENT_143	[p7l1100t3130r1212b3185],
2	authors	NNS	O	author	nsubj	3	SENT_143	[p7l1239t3130r1470b3185],
3	showed	VBD	O	show	_	0	SENT_143	[p7l1498t3130r1735b3185],
4	that	IN	O	that	complm	10	SENT_143	[p7l1761t3130r1885b3185],
5	high-on	JJ	O	high-on	amod	8	SENT_143	[p7l1910t3130r2151b3199],
6	clopidogrel	NN	O	clopidogrel	nn	8	SENT_143	[p7l11t3219r354b3288],
7	platelet	NN	O	platelet	nn	8	SENT_143	[p7l398t3219r630b3288],
8	reactivity	NN	O	reactivity	nsubjpass	10	SENT_143	[p7l673t3220r962b3288],
9	was	VBD	O	be	auxpass	10	SENT_143	[p7l1003t3235r1122b3274],
10	overcome	VBN	O	overcome	ccomp	3	SENT_143	[p7l1167t3235r1468b3274],
11	in	IN	O	in	dep	10	SENT_143	[p7l1512t3220r1568b3274],
12	about	IN	O	about	_	0	SENT_143	[p7l1612t3219r1786b3274],
13	90	CD	PERCENT	90	num	14	SENT_143	[p7l1828t3222r1944b3274],
14	%	NN	PERCENT	%	prep_about	10	SENT_143	[p7l1828t3222r1944b3274],
15	of	IN	O	of	_	0	SENT_143	[p7l1988t3219r2051b3274],
16	*	NN	O	*	prep_of	14	SENT_143	[p7l2088t3219r2148b3274],
17	2	CD	NUMBER	2	num	16	SENT_143	[p7l2088t3219r2148b3274],

1	carriers	NNS	O	carrier	_	0	SENT_144	[p8l11t18r240b72],
2	by	IN	O	by	_	0	SENT_144	[p8l258t17r332b85],
3	increased	VBN	O	increase	prep_by	1	SENT_144	[p8l349t17r639b72],
4	and	CC	O	and	_	0	SENT_144	[p8l658t17r769b72],
5	tailored	VBN	O	tailor	amod	6	SENT_144	[p8l787t17r1023b72],
6	clopidogrel	NN	O	clopidogrel	conj_and	3	SENT_144	[p8l1042t17r1385b85],
7	loading	VBG	O	load	partmod	6	SENT_144	[p8l1404t17r1631b85],
8	doses	NNS	O	dose	nsubj	11	SENT_144	[p8l1648t17r1816b72],
9	[	CD	NUMBER	[	number	10	SENT_144	[p8l1838t17r1971b85],
10	34	CD	NUMBER	34	num	11	SENT_144	[p8l1838t17r1971b85],
11	]	NN	O	]	xcomp	7	SENT_144	[p8l1838t17r1971b85],
12	.	.	O	.	_	0	SENT_144	[p8l1838t17r1971b85],

1	In	IN	O	in	_	0	SENT_145	[p8l1991t20r2048b71],
2	H2	NN	O	h2	nn	3	SENT_145	[p8l2066t20r2149b71],
3	homozygotes	NNS	O	homozygote	prep_in	11	SENT_145	[p8l11t106r436b174],
4	,	,	O	,	_	0	SENT_145	[p8l11t106r436b174],
5	increasing	VBG	O	increase	csubj	11	SENT_145	[p8l467t106r780b174],
6	the	DT	O	the	det	8	SENT_145	[p8l808t106r905b161],
7	clopidogrel	NN	O	clopidogrel	nn	8	SENT_145	[p8l935t105r1278b174],
8	dosage	NN	O	dosage	dobj	5	SENT_145	[p8l1308t106r1519b174],
9	can	MD	O	can	aux	11	SENT_145	[p8l1548t121r1652b161],
10	be	VB	O	be	cop	11	SENT_145	[p8l1680t106r1750b161],
11	sufﬁcient	JJ	O	sufﬁcient	_	0	SENT_145	[p8l1781t105r2064b161],
12	to	TO	O	to	aux	13	SENT_145	[p8l2091t114r2150b161],
13	obtain	VB	O	obtain	xcomp	11	SENT_145	[p8l11t194r204b249],
14	a	DT	O	a	det	17	SENT_145	[p8l230t210r261b249],
15	good	JJ	O	good	amod	17	SENT_145	[p8l287t194r436b263],
16	antiplatelet	JJ	O	antiplatelet	amod	17	SENT_145	[p8l463t194r816b263],
17	response	NN	O	response	dobj	13	SENT_145	[p8l842t210r1128b263],
18	.	.	O	.	_	0	SENT_145	[p8l842t210r1128b263],

1	When	WRB	O	when	advmod	6	SENT_146	[p8l1154t194r1341b249],
2	no	DT	O	no	det	4	SENT_146	[p8l1367t210r1442b249],
3	genetic	JJ	O	genetic	amod	4	SENT_146	[p8l1467t195r1691b263],
4	explanation	NN	O	explanation	nsubjpass	6	SENT_146	[p8l1715t194r2079b263],
5	is	VBZ	O	be	auxpass	6	SENT_146	[p8l2106t195r2150b249],
6	found	VBN	O	find	advcl	24	SENT_146	[p8l11t283r188b338],
7	in	IN	O	in	_	0	SENT_146	[p8l225t284r282b337],
8	patients	NNS	O	patient	prep_in	6	SENT_146	[p8l318t284r564b352],
9	who	WP	O	who	nsubj	10	SENT_146	[p8l599t283r734b338],
10	exhibit	VBP	O	exhibit	rcmod	8	SENT_146	[p8l771t283r986b338],
11	clopidogrel	NN	O	clopidogrel	nn	12	SENT_146	[p8l1021t283r1364b352],
12	resistance	NN	O	resistance	dobj	10	SENT_146	[p8l1402t284r1706b338],
13	despite	IN	O	despite	_	0	SENT_146	[p8l1743t283r1964b352],
14	good	JJ	O	good	amod	15	SENT_146	[p8l2000t283r2150b352],
15	adherence	NN	O	adherence	prep_despite	10	SENT_146	[p8l11t372r329b427],
16	to	TO	O	to	_	0	SENT_146	[p8l365t380r424b427],
17	the	DT	O	the	det	19	SENT_146	[p8l461t372r558b427],
18	medication	NN	O	medication	nn	19	SENT_146	[p8l596t372r940b427],
19	regimen	NN	O	regimen	prep_to	15	SENT_146	[p8l976t373r1244b441],
20	,	,	O	,	_	0	SENT_146	[p8l976t373r1244b441],
21	a	DT	O	a	det	23	SENT_146	[p8l1282t388r1313b427],
22	dosage	NN	O	dosage	nn	23	SENT_146	[p8l1349t372r1560b441],
23	increase	NN	O	increase	nsubj	24	SENT_146	[p8l1597t373r1848b427],
24	deserves	VBZ	O	deserve	_	0	SENT_146	[p8l1885t372r2150b427],
25	consideration	NN	O	consideration	dobj	24	SENT_146	[p8l11t461r443b517],
26	.	.	O	.	_	0	SENT_146	[p8l11t461r443b517],

1	In	IN	O	in	_	0	SENT_147	[p8l464t465r521b516],
2	all	DT	O	all	det	3	SENT_147	[p8l540t461r610b516],
3	cases	NNS	O	case	prep_in	10	SENT_147	[p8l629t477r801b525],
4	,	,	O	,	_	0	SENT_147	[p8l629t477r801b525],
5	the	DT	O	the	det	7	SENT_147	[p8l820t461r917b516],
6	biological	JJ	O	biological	amod	7	SENT_147	[p8l936t461r1230b530],
7	tests	NNS	O	test	nsubjpass	10	SENT_147	[p8l1249t469r1389b516],
8	should	MD	O	should	aux	10	SENT_147	[p8l1410t461r1613b516],
9	be	VB	O	be	auxpass	10	SENT_147	[p8l1632t461r1702b516],
10	repeated	VBN	O	repeat	_	0	SENT_147	[p8l1722t461r1991b530],
11	after	IN	O	after	_	0	SENT_147	[p8l2010t461r2152b516],
12	the	DT	O	the	det	14	SENT_147	[p8l10t551r108b606],
13	treatment	NN	O	treatment	nn	14	SENT_147	[p8l132t559r441b606],
14	change	NN	O	change	prep_after	10	SENT_147	[p8l463t551r694b619],
15	.	.	O	.	_	0	SENT_147	[p8l463t551r694b619],

1	3	LS	NUMBER	3	_	0	SENT_148	[p8l9t749r63b801],
2	.	.	O	.	_	0	SENT_148	[p8l9t749r63b801],

1	Conclusion	NN	O	conclusion	_	0	SENT_149	[p8l89t747r447b801],

1	Our	PRP$	O	we	poss	2	SENT_150	[p8l113t928r227b980],
2	case	NN	O	case	nsubj	5	SENT_150	[p8l266t933r645b994],
3	—	CD	NUMBER	—	num	4	SENT_150	[p8l266t933r645b994],
4	reports	NNS	O	report	dep	2	SENT_150	[p8l266t933r645b994],
5	underline	VBP	O	underline	_	0	SENT_150	[p8l687t925r983b980],
6	the	DT	O	the	det	7	SENT_150	[p8l1025t925r1122b980],
7	value	NN	O	value	dobj	5	SENT_150	[p8l1162t925r1326b980],
8	of	IN	O	of	_	0	SENT_150	[p8l1369t925r1432b980],
9	combining	VBG	O	combine	prepc_of	7	SENT_150	[p8l1467t925r1793b994],
10	laboratory	NN	O	laboratory	nn	11	SENT_150	[p8l1834t925r2153b994],
11	assays	NNS	O	assay	dobj	9	SENT_150	[p8l11t1030r201b1083],
12	and	CC	O	and	_	0	SENT_150	[p8l247t1014r358b1069],
13	genotyping	VBG	O	genotype	prepc_of	7	SENT_150	[p8l404t1015r752b1083],
14	to	TO	O	to	aux	15	SENT_150	[p8l796t1022r855b1069],
15	elucidate	VB	O	elucidate	ccomp	13	SENT_150	[p8l901t1014r1179b1069],
16	the	DT	O	the	det	17	SENT_150	[p8l1224t1014r1321b1069],
17	mechanism	NN	O	mechanism	dobj	15	SENT_150	[p8l1368t1014r1722b1069],
18	of	IN	O	of	_	0	SENT_150	[p8l1766t1014r1830b1069],
19	high	JJ	O	high	amod	22	SENT_150	[p8l1868t1014r2003b1083],
20	ontreatment	JJ	O	ontreatment	amod	22	SENT_150	[p8l2048t1030r2150b1069, p8l10t1111r319b1158],
21	platelet	NN	O	platelet	nn	22	SENT_150	[p8l346t1103r578b1172],
22	reactivity	NN	O	reactivity	prep_of	17	SENT_150	[p8l606t1104r895b1172],
23	and	CC	O	and	_	0	SENT_150	[p8l922t1103r1033b1158],
24	to	TO	O	to	aux	25	SENT_150	[p8l1062t1111r1121b1158],
25	design	VB	O	design	conj_and	15	SENT_150	[p8l1151t1103r1350b1172],
26	individualized	JJ	O	individualized	amod	28	SENT_150	[p8l1379t1103r1815b1158],
27	treatment	NN	O	treatment	nn	28	SENT_150	[p8l1844t1111r2153b1158],
28	strategies	NNS	O	strategy	dobj	25	SENT_150	[p8l12t1193r320b1261],
29	,	,	O	,	_	0	SENT_150	[p8l12t1193r320b1261],
30	which	WDT	O	which	nsubj	31	SENT_150	[p8l343t1193r533b1248],
31	proved	VBD	O	prove	rcmod	28	SENT_150	[p8l557t1193r771b1261],
32	beneﬁcial	JJ	O	beneﬁcial	acomp	31	SENT_150	[p8l796t1192r1105b1248],
33	.	.	O	.	_	0	SENT_150	[p8l796t1192r1105b1248],

1	Funding	NNP	O	Funding	nn	2	SENT_151	[p8l10t1388r279b1457],
2	sources	NNS	O	source	_	0	SENT_151	[p8l302t1403r544b1443],

1	This	DT	O	this	det	2	SENT_152	[p8l110t1567r236b1622],
2	work	NN	O	work	nsubjpass	4	SENT_152	[p8l273t1567r434b1622],
3	was	VBD	O	be	auxpass	4	SENT_152	[p8l469t1583r588b1622],
4	supported	VBN	O	support	_	0	SENT_152	[p8l628t1567r939b1635],
5	in	IN	O	in	_	0	SENT_152	[p8l978t1568r1034b1621],
6	part	NN	O	part	prep_in	4	SENT_152	[p8l1073t1575r1197b1635],
7	by	IN	O	by	_	0	SENT_152	[p8l1233t1567r1307b1635],
8	research	NN	O	research	nn	9	SENT_152	[p8l1344t1567r1603b1622],
9	grants	NNS	O	grant	agent	4	SENT_152	[p8l1640t1575r1831b1635],
10	from	IN	O	from	_	0	SENT_152	[p8l1870t1567r2016b1622],
11	the	DT	O	the	det	14	SENT_152	[p8l2053t1567r2150b1622],
12	Leducq	NNP	ORGANIZATION	Leducq	nn	14	SENT_152	[p8l11t1656r228b1724],
13	TransAtlantic	NNP	ORGANIZATION	TransAtlantic	nn	14	SENT_152	[p8l264t1656r675b1711],
14	Network	NNP	ORGANIZATION	Network	prep_from	4	SENT_152	[p8l715t1656r983b1711],
15	of	IN	ORGANIZATION	of	_	0	SENT_152	[p8l1021t1656r1084b1711],
16	Excellence	NNP	ORGANIZATION	Excellence	prep_of	14	SENT_152	[p8l1117t1656r1438b1711],
17	on	IN	O	on	_	0	SENT_152	[p8l1478t1672r1553b1711],
18	Atherothrombosis	NNP	ORGANIZATION	Atherothrombosis	nn	23	SENT_152	[p8l1591t1656r2150b1711],
19	Research	NNP	ORGANIZATION	Research	nn	23	SENT_152	[p8l11t1745r284b1800],
20	(	NNP	O	(	nn	23	SENT_152	[p8l312t1745r511b1814],
21	Grant	NNP	O	Grant	nn	23	SENT_152	[p8l312t1745r511b1814],
22	04CVD0l	NN	O	04cvd0l	nn	23	SENT_152	[p8l535t1748r812b1800],
23	)	NN	O	)	prep_on	16	SENT_152	[p8l827t1745r863b1814],
24	.	.	O	.	_	0	SENT_152	[p8l827t1745r863b1814],

1	Conﬂict	NN	O	conﬂict	_	0	SENT_153	[p8l10t1941r259b1995],
2	of	IN	O	of	_	0	SENT_153	[p8l284t1941r353b1995],
3	interest	NN	O	interest	nn	4	SENT_153	[p8l373t1941r623b1995],
4	statement	NN	O	statement	prep_of	1	SENT_153	[p8l647t1948r976b1995],

1	The	DT	O	the	det	2	SENT_154	[p8l110t2119r222b2174],
2	authors	NNS	O	author	nsubj	3	SENT_154	[p8l247t2119r479b2174],
3	conﬁrm	VBP	O	conﬁrm	_	0	SENT_154	[p8l504t2119r743b2174],
4	that	IN	O	that	complm	6	SENT_154	[p8l766t2119r889b2174],
5	there	EX	O	there	expl	6	SENT_154	[p8l912t2119r1072b2174],
6	are	VBP	O	be	ccomp	3	SENT_154	[p8l1096t2135r1189b2174],
7	no	DT	O	no	det	8	SENT_154	[p8l1215t2135r1289b2174],
8	conﬂicts	NNS	O	conﬂicts	nsubj	6	SENT_154	[p8l1314t2119r1568b2174],
9	of	IN	O	of	_	0	SENT_154	[p8l1593t2119r1657b2174],
10	interest	NN	O	interest	prep_of	8	SENT_154	[p8l1674t2120r1923b2174],
11	.	.	O	.	_	0	SENT_154	[p8l1674t2120r1923b2174],

1	Acknowledgements	NNS	O	acknowledgement	_	0	SENT_155	[p8l7t2314r648b2383],

1	We	PRP	O	we	nsubj	3	SENT_156	[p8l110t2496r214b2548],
2	are	VBP	O	be	cop	3	SENT_156	[p8l237t2509r331b2548],
3	grateful	JJ	O	grateful	_	0	SENT_156	[p8l352t2493r590b2562],
4	to	TO	O	to	_	0	SENT_156	[p8l612t2501r671b2548],
5	V.	NNP	PERSON	V.	nn	6	SENT_156	[p8l691t2496r749b2549],
6	Remones	NNP	PERSON	Remones	prep_to	3	SENT_156	[p8l773t2496r1067b2556],
7	,	,	O	,	_	0	SENT_156	[p8l773t2496r1067b2556],
8	J.	NNP	PERSON	J.	nn	9	SENT_156	[p8l1082t2496r1121b2562],
9	Touati	NNP	PERSON	Touati	prep_to	3	SENT_156	[p8l1141t2494r1350b2556],
10	,	,	O	,	_	0	SENT_156	[p8l1141t2494r1350b2556],
11	F.	NNP	PERSON	F.	nn	12	SENT_156	[p8l1374t2496r1417b2549],
12	Desvard	NNP	PERSON	Desvard	prep_to	3	SENT_156	[p8l1442t2493r1704b2557],
13	,	,	O	,	_	0	SENT_156	[p8l1442t2493r1704b2557],
14	and	CC	O	and	_	0	SENT_156	[p8l1727t2493r1839b2548],
15	F.	NNP	PERSON	F.	nn	17	SENT_156	[p8l1862t2496r1906b2549],
16	Dali	NNP	PERSON	Dali	nn	17	SENT_156	[p8l1930t2493r2048b2548],
17	Ali	NNP	PERSON	Ali	conj_and	6	SENT_156	[p8l2068t2493r2150b2547],
18	for	IN	O	for	_	0	SENT_156	[p8l11t2582r96b2636],
19	excellent	JJ	O	excellent	amod	21	SENT_156	[p8l119t2582r398b2636],
20	technical	JJ	O	technical	amod	21	SENT_156	[p8l419t2582r696b2636],
21	assistance	NN	O	assistance	prep_for	17	SENT_156	[p8l720t2583r1042b2637],
22	.	.	O	.	_	0	SENT_156	[p8l720t2583r1042b2637],

1	References	NNS	O	reference	_	0	SENT_157	[p8l10t2777r359b2831],

1	[	NN	O	[	nn	5	SENT_158	[p8l40t2923r101b2977],
2	1	CD	NUMBER	1	num	5	SENT_158	[p8l40t2923r101b2977],
3	]	CD	NUMBER	]	num	5	SENT_158	[p8l40t2923r101b2977],
4	Snoep	NNP	PERSON	Snoep	nn	5	SENT_158	[p8l135t2925r283b2977],
5	JD	NNP	O	JD	_	0	SENT_158	[p8l297t2926r367b2977],
6	,	,	O	,	_	0	SENT_158	[p8l297t2926r367b2977],
7	Hovens	NNP	ORGANIZATION	Hovens	nn	8	SENT_158	[p8l388t2926r569b2967],
8	MM	NN	ORGANIZATION	mm	appos	5	SENT_158	[p8l590t2926r699b2973],
9	,	,	O	,	_	0	SENT_158	[p8l590t2926r699b2973],
10	Eikenboom	NNP	ORGANIZATION	Eikenboom	nn	11	SENT_158	[p8l720t2923r997b2967],
11	JC	NNP	ORGANIZATION	JC	appos	8	SENT_158	[p8l1010t2925r1073b2977],
12	,	,	O	,	_	0	SENT_158	[p8l1010t2925r1073b2977],
13	van	NNP	O	van	nn	16	SENT_158	[p8l1092t2936r1181b2967],
14	der	NNP	O	der	nn	16	SENT_158	[p8l1201t2923r1281b2967],
15	Bom	NNP	O	Bom	nn	16	SENT_158	[p8l1300t2926r1410b2967],
16	JG	NNP	O	JG	appos	8	SENT_158	[p8l1423t2925r1492b2977],
17	,	,	O	,	_	0	SENT_158	[p8l1423t2925r1492b2977],
18	Jukema	NNP	O	Jukema	nn	19	SENT_158	[p8l1506t2923r1694b2977],
19	JW	NNP	O	JW	appos	8	SENT_158	[p8l1708t2926r1796b2977],
20	,	,	O	,	_	0	SENT_158	[p8l1708t2926r1796b2977],
21	Huisman	NNP	PERSON	Huisman	nn	22	SENT_158	[p8l1816t2924r2036b2967],
22	MV	NNP	O	MV	appos	8	SENT_158	[p8l2055t2926r2150b2967],
23	.	.	O	.	_	0	SENT_158	[p8l2055t2926r2150b2967],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_159	[p8l135t2989r416b3043],
2	nonresponsiveness	NN	O	nonresponsiveness	_	0	SENT_159	[p8l449t2989r917b3043],
3	in	IN	O	in	_	0	SENT_159	[p8l950t2989r994b3032],
4	patients	NNS	O	patient	prep_in	2	SENT_159	[p8l1026t2989r1222b3043],
5	undergoing	VBG	O	undergo	partmod	4	SENT_159	[p8l1254t2989r1538b3043],
6	percutaneous	JJ	O	percutaneous	amod	8	SENT_159	[p8l1569t2995r1901b3043],
7	coronary	JJ	O	coronary	amod	8	SENT_159	[p8l1933t3001r2152b3043],
8	intervention	NN	O	intervention	dobj	5	SENT_159	[p8l135t3056r440b3099],
9	with	IN	O	with	_	0	SENT_159	[p8l465t3055r578b3099],
10	stenting	NN	O	stenting	prep_with	5	SENT_159	[p8l603t3056r817b3110],
11	:	:	O	:	_	0	SENT_159	[p8l603t3056r817b3110],
12	a	DT	O	a	det	14	SENT_159	[p8l846t3068r871b3099],
13	systematic	JJ	O	systematic	amod	14	SENT_159	[p8l896t3056r1158b3110],
14	review	NN	O	review	dep	2	SENT_159	[p8l1183t3056r1351b3099],
15	and	CC	O	and	_	0	SENT_159	[p8l1375t3055r1464b3099],
16	meta-analysis	NN	O	meta-analysis	conj_and	14	SENT_159	[p8l1490t3055r1844b3110],
17	.	.	O	.	_	0	SENT_159	[p8l1490t3055r1844b3110],

1	Am	VBP	O	be	dep	2	SENT_160	[p8l1868t3057r1953b3098],
2	Heart	NNP	O	Heart	_	0	SENT_160	[p8l1978t3058r2151b3110],
3	]	CD	NUMBER	]	number	4	SENT_160	[p8l1978t3058r2151b3110],
4	2007	CD	DATE	2007	amod	2	SENT_160	[p8l135t3123r586b3171],
5	;	:	O	;	_	0	SENT_160	[p8l135t3123r586b3171],
6	154:221	CD	NUMBER	154:221	dep	4	SENT_160	[p8l135t3123r586b3171],
7	—	CD	NUMBER	—	num	8	SENT_160	[p8l135t3123r586b3171],
8	31	CD	NUMBER	31	dep	6	SENT_160	[p8l135t3123r586b3171],
9	.	.	O	.	_	0	SENT_160	[p8l135t3123r586b3171],

1	[	NN	O	[	_	0	SENT_161	[p8l40t3187r101b3241],
2	2	CD	NUMBER	2	num	1	SENT_161	[p8l40t3187r101b3241],
3	]	CD	NUMBER	]	num	5	SENT_161	[p8l40t3187r101b3241],
4	Fontana	NNP	ORGANIZATION	Fontana	nn	5	SENT_161	[p8l135t3190r331b3231],
5	P	NN	ORGANIZATION	p	dep	1	SENT_161	[p8l364t3190r403b3237],
6	,	,	O	,	_	0	SENT_161	[p8l364t3190r403b3237],
7	Dupont	NNP	ORGANIZATION	Dupont	nn	8	SENT_161	[p8l438t3190r622b3241],
8	A	NNP	O	A	appos	5	SENT_161	[p8l652t3189r699b3237],
9	,	,	O	,	_	0	SENT_161	[p8l652t3189r699b3237],
10	Gandrille	NNP	O	Gandrille	nn	11	SENT_161	[p8l733t3187r958b3231],
11	S	NNP	O	S	appos	5	SENT_161	[p8l994t3189r1030b3237],
12	,	,	O	,	_	0	SENT_161	[p8l994t3189r1030b3237],
13	Bachelot-Loza	NNP	O	Bachelot-Loza	nn	14	SENT_161	[p8l1065t3187r1408b3231],
14	C	NNP	O	C	appos	5	SENT_161	[p8l1442t3189r1483b3237],
15	,	,	O	,	_	0	SENT_161	[p8l1442t3189r1483b3237],
16	Reny	NNP	PERSON	Reny	nn	17	SENT_161	[p8l1517t3190r1639b3241],
17	JL	NNP	PERSON	JL	appos	5	SENT_161	[p8l1666t3190r1724b3241],
18	,	,	O	,	_	0	SENT_161	[p8l1666t3190r1724b3241],
19	Aiach	NNP	O	Aiach	nn	20	SENT_161	[p8l1755t3187r1892b3231],
20	M	NNP	O	M	appos	5	SENT_161	[p8l1926t3190r1985b3237],
21	,	,	O	,	_	0	SENT_161	[p8l1926t3190r1985b3237],
22	et	FW	O	et	nn	23	SENT_161	[p8l2020t3193r2066b3231],
23	al.	FW	O	al.	appos	5	SENT_161	[p8l2098t3187r2150b3231],
24	.	.	O	.	_	0	SENT_161	[p8l2098t3187r2150b3231],

1	Adenosine	NN	LOCATION	adenosine	nsubjpass	6	SENT_162	[p8l133t3253r392b3297],
2	diphosphate-induced	JJ	O	diphosphate-induced	amod	4	SENT_162	[p8l421t3253r947b3308],
3	platelet	NN	O	platelet	nn	4	SENT_162	[p8l977t3253r1163b3308],
4	aggregation	NN	O	aggregation	dep	1	SENT_162	[p8l1191t3254r1481b3308],
5	is	VBZ	O	be	auxpass	6	SENT_162	[p8l1510t3254r1545b3297],
6	associated	VBN	O	associate	_	0	SENT_162	[p8l1575t3253r1827b3297],
7	with	IN	O	with	_	0	SENT_162	[p8l1855t3253r1968b3297],
8	P2Y12	NN	O	p2y12	nn	11	SENT_162	[p8l1997t3255r2149b3296],
9	gene	NN	O	gene	nn	11	SENT_162	[p8l134t3331r250b3373],
10	sequence	NN	O	sequence	nn	11	SENT_162	[p8l270t3331r497b3373],
11	variations	NNS	O	variation	prep_with	6	SENT_162	[p8l516t3319r759b3362],
12	in	IN	O	in	_	0	SENT_162	[p8l781t3320r826b3362],
13	healthy	JJ	O	healthy	amod	14	SENT_162	[p8l846t3319r1031b3373],
14	subjects	NNS	O	subject	prep_in	6	SENT_162	[p8l1050t3319r1259b3373],
15	.	.	O	.	_	0	SENT_162	[p8l1050t3319r1259b3373],

1	Circulation	NN	O	circulation	_	0	SENT_163	[p8l1280t3319r1547b3362],
2	2003	CD	DATE	2003	num	1	SENT_163	[p8l1567t3321r2019b3369],
3	;	:	O	;	_	0	SENT_163	[p8l1567t3321r2019b3369],
4	108:989	CD	NUMBER	108:989	number	5	SENT_163	[p8l1567t3321r2019b3369],
5	—	CD	NUMBER	—	dep	1	SENT_163	[p8l1567t3321r2019b3369],
6	95	CD	NUMBER	95	dep	5	SENT_163	[p8l1567t3321r2019b3369],
7	.	.	O	.	_	0	SENT_163	[p8l1567t3321r2019b3369],

1	[	NN	O	[	_	0	SENT_164	[p8l40t3384r101b3439],
2	3	CD	NUMBER	3	num	1	SENT_164	[p8l40t3384r101b3439],
3	]	CD	NUMBER	]	num	5	SENT_164	[p8l40t3384r101b3439],
4	Fontana	NNP	ORGANIZATION	Fontana	nn	5	SENT_164	[p8l135t3387r331b3428],
5	P	NN	ORGANIZATION	p	dep	1	SENT_164	[p8l357t3387r395b3435],
6	,	,	O	,	_	0	SENT_164	[p8l357t3387r395b3435],
7	Gaussem	NNP	ORGANIZATION	Gaussem	nn	8	SENT_164	[p8l423t3387r644b3428],
8	P	NN	ORGANIZATION	p	appos	5	SENT_164	[p8l671t3387r709b3435],
9	,	,	O	,	_	0	SENT_164	[p8l671t3387r709b3435],
10	Aiach	NNP	O	Aiach	nn	11	SENT_164	[p8l734t3385r871b3428],
11	M	NNP	O	M	appos	5	SENT_164	[p8l897t3387r956b3435],
12	,	,	O	,	_	0	SENT_164	[p8l897t3387r956b3435],
13	Fiessinger	NNP	O	Fiessinger	nn	14	SENT_164	[p8l983t3385r1229b3439],
14	JN	NN	O	jn	appos	5	SENT_164	[p8l1248t3387r1319b3439],
15	,	,	O	,	_	0	SENT_164	[p8l1248t3387r1319b3439],
16	Emmerich	NNP	PERSON	Emmerich	nn	17	SENT_164	[p8l1346t3384r1649b3439],
17	]	NNP	O	]	appos	5	SENT_164	[p8l1346t3384r1649b3439],
18	,	,	O	,	_	0	SENT_164	[p8l1346t3384r1649b3439],
19	Reny	NNP	PERSON	Reny	nn	20	SENT_164	[p8l1676t3387r1798b3439],
20	JL	NNP	PERSON	JL	appos	5	SENT_164	[p8l1817t3387r1875b3439],
21	.	.	O	.	_	0	SENT_164	[p8l1817t3387r1875b3439],

1	P2Y12	NN	O	p2y12	nn	3	SENT_165	[p8l1903t3387r2055b3428],
2	H2	NN	O	h2	nn	3	SENT_165	[p8l2083t3387r2149b3428],
3	haplotype	NN	O	haplotype	nsubjpass	5	SENT_165	[p8l135t3451r380b3505],
4	is	VBZ	O	be	auxpass	5	SENT_165	[p8l411t3451r446b3494],
5	associated	VBN	O	associate	_	0	SENT_165	[p8l477t3451r729b3494],
6	with	IN	O	with	_	0	SENT_165	[p8l758t3451r871b3494],
7	peripheral	JJ	O	peripheral	amod	9	SENT_165	[p8l901t3451r1155b3505],
8	arterial	JJ	O	arterial	amod	9	SENT_165	[p8l1186t3451r1362b3494],
9	disease	NN	O	disease	prep_with	5	SENT_165	[p8l1392t3451r1584b3495],
10	:	:	O	:	_	0	SENT_165	[p8l1392t3451r1584b3495],
11	a	DT	O	a	det	13	SENT_165	[p8l1618t3463r1643b3494],
12	case-control	JJ	O	case-control	amod	13	SENT_165	[p8l1672t3451r1973b3494],
13	study	NN	O	study	dep	9	SENT_165	[p8l2004t3451r2150b3505],
14	.	.	O	.	_	0	SENT_165	[p8l2004t3451r2150b3505],

1	Circulation	NN	O	circulation	_	0	SENT_166	[p8l135t3517r402b3561],
2	2003	CD	DATE	2003	num	1	SENT_166	[p8l422t3519r874b3568],
3	;	:	O	;	_	0	SENT_166	[p8l422t3519r874b3568],
4	108:2971	CD	NUMBER	108:2971	number	5	SENT_166	[p8l422t3519r874b3568],
5	—	CD	NUMBER	—	dep	1	SENT_166	[p8l422t3519r874b3568],
6	3	CD	NUMBER	3	dep	5	SENT_166	[p8l422t3519r874b3568],
7	.	.	O	.	_	0	SENT_166	[p8l422t3519r874b3568],

1	[	NN	O	[	nn	5	SENT_167	[p8l40t3583r101b3638],
2	4	CD	NUMBER	4	num	5	SENT_167	[p8l40t3583r101b3638],
3	]	CD	NUMBER	]	num	5	SENT_167	[p8l40t3583r101b3638],
4	Bura	NNP	MISC	Bura	nn	5	SENT_167	[p8l135t3586r246b3627],
5	A	NNP	MISC	A	_	0	SENT_167	[p8l265t3585r312b3634],
6	,	,	O	,	_	0	SENT_167	[p8l265t3585r312b3634],
7	Bachelot-Loza	NNP	O	Bachelot-Loza	nn	8	SENT_167	[p8l334t3583r677b3627],
8	C	NNP	O	C	appos	5	SENT_167	[p8l700t3585r740b3633],
9	,	,	O	,	_	0	SENT_167	[p8l700t3585r740b3633],
10	Dali-Ali	NNP	PERSON	Dali-Ali	nn	11	SENT_167	[p8l762t3583r946b3627],
11	F	NN	O	f	appos	5	SENT_167	[p8l968t3586r1003b3634],
12	,	,	O	,	_	0	SENT_167	[p8l968t3586r1003b3634],
13	Aiach	NNP	O	Aiach	nn	14	SENT_167	[p8l1024t3583r1161b3627],
14	M	NNP	O	M	appos	5	SENT_167	[p8l1182t3586r1241b3633],
15	,	,	O	,	_	0	SENT_167	[p8l1182t3586r1241b3633],
16	Gaussem	NNP	PERSON	Gaussem	nn	18	SENT_167	[p8l1263t3585r1484b3627],
17	P.	NNP	PERSON	P.	nn	18	SENT_167	[p8l1506t3586r1544b3627],
18	Role	NN	PERSON	role	appos	5	SENT_167	[p8l1567t3583r1672b3627],
19	of	IN	O	of	_	0	SENT_167	[p8l1693t3583r1744b3627],
20	the	DT	O	the	det	23	SENT_167	[p8l1759t3583r1837b3627],
21	P2Y12	NN	O	p2y12	nn	23	SENT_167	[p8l1859t3585r2012b3626],
22	gene	NN	O	gene	nn	23	SENT_167	[p8l2034t3596r2150b3638],
23	polymorphism	NN	O	polymorphism	prep_of	18	SENT_167	[p8l135t3649r497b3703],
24	in	IN	O	in	_	0	SENT_167	[p8l534t3649r579b3692],
25	platelet	NN	O	platelet	nn	26	SENT_167	[p8l615t3649r800b3703],
26	responsiveness	NN	O	responsiveness	prep_in	23	SENT_167	[p8l836t3649r1207b3703],
27	to	TO	O	to	_	0	SENT_167	[p8l1244t3655r1291b3692],
28	clopidogrel	NN	O	clopidogrel	prep_to	26	SENT_167	[p8l1328t3649r1603b3703],
29	in	IN	O	in	_	0	SENT_167	[p8l1639t3650r1685b3692],
30	healthy	JJ	O	healthy	amod	31	SENT_167	[p8l1721t3649r1905b3703],
31	subjects	NNS	O	subject	prep_in	28	SENT_167	[p8l1941t3649r2150b3703],
32	.	.	O	.	_	0	SENT_167	[p8l1941t3649r2150b3703],

1	J	NNP	O	J	nn	3	SENT_168	[p8l128t3717r148b3769],
2	Thromb	NNP	O	Thromb	nn	3	SENT_168	[p8l165t3715r361b3758],
3	Haemost	NNP	O	Haemost	_	0	SENT_168	[p8l381t3717r599b3758],
4	2006	CD	DATE	2006	num	3	SENT_168	[p8l618t3717r1007b3765],
5	;	:	O	;	_	0	SENT_168	[p8l618t3717r1007b3765],
6	4:2096	CD	NUMBER	4:2096	num	7	SENT_168	[p8l618t3717r1007b3765],
7	—	NN	O	—	dep	3	SENT_168	[p8l618t3717r1007b3765],
8	7	CD	NUMBER	7	dep	7	SENT_168	[p8l618t3717r1007b3765],
9	.	.	O	.	_	0	SENT_168	[p8l618t3717r1007b3765],

1	[	NN	O	[	_	0	SENT_169	[p9l40t12r101b67],
2	5	CD	NUMBER	5	num	1	SENT_169	[p9l40t12r101b67],
3	]	CD	NUMBER	]	num	5	SENT_169	[p9l40t12r101b67],
4	Staritz	NNP	O	Staritz	nn	5	SENT_169	[p9l135t13r292b56],
5	P	NN	O	p	dep	1	SENT_169	[p9l309t15r347b63],
6	,	,	O	,	_	0	SENT_169	[p9l309t15r347b63],
7	Kurz	NNP	PERSON	Kurz	nn	8	SENT_169	[p9l366t15r479b56],
8	K	NNP	PERSON	K	appos	5	SENT_169	[p9l496t15r539b63],
9	,	,	O	,	_	0	SENT_169	[p9l496t15r539b63],
10	Stoll	NNP	PERSON	Stoll	nn	11	SENT_169	[p9l557t13r664b56],
11	M	NNP	O	M	appos	5	SENT_169	[p9l682t15r740b63],
12	,	,	O	,	_	0	SENT_169	[p9l682t15r740b63],
13	Giannitsis	NNP	PERSON	Giannitsis	nn	14	SENT_169	[p9l758t13r1000b56],
14	E	NNP	PERSON	E	appos	5	SENT_169	[p9l1018t15r1057b63],
15	,	,	O	,	_	0	SENT_169	[p9l1018t15r1057b63],
16	Katus	NNP	LOCATION	Katus	nn	17	SENT_169	[p9l1076t15r1210b56],
17	HA	NNP	LOCATION	HA	appos	5	SENT_169	[p9l1228t15r1312b63],
18	,	,	O	,	_	0	SENT_169	[p9l1228t15r1312b63],
19	Ivandic	NNP	O	Ivandic	nn	20	SENT_169	[p9l1331t13r1508b56],
20	BT	NNP	O	BT	appos	5	SENT_169	[p9l1525t15r1595b57],
21	.	.	O	.	_	0	SENT_169	[p9l1525t15r1595b57],

1	Platelet	NN	O	platelet	nn	2	SENT_170	[p9l1613t13r1797b56],
2	reactivity	NN	O	reactivity	nsubjpass	7	SENT_170	[p9l1813t13r2046b67],
3	and	CC	O	and	_	0	SENT_170	[p9l2061t13r2150b56],
4	clopidogrel	NN	O	clopidogrel	nn	5	SENT_170	[p9l135t79r410b134],
5	resistance	NN	O	resistance	conj_and	2	SENT_170	[p9l437t80r681b123],
6	are	VBP	O	be	auxpass	7	SENT_170	[p9l707t92r782b123],
7	associated	VBN	O	associate	_	0	SENT_170	[p9l808t79r1061b123],
8	with	IN	O	with	_	0	SENT_170	[p9l1086t79r1199b123],
9	the	DT	O	the	det	11	SENT_170	[p9l1224t79r1302b123],
10	H2	NN	O	h2	nn	11	SENT_170	[p9l1329t81r1395b122],
11	haplotype	NN	O	haplotype	prep_with	7	SENT_170	[p9l1423t79r1668b134],
12	of	IN	O	of	_	0	SENT_170	[p9l1695t79r1746b123],
13	the	DT	O	the	det	16	SENT_170	[p9l1765t79r1843b123],
14	P2Y12-ADP	NN	O	p2y12-adp	nn	16	SENT_170	[p9l1870t81r2151b122],
15	receptor	NN	O	receptor	nn	16	SENT_170	[p9l135t151r342b199],
16	gene	NN	O	gene	prep_of	11	SENT_170	[p9l359t157r488b199],
17	.	.	O	.	_	0	SENT_170	[p9l359t157r488b199],

1	IntJ	NN	O	intj	nn	2	SENT_171	[p9l509t147r607b199],
2	Cardiol	NN	O	cardiol	_	0	SENT_171	[p9l627t144r800b188],
3	2009	CD	DATE	2009	dep	2	SENT_171	[p9l820t147r1160b195],
4	;	:	O	;	_	0	SENT_171	[p9l820t147r1160b195],
5	133:341	CD	NUMBER	133:341	num	6	SENT_171	[p9l820t147r1160b195],
6	-5	CD	NUMBER	-5	dep	2	SENT_171	[p9l1170t147r1240b188],
7	.	.	O	.	_	0	SENT_171	[p9l1170t147r1240b188],

1	[	NN	O	[	nn	5	SENT_172	[p9l40t211r101b265],
2	6	CD	NUMBER	6	num	5	SENT_172	[p9l40t211r101b265],
3	]	CD	NUMBER	]	num	5	SENT_172	[p9l40t211r101b265],
4	Hulot	NNP	PERSON	Hulot	nn	5	SENT_172	[p9l135t211r272b255],
5	JS	NNP	O	JS	_	0	SENT_172	[p9l286t213r346b265],
6	,	,	O	,	_	0	SENT_172	[p9l286t213r346b265],
7	Bura	NNP	PERSON	Bura	nn	8	SENT_172	[p9l369t214r480b255],
8	A	NNP	O	A	appos	5	SENT_172	[p9l500t213r546b261],
9	,	,	O	,	_	0	SENT_172	[p9l500t213r546b261],
10	Villard	NNP	ORGANIZATION	Villard	nn	11	SENT_172	[p9l567t211r731b255],
11	E	NNP	ORGANIZATION	E	appos	8	SENT_172	[p9l754t214r792b261],
12	,	,	O	,	_	0	SENT_172	[p9l754t214r792b261],
13	Azizi	NNP	O	Azizi	nn	14	SENT_172	[p9l813t212r933b254],
14	M	NNP	O	M	appos	8	SENT_172	[p9l956t214r1014b261],
15	,	,	O	,	_	0	SENT_172	[p9l956t214r1014b261],
16	Remones	NNP	O	Remones	nn	17	SENT_172	[p9l1038t214r1260b255],
17	V	NNP	O	V	appos	8	SENT_172	[p9l1282t214r1328b261],
18	,	,	O	,	_	0	SENT_172	[p9l1282t214r1328b261],
19	Goyenvalle	NNP	O	Goyenvalle	nn	20	SENT_172	[p9l1351t211r1623b265],
20	C	NNP	O	C	appos	8	SENT_172	[p9l1647t213r1687b261],
21	,	,	O	,	_	0	SENT_172	[p9l1647t213r1687b261],
22	et	FW	O	et	nn	23	SENT_172	[p9l1710t217r1756b255],
23	al.	FW	O	al.	appos	8	SENT_172	[p9l1777t211r1829b255],
24	.	.	O	.	_	0	SENT_172	[p9l1777t211r1829b255],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_173	[p9l1852t211r2150b265],
2	P450	NN	O	p450	nsubj	9	SENT_173	[p9l135t279r255b321],
3	2C19	NN	O	2c19	nn	5	SENT_173	[p9l276t279r398b321],
4	loss-of-function	NN	O	loss-of-function	nn	5	SENT_173	[p9l420t277r811b321],
5	polymorphism	NN	O	polymorphism	dep	2	SENT_173	[p9l832t277r1194b332],
6	is	VBZ	O	be	cop	9	SENT_173	[p9l1215t278r1250b321],
7	a	DT	O	a	det	9	SENT_173	[p9l1272t290r1297b321],
8	major	JJ	O	major	amod	9	SENT_173	[p9l1318t278r1462b332],
9	determinant	NN	O	determinant	_	0	SENT_173	[p9l1482t277r1790b321],
10	of	IN	O	of	_	0	SENT_173	[p9l1810t277r1861b321],
11	clopidogrel	NN	O	clopidogrel	nn	12	SENT_173	[p9l1875t277r2150b332],
12	responsiveness	NN	O	responsiveness	prep_of	9	SENT_173	[p9l135t344r507b397],
13	in	IN	O	in	_	0	SENT_173	[p9l528t344r573b386],
14	healthy	JJ	O	healthy	amod	15	SENT_173	[p9l593t343r778b397],
15	subjects	NNS	O	subject	prep_in	12	SENT_173	[p9l797t343r1006b397],
16	.	.	O	.	_	0	SENT_173	[p9l797t343r1006b397],

1	Blood	NN	O	blood	_	0	SENT_174	[p9l1027t343r1164b386],
2	2006	CD	DATE	2006	num	1	SENT_174	[p9l1185t345r1636b393],
3	;	:	O	;	_	0	SENT_174	[p9l1185t345r1636b393],
4	108:2244	CD	NUMBER	108:2244	num	5	SENT_174	[p9l1185t345r1636b393],
5	—	NN	O	—	dep	1	SENT_174	[p9l1185t345r1636b393],
6	7	CD	NUMBER	7	dep	5	SENT_174	[p9l1185t345r1636b393],
7	.	.	O	.	_	0	SENT_174	[p9l1185t345r1636b393],

1	[	NN	O	[	nsubj	13	SENT_175	[p9l40t408r101b463],
2	7	CD	NUMBER	7	num	3	SENT_175	[p9l40t408r101b463],
3	]	NN	O	]	npadvmod	4	SENT_175	[p9l40t408r101b463],
4	Mega	JJ	O	mega	amod	5	SENT_175	[p9l135t411r268b463],
5	JL	NN	O	jl	dep	1	SENT_175	[p9l280t411r338b463],
6	,	,	O	,	_	0	SENT_175	[p9l280t411r338b463],
7	Close	NNP	O	Close	nn	8	SENT_175	[p9l357t409r485b452],
8	SL	NNP	O	SL	appos	1	SENT_175	[p9l504t411r568b459],
9	,	,	O	,	_	0	SENT_175	[p9l504t411r568b459],
10	Wiviott	NNP	PERSON	Wiviott	nn	11	SENT_175	[p9l585t409r773b452],
11	SD	NN	O	sd	appos	8	SENT_175	[p9l792t411r866b459],
12	,	,	O	,	_	0	SENT_175	[p9l792t411r866b459],
13	Shen	VBN	PERSON	shen	_	0	SENT_175	[p9l886t408r1005b452],
14	L	NN	PERSON	l	dobj	13	SENT_175	[p9l1025t411r1059b459],
15	,	,	O	,	_	0	SENT_175	[p9l1025t411r1059b459],
16	Hockett	NNP	PERSON	Hockett	nn	17	SENT_175	[p9l1079t408r1271b452],
17	RD	NNP	O	RD	appos	14	SENT_175	[p9l1289t411r1369b459],
18	,	,	O	,	_	0	SENT_175	[p9l1289t411r1369b459],
19	Brandt	NNP	PERSON	Brandt	nn	20	SENT_175	[p9l1389t408r1555b452],
20	JT	NNP	O	JT	appos	14	SENT_175	[p9l1566t411r1627b463],
21	,	,	O	,	_	0	SENT_175	[p9l1566t411r1627b463],
22	et	FW	O	et	nn	23	SENT_175	[p9l1647t415r1693b452],
23	al.	FW	O	al.	appos	14	SENT_175	[p9l1710t408r1763b452],
24	.	.	O	.	_	0	SENT_175	[p9l1710t408r1763b452],

1	Cytochrome	NN	O	cytochrome	nn	3	SENT_176	[p9l1783t409r2080b463],
2	p450	NN	O	p450	nn	3	SENT_176	[p9l2100t421r2150b463, p9l133t477r224b518],
3	polymorphisms	NNS	O	polymorphism	_	0	SENT_176	[p9l243t475r628b529],
4	and	CC	O	and	_	0	SENT_176	[p9l647t475r737b518],
5	response	NN	O	response	conj_and	3	SENT_176	[p9l755t487r974b529],
6	to	TO	O	to	_	0	SENT_176	[p9l992t481r1039b518],
7	clopidogrel	NN	O	clopidogrel	prep_to	3	SENT_176	[p9l1057t475r1344b529],
8	.	.	O	.	_	0	SENT_176	[p9l1057t475r1344b529],

1	N	NN	O	n	nn	2	SENT_177	[p9l1364t477r1400b518],
2	EnglJ	NN	O	englj	nsubj	3	SENT_177	[p9l1418t475r1555b529],
3	Med	VBD	O	med	_	0	SENT_177	[p9l1573t475r1680b518],
4	2009	CD	DATE	2009	dobj	3	SENT_177	[p9l1699t477r2150b525],
5	;	:	O	;	_	0	SENT_177	[p9l1699t477r2150b525],
6	360:354	CD	NUMBER	360:354	number	7	SENT_177	[p9l1699t477r2150b525],
7	—	CD	NUMBER	—	dep	4	SENT_177	[p9l1699t477r2150b525],
8	62	CD	NUMBER	62	dep	7	SENT_177	[p9l1699t477r2150b525],
9	.	.	O	.	_	0	SENT_177	[p9l1699t477r2150b525],

1	[	NN	O	[	nn	5	SENT_178	[p9l40t541r101b596],
2	8	CD	NUMBER	8	num	5	SENT_178	[p9l40t541r101b596],
3	]	CD	NUMBER	]	num	5	SENT_178	[p9l40t541r101b596],
4	Collet	NNP	ORGANIZATION	Collet	nn	5	SENT_178	[p9l135t541r276b585],
5	JP	NNP	ORGANIZATION	JP	_	0	SENT_178	[p9l291t544r353b596],
6	,	,	O	,	_	0	SENT_178	[p9l291t544r353b596],
7	Hulot	NNP	PERSON	Hulot	nn	8	SENT_178	[p9l377t541r514b585],
8	JS	NNP	O	JS	appos	5	SENT_178	[p9l529t543r589b596],
9	,	,	O	,	_	0	SENT_178	[p9l529t543r589b596],
10	Pena	NNP	PERSON	Pena	nn	11	SENT_178	[p9l613t544r729b585],
11	A	NNP	O	A	appos	8	SENT_178	[p9l750t543r796b592],
12	,	,	O	,	_	0	SENT_178	[p9l750t543r796b592],
13	Villard	NNP	ORGANIZATION	Villard	nn	14	SENT_178	[p9l818t541r981b585],
14	E	NNP	ORGANIZATION	E	appos	8	SENT_178	[p9l1006t544r1044b592],
15	,	,	O	,	_	0	SENT_178	[p9l1006t544r1044b592],
16	Esteve	NNP	O	Esteve	nn	17	SENT_178	[p9l1069t544r1225b585],
17	JB	NNP	O	JB	appos	8	SENT_178	[p9l1243t544r1306b596],
18	,	,	O	,	_	0	SENT_178	[p9l1243t544r1306b596],
19	Silvain	NNP	PERSON	Silvain	nn	20	SENT_178	[p9l1330t541r1492b585],
20	J	NNP	PERSON	J	appos	8	SENT_178	[p9l1509t544r1540b596],
21	,	,	O	,	_	0	SENT_178	[p9l1509t544r1540b596],
22	et	FW	O	et	nn	23	SENT_178	[p9l1565t548r1611b585],
23	al.	FW	O	al.	appos	8	SENT_178	[p9l1632t541r1684b585],
24	.	.	O	.	_	0	SENT_178	[p9l1632t541r1684b585],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_179	[p9l1708t541r2006b596],
2	P450	NN	O	p450	_	0	SENT_179	[p9l2030t543r2150b585],

1	2C19	CD	NUMBER	2c19	num	2	SENT_180	[p9l135t609r256b651],
2	polymorphism	NN	O	polymorphism	_	0	SENT_180	[p9l278t607r641b662],
3	in	IN	O	in	_	0	SENT_180	[p9l662t608r707b650],
4	young	JJ	O	young	amod	5	SENT_180	[p9l726t620r880b662],
5	patients	NNS	O	patient	prep_in	2	SENT_180	[p9l900t608r1096b662],
6	treated	VBN	O	treat	partmod	5	SENT_180	[p9l1118t607r1292b651],
7	with	IN	O	with	_	0	SENT_180	[p9l1313t607r1426b651],
8	clopidogrel	NN	O	clopidogrel	prep_with	6	SENT_180	[p9l1447t607r1722b662],
9	after	IN	O	after	_	0	SENT_180	[p9l1744t607r1857b651],
10	myocardial	JJ	O	myocardial	amod	11	SENT_180	[p9l1877t607r2150b662],
11	infarction	NN	O	infarction	prep_after	6	SENT_180	[p9l135t673r387b717],
12	:	:	O	:	_	0	SENT_180	[p9l135t673r387b717],
13	a	DT	O	a	det	14	SENT_180	[p9l411t685r436b716],
14	cohort	NN	O	cohort	dep	2	SENT_180	[p9l455t673r614b716],
15	study	NN	O	study	dep	14	SENT_180	[p9l634t673r779b727],
16	.	.	O	.	_	0	SENT_180	[p9l634t673r779b727],

1	Lancet	NNP	O	Lancet	_	0	SENT_181	[p9l800t676r959b716],
2	2009	CD	DATE	2009	num	1	SENT_181	[p9l977t675r1429b723],
3	;	:	O	;	_	0	SENT_181	[p9l977t675r1429b723],
4	373:309	CD	NUMBER	373:309	number	5	SENT_181	[p9l977t675r1429b723],
5	—	CD	NUMBER	—	dep	1	SENT_181	[p9l977t675r1429b723],
6	17	CD	NUMBER	17	dep	5	SENT_181	[p9l977t675r1429b723],
7	.	.	O	.	_	0	SENT_181	[p9l977t675r1429b723],

1	Letter	NN	O	letter	_	0	SENT_182	[p9l456t804r523b824],
2	to	TO	O	to	_	0	SENT_182	[p9l533t805r554b824],
3	the	DT	O	the	det	4	SENT_182	[p9l565t802r600b824],
4	Editors	NNP	O	Editors	prep_to	1	SENT_182	[p9l609t802r796b829],
5	.	.	O	.	_	0	SENT_182	[p9l609t802r796b829],

1	—	NN	O	—	_	0	SENT_183	[p9l609t802r796b829],
2	.	.	O	.	_	0	SENT_183	[p9l609t802r796b829],

1	in	IN	O	in	_	0	SENT_184	[p9l609t802r796b829],
2	.	.	O	.	_	0	SENT_184	[p9l609t802r796b829],

1	—	NN	O	—	_	0	SENT_185	[p9l609t802r796b829],
2	.	.	O	.	_	0	SENT_185	[p9l609t802r796b829],

1	Chief	NNP	O	Chief	_	0	SENT_186	[p9l609t802r796b829],
2	95	CD	NUMBER	95	dep	1	SENT_186	[p9l1676t803r1704b824],

1	Shuldiner	NNP	PERSON	Shuldiner	nn	2	SENT_187	[p9l128t931r367b974],
2	AR	NNS	O	ar	_	0	SENT_187	[p9l391t933r470b981],
3	,	,	O	,	_	0	SENT_187	[p9l391t933r470b981],
4	O'Connell	NNP	PERSON	O'Connell	nn	5	SENT_187	[p9l498t931r734b974],
5	JR	NNP	O	JR	appos	2	SENT_187	[p9l755t933r819b985],
6	,	,	O	,	_	0	SENT_187	[p9l755t933r819b985],
7	Bliden	NNP	PERSON	Bliden	nn	8	SENT_187	[p9l847t931r1001b974],
8	KP	NNP	O	KP	appos	5	SENT_187	[p9l1029t933r1102b981],
9	,	,	O	,	_	0	SENT_187	[p9l1029t933r1102b981],
10	Gandhi	NNP	PERSON	Gandhi	nn	11	SENT_187	[p9l1130t931r1306b974],
11	A	NNP	O	A	appos	5	SENT_187	[p9l1331t933r1377b981],
12	,	,	O	,	_	0	SENT_187	[p9l1331t933r1377b981],
13	Ryan	NNP	PERSON	Ryan	nn	14	SENT_187	[p9l1405t933r1525b985],
14	K	NNP	PERSON	K	appos	5	SENT_187	[p9l1552t933r1596b981],
15	,	,	O	,	_	0	SENT_187	[p9l1552t933r1596b981],
16	Horenstein	NNP	PERSON	Horenstein	nn	17	SENT_187	[p9l1623t931r1895b974],
17	RB	NN	O	rb	appos	5	SENT_187	[p9l1922t933r1996b981],
18	,	,	O	,	_	0	SENT_187	[p9l1922t933r1996b981],
19	et	FW	O	et	nn	20	SENT_187	[p9l2024t937r2070b974],
20	al.	FW	O	al.	appos	5	SENT_187	[p9l2095t931r2147b975],
21	.	.	O	.	_	0	SENT_187	[p9l2095t931r2147b975],

1	Association	NNP	O	Association	_	0	SENT_188	[p9l126t998r407b1041],
2	of	IN	O	of	_	0	SENT_188	[p9l431t997r482b1041],
3	cytochrome	NN	O	cytochrome	nn	6	SENT_188	[p9l500t997r791b1052],
4	P450	NN	O	p450	nn	6	SENT_188	[p9l816t999r936b1041],
5	2C19	NN	O	2c19	nn	6	SENT_188	[p9l960t999r1082b1041],
6	genotype	NN	O	genotype	prep_of	1	SENT_188	[p9l1105t1004r1334b1052],
7	with	IN	O	with	_	0	SENT_188	[p9l1357t997r1470b1041],
8	the	DT	O	the	det	10	SENT_188	[p9l1493t997r1571b1041],
9	antiplatelet	JJ	O	antiplatelet	amod	10	SENT_188	[p9l1594t997r1878b1052],
10	effect	NN	O	effect	prep_with	1	SENT_188	[p9l1900t997r2036b1041],
11	and	CC	O	and	_	0	SENT_188	[p9l2058t997r2147b1041],
12	clinical	JJ	O	clinical	amod	13	SENT_188	[p9l128t1062r300b1106],
13	efﬁcacy	NN	O	efﬁcacy	conj_and	10	SENT_188	[p9l320t1062r506b1117],
14	of	IN	O	of	_	0	SENT_188	[p9l524t1062r575b1106],
15	clopidogrel	NN	O	clopidogrel	nn	16	SENT_188	[p9l589t1062r865b1117],
16	therapy	NN	O	therapy	prep_of	1	SENT_188	[p9l885t1062r1086b1117],
17	.	.	O	.	_	0	SENT_188	[p9l885t1062r1086b1117],

1	Jama	NNP	O	Jama	_	0	SENT_189	[p9l1101t1065r1226b1117],
2	2009	CD	DATE	2009	num	1	SENT_189	[p9l1246t1065r1698b1113],
3	;	:	O	;	_	0	SENT_189	[p9l1246t1065r1698b1113],
4	302:849	CD	NUMBER	302:849	number	5	SENT_189	[p9l1246t1065r1698b1113],
5	—	CD	NUMBER	—	dep	1	SENT_189	[p9l1246t1065r1698b1113],
6	57	CD	NUMBER	57	dep	5	SENT_189	[p9l1246t1065r1698b1113],
7	.	.	O	.	_	0	SENT_189	[p9l1246t1065r1698b1113],

1	Hulot	NNP	PERSON	Hulot	nn	2	SENT_190	[p9l132t1129r269b1173],
2	JS	NNP	O	JS	_	0	SENT_190	[p9l277t1131r336b1183],
3	,	,	O	,	_	0	SENT_190	[p9l277t1131r336b1183],
4	Wuerzner	NNP	O	Wuerzner	nn	5	SENT_190	[p9l350t1132r601b1173],
5	G	NNP	O	G	appos	2	SENT_190	[p9l615t1131r661b1179],
6	,	,	O	,	_	0	SENT_190	[p9l615t1131r661b1179],
7	Bachelot-Loza	NNP	O	Bachelot-Loza	nn	8	SENT_190	[p9l677t1129r1021b1173],
8	C	NNP	O	C	appos	5	SENT_190	[p9l1037t1131r1078b1179],
9	,	,	O	,	_	0	SENT_190	[p9l1037t1131r1078b1179],
10	Azizi	NNP	O	Azizi	nn	11	SENT_190	[p9l1091t1130r1211b1172],
11	M	NNP	O	M	appos	5	SENT_190	[p9l1227t1132r1286b1179],
12	,	,	O	,	_	0	SENT_190	[p9l1227t1132r1286b1179],
13	Blanchard	NNP	PERSON	Blanchard	nn	14	SENT_190	[p9l1303t1129r1548b1173],
14	A	NNP	O	A	appos	5	SENT_190	[p9l1562t1131r1608b1179],
15	,	,	O	,	_	0	SENT_190	[p9l1562t1131r1608b1179],
16	Peyrard	NNP	PERSON	Peyrard	nn	17	SENT_190	[p9l1625t1129r1813b1183],
17	S	NNP	O	S	appos	5	SENT_190	[p9l1830t1131r1867b1179],
18	,	,	O	,	_	0	SENT_190	[p9l1830t1131r1867b1179],
19	et	FW	O	et	nn	20	SENT_190	[p9l1883t1135r1929b1173],
20	al.	FW	O	al.	appos	5	SENT_190	[p9l1943t1129r1995b1173],
21	.	.	O	.	_	0	SENT_190	[p9l1943t1129r1995b1173],

1	Effect	NN	O	effect	_	0	SENT_191	[p9l2012t1129r2149b1173],
2	of	IN	O	of	_	0	SENT_191	[p9l132t1195r183b1239],
3	an	DT	O	a	det	7	SENT_191	[p9l197t1208r255b1239],
4	increased	VBN	O	increase	amod	7	SENT_191	[p9l276t1195r509b1239],
5	clopidogrel	NN	O	clopidogrel	nn	7	SENT_191	[p9l531t1195r806b1250],
6	maintenance	NN	O	maintenance	nn	7	SENT_191	[p9l828t1196r1147b1239],
7	dose	NN	O	dose	prep_of	1	SENT_191	[p9l1168t1195r1280b1239],
8	or	CC	O	or	_	0	SENT_191	[p9l1302t1208r1352b1239],
9	lansoprazole	NN	O	lansoprazole	nn	10	SENT_191	[p9l1371t1195r1683b1250],
10	co-administration	NN	O	co-administration	prep_of	1	SENT_191	[p9l1704t1195r2147b1239],
11	on	IN	O	on	_	0	SENT_191	[p9l132t1273r192b1304],
12	the	DT	O	the	det	14	SENT_191	[p9l230t1261r308b1304],
13	antiplatelet	JJ	O	antiplatelet	amod	14	SENT_191	[p9l347t1261r633b1315],
14	response	NN	O	response	prep_on	7	SENT_191	[p9l670t1273r889b1315],
15	to	TO	O	to	_	0	SENT_191	[p9l928t1267r975b1304],
16	clopidogrel	NN	O	clopidogrel	prep_to	14	SENT_191	[p9l1014t1261r1292b1315],
17	in	IN	O	in	_	0	SENT_191	[p9l1331t1262r1376b1304],
18	CYP2C19-genotyped	JJ	O	cyp2c19-genotyped	amod	19	SENT_191	[p9l1415t1261r1923b1315],
19	healthy	JJ	O	healthy	amod	20	SENT_191	[p9l1963t1261r2149b1315],
20	subjects	NNS	O	subject	prep_in	16	SENT_191	[p9l132t1327r341b1381],
21	.	.	O	.	_	0	SENT_191	[p9l132t1327r341b1381],

1	J	NNP	O	J	nn	3	SENT_192	[p9l356t1330r376b1381],
2	Thromb	NNP	O	Thromb	nn	3	SENT_192	[p9l393t1327r588b1371],
3	Haemost	NNP	O	Haemost	_	0	SENT_192	[p9l609t1330r828b1371],
4	2010	CD	DATE	2010	num	3	SENT_192	[p9l846t1329r1205b1377],
5	;	:	O	;	_	0	SENT_192	[p9l846t1329r1205b1377],
6	8:610	CD	NUMBER	8:610	number	7	SENT_192	[p9l846t1329r1205b1377],
7	—	CD	NUMBER	—	dep	3	SENT_192	[p9l846t1329r1205b1377],
8	3	CD	NUMBER	3	dep	7	SENT_192	[p9l846t1329r1205b1377],
9	.	.	O	.	_	0	SENT_192	[p9l846t1329r1205b1377],

1	Gum	NN	O	gum	nn	2	SENT_193	[p9l132t1395r249b1436],
2	PA	NN	O	pa	_	0	SENT_193	[p9l269t1395r344b1443],
3	,	,	O	,	_	0	SENT_193	[p9l269t1395r344b1443],
4	Kottke-Marchant	JJ	O	kottke-marchant	amod	5	SENT_193	[p9l365t1393r788b1436],
5	K	NN	O	k	appos	2	SENT_193	[p9l808t1395r851b1443],
6	,	,	O	,	_	0	SENT_193	[p9l808t1395r851b1443],
7	Welsh	NNP	ORGANIZATION	Welsh	nn	8	SENT_193	[p9l870t1393r1026b1436],
8	PA	NN	ORGANIZATION	pa	appos	2	SENT_193	[p9l1047t1395r1121b1443],
9	,	,	O	,	_	0	SENT_193	[p9l1047t1395r1121b1443],
10	White	NNP	O	White	appos	2	SENT_193	[p9l1140t1393r1337b1447],
11	]	CD	NUMBER	]	num	10	SENT_193	[p9l1140t1393r1337b1447],
12	,	,	O	,	_	0	SENT_193	[p9l1140t1393r1337b1447],
13	Topol	NNP	PERSON	Topol	nn	14	SENT_193	[p9l1356t1393r1494b1447],
14	EJ	NNP	O	EJ	appos	2	SENT_193	[p9l1515t1395r1570b1447],
15	.	.	O	.	_	0	SENT_193	[p9l1515t1395r1570b1447],

1	A	DT	O	a	det	5	SENT_194	[p9l1589t1395r1625b1436],
2	prospective	JJ	O	prospective	amod	5	SENT_194	[p9l1643t1393r1941b1447],
3	,	,	O	,	_	0	SENT_194	[p9l1643t1393r1941b1447],
4	blinded	JJ	O	blinded	amod	5	SENT_194	[p9l1962t1393r2147b1436],
5	determination	NN	O	determination	_	0	SENT_194	[p9l132t1459r486b1503],
6	of	IN	O	of	_	0	SENT_194	[p9l508t1459r560b1503],
7	the	DT	O	the	det	9	SENT_194	[p9l575t1459r653b1503],
8	natural	JJ	O	natural	amod	9	SENT_194	[p9l676t1459r851b1503],
9	history	NN	O	history	prep_of	5	SENT_194	[p9l874t1459r1047b1514],
10	of	IN	O	of	_	0	SENT_194	[p9l1068t1459r1119b1503],
11	aspirin	NN	O	aspirin	nn	12	SENT_194	[p9l1135t1460r1303b1514],
12	resistance	NN	O	resistance	prep_of	9	SENT_194	[p9l1326t1460r1570b1503],
13	among	IN	O	among	_	0	SENT_194	[p9l1593t1472r1762b1514],
14	stable	JJ	O	stable	amod	15	SENT_194	[p9l1784t1459r1927b1503],
15	patients	NNS	O	patient	prep_among	5	SENT_194	[p9l1950t1460r2147b1514],
16	with	IN	O	with	_	0	SENT_194	[p9l130t1525r244b1569],
17	cardiovascular	JJ	O	cardiovascular	amod	18	SENT_194	[p9l264t1525r621b1569],
18	disease	NN	O	disease	prep_with	5	SENT_194	[p9l639t1525r828b1569],
19	.	.	O	.	_	0	SENT_194	[p9l639t1525r828b1569],

1	J	NNP	O	J	nn	4	SENT_195	[p9l843t1528r863b1580],
2	Am	NNP	O	Am	nn	4	SENT_195	[p9l880t1527r965b1568],
3	Coll	NNP	O	Coll	nn	4	SENT_195	[p9l985t1525r1076b1569],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_195	[p9l1096t1525r1269b1569],
5	2003	CD	DATE	2003	num	4	SENT_195	[p9l1289t1527r1679b1576],
6	;	:	O	;	_	0	SENT_195	[p9l1289t1527r1679b1576],
7	41:961	CD	NUMBER	41:961	number	8	SENT_195	[p9l1289t1527r1679b1576],
8	—	CD	NUMBER	—	dep	4	SENT_195	[p9l1289t1527r1679b1576],
9	5	CD	NUMBER	5	dep	8	SENT_195	[p9l1289t1527r1679b1576],
10	.	.	O	.	_	0	SENT_195	[p9l1289t1527r1679b1576],

1	Marcucci	NNP	PERSON	Marcucci	nn	2	SENT_196	[p9l132t1592r353b1635],
2	R	NNP	PERSON	R	_	0	SENT_196	[p9l384t1594r425b1641],
3	,	,	O	,	_	0	SENT_196	[p9l384t1594r425b1641],
4	Gori	NNP	ORGANIZATION	Gori	nn	5	SENT_196	[p9l456t1592r559b1635],
5	AM	NNP	ORGANIZATION	AM	appos	2	SENT_196	[p9l586t1593r683b1641],
6	,	,	O	,	_	0	SENT_196	[p9l586t1593r683b1641],
7	Paniccia	NNP	PERSON	Paniccia	nn	8	SENT_196	[p9l714t1592r913b1635],
8	R	NNP	PERSON	R	appos	5	SENT_196	[p9l942t1594r984b1641],
9	,	,	O	,	_	0	SENT_196	[p9l942t1594r984b1641],
10	Giglioli	NNP	ORGANIZATION	Giglioli	nn	11	SENT_196	[p9l1015t1591r1189b1645],
11	C	NNP	ORGANIZATION	C	appos	5	SENT_196	[p9l1219t1593r1260b1641],
12	,	,	O	,	_	0	SENT_196	[p9l1219t1593r1260b1641],
13	Buonamici	NNP	O	Buonamici	nn	14	SENT_196	[p9l1290t1592r1549b1635],
14	P	NN	O	p	appos	5	SENT_196	[p9l1580t1594r1619b1641],
15	,	,	O	,	_	0	SENT_196	[p9l1580t1594r1619b1641],
16	Antoniucci	NN	PERSON	antoniuccus	nn	17	SENT_196	[p9l1647t1592r1913b1635],
17	D	NN	O	d	appos	5	SENT_196	[p9l1943t1594r1990b1641],
18	,	,	O	,	_	0	SENT_196	[p9l1943t1594r1990b1641],
19	et	FW	O	et	nn	20	SENT_196	[p9l2021t1597r2067b1635],
20	al.	FW	O	al.	appos	5	SENT_196	[p9l2095t1591r2147b1635],
21	.	.	O	.	_	0	SENT_196	[p9l2095t1591r2147b1635],

1	Residual	JJ	O	residual	amod	3	SENT_197	[p9l132t1657r338b1701],
2	platelet	NN	O	platelet	nn	3	SENT_197	[p9l363t1657r550b1711],
3	reactivity	NN	O	reactivity	nsubjpass	5	SENT_197	[p9l574t1658r806b1711],
4	is	VBZ	O	be	auxpass	5	SENT_197	[p9l830t1658r866b1701],
5	associated	VBN	O	associate	_	0	SENT_197	[p9l891t1657r1143b1701],
6	with	IN	O	with	_	0	SENT_197	[p9l1167t1657r1280b1701],
7	clinical	JJ	O	clinical	amod	10	SENT_197	[p9l1305t1657r1477b1701],
8	and	CC	O	and	_	0	SENT_197	[p9l1503t1657r1592b1701],
9	laboratory	NN	O	laboratory	amod	10	SENT_197	[p9l1617t1657r1873b1711],
10	characteristics	NNS	O	characteristic	prep_with	5	SENT_197	[p9l1896t1657r2147b1701, p9l132t1723r253b1766],
11	in	IN	O	in	_	0	SENT_197	[p9l273t1723r318b1766],
12	patients	NNS	O	patient	nsubj	17	SENT_197	[p9l338t1723r534b1777],
13	with	IN	O	with	_	0	SENT_197	[p9l553t1723r666b1766],
14	ischemic	JJ	O	ischemic	amod	16	SENT_197	[p9l686t1723r901b1766],
15	heart	NN	O	heart	nn	16	SENT_197	[p9l920t1723r1049b1766],
16	disease	NN	O	disease	prep_with	12	SENT_197	[p9l1067t1723r1244b1766],
17	undergoing	VBG	O	undergo	prepc_in	5	SENT_197	[p9l1263t1723r1548b1777],
18	PC	NN	O	pc	nn	19	SENT_197	[p9l1567t1725r1642b1766],
19	]	NN	O	]	dobj	17	SENT_197	[p9l1567t1725r1642b1766],
20	on	IN	O	on	_	0	SENT_197	[p9l1662t1735r1722b1766],
21	dual	JJ	O	dual	amod	23	SENT_197	[p9l1741t1723r1846b1766],
22	antiplatelet	JJ	O	antiplatelet	amod	23	SENT_197	[p9l1866t1723r2149b1777],
23	therapy	NN	O	therapy	prep_on	17	SENT_197	[p9l131t1789r333b1844],
24	.	.	O	.	_	0	SENT_197	[p9l131t1789r333b1844],

1	Atherosclerosis	NNP	O	Atherosclerosis	_	0	SENT_198	[p9l352t1789r729b1833],
2	2007	CD	DATE	2007	num	1	SENT_198	[p9l750t1791r1231b1840],
3	;	:	O	;	_	0	SENT_198	[p9l750t1791r1231b1840],
4	195	CD	NUMBER	195	num	6	SENT_198	[p9l750t1791r1231b1840],
5	:	:	O	:	_	0	SENT_198	[p9l750t1791r1231b1840],
6	e217	CD	NUMBER	e217	dep	1	SENT_198	[p9l750t1791r1231b1840],
7	—	CD	NUMBER	—	number	8	SENT_198	[p9l750t1791r1231b1840],
8	23	CD	NUMBER	23	dep	6	SENT_198	[p9l750t1791r1231b1840],
9	.	.	O	.	_	0	SENT_198	[p9l750t1791r1231b1840],

1	Sibbing	VBG	O	sibb	_	0	SENT_199	[p9l132t1854r314b1909],
2	D	NN	O	d	dobj	1	SENT_199	[p9l334t1857r381b1905],
3	,	,	O	,	_	0	SENT_199	[p9l334t1857r381b1905],
4	Morath	NNP	PERSON	Morath	nn	5	SENT_199	[p9l402t1855r583b1898],
5	T	NN	O	t	appos	2	SENT_199	[p9l600t1857r641b1905],
6	,	,	O	,	_	0	SENT_199	[p9l600t1857r641b1905],
7	Stegherr	NN	PERSON	stegherr	nn	8	SENT_199	[p9l663t1854r872b1909],
8	J	NN	PERSON	j	appos	2	SENT_199	[p9l885t1857r916b1909],
9	,	,	O	,	_	0	SENT_199	[p9l885t1857r916b1909],
10	Braun	NNP	PERSON	Braun	nn	11	SENT_199	[p9l937t1857r1081b1898],
11	S	NNP	O	S	appos	2	SENT_199	[p9l1101t1857r1138b1905],
12	,	,	O	,	_	0	SENT_199	[p9l1101t1857r1138b1905],
13	Vogt	NNP	PERSON	Vogt	nn	14	SENT_199	[p9l1157t1857r1273b1909],
14	W	NNP	O	W	appos	2	SENT_199	[p9l1290t1857r1357b1905],
15	,	,	O	,	_	0	SENT_199	[p9l1290t1857r1357b1905],
16	Hadamitzky	NNP	O	Hadamitzky	nn	17	SENT_199	[p9l1378t1854r1677b1909],
17	M	NNP	O	M	appos	2	SENT_199	[p9l1696t1857r1755b1905],
18	,	,	O	,	_	0	SENT_199	[p9l1696t1857r1755b1905],
19	et	FW	O	et	nn	20	SENT_199	[p9l1776t1861r1822b1898],
20	al.	FW	O	al.	appos	2	SENT_199	[p9l1841t1854r1893b1898],
21	.	.	O	.	_	0	SENT_199	[p9l1841t1854r1893b1898],

1	Impact	NN	O	impact	_	0	SENT_200	[p9l1914t1857r2084b1909],
2	of	IN	O	of	_	0	SENT_200	[p9l2103t1854r2154b1898],
3	proton	NN	O	proton	nn	5	SENT_200	[p9l132t1927r297b1975],
4	pump	NN	O	pump	nn	5	SENT_200	[p9l312t1934r455b1975],
5	inhibitors	NNS	O	inhibitor	prep_of	1	SENT_200	[p9l470t1921r708b1965],
6	on	IN	O	on	_	0	SENT_200	[p9l723t1934r783b1965],
7	the	DT	O	the	det	9	SENT_200	[p9l797t1921r875b1965],
8	antiplatelet	JJ	O	antiplatelet	amod	9	SENT_200	[p9l890t1921r1173b1975],
9	effects	NNS	O	effect	prep_on	1	SENT_200	[p9l1187t1921r1343b1965],
10	of	IN	O	of	_	0	SENT_200	[p9l1359t1921r1410b1965],
11	clopidogrel	NN	O	clopidogrel	prep_of	9	SENT_200	[p9l1418t1921r1706b1975],
12	.	.	O	.	_	0	SENT_200	[p9l1418t1921r1706b1975],

1	Thromb	NNP	O	Thromb	nn	2	SENT_201	[p9l1720t1921r1915b1965],
2	Haemost	NNP	O	Haemost	_	0	SENT_201	[p9l1930t1924r2149b1965],
3	2009	CD	DATE	2009	num	2	SENT_201	[p9l131t1989r552b2037],
4	;	:	O	;	_	0	SENT_201	[p9l131t1989r552b2037],
5	101:714	CD	NUMBER	101:714	number	6	SENT_201	[p9l131t1989r552b2037],
6	—	CD	NUMBER	—	dep	2	SENT_201	[p9l131t1989r552b2037],
7	9	CD	NUMBER	9	dep	6	SENT_201	[p9l131t1989r552b2037],
8	.	.	O	.	_	0	SENT_201	[p9l131t1989r552b2037],

1	Kreutz	NNP	PERSON	Kreutz	nn	2	SENT_202	[p9l132t2056r293b2096],
2	RP	NNP	O	RP	_	0	SENT_202	[p9l317t2056r389b2103],
3	,	,	O	,	_	0	SENT_202	[p9l317t2056r389b2103],
4	Stanek	NNP	PERSON	Stanek	nn	5	SENT_202	[p9l415t2053r580b2096],
5	EJ	NNP	O	EJ	appos	2	SENT_202	[p9l603t2056r658b2107],
6	,	,	O	,	_	0	SENT_202	[p9l603t2056r658b2107],
7	Aubert	NNP	PERSON	Aubert	nn	8	SENT_202	[p9l681t2053r851b2096],
8	R	NNP	PERSON	R	appos	5	SENT_202	[p9l874t2056r916b2103],
9	,	,	O	,	_	0	SENT_202	[p9l874t2056r916b2103],
10	Yao	NNP	PERSON	Yao	nn	11	SENT_202	[p9l938t2056r1029b2096],
11	J	NNP	PERSON	J	appos	5	SENT_202	[p9l1047t2056r1078b2107],
12	,	,	O	,	_	0	SENT_202	[p9l1047t2056r1078b2107],
13	Breall	NNP	PERSON	Breall	nn	14	SENT_202	[p9l1103t2053r1241b2096],
14	JA	NNP	O	JA	appos	5	SENT_202	[p9l1259t2055r1327b2107],
15	,	,	O	,	_	0	SENT_202	[p9l1259t2055r1327b2107],
16	Desta	NNP	O	Desta	nn	17	SENT_202	[p9l1352t2056r1487b2096],
17	Z	NNP	O	Z	appos	5	SENT_202	[p9l1510t2056r1550b2103],
18	,	,	O	,	_	0	SENT_202	[p9l1510t2056r1550b2103],
19	et	FW	O	et	nn	20	SENT_202	[p9l1575t2059r1621b2096],
20	al.	FW	O	al.	appos	5	SENT_202	[p9l1644t2053r1696b2097],
21	.	.	O	.	_	0	SENT_202	[p9l1644t2053r1696b2097],

1	Impact	NN	O	impact	_	0	SENT_203	[p9l1721t2056r1890b2107],
2	of	IN	O	of	_	0	SENT_203	[p9l1914t2053r1964b2096],
3	proton	NN	O	proton	nn	5	SENT_203	[p9l1982t2059r2148b2107],
4	pump	NN	O	pump	nn	5	SENT_203	[p9l132t2131r277b2173],
5	inhibitors	NNS	O	inhibitor	prep_of	1	SENT_203	[p9l318t2118r563b2162],
6	on	IN	O	on	_	0	SENT_203	[p9l603t2131r665b2162],
7	the	DT	O	the	det	8	SENT_203	[p9l704t2118r784b2162],
8	effectiveness	NN	O	effectiveness	prep_on	5	SENT_203	[p9l824t2118r1151b2162],
9	of	IN	O	of	_	0	SENT_203	[p9l1191t2118r1244b2162],
10	clopidogrel	NN	O	clopidogrel	prep_of	8	SENT_203	[p9l1277t2118r1562b2173],
11	after	IN	O	after	_	0	SENT_203	[p9l1602t2118r1720b2162],
12	coronary	JJ	O	coronary	amod	14	SENT_203	[p9l1758t2131r1984b2173],
13	stent	NN	O	stent	nn	14	SENT_203	[p9l2023t2125r2149b2162],
14	placement	NN	O	placement	prep_after	10	SENT_203	[p9l132t2185r404b2239],
15	:	:	O	:	_	0	SENT_203	[p9l132t2185r404b2239],
16	the	DT	O	the	det	18	SENT_203	[p9l433t2185r511b2228],
17	clopidogrel	NN	O	clopidogrel	nn	18	SENT_203	[p9l537t2185r812b2239],
18	medco	NN	O	medco	dep	1	SENT_203	[p9l839t2185r1001b2228],
19	outcomes	NNS	O	outcome	nn	20	SENT_203	[p9l1027t2191r1264b2228],
20	study	NN	O	study	dep	18	SENT_203	[p9l1291t2185r1437b2239],
21	.	.	O	.	_	0	SENT_203	[p9l1291t2185r1437b2239],

1	Pharmacotherapy	NNP	O	Pharmacotherapy	_	0	SENT_204	[p9l1464t2185r1902b2239],
2	2010	CD	DATE	2010	num	1	SENT_204	[p9l1926t2187r2144b2235],
3	;	:	O	;	_	0	SENT_204	[p9l1926t2187r2144b2235],
4	30	CD	NUMBER	30	num	6	SENT_204	[p9l1926t2187r2144b2235],
5	:	:	O	:	_	0	SENT_204	[p9l1926t2187r2144b2235],
6	787-96	CD	NUMBER	787-96	dep	1	SENT_204	[p9l132t2254r328b2296],
7	.	.	O	.	_	0	SENT_204	[p9l132t2254r328b2296],

1	SawJ	NN	O	sawj	_	0	SENT_205	[p9l132t2320r271b2373],
2	,	,	O	,	_	0	SENT_205	[p9l132t2320r271b2373],
3	Brennan	NNP	PERSON	Brennan	nn	4	SENT_205	[p9l286t2321r492b2362],
4	DM	NN	O	dm	appos	1	SENT_205	[p9l507t2321r604b2368],
5	,	,	O	,	_	0	SENT_205	[p9l507t2321r604b2368],
6	Steinhubl	NNP	O	Steinhubl	nn	7	SENT_205	[p9l619t2318r853b2362],
7	SR	NN	O	sr	appos	4	SENT_205	[p9l868t2320r938b2368],
8	,	,	O	,	_	0	SENT_205	[p9l868t2320r938b2368],
9	Bhatt	NNP	PERSON	Bhatt	nn	10	SENT_205	[p9l954t2318r1084b2362],
10	DL	NNP	O	DL	appos	4	SENT_205	[p9l1098t2321r1171b2368],
11	,	,	O	,	_	0	SENT_205	[p9l1098t2321r1171b2368],
12	Mak	NNP	PERSON	Mak	nn	13	SENT_205	[p9l1187t2318r1293b2362],
13	KH	NNP	O	KH	appos	4	SENT_205	[p9l1306t2321r1390b2369],
14	,	,	O	,	_	0	SENT_205	[p9l1306t2321r1390b2369],
15	Fox	NNP	ORGANIZATION	Fox	nn	16	SENT_205	[p9l1405t2321r1491b2362],
16	K	NNP	ORGANIZATION	K	appos	4	SENT_205	[p9l1505t2321r1548b2369],
17	,	,	O	,	_	0	SENT_205	[p9l1505t2321r1548b2369],
18	et	FW	O	et	nn	19	SENT_205	[p9l1563t2325r1609b2362],
19	al.	FW	O	al.	appos	4	SENT_205	[p9l1622t2318r1674b2362],
20	.	.	O	.	_	0	SENT_205	[p9l1622t2318r1674b2362],

1	Lack	NN	O	lack	_	0	SENT_206	[p9l1690t2318r1798b2362],
2	of	IN	O	of	_	0	SENT_206	[p9l1811t2318r1862b2362],
3	evidence	NN	O	evidence	prep_of	1	SENT_206	[p9l1870t2318r2088b2362],
4	of	IN	O	of	_	0	SENT_206	[p9l2103t2318r2154b2362],
5	a	DT	O	a	det	7	SENT_206	[p9l131t2397r156b2428],
6	clopidogrel-statin	JJ	O	clopidogrel-statin	amod	7	SENT_206	[p9l174t2384r612b2438],
7	interaction	NN	O	interaction	prep_of	1	SENT_206	[p9l631t2385r900b2428],
8	in	IN	O	in	_	0	SENT_206	[p9l918t2385r963b2427],
9	the	DT	O	the	det	11	SENT_206	[p9l981t2384r1059b2428],
10	CHARISMA	NN	O	charisma	nn	11	SENT_206	[p9l1077t2386r1348b2428],
11	trial	NN	O	trial	prep_in	7	SENT_206	[p9l1364t2384r1506b2438],
12	.	.	O	.	_	0	SENT_206	[p9l1364t2384r1506b2438],

1	J	NNP	O	J	nn	4	SENT_207	[p9l1364t2384r1506b2438],
2	Am	NNP	O	Am	nn	4	SENT_207	[p9l1522t2386r1608b2427],
3	Coll	NNP	O	Coll	nn	4	SENT_207	[p9l1625t2384r1716b2428],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_207	[p9l1734t2384r1908b2428],
5	2007	CD	DATE	2007	num	4	SENT_207	[p9l1926t2386r2144b2434],
6	;	:	O	;	_	0	SENT_207	[p9l1926t2386r2144b2434],
7	50	CD	NUMBER	50	num	9	SENT_207	[p9l1926t2386r2144b2434],
8	:	:	O	:	_	0	SENT_207	[p9l1926t2386r2144b2434],
9	291-5	CD	NUMBER	291-5	dep	4	SENT_207	[p9l131t2453r297b2495],
10	.	.	O	.	_	0	SENT_207	[p9l131t2453r297b2495],

1	Pena	NNP	PERSON	Pena	nn	2	SENT_208	[p9l132t2519r249b2560],
2	A	NNP	O	A	_	0	SENT_208	[p9l263t2519r310b2567],
3	,	,	O	,	_	0	SENT_208	[p9l263t2519r310b2567],
4	Collet	NNP	ORGANIZATION	Collet	nn	5	SENT_208	[p9l328t2517r469b2560],
5	JP	NNP	ORGANIZATION	JP	appos	2	SENT_208	[p9l479t2519r541b2571],
6	,	,	O	,	_	0	SENT_208	[p9l479t2519r541b2571],
7	Hulot	NNP	PERSON	Hulot	nn	8	SENT_208	[p9l560t2517r696b2560],
8	JS	NNP	O	JS	appos	5	SENT_208	[p9l706t2519r766b2571],
9	,	,	O	,	_	0	SENT_208	[p9l706t2519r766b2571],
10	Silvain	NNP	PERSON	Silvain	nn	11	SENT_208	[p9l785t2517r948b2560],
11	J	NNP	PERSON	J	appos	5	SENT_208	[p9l959t2519r990b2571],
12	,	,	O	,	_	0	SENT_208	[p9l959t2519r990b2571],
13	Barthelemy	NNP	PERSON	Barthelemy	nn	14	SENT_208	[p9l1009t2517r1294b2571],
14	O	NNP	PERSON	O	appos	5	SENT_208	[p9l1311t2519r1357b2567],
15	,	,	O	,	_	0	SENT_208	[p9l1311t2519r1357b2567],
16	Beygui	NNP	O	Beygui	nn	17	SENT_208	[p9l1376t2517r1540b2571],
17	F	NN	O	f	appos	5	SENT_208	[p9l1558t2519r1593b2567],
18	,	,	O	,	_	0	SENT_208	[p9l1558t2519r1593b2567],
19	et	FW	O	et	nn	20	SENT_208	[p9l1612t2523r1658b2560],
20	al.	FW	O	al.	appos	5	SENT_208	[p9l1674t2517r1726b2561],
21	.	.	O	.	_	0	SENT_208	[p9l1674t2517r1726b2561],

1	Can	MD	O	can	aux	3	SENT_209	[p9l1745t2519r1835b2560],
2	we	PRP	O	we	nsubj	3	SENT_209	[p9l1851t2529r1924b2560],
3	override	VB	O	override	_	0	SENT_209	[p9l1942t2517r2147b2560],
4	clopidogrel	NN	O	clopidogrel	nn	5	SENT_209	[p9l132t2583r407b2638],
5	resistance	NN	O	resistance	dobj	3	SENT_209	[p9l428t2584r700b2627],
6	?	.	O	?	_	0	SENT_209	[p9l428t2584r700b2627],

1	Circulation	NN	O	circulation	_	0	SENT_210	[p9l722t2583r990b2627],
2	2009	CD	DATE	2009	num	1	SENT_210	[p9l1010t2585r1462b2633],
3	;	:	O	;	_	0	SENT_210	[p9l1010t2585r1462b2633],
4	119:2854	CD	NUMBER	119:2854	num	5	SENT_210	[p9l1010t2585r1462b2633],
5	—	NN	O	—	dep	1	SENT_210	[p9l1010t2585r1462b2633],
6	7	CD	NUMBER	7	dep	5	SENT_210	[p9l1010t2585r1462b2633],
7	.	.	O	.	_	0	SENT_210	[p9l1010t2585r1462b2633],

1	Barker	NNP	PERSON	Barker	nn	2	SENT_211	[p9l132t2648r293b2692],
2	CM	NN	O	cm	_	0	SENT_211	[p9l311t2651r401b2699],
3	,	,	O	,	_	0	SENT_211	[p9l311t2651r401b2699],
4	Murray	NNP	PERSON	Murray	nn	5	SENT_211	[p9l421t2651r604b2703],
5	SS	NNP	O	SS	appos	2	SENT_211	[p9l621t2651r686b2699],
6	,	,	O	,	_	0	SENT_211	[p9l621t2651r686b2699],
7	Teirstein	NNP	ORGANIZATION	Teirstein	nn	8	SENT_211	[p9l703t2649r920b2692],
8	PS	NNP	ORGANIZATION	PS	appos	5	SENT_211	[p9l939t2651r1006b2699],
9	,	,	O	,	_	0	SENT_211	[p9l939t2651r1006b2699],
10	Kandzari	NNP	ORGANIZATION	Kandzari	nn	11	SENT_211	[p9l1026t2648r1242b2692],
11	DE	NN	ORGANIZATION	de	appos	5	SENT_211	[p9l1262t2651r1339b2699],
12	,	,	O	,	_	0	SENT_211	[p9l1262t2651r1339b2699],
13	Topol	NNP	ORGANIZATION	Topol	nn	14	SENT_211	[p9l1356t2649r1494b2703],
14	EJ	NNP	ORGANIZATION	EJ	appos	5	SENT_211	[p9l1514t2651r1569b2703],
15	,	,	O	,	_	0	SENT_211	[p9l1514t2651r1569b2703],
16	Price	NNP	O	Price	nn	17	SENT_211	[p9l1589t2649r1707b2692],
17	MJ	NNP	O	MJ	appos	5	SENT_211	[p9l1727t2651r1802b2703],
18	.	.	O	.	_	0	SENT_211	[p9l1727t2651r1802b2703],

1	Pilot	NN	O	pilot	nn	2	SENT_212	[p9l1822t2648r1932b2692],
2	study	NN	O	study	_	0	SENT_212	[p9l1950t2648r2085b2703],
3	of	IN	O	of	_	0	SENT_212	[p9l2103t2648r2154b2692],
4	the	DT	O	the	det	6	SENT_212	[p9l131t2715r209b2759],
5	antiplatelet	JJ	O	antiplatelet	amod	6	SENT_212	[p9l247t2715r530b2769],
6	effect	NN	O	effect	prep_of	2	SENT_212	[p9l567t2715r702b2759],
7	of	IN	O	of	_	0	SENT_212	[p9l739t2715r790b2759],
8	increased	VBN	O	increase	amod	11	SENT_212	[p9l821t2715r1055b2759],
9	clopidogrel	NN	O	clopidogrel	nn	11	SENT_212	[p9l1093t2715r1369b2769],
10	maintenance	NN	O	maintenance	nn	11	SENT_212	[p9l1407t2716r1726b2759],
11	dosing	NN	O	dosing	prep_of	6	SENT_212	[p9l1765t2715r1927b2769],
12	and	CC	O	and	_	0	SENT_212	[p9l1964t2715r2053b2759],
13	its	PRP$	O	its	poss	14	SENT_212	[p9l2092t2716r2147b2759],
14	relationship	NN	O	relationship	prep_of	6	SENT_212	[p9l132t2781r426b2836],
15	to	TO	O	to	_	0	SENT_212	[p9l444t2788r491b2825],
16	CYP2C19	NN	O	cyp2c19	nn	17	SENT_212	[p9l509t2783r728b2825],
17	genotype	NN	O	genotype	prep_to	14	SENT_212	[p9l745t2788r974b2836],
18	in	IN	O	in	_	0	SENT_212	[p9l992t2782r1037b2824],
19	patients	NNS	O	patient	prep_in	17	SENT_212	[p9l1054t2782r1251b2836],
20	with	IN	O	with	_	0	SENT_212	[p9l1269t2781r1382b2825],
21	high	JJ	O	high	amod	23	SENT_212	[p9l1399t2781r1507b2836],
22	on-treatment	JJ	O	on-treatment	amod	23	SENT_212	[p9l1524t2788r1857b2825],
23	reactivity	NN	O	reactivity	prep_with	19	SENT_212	[p9l1874t2782r2148b2836],
24	.	.	O	.	_	0	SENT_212	[p9l1874t2782r2148b2836],

1	J	NNP	O	J	nn	4	SENT_213	[p9l1874t2782r2148b2836],
2	Am	NNP	O	Am	nn	4	SENT_213	[p9l129t2849r215b2890],
3	Coll	NNP	O	Coll	nn	4	SENT_213	[p9l234t2847r325b2890],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_213	[p9l345t2847r519b2890],
5	2010	CD	DATE	2010	num	4	SENT_213	[p9l539t2849r929b2897],
6	;	:	O	;	_	0	SENT_213	[p9l539t2849r929b2897],
7	3:1001	CD	NUMBER	3:1001	num	8	SENT_213	[p9l539t2849r929b2897],
8	—	NN	O	—	dep	4	SENT_213	[p9l539t2849r929b2897],
9	7	CD	NUMBER	7	dep	8	SENT_213	[p9l539t2849r929b2897],
10	.	.	O	.	_	0	SENT_213	[p9l539t2849r929b2897],

1	Aleil	NN	O	aleil	nn	2	SENT_214	[p9l129t2912r240b2956],
2	B	NN	O	b	nsubj	20	SENT_214	[p9l262t2915r302b2963],
3	,	,	O	,	_	0	SENT_214	[p9l262t2915r302b2963],
4	Rochoux	NNP	PERSON	Rochoux	nn	5	SENT_214	[p9l325t2913r538b2956],
5	G	NNP	PERSON	G	appos	2	SENT_214	[p9l559t2915r605b2963],
6	,	,	O	,	_	0	SENT_214	[p9l559t2915r605b2963],
7	Monassier	NNP	O	Monassier	nn	8	SENT_214	[p9l628t2913r882b2956],
8	JP	NNP	O	JP	appos	2	SENT_214	[p9l895t2915r957b2967],
9	,	,	O	,	_	0	SENT_214	[p9l895t2915r957b2967],
10	Cazenave	NNP	PERSON	Cazenave	nn	11	SENT_214	[p9l980t2915r1210b2956],
11	JP	NNP	O	JP	appos	2	SENT_214	[p9l1226t2915r1287b2967],
12	,	,	O	,	_	0	SENT_214	[p9l1226t2915r1287b2967],
13	Gachet	NNP	PERSON	Gachet	nn	15	SENT_214	[p9l1310t2912r1480b2956],
14	C.	NNP	PERSON	C.	nn	15	SENT_214	[p9l1500t2915r1541b2956],
15	Ticlopidine	NNP	PERSON	Ticlopidine	appos	2	SENT_214	[p9l1561t2912r1835b2967],
16	could	MD	O	could	aux	20	SENT_214	[p9l1858t2912r1991b2956],
17	be	VB	O	be	cop	20	SENT_214	[p9l2012t2912r2068b2956],
18	an	DT	O	a	det	20	SENT_214	[p9l2090t2925r2148b2956],
19	alternative	JJ	O	alternative	amod	20	SENT_214	[p9l131t2979r396b3022],
20	therapy	NN	O	therapy	_	0	SENT_214	[p9l424t2979r615b3033],
21	in	IN	O	in	_	0	SENT_214	[p9l641t2979r687b3022],
22	the	DT	O	the	det	23	SENT_214	[p9l713t2979r791b3022],
23	case	NN	O	case	prep_in	20	SENT_214	[p9l819t2991r920b3022],
24	of	IN	O	of	_	0	SENT_214	[p9l948t2978r999b3022],
25	pharmacological	JJ	O	pharmacological	amod	26	SENT_214	[p9l1020t2979r1426b3033],
26	resistance	NN	O	resistance	prep_of	23	SENT_214	[p9l1455t2979r1699b3022],
27	to	TO	O	to	_	0	SENT_214	[p9l1727t2985r1774b3022],
28	clopidogrel	NN	O	clopidogrel	prep_to	26	SENT_214	[p9l1802t2979r2092b3033],
29	:	:	O	:	_	0	SENT_214	[p9l1802t2979r2092b3033],
30	a	DT	O	a	det	31	SENT_214	[p9l2123t2991r2148b3022],
31	report	NN	O	report	dep	20	SENT_214	[p9l132t3052r285b3100],
32	of	IN	O	of	_	0	SENT_214	[p9l304t3045r355b3089],
33	three	CD	NUMBER	three	num	34	SENT_214	[p9l368t3045r496b3089],
34	cases	NNS	O	case	prep_of	31	SENT_214	[p9l517t3048r689b3100],
35	.	.	O	.	_	0	SENT_214	[p9l517t3048r689b3100],

1	J	NNP	O	J	nn	3	SENT_215	[p9l517t3048r689b3100],
2	Thromb	NNP	O	Thromb	nn	3	SENT_215	[p9l706t3045r902b3089],
3	Haemost	NNP	O	Haemost	_	0	SENT_215	[p9l922t3048r1141b3089],
4	2007	CD	DATE	2007	num	3	SENT_215	[p9l1160t3047r1549b3095],
5	;	:	O	;	_	0	SENT_215	[p9l1160t3047r1549b3095],
6	5:879	CD	NUMBER	5:879	number	7	SENT_215	[p9l1160t3047r1549b3095],
7	—	CD	NUMBER	—	dep	3	SENT_215	[p9l1160t3047r1549b3095],
8	81	CD	NUMBER	81	dep	7	SENT_215	[p9l1160t3047r1549b3095],
9	.	.	O	.	_	0	SENT_215	[p9l1160t3047r1549b3095],

1	Antman	NNP	ORGANIZATION	Antman	nn	2	SENT_216	[p9l129t3113r328b3155],
2	EM	NNP	ORGANIZATION	EM	_	0	SENT_216	[p9l346t3114r434b3162],
3	,	,	O	,	_	0	SENT_216	[p9l346t3114r434b3162],
4	Wiviott	NNP	PERSON	Wiviott	nn	5	SENT_216	[p9l451t3112r640b3155],
5	SD	NN	O	sd	appos	2	SENT_216	[p9l656t3113r731b3161],
6	,	,	O	,	_	0	SENT_216	[p9l656t3113r731b3161],
7	Murphy	NNP	ORGANIZATION	Murphy	nn	8	SENT_216	[p9l750t3111r948b3166],
8	SA	NNP	ORGANIZATION	SA	appos	5	SENT_216	[p9l964t3113r1036b3161],
9	,	,	O	,	_	0	SENT_216	[p9l964t3113r1036b3161],
10	Voitk	NNP	PERSON	Voitk	nn	11	SENT_216	[p9l1052t3111r1185b3155],
11	J	NNP	PERSON	J	appos	5	SENT_216	[p9l1195t3114r1226b3166],
12	,	,	O	,	_	0	SENT_216	[p9l1195t3114r1226b3166],
13	Hasin	NNP	O	Hasin	nn	14	SENT_216	[p9l1244t3112r1382b3155],
14	Y	NN	O	y	appos	5	SENT_216	[p9l1397t3114r1441b3161],
15	,	,	O	,	_	0	SENT_216	[p9l1397t3114r1441b3161],
16	Widimsky	NNP	O	Widimsky	nn	17	SENT_216	[p9l1457t3111r1711b3166],
17	P	NN	O	p	appos	5	SENT_216	[p9l1728t3114r1767b3161],
18	,	,	O	,	_	0	SENT_216	[p9l1728t3114r1767b3161],
19	et	FW	O	et	nn	20	SENT_216	[p9l1785t3118r1831b3155],
20	al.	FW	O	al.	appos	5	SENT_216	[p9l1848t3111r1899b3155],
21	.	.	O	.	_	0	SENT_216	[p9l1848t3111r1899b3155],

1	Early	RB	O	early	dep	4	SENT_217	[p9l1918t3111r2042b3166],
2	and	CC	O	and	_	0	SENT_217	[p9l2058t3111r2147b3155],
3	late	RB	O	late	dep	4	SENT_217	[p9l132t3177r220b3220],
4	beneﬁts	NNS	O	beneﬁts	_	0	SENT_217	[p9l239t3177r434b3220],
5	of	IN	O	of	_	0	SENT_217	[p9l455t3177r506b3220],
6	prasugrel	NN	O	prasugrel	prep_of	4	SENT_217	[p9l519t3177r750b3231],
7	in	IN	O	in	_	0	SENT_217	[p9l771t3178r816b3220],
8	patients	NNS	O	patient	prep_in	6	SENT_217	[p9l836t3178r1033b3231],
9	with	IN	O	with	_	0	SENT_217	[p9l1052t3177r1165b3220],
10	acute	JJ	O	acute	amod	12	SENT_217	[p9l1185t3183r1315b3220],
11	coronary	JJ	O	coronary	amod	12	SENT_217	[p9l1336t3189r1555b3231],
12	syndromes	NNS	O	syndrome	prep_with	8	SENT_217	[p9l1575t3177r1844b3231],
13	undergoing	VBG	O	undergo	partmod	12	SENT_217	[p9l1864t3177r2148b3231],
14	percutaneous	JJ	O	percutaneous	amod	16	SENT_217	[p9l132t3249r478b3297],
15	coronary	JJ	O	coronary	amod	16	SENT_217	[p9l519t3256r747b3297],
16	intervention	NN	O	intervention	dobj	13	SENT_217	[p9l786t3244r1122b3287],
17	:	:	O	:	_	0	SENT_217	[p9l786t3244r1122b3287],
18	a	DT	O	a	det	19	SENT_217	[p9l1166t3256r1191b3287],
19	TRITON-TIMI	NN	O	triton-timus	dep	16	SENT_217	[p9l1229t3245r1564b3287],
20	38	CD	NUMBER	38	number	21	SENT_217	[p9l1604t3245r1664b3287],
21	(	CD	NUMBER	(	num	22	SENT_217	[p9l1709t3243r1856b3297],
22	TRial	NN	O	trial	dep	19	SENT_217	[p9l1709t3243r1856b3297],
23	to	TO	O	to	aux	24	SENT_217	[p9l1896t3249r1945b3287],
24	Assess	VB	O	assess	xcomp	13	SENT_217	[p9l1983t3245r2147b3287],
25	Improvement	NN	O	improvement	dobj	24	SENT_217	[p9l132t3311r470b3363],
26	in	IN	O	in	_	0	SENT_217	[p9l497t3309r542b3352],
27	Therapeutic	JJ	O	therapeutic	amod	28	SENT_217	[p9l567t3309r863b3363],
28	Outcomes	NNS	O	outcome	prep_in	25	SENT_217	[p9l890t3311r1135b3352],
29	by	IN	O	by	_	0	SENT_217	[p9l1162t3309r1221b3363],
30	Optimizing	VBG	O	optimize	prepc_by	24	SENT_217	[p9l1248t3309r1523b3363],
31	Platelet	NN	O	platelet	nn	32	SENT_217	[p9l1549t3309r1734b3352],
32	lnhibitioN	NN	O	lnhibition	dobj	30	SENT_217	[p9l1761t3309r2008b3352],
33	with	IN	O	with	_	0	SENT_217	[p9l2034t3309r2148b3352],
34	Prasugrel-Thrombolysis	NNP	O	Prasugrel-Thrombolysis	prep_with	30	SENT_217	[p9l132t3375r719b3430],
35	In	IN	O	in	_	0	SENT_217	[p9l755t3378r801b3418],
36	Myocardial	JJ	O	myocardial	amod	39	SENT_217	[p9l836t3375r1110b3430],
37	Infarction	NN	O	infarction	nn	39	SENT_217	[p9l1145t3375r1404b3429],
38	)	NN	O	)	nn	39	SENT_217	[p9l1145t3375r1404b3429],
39	analysis	NN	O	analysis	prep_in	30	SENT_217	[p9l1442t3375r1648b3430],
40	.	.	O	.	_	0	SENT_217	[p9l1442t3375r1648b3430],

1	J	NNP	O	J	nn	4	SENT_218	[p9l1677t3378r1697b3430],
2	Am	NNP	O	Am	nn	4	SENT_218	[p9l1729t3377r1814b3418],
3	Coll	NNP	O	Coll	nn	4	SENT_218	[p9l1848t3375r1939b3419],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_218	[p9l1974t3375r2147b3419],
5	2008	CD	DATE	2008	num	4	SENT_218	[p9l131t3443r584b3491],
6	;	:	O	;	_	0	SENT_218	[p9l131t3443r584b3491],
7	51:2028	CD	NUMBER	51:2028	number	8	SENT_218	[p9l131t3443r584b3491],
8	—	CD	NUMBER	—	dep	4	SENT_218	[p9l131t3443r584b3491],
9	33	CD	NUMBER	33	dep	8	SENT_218	[p9l131t3443r584b3491],
10	.	.	O	.	_	0	SENT_218	[p9l131t3443r584b3491],

1	Mega	JJ	O	mega	amod	2	SENT_219	[p9l132t3510r265b3561],
2	JL	NN	O	jl	nsubj	10	SENT_219	[p9l275t3510r333b3561],
3	,	,	O	,	_	0	SENT_219	[p9l275t3510r333b3561],
4	Close	NNP	O	Close	nn	5	SENT_219	[p9l350t3507r477b3551],
5	SL	NNP	O	SL	appos	2	SENT_219	[p9l495t3509r558b3557],
6	,	,	O	,	_	0	SENT_219	[p9l495t3509r558b3557],
7	Wiviott	NNP	PERSON	Wiviott	nn	8	SENT_219	[p9l573t3508r762b3551],
8	SD	NN	O	sd	appos	5	SENT_219	[p9l777t3509r853b3557],
9	,	,	O	,	_	0	SENT_219	[p9l777t3509r853b3557],
10	Shen	VBN	ORGANIZATION	shen	_	0	SENT_219	[p9l870t3507r989b3551],
11	L	NN	ORGANIZATION	l	dobj	10	SENT_219	[p9l1006t3510r1041b3557],
12	,	,	O	,	_	0	SENT_219	[p9l1006t3510r1041b3557],
13	Walker	NNP	ORGANIZATION	Walker	nn	14	SENT_219	[p9l1056t3507r1237b3551],
14	JR	NNP	ORGANIZATION	JR	appos	11	SENT_219	[p9l1246t3510r1311b3561],
15	,	,	O	,	_	0	SENT_219	[p9l1246t3510r1311b3561],
16	Simon	NNP	PERSON	Simon	nn	17	SENT_219	[p9l1329t3508r1483b3551],
17	T	NN	PERSON	t	appos	11	SENT_219	[p9l1498t3510r1538b3557],
18	,	,	O	,	_	0	SENT_219	[p9l1498t3510r1538b3557],
19	et	FW	O	et	nn	20	SENT_219	[p9l1555t3513r1602b3551],
20	al.	FW	O	al.	appos	11	SENT_219	[p9l1617t3507r1669b3551],
21	.	.	O	.	_	0	SENT_219	[p9l1617t3507r1669b3551],

1	Genetic	JJ	O	genetic	amod	2	SENT_220	[p9l1687t3508r1873b3551],
2	variants	NNS	O	variant	_	0	SENT_220	[p9l1888t3508r2085b3551],
3	in	IN	O	in	_	0	SENT_220	[p9l2102t3508r2148b3550],
4	ABCB1	NN	O	abcb1	prep_in	2	SENT_220	[p9l129t3576r292b3618],
5	and	CC	O	and	_	0	SENT_220	[p9l338t3574r430b3618],
6	CYP2C19	NN	O	cyp2c19	prep_in	2	SENT_220	[p9l472t3576r698b3618],
7	and	CC	O	and	_	0	SENT_220	[p9l740t3574r832b3618],
8	cardiovascular	JJ	O	cardiovascular	amod	9	SENT_220	[p9l873t3574r1249b3618],
9	outcomes	NNS	O	outcome	prep_in	2	SENT_220	[p9l1287t3581r1535b3618],
10	after	IN	O	after	_	0	SENT_220	[p9l1576t3574r1695b3618],
11	treatment	NN	O	treatment	prep_after	2	SENT_220	[p9l1734t3581r1992b3618],
12	with	IN	O	with	_	0	SENT_220	[p9l2031t3574r2148b3618],
13	clopidogrel	NN	O	clopidogrel	prep_with	11	SENT_220	[p10l132t18r408b72],
14	and	CC	O	and	_	0	SENT_220	[p10l446t18r536b61],
15	prasugrel	NN	O	prasugrel	conj_and	13	SENT_220	[p10l575t18r806b72],
16	in	IN	O	in	_	0	SENT_220	[p10l845t18r890b61],
17	the	DT	O	the	det	18	SENT_220	[p10l928t18r1006b61],
18	TRlTON	NN	O	trlton	prep_in	2	SENT_220	[p10l1043t20r1366b61],
19	.	.	O	.	_	0	SENT_220	[p10l1043t20r1366b61],

1	—	NN	O	—	_	0	SENT_221	[p10l1043t20r1366b61],
2	.	.	O	.	_	0	SENT_221	[p10l1043t20r1366b61],

1	TIMI	NNP	ORGANIZATION	TIMI	nn	3	SENT_222	[p10l1043t20r1366b61],
2	38	CD	NUMBER	38	num	3	SENT_222	[p10l1403t20r1462b61],
3	trial	NN	O	trial	_	0	SENT_222	[p10l1501t18r1615b62],
4	:	:	O	:	_	0	SENT_222	[p10l1501t18r1615b62],
5	a	DT	O	a	det	7	SENT_222	[p10l1657t30r1682b61],
6	pharmacogenetic	JJ	O	pharmacogenetic	amod	7	SENT_222	[p10l1720t18r2149b72],
7	analysis	NN	O	analysis	dep	3	SENT_222	[p10l131t83r338b138],
8	.	.	O	.	_	0	SENT_222	[p10l131t83r338b138],

1	Lancet	NNP	O	Lancet	_	0	SENT_223	[p10l358t86r518b127],
2	2010	CD	DATE	2010	num	1	SENT_223	[p10l536t86r1020b134],
3	;	:	O	;	_	0	SENT_223	[p10l536t86r1020b134],
4	376:13	CD	NUMBER	376:13	num	5	SENT_223	[p10l536t86r1020b134],
5	l2	NN	O	l2	dep	1	SENT_223	[p10l536t86r1020b134],
6	—	CD	NUMBER	—	number	7	SENT_223	[p10l536t86r1020b134],
7	19	CD	NUMBER	19	dep	5	SENT_223	[p10l536t86r1020b134],
8	.	.	O	.	_	0	SENT_223	[p10l536t86r1020b134],

1	[	NN	O	[	_	0	SENT_224	[p10l6t149r98b204],
2	21	CD	NUMBER	21	num	1	SENT_224	[p10l6t149r98b204],
3	]	CD	NUMBER	]	num	5	SENT_224	[p10l6t149r98b204],
4	Wiviott	NNP	PERSON	Wiviott	nn	5	SENT_224	[p10l129t150r318b193],
5	SD	NN	O	sd	dep	1	SENT_224	[p10l337t152r412b200],
6	,	,	O	,	_	0	SENT_224	[p10l337t152r412b200],
7	Antman	NNP	ORGANIZATION	Antman	nn	8	SENT_224	[p10l430t152r628b193],
8	EM	NNP	ORGANIZATION	EM	appos	5	SENT_224	[p10l649t152r738b200],
9	,	,	O	,	_	0	SENT_224	[p10l649t152r738b200],
10	Braunwald	NNP	PERSON	Braunwald	nn	12	SENT_224	[p10l759t150r1025b193],
11	E.	NNP	O	E.	nn	12	SENT_224	[p10l1046t152r1084b194],
12	Prasugrel	NNP	O	Prasugrel	appos	5	SENT_224	[p10l1106t150r1346b204],
13	.	.	O	.	_	0	SENT_224	[p10l1106t150r1346b204],

1	Circulation	NN	O	circulation	_	0	SENT_225	[p10l1367t150r1636b193],
2	2010	CD	DATE	2010	num	1	SENT_225	[p10l1655t152r2139b200],
3	;	:	O	;	_	0	SENT_225	[p10l1655t152r2139b200],
4	122:394	CD	NUMBER	122:394	num	5	SENT_225	[p10l1655t152r2139b200],
5	—	NN	O	—	dep	1	SENT_225	[p10l1655t152r2139b200],
6	403	CD	NUMBER	403	dep	5	SENT_225	[p10l1655t152r2139b200],
7	.	.	O	.	_	0	SENT_225	[p10l1655t152r2139b200],

1	[	NN	O	[	_	0	SENT_226	[p10l6t216r98b271],
2	22	CD	NUMBER	22	num	1	SENT_226	[p10l6t216r98b271],
3	]	CD	NUMBER	]	num	5	SENT_226	[p10l6t216r98b271],
4	Gurbel	NNP	O	Gurbel	nn	5	SENT_226	[p10l132t216r296b260],
5	PA	NN	O	pa	dep	1	SENT_226	[p10l322t218r396b267],
6	,	,	O	,	_	0	SENT_226	[p10l322t218r396b267],
7	Bliden	NNP	PERSON	Bliden	nn	8	SENT_226	[p10l422t216r576b260],
8	KP	NNP	O	KP	appos	5	SENT_226	[p10l602t219r676b266],
9	,	,	O	,	_	0	SENT_226	[p10l602t219r676b266],
10	Butler	NNP	PERSON	Butler	nn	11	SENT_226	[p10l702t216r851b260],
11	K	NNP	PERSON	K	appos	5	SENT_226	[p10l875t219r918b266],
12	,	,	O	,	_	0	SENT_226	[p10l875t219r918b266],
13	Antonino	NNP	PERSON	Antonino	nn	14	SENT_226	[p10l941t217r1172b260],
14	MJ	NNP	PERSON	MJ	appos	5	SENT_226	[p10l1197t219r1272b271],
15	,	,	O	,	_	0	SENT_226	[p10l1197t219r1272b271],
16	Wei	NNP	PERSON	Wei	nn	17	SENT_226	[p10l1296t217r1395b260],
17	C	NNP	O	C	appos	5	SENT_226	[p10l1421t218r1461b267],
18	,	,	O	,	_	0	SENT_226	[p10l1421t218r1461b267],
19	Teng	NNP	PERSON	Teng	nn	20	SENT_226	[p10l1485t219r1606b271],
20	R	NNP	PERSON	R	appos	5	SENT_226	[p10l1630t219r1672b267],
21	,	,	O	,	_	0	SENT_226	[p10l1630t219r1672b267],
22	et	FW	O	et	nn	23	SENT_226	[p10l1697t223r1743b260],
23	al.	FW	O	al.	appos	5	SENT_226	[p10l1767t216r1819b260],
24	.	.	O	.	_	0	SENT_226	[p10l1767t216r1819b260],

1	Response	NN	O	response	_	0	SENT_227	[p10l1846t219r2075b271],
2	to	TO	O	to	_	0	SENT_227	[p10l2100t223r2148b260],
3	ticagrelor	NN	O	ticagrelor	prep_to	1	SENT_227	[p10l131t282r368b337],
4	in	IN	O	in	_	0	SENT_227	[p10l391t283r436b325],
5	clopidogrel	NN	O	clopidogrel	nn	6	SENT_227	[p10l460t282r736b337],
6	nonresponders	NNS	O	nonresponder	prep_in	3	SENT_227	[p10l761t282r1130b337],
7	and	CC	O	and	_	0	SENT_227	[p10l1155t282r1244b326],
8	responders	NNS	O	responder	prep_in	3	SENT_227	[p10l1269t282r1542b337],
9	and	CC	O	and	_	0	SENT_227	[p10l1567t282r1656b326],
10	effect	NN	O	effect	prep_to	1	SENT_227	[p10l1681t282r1816b326],
11	of	IN	O	of	_	0	SENT_227	[p10l1839t282r1890b326],
12	switching	NN	O	switching	nn	13	SENT_227	[p10l1908t282r2148b337],
13	therapies	NNS	O	therapy	prep_of	10	SENT_227	[p10l131t348r375b402],
14	:	:	O	:	_	0	SENT_227	[p10l131t348r375b402],
15	the	DT	O	the	det	17	SENT_227	[p10l398t348r476b391],
16	RESPOND	NNP	O	RESPOND	nn	17	SENT_227	[p10l497t350r733b391],
17	study	NN	O	study	dep	1	SENT_227	[p10l754t348r900b402],
18	.	.	O	.	_	0	SENT_227	[p10l754t348r900b402],

1	Circulation	NN	O	circulation	_	0	SENT_228	[p10l921t348r1188b391],
2	2010	CD	DATE	2010	num	1	SENT_228	[p10l1208t350r1692b398],
3	;	:	O	;	_	0	SENT_228	[p10l1208t350r1692b398],
4	121:1	CD	NUMBER	121:1	num	5	SENT_228	[p10l1208t350r1692b398],
5	l88	NN	O	l88	dep	1	SENT_228	[p10l1208t350r1692b398],
6	—	CD	NUMBER	—	number	7	SENT_228	[p10l1208t350r1692b398],
7	99	CD	NUMBER	99	dep	5	SENT_228	[p10l1208t350r1692b398],
8	.	.	O	.	_	0	SENT_228	[p10l1208t350r1692b398],

1	[	NN	O	[	_	0	SENT_229	[p10l6t414r98b468],
2	23	CD	NUMBER	23	num	1	SENT_229	[p10l6t414r98b468],
3	]	CD	NUMBER	]	num	5	SENT_229	[p10l6t414r98b468],
4	Gurbel	NNP	O	Gurbel	nn	5	SENT_229	[p10l132t414r296b458],
5	PA	NN	O	pa	dep	1	SENT_229	[p10l322t416r396b464],
6	,	,	O	,	_	0	SENT_229	[p10l322t416r396b464],
7	Bliden	NNP	PERSON	Bliden	nn	8	SENT_229	[p10l423t414r577b458],
8	KP	NNP	O	KP	appos	5	SENT_229	[p10l602t417r676b464],
9	,	,	O	,	_	0	SENT_229	[p10l602t417r676b464],
10	Butler	NNP	PERSON	Butler	nn	11	SENT_229	[p10l702t414r851b458],
11	K	NNP	PERSON	K	appos	5	SENT_229	[p10l875t417r918b464],
12	,	,	O	,	_	0	SENT_229	[p10l875t417r918b464],
13	Tantry	NNP	LOCATION	Tantry	nn	14	SENT_229	[p10l942t417r1105b468],
14	US	NNP	LOCATION	US	appos	5	SENT_229	[p10l1128t416r1204b464],
15	,	,	O	,	_	0	SENT_229	[p10l1128t416r1204b464],
16	Gesheff	NNP	ORGANIZATION	Gesheff	nn	17	SENT_229	[p10l1230t414r1420b458],
17	T	NN	ORGANIZATION	t	appos	5	SENT_229	[p10l1436t417r1477b464],
18	,	,	O	,	_	0	SENT_229	[p10l1436t417r1477b464],
19	Wei	NNP	PERSON	Wei	nn	20	SENT_229	[p10l1501t415r1601b458],
20	C	NNP	O	C	appos	5	SENT_229	[p10l1626t416r1666b464],
21	,	,	O	,	_	0	SENT_229	[p10l1626t416r1666b464],
22	et	FW	O	et	nn	23	SENT_229	[p10l1692t420r1738b458],
23	al.	FW	O	al.	appos	5	SENT_229	[p10l1762t414r1814b458],
24	.	.	O	.	_	0	SENT_229	[p10l1762t414r1814b458],

1	Randomized	VBN	O	randomize	_	0	SENT_230	[p10l1841t414r2147b458],
2	double-blind	JJ	O	double-blind	amod	3	SENT_230	[p10l132t480r449b523],
3	assessment	NN	O	assessment	dobj	1	SENT_230	[p10l473t486r754b523],
4	of	IN	O	of	_	0	SENT_230	[p10l776t479r827b523],
5	the	DT	O	the	det	6	SENT_230	[p10l843t480r921b523],
6	ONSET	NNP	O	ONSET	prep_of	3	SENT_230	[p10l945t482r1111b523],
7	and	CC	O	and	_	0	SENT_230	[p10l1132t480r1222b523],
8	OFFSET	NNP	O	OFFSET	prep_of	3	SENT_230	[p10l1246t482r1426b523],
9	of	IN	O	of	_	0	SENT_230	[p10l1448t479r1499b523],
10	the	DT	O	the	det	12	SENT_230	[p10l1515t480r1593b523],
11	antiplatelet	JJ	O	antiplatelet	amod	12	SENT_230	[p10l1616t480r1900b534],
12	effects	NNS	O	effect	prep_of	3	SENT_230	[p10l1922t479r2079b523],
13	of	IN	O	of	_	0	SENT_230	[p10l2103t479r2154b523],
14	ticagrelor	NN	O	ticagrelor	prep_of	12	SENT_230	[p10l131t546r368b601],
15	versus	CC	O	versus	_	0	SENT_230	[p10l386t559r543b590],
16	clopidogrel	NN	O	clopidogrel	dobj	1	SENT_230	[p10l565t546r841b601],
17	in	IN	O	in	_	0	SENT_230	[p10l863t547r909b589],
18	patients	NNS	O	patient	prep_in	16	SENT_230	[p10l929t547r1126b601],
19	with	IN	O	with	_	0	SENT_230	[p10l1147t546r1260b590],
20	stable	JJ	O	stable	amod	23	SENT_230	[p10l1282t546r1424b590],
21	coronary	JJ	O	coronary	amod	23	SENT_230	[p10l1446t559r1665b601],
22	artery	NN	O	artery	nn	23	SENT_230	[p10l1685t553r1833b601],
23	disease	NN	O	disease	prep_with	1	SENT_230	[p10l1853t546r2045b590],
24	:	:	O	:	_	0	SENT_230	[p10l1853t546r2045b590],
25	the	DT	O	the	det	27	SENT_230	[p10l2069t546r2147b590],
26	ONSET/OFFSET	NNP	O	ONSET/OFFSET	nn	27	SENT_230	[p10l132t613r500b662],
27	study	NN	O	study	dep	23	SENT_230	[p10l519t611r665b666],
28	.	.	O	.	_	0	SENT_230	[p10l519t611r665b666],

1	Circulation	NN	O	circulation	_	0	SENT_231	[p10l686t611r953b655],
2	2009	CD	DATE	2009	num	1	SENT_231	[p10l973t614r1457b662],
3	;	:	O	;	_	0	SENT_231	[p10l973t614r1457b662],
4	120:2577	CD	NUMBER	120:2577	number	5	SENT_231	[p10l973t614r1457b662],
5	—	CD	NUMBER	—	dep	1	SENT_231	[p10l973t614r1457b662],
6	85	CD	NUMBER	85	dep	5	SENT_231	[p10l973t614r1457b662],
7	.	.	O	.	_	0	SENT_231	[p10l973t614r1457b662],

1	[	NN	O	[	nn	5	SENT_232	[p10l6t678r98b732],
2	24	CD	NUMBER	24	num	5	SENT_232	[p10l6t678r98b732],
3	]	CD	NUMBER	]	num	5	SENT_232	[p10l6t678r98b732],
4	Storey	NNP	O	Storey	nn	5	SENT_232	[p10l132t680r289b732],
5	RF	NNP	O	RF	_	0	SENT_232	[p10l306t681r375b728],
6	,	,	O	,	_	0	SENT_232	[p10l306t681r375b728],
7	Angiolillo	NNP	O	Angiolillo	nn	8	SENT_232	[p10l391t678r628b732],
8	DJ	NNP	O	DJ	appos	5	SENT_232	[p10l648t681r711b732],
9	,	,	O	,	_	0	SENT_232	[p10l648t681r711b732],
10	Patil	NNP	PERSON	Patil	nn	11	SENT_232	[p10l730t678r836b722],
11	SB	NN	O	sb	appos	8	SENT_232	[p10l854t680r923b728],
12	,	,	O	,	_	0	SENT_232	[p10l854t680r923b728],
13	Desai	NNP	PERSON	Desai	nn	14	SENT_232	[p10l942t679r1073b722],
14	B	NNP	PERSON	B	appos	8	SENT_232	[p10l1091t681r1132b728],
15	,	,	O	,	_	0	SENT_232	[p10l1091t681r1132b728],
16	Ecob	NNP	PERSON	Ecob	nn	17	SENT_232	[p10l1151t678r1265b722],
17	R	NNP	O	R	appos	8	SENT_232	[p10l1283t681r1325b728],
18	,	,	O	,	_	0	SENT_232	[p10l1283t681r1325b728],
19	Husted	NNP	PERSON	Husted	nn	20	SENT_232	[p10l1344t678r1517b722],
20	S	NNP	O	S	appos	8	SENT_232	[p10l1536t680r1573b728],
21	,	,	O	,	_	0	SENT_232	[p10l1536t680r1573b728],
22	et	FW	O	et	nn	23	SENT_232	[p10l1591t684r1638b722],
23	al.	FW	O	al.	appos	8	SENT_232	[p10l1654t678r1706b722],
24	.	.	O	.	_	0	SENT_232	[p10l1654t678r1706b722],

1	Inhibitory	JJ	O	inhibitory	amod	2	SENT_233	[p10l1726t678r1971b732],
2	Effects	NNS	O	effect	nsubj	5	SENT_233	[p10l1988t678r2147b722],
3	of	IN	O	of	_	0	SENT_233	[p10l132t744r183b788],
4	Ticagrelor	NNP	O	Ticagrelor	prep_of	2	SENT_233	[p10l199t744r447b799],
5	Compared	VBD	O	compare	_	0	SENT_233	[p10l471t744r723b799],
6	With	IN	O	with	_	0	SENT_233	[p10l746t744r871b788],
7	Clopidogrel	NN	O	clopidogrel	prep_with	25	SENT_233	[p10l895t744r1178b799],
8	on	IN	O	on	_	0	SENT_233	[p10l1203t757r1263b788],
9	Platelet	NN	O	platelet	nn	10	SENT_233	[p10l1288t744r1472b788],
10	Function	NN	O	function	prep_on	7	SENT_233	[p10l1496t745r1710b788],
11	in	IN	O	in	_	0	SENT_233	[p10l1735t745r1780b787],
12	Patients	NNS	O	patient	prep_in	10	SENT_233	[p10l1805t745r2000b788],
13	With	IN	O	with	_	0	SENT_233	[p10l2023t744r2148b788],
14	Acute	JJ	O	acute	amod	16	SENT_233	[p10l129t812r270b853],
15	Coronary	JJ	O	coronary	amod	16	SENT_233	[p10l302t812r528b864],
16	Syndromes	NNS	O	syndrome	prep_with	12	SENT_233	[p10l558t810r832b864],
17	The	DT	O	the	det	21	SENT_233	[p10l861t810r952b853],
18	PLATO	NNP	O	PLATO	nn	21	SENT_233	[p10l983t812r1141b853],
19	(	CD	NUMBER	(	num	21	SENT_233	[p10l1175t810r1411b864],
20	PLATelet	NN	O	platelet	nn	21	SENT_233	[p10l1175t810r1411b864],
21	inhibition	NN	O	inhibition	nsubj	25	SENT_233	[p10l1441t810r1681b853],
22	and	CC	O	and	_	0	SENT_233	[p10l1712t810r1801b853],
23	patient	NN	O	patient	nn	24	SENT_233	[p10l1833t810r2008b864],
24	Outcomes	NNS	O	outcome	conj_and	21	SENT_233	[p10l2038t812r2147b853, p10l132t876r307b929],
25	)	VBP	O	)	ccomp	5	SENT_233	[p10l2038t812r2147b853, p10l132t876r307b929],
26	PLATELET	NN	O	platelet	nn	27	SENT_233	[p10l331t877r571b919],
27	Substudy	NN	O	substudy	dobj	25	SENT_233	[p10l589t875r827b930],
28	.	.	O	.	_	0	SENT_233	[p10l589t875r827b930],

1	JACC	NNP	O	JACC	nn	3	SENT_234	[p10l841t877r962b930],
2	Cardiovasc	NNP	O	Cardiovasc	nn	3	SENT_234	[p10l981t875r1247b919],
3	Interv	NNP	O	Interv	_	0	SENT_234	[p10l1266t878r1413b919],
4	2010	CD	DATE	2010	num	3	SENT_234	[p10l1432t878r1884b926],
5	;	:	O	;	_	0	SENT_234	[p10l1432t878r1884b926],
6	56:1456	CD	NUMBER	56:1456	number	7	SENT_234	[p10l1432t878r1884b926],
7	—	CD	NUMBER	—	dep	3	SENT_234	[p10l1432t878r1884b926],
8	62	CD	NUMBER	62	dep	7	SENT_234	[p10l1432t878r1884b926],
9	.	.	O	.	_	0	SENT_234	[p10l1432t878r1884b926],

1	[	NN	O	[	nn	4	SENT_235	[p10l6t941r98b996],
2	25	CD	NUMBER	25	num	4	SENT_235	[p10l6t941r98b996],
3	]	NN	O	]	nn	4	SENT_235	[p10l6t941r98b996],
4	Wallentin	NN	PERSON	wallentin	_	0	SENT_235	[p10l129t942r375b985],
5	L	NN	PERSON	l	dep	4	SENT_235	[p10l394t944r429b992],
6	,	,	O	,	_	0	SENT_235	[p10l394t944r429b992],
7	James	NNP	PERSON	James	nn	8	SENT_235	[p10l442t944r591b996],
8	S	NNP	PERSON	S	appos	5	SENT_235	[p10l612t944r648b992],
9	,	,	O	,	_	0	SENT_235	[p10l612t944r648b992],
10	Storey	NNP	PERSON	Storey	nn	11	SENT_235	[p10l668t944r825b996],
11	RF	NNP	PERSON	RF	appos	5	SENT_235	[p10l843t944r912b992],
12	,	,	O	,	_	0	SENT_235	[p10l843t944r912b992],
13	Armstrong	NNP	ORGANIZATION	Armstrong	nn	14	SENT_235	[p10l930t944r1196b996],
14	M	NNP	ORGANIZATION	M	appos	5	SENT_235	[p10l1215t944r1273b992],
15	,	,	O	,	_	0	SENT_235	[p10l1215t944r1273b992],
16	Barratt	NNP	ORGANIZATION	Barratt	nn	17	SENT_235	[p10l1294t944r1463b985],
17	BJ	NNP	ORGANIZATION	BJ	appos	5	SENT_235	[p10l1481t944r1538b996],
18	,	,	O	,	_	0	SENT_235	[p10l1481t944r1538b996],
19	Horrow	NNP	PERSON	Horrow	nn	20	SENT_235	[p10l1559t944r1749b985],
20	J	NNP	PERSON	J	appos	5	SENT_235	[p10l1761t944r1792b996],
21	,	,	O	,	_	0	SENT_235	[p10l1761t944r1792b996],
22	et	FW	O	et	nn	23	SENT_235	[p10l1812t948r1858b985],
23	al.	FW	O	al.	appos	5	SENT_235	[p10l1876t942r1928b986],
24	.	.	O	.	_	0	SENT_235	[p10l1876t942r1928b986],

1	Effect	NN	O	effect	_	0	SENT_236	[p10l1948t941r2085b985],
2	of	IN	O	of	_	0	SENT_236	[p10l2103t941r2154b985],
3	CYP2Cl9	NN	O	cyp2cl9	nn	8	SENT_236	[p10l132t1010r350b1052],
4	and	CC	O	and	_	0	SENT_236	[p10l370t1008r459b1052],
5	ABCB1	NN	O	abcb1	nn	8	SENT_236	[p10l476t1010r632b1052],
6	single	JJ	O	single	amod	8	SENT_236	[p10l658t1008r800b1063],
7	nucleotide	NN	O	nucleotide	nn	8	SENT_236	[p10l819t1008r1077b1052],
8	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_236	[p10l1097t1008r1483b1063],
9	on	IN	O	on	_	0	SENT_236	[p10l1503t1021r1563b1052],
10	outcomes	NNS	O	outcome	prep_on	1	SENT_236	[p10l1582t1015r1819b1052],
11	of	IN	O	of	_	0	SENT_236	[p10l1839t1008r1889b1052],
12	treatment	NN	O	treatment	prep_of	10	SENT_236	[p10l1901t1015r2149b1052],
13	with	IN	O	with	_	0	SENT_236	[p10l130t1074r244b1118],
14	ticagrelor	NN	O	ticagrelor	prep_with	12	SENT_236	[p10l280t1074r516b1129],
15	versus	CC	O	versus	prep	14	SENT_236	[p10l550t1087r707b1118],
16	clopidogrel	NN	O	clopidogrel	dep	15	SENT_236	[p10l745t1074r1021b1129],
17	for	IN	O	for	_	0	SENT_236	[p10l1058t1074r1126b1118],
18	acute	JJ	O	acute	amod	20	SENT_236	[p10l1162t1081r1292b1118],
19	coronary	JJ	O	coronary	amod	20	SENT_236	[p10l1328t1087r1548b1129],
20	syndromes	NNS	O	syndrome	prep_for	16	SENT_236	[p10l1584t1074r1869b1129],
21	:	:	O	:	_	0	SENT_236	[p10l1584t1074r1869b1129],
22	a	DT	O	a	det	24	SENT_236	[p10l1909t1087r1934b1118],
23	genetic	JJ	O	genetic	amod	24	SENT_236	[p10l1969t1075r2148b1129],
24	substudy	NN	O	substudy	dep	1	SENT_236	[p10l132t1140r355b1194],
25	of	IN	O	of	_	0	SENT_236	[p10l374t1140r425b1183],
26	the	DT	O	the	det	28	SENT_236	[p10l438t1140r516b1183],
27	PLATO	NNP	O	PLATO	nn	28	SENT_236	[p10l537t1142r694b1183],
28	trial	NN	O	trial	prep_of	24	SENT_236	[p10l714t1140r825b1184],
29	.	.	O	.	_	0	SENT_236	[p10l714t1140r825b1184],

1	Lancet	NNP	O	Lancet	_	0	SENT_237	[p10l846t1143r1004b1183],
2	2010	CD	DATE	2010	num	1	SENT_237	[p10l1023t1142r1476b1190],
3	;	:	O	;	_	0	SENT_237	[p10l1023t1142r1476b1190],
4	376:1320	CD	NUMBER	376:1320	number	5	SENT_237	[p10l1023t1142r1476b1190],
5	—	CD	NUMBER	—	dep	1	SENT_237	[p10l1023t1142r1476b1190],
6	8	CD	NUMBER	8	dep	5	SENT_237	[p10l1023t1142r1476b1190],
7	.	.	O	.	_	0	SENT_237	[p10l1023t1142r1476b1190],

1	[	NN	O	[	nn	5	SENT_238	[p10l6t1205r98b1260],
2	26	CD	NUMBER	26	num	5	SENT_238	[p10l6t1205r98b1260],
3	]	CD	NUMBER	]	num	5	SENT_238	[p10l6t1205r98b1260],
4	Brandt	NNP	PERSON	Brandt	nn	5	SENT_238	[p10l132t1206r297b1249],
5	JT	NNP	O	JT	_	0	SENT_238	[p10l311t1208r373b1260],
6	,	,	O	,	_	0	SENT_238	[p10l311t1208r373b1260],
7	Close	NNP	O	Close	nn	8	SENT_238	[p10l395t1206r523b1249],
8	SL	NNP	O	SL	appos	5	SENT_238	[p10l545t1208r608b1256],
9	,	,	O	,	_	0	SENT_238	[p10l545t1208r608b1256],
10	Iturria	NNP	PERSON	Iturria	nn	11	SENT_238	[p10l631t1206r784b1249],
11	SJ	NNP	O	SJ	appos	8	SENT_238	[p10l806t1208r858b1260],
12	,	,	O	,	_	0	SENT_238	[p10l806t1208r858b1260],
13	Payne	NNP	PERSON	Payne	nn	14	SENT_238	[p10l882t1208r1027b1260],
14	CD	NNP	O	CD	appos	8	SENT_238	[p10l1049t1208r1128b1256],
15	,	,	O	,	_	0	SENT_238	[p10l1049t1208r1128b1256],
16	Farid	NNP	ORGANIZATION	Farid	nn	17	SENT_238	[p10l1151t1206r1272b1249],
17	NA	NNP	ORGANIZATION	NA	appos	8	SENT_238	[p10l1295t1208r1378b1256],
18	,	,	O	,	_	0	SENT_238	[p10l1295t1208r1378b1256],
19	Ernest	NNP	PERSON	Ernest	nn	21	SENT_238	[p10l1401t1208r1557b1249],
20	2nd	JJ	ORDINAL	2nd	amod	21	SENT_238	[p10l1577t1206r1669b1249],
21	CS	NN	O	c	appos	8	SENT_238	[p10l1692t1208r1761b1256],
22	,	,	O	,	_	0	SENT_238	[p10l1692t1208r1761b1256],
23	et	FW	O	et	nn	24	SENT_238	[p10l1783t1212r1830b1249],
24	al.	FW	O	al.	appos	8	SENT_238	[p10l1850t1206r1902b1250],
25	.	.	O	.	_	0	SENT_238	[p10l1850t1206r1902b1250],

1	Common	JJ	O	common	amod	2	SENT_239	[p10l1924t1208r2147b1249],
2	polymorphisms	NNS	O	polymorphism	nsubj	7	SENT_239	[p10l132t1272r530b1326],
3	of	IN	O	of	_	0	SENT_239	[p10l571t1271r623b1315],
4	CYP2C19	NN	O	cyp2c19	prep_of	2	SENT_239	[p10l657t1274r882b1315],
5	and	CC	O	and	_	0	SENT_239	[p10l922t1272r1013b1315],
6	CYP2C9	NN	O	cyp2c9	conj_and	4	SENT_239	[p10l1054t1274r1247b1315],
7	affect	VBP	O	affect	_	0	SENT_239	[p10l1287t1271r1428b1315],
8	the	DT	O	the	det	12	SENT_239	[p10l1466t1272r1546b1315],
9	pharmacokinetic	JJ	O	pharmacokinetic	amod	12	SENT_239	[p10l1587t1272r2016b1326],
10	and	CC	O	and	_	0	SENT_239	[p10l2055t1272r2147b1315],
11	pharmacodynamic	JJ	O	pharmacodynamic	amod	12	SENT_239	[p10l132t1338r592b1393],
12	response	NN	O	response	dobj	7	SENT_239	[p10l613t1351r831b1393],
13	to	TO	O	to	_	0	SENT_239	[p10l852t1345r899b1382],
14	clopidogrel	NN	O	clopidogrel	prep_to	12	SENT_239	[p10l920t1338r1195b1393],
15	but	CC	O	but	_	0	SENT_239	[p10l1216t1338r1298b1382],
16	not	RB	O	not	_	0	SENT_239	[p10l1318t1345r1399b1382],
17	prasugrel	NN	O	prasugrel	dobj	7	SENT_239	[p10l1418t1338r1695b1393],
18	.	.	O	.	_	0	SENT_239	[p10l1418t1338r1695b1393],

1	J	NNP	O	J	nn	3	SENT_240	[p10l1418t1338r1695b1393],
2	Thromb	NNP	O	Thromb	nn	3	SENT_240	[p10l1713t1338r1910b1382],
3	Haemost	NNP	O	Haemost	_	0	SENT_240	[p10l1930t1341r2149b1382],
4	2007	CD	DATE	2007	num	3	SENT_240	[p10l131t1406r553b1454],
5	;	:	O	;	_	0	SENT_240	[p10l131t1406r553b1454],
6	5:2429	CD	NUMBER	5:2429	number	7	SENT_240	[p10l131t1406r553b1454],
7	—	CD	NUMBER	—	dep	3	SENT_240	[p10l131t1406r553b1454],
8	36	CD	NUMBER	36	dep	7	SENT_240	[p10l131t1406r553b1454],
9	.	.	O	.	_	0	SENT_240	[p10l131t1406r553b1454],

1	[	NN	O	[	nsubj	13	SENT_241	[p10l6t1470r98b1524],
2	27	CD	NUMBER	27	num	1	SENT_241	[p10l6t1470r98b1524],
3	]	CD	NUMBER	]	num	5	SENT_241	[p10l6t1470r98b1524],
4	Mega	JJ	O	mega	amod	5	SENT_241	[p10l132t1473r265b1524],
5	JL	NN	O	jl	dep	1	SENT_241	[p10l282t1473r340b1524],
6	,	,	O	,	_	0	SENT_241	[p10l282t1473r340b1524],
7	Close	NNP	O	Close	nn	8	SENT_241	[p10l365t1470r492b1514],
8	SL	NNP	O	SL	nsubj	13	SENT_241	[p10l516t1472r579b1520],
9	,	,	O	,	_	0	SENT_241	[p10l516t1472r579b1520],
10	Wiviott	NNP	PERSON	Wiviott	nn	11	SENT_241	[p10l602t1471r791b1514],
11	SD	NN	O	sd	appos	8	SENT_241	[p10l813t1472r889b1520],
12	,	,	O	,	_	0	SENT_241	[p10l813t1472r889b1520],
13	Shen	VBN	PERSON	shen	_	0	SENT_241	[p10l913t1470r1033b1514],
14	L	NN	PERSON	l	dobj	13	SENT_241	[p10l1056t1473r1091b1520],
15	,	,	O	,	_	0	SENT_241	[p10l1056t1473r1091b1520],
16	Hockett	NNP	PERSON	Hockett	nn	17	SENT_241	[p10l1116t1470r1308b1514],
17	RD	NNP	O	RD	appos	14	SENT_241	[p10l1331t1473r1411b1520],
18	,	,	O	,	_	0	SENT_241	[p10l1331t1473r1411b1520],
19	Brandt	NNP	PERSON	Brandt	nn	20	SENT_241	[p10l1436t1470r1602b1514],
20	JT	NNP	O	JT	appos	14	SENT_241	[p10l1618t1473r1679b1524],
21	,	,	O	,	_	0	SENT_241	[p10l1618t1473r1679b1524],
22	et	FW	O	et	nn	23	SENT_241	[p10l1703t1476r1750b1514],
23	al.	FW	O	al.	appos	14	SENT_241	[p10l1772t1470r1824b1514],
24	.	.	O	.	_	0	SENT_241	[p10l1772t1470r1824b1514],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_242	[p10l1849t1470r2147b1524],
2	P450	NN	O	p450	_	0	SENT_242	[p10l132t1538r253b1580],
3	genetic	JJ	O	genetic	amod	4	SENT_242	[p10l285t1537r464b1591],
4	polymorphisms	NNS	O	polymorphism	dep	2	SENT_242	[p10l498t1536r884b1591],
5	and	CC	O	and	_	0	SENT_242	[p10l919t1536r1008b1580],
6	the	DT	O	the	det	7	SENT_242	[p10l1041t1536r1119b1580],
7	response	NN	O	response	conj_and	2	SENT_242	[p10l1154t1549r1372b1591],
8	to	TO	O	to	_	0	SENT_242	[p10l1406t1543r1453b1580],
9	prasugrel	NN	O	prasugrel	prep_to	7	SENT_242	[p10l1488t1536r1733b1591],
10	:	:	O	:	_	0	SENT_242	[p10l1488t1536r1733b1591],
11	relationship	NN	O	relationship	dep	2	SENT_242	[p10l1772t1536r2066b1591],
12	to	TO	O	to	_	0	SENT_242	[p10l2100t1543r2148b1580],
13	pharmacokinetic	JJ	O	pharmacokinetic	prep_to	11	SENT_242	[p10l132t1602r590b1656],
14	,	,	O	,	_	0	SENT_242	[p10l132t1602r590b1656],
15	pharmacodynamic	JJ	O	pharmacodynamic	prep_to	11	SENT_242	[p10l634t1602r1138b1656],
16	,	,	O	,	_	0	SENT_242	[p10l634t1602r1138b1656],
17	and	CC	O	and	_	0	SENT_242	[p10l1181t1602r1274b1645],
18	clinical	JJ	O	clinical	amod	19	SENT_242	[p10l1318t1602r1505b1645],
19	outcomes	NNS	O	outcome	conj_and	13	SENT_242	[p10l1548t1608r1815b1646],
20	.	.	O	.	_	0	SENT_242	[p10l1548t1608r1815b1646],

1	Circulation	NN	O	circulation	_	0	SENT_243	[p10l1858t1602r2148b1645],
2	2009	CD	DATE	2009	num	1	SENT_243	[p10l131t1670r615b1718],
3	;	:	O	;	_	0	SENT_243	[p10l131t1670r615b1718],
4	119:2553	CD	NUMBER	119:2553	number	5	SENT_243	[p10l131t1670r615b1718],
5	—	CD	NUMBER	—	dep	1	SENT_243	[p10l131t1670r615b1718],
6	60	CD	NUMBER	60	dep	5	SENT_243	[p10l131t1670r615b1718],
7	.	.	O	.	_	0	SENT_243	[p10l131t1670r615b1718],

1	[	NN	O	[	nn	5	SENT_244	[p10l6t1733r98b1788],
2	28	CD	NUMBER	28	num	5	SENT_244	[p10l6t1733r98b1788],
3	]	CD	NUMBER	]	num	5	SENT_244	[p10l6t1733r98b1788],
4	Serebruany	NNP	O	Serebruany	nn	5	SENT_244	[p10l132t1734r413b1788],
5	V	NNP	O	V	_	0	SENT_244	[p10l430t1736r476b1784],
6	,	,	O	,	_	0	SENT_244	[p10l430t1736r476b1784],
7	Floyd	NNP	PERSON	Floyd	nn	8	SENT_244	[p10l497t1734r629b1788],
8	J	NNP	PERSON	J	appos	5	SENT_244	[p10l643t1736r674b1788],
9	,	,	O	,	_	0	SENT_244	[p10l643t1736r674b1788],
10	Chew	NNP	O	Chew	nn	11	SENT_244	[p10l695t1734r833b1777],
11	D.	NNP	O	D.	appos	5	SENT_244	[p10l852t1736r898b1778],
12	Excess	JJ	O	excess	rcmod	11	SENT_244	[p10l920t1736r1078b1777],
13	of	IN	O	of	_	0	SENT_244	[p10l1098t1734r1150b1777],
14	Solid	JJ	O	solid	amod	15	SENT_244	[p10l1164t1734r1283b1777],
15	Cancers	NNPS	O	Cancers	prep_of	12	SENT_244	[p10l1303t1736r1492b1777],
16	After	IN	O	after	dep	12	SENT_244	[p10l1511t1734r1635b1777],
17	Prasugrel	NNP	O	Prasugrel	pobj	16	SENT_244	[p10l1654t1734r1898b1788],
18	:	:	O	:	_	0	SENT_244	[p10l1654t1734r1898b1788],
19	The	DT	O	the	det	20	SENT_244	[p10l1920t1734r2010b1777],
20	Food	NNP	O	Food	dep	5	SENT_244	[p10l2030t1734r2147b1777],
21	and	CC	O	and	_	0	SENT_244	[p10l131t1800r221b1844],
22	Drug	NNP	O	Drug	nn	24	SENT_244	[p10l242t1803r362b1855],
23	Administration	NNP	O	Administration	nn	24	SENT_244	[p10l378t1800r753b1844],
24	Outlook	NNP	O	Outlook	dep	5	SENT_244	[p10l774t1800r980b1844],
25	.	.	O	.	_	0	SENT_244	[p10l774t1800r980b1844],

1	AmJ	NN	O	amj	nn	2	SENT_245	[p10l998t1802r1116b1855],
2	Ther	NN	O	ther	_	0	SENT_245	[p10l1133t1800r1248b1844],
3	in	IN	O	in	_	0	SENT_245	[p10l1266t1801r1311b1843],
4	press	NN	O	press	prep_in	2	SENT_245	[p10l1331t1813r1469b1855],
5	.	.	O	.	_	0	SENT_245	[p10l1331t1813r1469b1855],

1	[	NN	O	[	_	0	SENT_246	[p10l11t1865r103b1920],
2	29	CD	NUMBER	29	num	1	SENT_246	[p10l11t1865r103b1920],
3	]	CD	NUMBER	]	num	5	SENT_246	[p10l11t1865r103b1920],
4	Cuisset	NN	O	cuisset	nn	5	SENT_246	[p10l137t1866r310b1909],
5	T	NN	O	t	dep	1	SENT_246	[p10l323t1868r363b1916],
6	,	,	O	,	_	0	SENT_246	[p10l323t1868r363b1916],
7	Frere	NNP	ORGANIZATION	Frere	nn	8	SENT_246	[p10l380t1868r505b1909],
8	C	NNP	ORGANIZATION	C	appos	5	SENT_246	[p10l521t1868r561b1916],
9	,	,	O	,	_	0	SENT_246	[p10l521t1868r561b1916],
10	Quilici	NNP	PERSON	Quilici	nn	11	SENT_246	[p10l578t1866r733b1918],
11	J	NNP	PERSON	J	appos	5	SENT_246	[p10l743t1868r774b1920],
12	,	,	O	,	_	0	SENT_246	[p10l743t1868r774b1920],
13	Morange	NNP	ORGANIZATION	Morange	nn	14	SENT_246	[p10l792t1868r1009b1920],
14	PE	NNP	ORGANIZATION	PE	appos	5	SENT_246	[p10l1026t1868r1095b1916],
15	,	,	O	,	_	0	SENT_246	[p10l1026t1868r1095b1916],
16	Saut	NNP	O	Saut	nn	17	SENT_246	[p10l1112t1868r1218b1909],
17	N	NNP	O	N	appos	5	SENT_246	[p10l1232t1868r1280b1916],
18	,	,	O	,	_	0	SENT_246	[p10l1232t1868r1280b1916],
19	Lambert	NNP	PERSON	Lambert	nn	20	SENT_246	[p10l1297t1866r1500b1909],
20	M	NNP	O	M	appos	5	SENT_246	[p10l1515t1868r1573b1916],
21	,	,	O	,	_	0	SENT_246	[p10l1515t1868r1573b1916],
22	et	FW	O	et	nn	23	SENT_246	[p10l1590t1872r1636b1909],
23	al.	FW	O	al.	appos	5	SENT_246	[p10l1650t1866r1702b1910],
24	.	.	O	.	_	0	SENT_246	[p10l1650t1866r1702b1910],

1	Role	NN	O	role	_	0	SENT_247	[p10l1719t1866r1824b1909],
2	of	IN	O	of	_	0	SENT_247	[p10l1840t1866r1890b1909],
3	the	DT	O	the	det	5	SENT_247	[p10l1899t1866r1977b1909],
4	T744C	NN	O	t744c	nn	5	SENT_247	[p10l1991t1868r2147b1909],
5	polymorphism	NN	O	polymorphism	prep_of	1	SENT_247	[p10l137t1932r499b1987],
6	of	IN	O	of	_	0	SENT_247	[p10l513t1932r564b1976],
7	the	DT	O	the	det	9	SENT_247	[p10l572t1932r650b1976],
8	P2Y12	NN	O	p2y12	nn	9	SENT_247	[p10l665t1934r817b1975],
9	gene	NN	O	gene	prep_of	1	SENT_247	[p10l833t1945r949b1987],
10	on	IN	O	on	_	0	SENT_247	[p10l965t1945r1024b1976],
11	platelet	NN	O	platelet	nn	12	SENT_247	[p10l1039t1932r1225b1987],
12	response	NN	O	response	prep_on	1	SENT_247	[p10l1239t1945r1456b1987],
13	to	TO	O	to	_	0	SENT_247	[p10l1471t1939r1519b1976],
14	a	DT	O	a	det	17	SENT_247	[p10l1533t1945r1558b1976],
15	600-mg	JJ	O	600-mg	amod	17	SENT_247	[p10l1573t1934r1765b1987],
16	loading	NN	O	loading	nn	17	SENT_247	[p10l1779t1932r1961b1987],
17	dose	NN	O	dose	prep_to	1	SENT_247	[p10l1975t1932r2086b1976],
18	of	IN	O	of	_	0	SENT_247	[p10l2101t1932r2152b1976],
19	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_247	[p10l137t1997r412b2052],
20	in	IN	O	in	_	0	SENT_247	[p10l451t1998r496b2041],
21	597	CD	NUMBER	597	num	22	SENT_247	[p10l535t2000r623b2041],
22	patients	NNS	O	patient	prep_in	1	SENT_247	[p10l663t1998r859b2052],
23	with	IN	O	with	_	0	SENT_247	[p10l897t1998r1010b2041],
24	non	JJ	O	non	prep_with	1	SENT_247	[p10l1048t2000r1458b2052],
25	.	.	O	.	_	0	SENT_247	[p10l1048t2000r1458b2052],

1	—	NN	O	—	_	0	SENT_248	[p10l1048t2000r1458b2052],
2	.	.	O	.	_	0	SENT_248	[p10l1048t2000r1458b2052],

1	ST-segment	JJ	O	st-segment	amod	2	SENT_249	[p10l1048t2000r1458b2052],
2	elevation	NN	O	elevation	_	0	SENT_249	[p10l1495t1997r1720b2041],
3	acute	JJ	O	acute	amod	5	SENT_249	[p10l1759t2004r1889b2041],
4	coronary	JJ	O	coronary	amod	5	SENT_249	[p10l1928t2010r2147b2052],
5	syndrome	NN	O	syndrome	dep	2	SENT_249	[p10l137t2064r394b2118],
6	.	.	O	.	_	0	SENT_249	[p10l137t2064r394b2118],

1	Thromb	NNP	O	Thromb	nn	2	SENT_250	[p10l412t2064r608b2108],
2	Res	NNP	O	Res	_	0	SENT_250	[p10l628t2067r709b2108],
3	2007	CD	DATE	2007	num	2	SENT_250	[p10l729t2066r1149b2114],
4	;	:	O	;	_	0	SENT_250	[p10l729t2066r1149b2114],
5	120:893	CD	NUMBER	120:893	number	6	SENT_250	[p10l729t2066r1149b2114],
6	—	CD	NUMBER	—	dep	2	SENT_250	[p10l729t2066r1149b2114],
7	9	CD	NUMBER	9	dep	6	SENT_250	[p10l729t2066r1149b2114],
8	.	.	O	.	_	0	SENT_250	[p10l729t2066r1149b2114],

1	[	RB	O	[	dep	5	SENT_251	[p10l11t2130r103b2185],
2	30	CD	NUMBER	30	num	5	SENT_251	[p10l11t2130r103b2185],
3	]	CD	NUMBER	]	num	5	SENT_251	[p10l11t2130r103b2185],
4	Hochholzer	NNP	O	Hochholzer	nn	5	SENT_251	[p10l137t2130r420b2174],
5	W	NNP	O	W	_	0	SENT_251	[p10l444t2133r511b2180],
6	,	,	O	,	_	0	SENT_251	[p10l444t2133r511b2180],
7	Trenk	NNP	ORGANIZATION	Trenk	nn	8	SENT_251	[p10l538t2130r681b2174],
8	D	NNP	ORGANIZATION	D	appos	5	SENT_251	[p10l708t2133r754b2181],
9	,	,	O	,	_	0	SENT_251	[p10l708t2133r754b2181],
10	Fromm	NNP	ORGANIZATION	Fromm	nn	11	SENT_251	[p10l783t2133r959b2174],
11	MF	NN	ORGANIZATION	mf	appos	5	SENT_251	[p10l987t2133r1072b2181],
12	,	,	O	,	_	0	SENT_251	[p10l987t2133r1072b2181],
13	Valina	NNP	ORGANIZATION	Valina	nn	14	SENT_251	[p10l1099t2130r1254b2174],
14	CM	NN	ORGANIZATION	cm	appos	11	SENT_251	[p10l1281t2132r1372b2181],
15	,	,	O	,	_	0	SENT_251	[p10l1281t2132r1372b2181],
16	Stratz	NNP	PERSON	Stratz	nn	17	SENT_251	[p10l1401t2132r1541b2174],
17	C	NNP	O	C	appos	11	SENT_251	[p10l1569t2132r1610b2180],
18	,	,	O	,	_	0	SENT_251	[p10l1569t2132r1610b2180],
19	Bestehorn	NNP	O	Bestehorn	nn	20	SENT_251	[p10l1638t2130r1885b2174],
20	HP	NNP	O	HP	appos	11	SENT_251	[p10l1914t2133r1992b2181],
21	,	,	O	,	_	0	SENT_251	[p10l1914t2133r1992b2181],
22	et	FW	O	et	nn	23	SENT_251	[p10l2021t2137r2067b2174],
23	al.	FW	O	al.	appos	11	SENT_251	[p10l2093t2130r2145b2174],
24	.	.	O	.	_	0	SENT_251	[p10l2093t2130r2145b2174],

1	Impact	NN	O	impact	_	0	SENT_252	[p10l137t2199r306b2250],
2	of	IN	O	of	_	0	SENT_252	[p10l330t2196r382b2239],
3	cytochrome	NN	O	cytochrome	nn	9	SENT_252	[p10l401t2196r692b2250],
4	P450	NN	O	p450	nn	9	SENT_252	[p10l718t2198r838b2239],
5	2C19	NN	O	2c19	nn	9	SENT_252	[p10l865t2198r986b2239],
6	loss	NN	O	loss	nn	9	SENT_252	[p10l1013t2196r1402b2239],
7	—	CD	NUMBER	—	num	9	SENT_252	[p10l1013t2196r1402b2239],
8	of-function	NN	O	of-function	nn	9	SENT_252	[p10l1013t2196r1402b2239],
9	polymorphism	NN	O	polymorphism	prep_of	1	SENT_252	[p10l1429t2196r1791b2250],
10	and	CC	O	and	_	0	SENT_252	[p10l1816t2196r1906b2239],
11	of	IN	O	of	_	0	SENT_252	[p10l1933t2196r1983b2239],
12	major	JJ	O	major	amod	14	SENT_252	[p10l2003t2197r2147b2250],
13	demographic	JJ	O	demographic	amod	14	SENT_252	[p10l137t2262r461b2316],
14	characteristics	NNS	O	characteristic	prep_of	15	SENT_252	[p10l498t2262r851b2306],
15	on	IN	O	on	conj_and	9	SENT_252	[p10l890t2275r950b2306],
16	residual	JJ	O	residual	amod	18	SENT_252	[p10l988t2262r1183b2306],
17	platelet	NN	O	platelet	nn	18	SENT_252	[p10l1221t2262r1407b2316],
18	function	NN	O	function	pobj	15	SENT_252	[p10l1444t2262r1649b2306],
19	after	IN	O	after	_	0	SENT_252	[p10l1686t2262r1800b2306],
20	loading	VBG	O	load	prepc_after	18	SENT_252	[p10l1837t2262r2019b2316],
21	and	CC	O	and	_	0	SENT_252	[p10l2056t2262r2145b2306],
22	maintenance	NN	O	maintenance	nn	23	SENT_252	[p10l137t2328r454b2371],
23	treatment	NN	O	treatment	pobj	15	SENT_252	[p10l470t2334r717b2371],
24	with	IN	O	with	_	0	SENT_252	[p10l731t2328r844b2371],
25	clopidogrel	NN	O	clopidogrel	prep_with	23	SENT_252	[p10l860t2328r1135b2382],
26	in	IN	O	in	_	0	SENT_252	[p10l1151t2328r1196b2371],
27	patients	NNS	O	patient	prep_in	25	SENT_252	[p10l1212t2328r1409b2382],
28	undergoing	VBG	O	undergo	partmod	27	SENT_252	[p10l1425t2328r1709b2382],
29	elective	JJ	O	elective	amod	32	SENT_252	[p10l1724t2328r1912b2371],
30	coronary	JJ	O	coronary	amod	32	SENT_252	[p10l1929t2340r2147b2382],
31	stent	NN	O	stent	nn	32	SENT_252	[p10l137t2401r259b2438],
32	placement	NN	O	placement	dobj	28	SENT_252	[p10l278t2394r580b2449],
33	.	.	O	.	_	0	SENT_252	[p10l278t2394r580b2449],

1	J	NNP	O	J	nn	4	SENT_253	[p10l278t2394r580b2449],
2	Am	NNP	O	Am	nn	4	SENT_253	[p10l597t2396r683b2437],
3	Coll	NNP	O	Coll	nn	4	SENT_253	[p10l702t2394r793b2438],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_253	[p10l813t2394r986b2438],
5	2010	CD	DATE	2010	num	4	SENT_253	[p10l1006t2396r1456b2445],
6	;	:	O	;	_	0	SENT_253	[p10l1006t2396r1456b2445],
7	55:2427	CD	NUMBER	55:2427	number	8	SENT_253	[p10l1006t2396r1456b2445],
8	—	CD	NUMBER	—	dep	4	SENT_253	[p10l1006t2396r1456b2445],
9	34	CD	NUMBER	34	dep	8	SENT_253	[p10l1006t2396r1456b2445],
10	.	.	O	.	_	0	SENT_253	[p10l1006t2396r1456b2445],

1	[	NN	O	[	_	0	SENT_254	[p10l11t2460r103b2515],
2	31	CD	NUMBER	31	num	1	SENT_254	[p10l11t2460r103b2515],
3	]	CD	NUMBER	]	num	5	SENT_254	[p10l11t2460r103b2515],
4	Giusti	NNP	PERSON	Giusti	nn	5	SENT_254	[p10l137t2461r278b2504],
5	B	NN	PERSON	b	dep	1	SENT_254	[p10l303t2463r343b2510],
6	,	,	O	,	_	0	SENT_254	[p10l303t2463r343b2510],
7	Gori	NNP	ORGANIZATION	Gori	nn	8	SENT_254	[p10l368t2461r471b2504],
8	AM	NNP	ORGANIZATION	AM	appos	5	SENT_254	[p10l493t2462r589b2511],
9	,	,	O	,	_	0	SENT_254	[p10l493t2462r589b2511],
10	Marcucci	NNP	PERSON	Marcucci	nn	11	SENT_254	[p10l614t2461r835b2504],
11	R	NNP	PERSON	R	appos	5	SENT_254	[p10l860t2463r901b2510],
12	,	,	O	,	_	0	SENT_254	[p10l860t2463r901b2510],
13	Saracini	NNP	PERSON	Saracini	nn	14	SENT_254	[p10l926t2461r1118b2504],
14	C	NNP	O	C	appos	5	SENT_254	[p10l1143t2463r1183b2510],
15	,	,	O	,	_	0	SENT_254	[p10l1143t2463r1183b2510],
16	Sestini	NNP	PERSON	Sestini	nn	17	SENT_254	[p10l1208t2461r1368b2504],
17	I	NNP	O	I	appos	5	SENT_254	[p10l1393t2463r1417b2511],
18	,	,	O	,	_	0	SENT_254	[p10l1393t2463r1417b2511],
19	Paniccia	NNP	PERSON	Paniccia	nn	20	SENT_254	[p10l1443t2461r1641b2504],
20	R	NNP	O	R	appos	5	SENT_254	[p10l1665t2463r1706b2510],
21	,	,	O	,	_	0	SENT_254	[p10l1665t2463r1706b2510],
22	et	FW	O	et	nn	23	SENT_254	[p10l1731t2467r1777b2504],
23	al.	FW	O	al.	appos	5	SENT_254	[p10l1799t2460r1851b2504],
24	.	.	O	.	_	0	SENT_254	[p10l1799t2460r1851b2504],

1	Relation	NN	O	relation	_	0	SENT_255	[p10l1877t2460r2077b2504],
2	of	IN	O	of	_	0	SENT_255	[p10l2101t2460r2152b2504],
3	cytochrome	NN	O	cytochrome	nn	9	SENT_255	[p10l137t2526r427b2580],
4	P450	NN	O	p450	nn	9	SENT_255	[p10l456t2528r576b2569],
5	2C19	NN	O	2c19	nn	9	SENT_255	[p10l605t2528r727b2569],
6	loss	NN	O	loss	nn	9	SENT_255	[p10l756t2526r1146b2569],
7	—	CD	NUMBER	—	num	9	SENT_255	[p10l756t2526r1146b2569],
8	of-function	NN	O	of-function	nn	9	SENT_255	[p10l756t2526r1146b2569],
9	polymorphism	NN	O	polymorphism	prep_of	1	SENT_255	[p10l1174t2526r1536b2580],
10	to	TO	O	to	_	0	SENT_255	[p10l1564t2532r1611b2569],
11	occurrence	NN	O	occurrence	prep_to	9	SENT_255	[p10l1640t2538r1909b2569],
12	of	IN	O	of	_	0	SENT_255	[p10l1938t2526r1989b2569],
13	drugeluting	VBG	O	drugelute	prepc_of	11	SENT_255	[p10l2011t2526r2145b2580, p10l137t2592r308b2646],
14	coronary	JJ	O	coronary	amod	16	SENT_255	[p10l327t2605r546b2646],
15	stent	NN	O	stent	nn	16	SENT_255	[p10l565t2598r687b2636],
16	thrombosis	NN	O	thrombosis	dobj	13	SENT_255	[p10l705t2592r994b2636],
17	.	.	O	.	_	0	SENT_255	[p10l705t2592r994b2636],

1	AmJ	NN	O	amj	nn	2	SENT_256	[p10l1013t2594r1130b2646],
2	Cardiol	NN	O	cardiol	_	0	SENT_256	[p10l1150t2592r1322b2636],
3	2009	CD	DATE	2009	dep	2	SENT_256	[p10l1343t2594r1794b2642],
4	;	:	O	;	_	0	SENT_256	[p10l1343t2594r1794b2642],
5	l03	CD	NUMBER	l03	num	6	SENT_256	[p10l1343t2594r1794b2642],
6	:806	CD	NUMBER	:806	dep	2	SENT_256	[p10l1343t2594r1794b2642],
7	—	NN	O	—	dep	6	SENT_256	[p10l1343t2594r1794b2642],
8	11	CD	NUMBER	11	num	7	SENT_256	[p10l1343t2594r1794b2642],
9	.	.	O	.	_	0	SENT_256	[p10l1343t2594r1794b2642],

1	[	NN	O	[	_	0	SENT_257	[p10l11t2657r103b2712],
2	32	CD	NUMBER	32	num	1	SENT_257	[p10l11t2657r103b2712],
3	]	CD	NUMBER	]	num	5	SENT_257	[p10l11t2657r103b2712],
4	Trenk	NN	PERSON	trenk	nn	5	SENT_257	[p10l134t2658r278b2701],
5	D	NN	O	d	dep	1	SENT_257	[p10l306t2660r352b2708],
6	,	,	O	,	_	0	SENT_257	[p10l306t2660r352b2708],
7	Hochholzer	NNP	PERSON	Hochholzer	nn	8	SENT_257	[p10l383t2658r667b2701],
8	W	NNP	PERSON	W	appos	5	SENT_257	[p10l693t2660r760b2708],
9	,	,	O	,	_	0	SENT_257	[p10l693t2660r760b2708],
10	Muller	NNP	PERSON	Muller	nn	11	SENT_257	[p10l791t2658r953b2701],
11	B	NNP	O	B	appos	5	SENT_257	[p10l982t2660r1022b2708],
12	,	,	O	,	_	0	SENT_257	[p10l982t2660r1022b2708],
13	Stratz	NNP	ORGANIZATION	Stratz	nn	14	SENT_257	[p10l1053t2660r1193b2701],
14	C	NNP	ORGANIZATION	C	appos	5	SENT_257	[p10l1223t2660r1264b2708],
15	,	,	O	,	_	0	SENT_257	[p10l1223t2660r1264b2708],
16	Valina	NNP	ORGANIZATION	Valina	nn	17	SENT_257	[p10l1291t2658r1446b2701],
17	CM	NN	ORGANIZATION	cm	appos	5	SENT_257	[p10l1476t2660r1567b2708],
18	,	,	O	,	_	0	SENT_257	[p10l1476t2660r1567b2708],
19	Schmiebusch	NNP	O	Schmiebusch	nn	20	SENT_257	[p10l1597t2658r1920b2701],
20	P	NN	O	p	appos	5	SENT_257	[p10l1950t2660r1988b2708],
21	,	,	O	,	_	0	SENT_257	[p10l1950t2660r1988b2708],
22	et	FW	O	et	nn	23	SENT_257	[p10l2019t2664r2065b2701],
23	al.	FW	O	al.	appos	5	SENT_257	[p10l2093t2658r2145b2702],
24	.	.	O	.	_	0	SENT_257	[p10l2093t2658r2145b2702],

1	Antiplatelet	JJ	O	antiplatelet	amod	2	SENT_258	[p10l134t2724r427b2779],
2	response	NN	O	response	_	0	SENT_258	[p10l445t2737r663b2779],
3	to	TO	O	to	_	0	SENT_258	[p10l682t2731r730b2768],
4	the	DT	O	the	det	7	SENT_258	[p10l749t2724r827b2768],
5	150-mg	JJ	O	150-mg	amod	7	SENT_258	[p10l848t2726r1038b2779],
6	maintenance	NN	O	maintenance	nn	7	SENT_258	[p10l1057t2725r1374b2768],
7	dose	NN	O	dose	prep_to	2	SENT_258	[p10l1395t2724r1506b2768],
8	of	IN	O	of	_	0	SENT_258	[p10l1526t2724r1577b2768],
9	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_258	[p10l1590t2724r1864b2779],
10	in	IN	O	in	_	0	SENT_258	[p10l1885t2725r1929b2767],
11	patients	NNS	O	patient	prep_in	2	SENT_258	[p10l1949t2725r2145b2779],
12	with	IN	O	with	_	0	SENT_258	[p10l135t2789r248b2833],
13	insufﬁcient	JJ	O	insufﬁcient	amod	15	SENT_258	[p10l266t2789r541b2833],
14	platelet	NN	O	platelet	nn	15	SENT_258	[p10l558t2790r744b2844],
15	inhibition	NN	O	inhibition	prep_with	2	SENT_258	[p10l760t2789r1000b2833],
16	after	IN	O	after	_	0	SENT_258	[p10l1017t2789r1131b2833],
17	clopidogrel	NN	O	clopidogrel	prep_after	2	SENT_258	[p10l1147t2789r1422b2844],
18	loading	VBG	O	load	partmod	17	SENT_258	[p10l1441t2789r1622b2844],
19	for	IN	O	for	_	0	SENT_258	[p10l1639t2789r1707b2833],
20	elective	JJ	O	elective	amod	23	SENT_258	[p10l1723t2789r1911b2833],
21	coronary	JJ	O	coronary	amod	23	SENT_258	[p10l1929t2802r2147b2844],
22	stent	NN	O	stent	nn	23	SENT_258	[p10l137t2862r259b2900],
23	placement	NN	O	placement	prep_for	18	SENT_258	[p10l277t2856r547b2910],
24	.	.	O	.	_	0	SENT_258	[p10l277t2856r547b2910],

1	Eurolntervention	NNP	O	Eurolntervention	_	0	SENT_259	[p10l567t2857r988b2900],
2	2008	CD	DATE	2008	num	1	SENT_259	[p10l1008t2858r1397b2906],
3	;	:	O	;	_	0	SENT_259	[p10l1008t2858r1397b2906],
4	4:214	CD	NUMBER	4:214	number	5	SENT_259	[p10l1008t2858r1397b2906],
5	—	CD	NUMBER	—	dep	1	SENT_259	[p10l1008t2858r1397b2906],
6	21	CD	NUMBER	21	dep	5	SENT_259	[p10l1008t2858r1397b2906],
7	.	.	O	.	_	0	SENT_259	[p10l1008t2858r1397b2906],

1	[	NN	O	[	_	0	SENT_260	[p10l11t2922r103b2977],
2	33	CD	NUMBER	33	num	1	SENT_260	[p10l11t2922r103b2977],
3	]	CD	NUMBER	]	num	5	SENT_260	[p10l11t2922r103b2977],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_260	[p10l137t2923r234b2965],
5	KA	NN	PERSON	ka	dep	1	SENT_260	[p10l255t2924r334b2972],
6	,	,	O	,	_	0	SENT_260	[p10l255t2924r334b2972],
7	Park	NNP	ORGANIZATION	Park	nn	8	SENT_260	[p10l357t2922r465b2966],
8	PW	NNP	ORGANIZATION	PW	appos	5	SENT_260	[p10l485t2925r580b2972],
9	,	,	O	,	_	0	SENT_260	[p10l485t2925r580b2972],
10	Hong	NNP	LOCATION	Hong	nn	12	SENT_260	[p10l602t2925r732b2977],
11	S	NNP	LOCATION	S	nn	12	SENT_260	[p10l752t2924r805b2977],
12	]	NN	O	]	appos	5	SENT_260	[p10l752t2924r805b2977],
13	,	,	O	,	_	0	SENT_260	[p10l752t2924r805b2977],
14	Park	NNP	O	Park	nn	15	SENT_260	[p10l828t2922r935b2966],
15	JY	NN	O	jy	appos	5	SENT_260	[p10l949t2925r1013b2977],
16	.	.	O	.	_	0	SENT_260	[p10l949t2925r1013b2977],

1	The	DT	O	the	det	2	SENT_261	[p10l1033t2922r1123b2966],
2	effect	NN	O	effect	_	0	SENT_261	[p10l1144t2922r1278b2966],
3	of	IN	O	of	_	0	SENT_261	[p10l1298t2922r1350b2966],
4	CYP2C19	NN	O	cyp2c19	nn	5	SENT_261	[p10l1364t2924r1582b2966],
5	polymorphism	NN	O	polymorphism	prep_of	2	SENT_261	[p10l1604t2922r1966b2977],
6	on	IN	O	on	_	0	SENT_261	[p10l1987t2935r2048b2966],
7	the	DT	O	the	det	8	SENT_261	[p10l2068t2922r2145b2966],
8	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	5	SENT_261	[p10l137t2988r573b3042],
9	and	CC	O	and	_	0	SENT_261	[p10l596t2988r685b3031],
10	pharmacodynamics	NNS	O	pharmacodynamic	prep_on	5	SENT_261	[p10l708t2988r1190b3042],
11	of	IN	O	of	_	0	SENT_261	[p10l1213t2988r1264b3031],
12	clopidogrel	NN	O	clopidogrel	prep_of	8	SENT_261	[p10l1280t2988r1570b3042],
13	:	:	O	:	_	0	SENT_261	[p10l1280t2988r1570b3042],
14	a	DT	O	a	det	16	SENT_261	[p10l1596t3000r1621b3031],
15	possible	JJ	O	possible	amod	16	SENT_261	[p10l1642t2988r1840b3042],
16	mechanism	NN	O	mechanism	dep	2	SENT_261	[p10l1863t2988r2146b3031],
17	for	IN	O	for	_	0	SENT_261	[p10l137t3053r205b3097],
18	clopidogrel	NN	O	clopidogrel	nn	19	SENT_261	[p10l223t3053r498b3108],
19	resistance	NN	O	resistance	prep_for	16	SENT_261	[p10l518t3054r774b3097],
20	.	.	O	.	_	0	SENT_261	[p10l518t3054r774b3097],

1	Clin	NNP	O	Clin	nn	3	SENT_262	[p10l795t3053r888b3097],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_262	[p10l909t3054r1168b3097],
3	Ther	NNP	O	Ther	_	0	SENT_262	[p10l1186t3053r1299b3097],
4	2008	CD	DATE	2008	num	3	SENT_262	[p10l1317t3056r1737b3104],
5	;	:	O	;	_	0	SENT_262	[p10l1317t3056r1737b3104],
6	84:236	CD	NUMBER	84:236	number	7	SENT_262	[p10l1317t3056r1737b3104],
7	—	CD	NUMBER	—	dep	3	SENT_262	[p10l1317t3056r1737b3104],
8	42	CD	NUMBER	42	dep	7	SENT_262	[p10l1317t3056r1737b3104],
9	.	.	O	.	_	0	SENT_262	[p10l1317t3056r1737b3104],

1	[	NN	O	[	nn	5	SENT_263	[p10l11t3119r103b3174],
2	34	CD	NUMBER	34	num	5	SENT_263	[p10l11t3119r103b3174],
3	]	CD	NUMBER	]	num	5	SENT_263	[p10l11t3119r103b3174],
4	Bonello	NNP	PERSON	Bonello	nn	5	SENT_263	[p10l137t3120r319b3163],
5	L	NNP	PERSON	L	_	0	SENT_263	[p10l335t3122r370b3170],
6	,	,	O	,	_	0	SENT_263	[p10l335t3122r370b3170],
7	Armero	NNP	LOCATION	Armero	nn	8	SENT_263	[p10l384t3121r571b3163],
8	S	NNP	O	S	appos	5	SENT_263	[p10l588t3122r624b3170],
9	,	,	O	,	_	0	SENT_263	[p10l588t3122r624b3170],
10	Ait	NNP	PERSON	Ait	nn	12	SENT_263	[p10l639t3120r710b3163],
11	Mokhtar	NNP	PERSON	Mokhtar	nn	12	SENT_263	[p10l725t3120r936b3163],
12	O	NNP	PERSON	O	appos	8	SENT_263	[p10l950t3122r997b3170],
13	,	,	O	,	_	0	SENT_263	[p10l950t3122r997b3170],
14	Mancini	NNP	PERSON	Mancini	nn	15	SENT_263	[p10l1014t3120r1211b3163],
15	J	NNP	PERSON	J	appos	8	SENT_263	[p10l1221t3122r1252b3174],
16	,	,	O	,	_	0	SENT_263	[p10l1221t3122r1252b3174],
17	Aldebert	NNP	PERSON	Aldebert	nn	18	SENT_263	[p10l1266t3120r1480b3163],
18	P	NN	PERSON	p	appos	8	SENT_263	[p10l1495t3122r1533b3170],
19	,	,	O	,	_	0	SENT_263	[p10l1495t3122r1533b3170],
20	Saut	NNP	O	Saut	nn	21	SENT_263	[p10l1550t3122r1656b3163],
21	N	NNP	O	N	appos	8	SENT_263	[p10l1671t3122r1718b3170],
22	,	,	O	,	_	0	SENT_263	[p10l1671t3122r1718b3170],
23	et	FW	O	et	nn	24	SENT_263	[p10l1735t3126r1781b3163],
24	al.	FW	O	al.	appos	8	SENT_263	[p10l1795t3120r1847b3164],
25	.	.	O	.	_	0	SENT_263	[p10l1795t3120r1847b3164],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_264	[p10l1864t3120r2145b3174],
2	loading	VBG	O	load	partmod	1	SENT_264	[p10l137t3186r318b3241],
3	dose	NN	O	dose	nn	4	SENT_264	[p10l342t3186r453b3230],
4	adjustment	NN	O	adjustment	dobj	2	SENT_264	[p10l477t3186r758b3241],
5	according	VBG	O	accord	_	0	SENT_264	[p10l782t3186r1021b3241],
6	to	TO	O	to	prepc_according_to	2	SENT_264	[p10l1044t3193r1091b3230],
7	platelet	NN	O	platelet	nn	9	SENT_264	[p10l1115t3186r1301b3241],
8	reactivity	NN	O	reactivity	nn	9	SENT_264	[p10l1324t3187r1556b3241],
9	monitoring	NN	O	monitoring	pobj	2	SENT_264	[p10l1579t3187r1856b3241],
10	in	IN	O	in	_	0	SENT_264	[p10l1880t3187r1925b3229],
11	patients	NNS	O	patient	prep_in	9	SENT_264	[p10l1949t3187r2145b3241],
12	carrying	VBG	O	carry	partmod	11	SENT_264	[p10l137t3253r339b3307],
13	the	DT	O	the	det	17	SENT_264	[p10l361t3252r439b3296],
14	2C19	NN	O	2c19	nn	17	SENT_264	[p10l463t3252r637b3296],
15	*	NN	O	*	nn	17	SENT_264	[p10l463t3252r637b3296],
16	2	CD	NUMBER	2	num	17	SENT_264	[p10l463t3252r637b3296],
17	loss	NN	O	loss	dobj	12	SENT_264	[p10l663t3252r752b3296],
18	of	IN	O	of	_	0	SENT_264	[p10l777t3252r828b3296],
19	function	NN	O	function	nn	20	SENT_264	[p10l846t3252r1049b3296],
20	polymorphism	NN	O	polymorphism	prep_of	17	SENT_264	[p10l1073t3252r1446b3307],
21	.	.	O	.	_	0	SENT_264	[p10l1073t3252r1446b3307],

1	J	NNP	O	J	nn	4	SENT_265	[p10l1464t3255r1484b3307],
2	Am	NNP	O	Am	nn	4	SENT_265	[p10l1505t3254r1590b3295],
3	Coll	NNP	O	Coll	nn	4	SENT_265	[p10l1613t3252r1704b3296],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_265	[p10l1728t3252r1901b3296],
5	2010	CD	DATE	2010	num	4	SENT_265	[p10l1925t3254r2142b3303],
6	;	:	O	;	_	0	SENT_265	[p10l1925t3254r2142b3303],
7	56	CD	NUMBER	56	num	9	SENT_265	[p10l1925t3254r2142b3303],
8	:	:	O	:	_	0	SENT_265	[p10l1925t3254r2142b3303],
9	1630-6	CD	NUMBER	1630-6	dep	4	SENT_265	[p10l139t3321r332b3363],
10	.	.	O	.	_	0	SENT_265	[p10l139t3321r332b3363],

1	Jean	NNP	PERSON	Jean	nn	3	SENT_266	[p10l1682t3456r1818b3521],
2	Szymezak	NNP	PERSON	Szymezak	nn	3	SENT_266	[p10l1842t3453r2148b3521],
3	AP	NNP	O	AP	_	0	SENT_266	[p10l420t3544r623b3605],
4	.	.	O	.	_	0	SENT_266	[p10l420t3544r623b3605],

1	—	NN	O	—	_	0	SENT_267	[p10l420t3544r623b3605],
2	.	.	O	.	_	0	SENT_267	[p10l420t3544r623b3605],

1	HP	NNP	O	HP	nn	6	SENT_268	[p10l420t3544r623b3605],
2	,	,	O	,	_	0	SENT_268	[p10l420t3544r623b3605],
3	Hopital	NNP	O	Hopital	appos	6	SENT_268	[p10l648t3541r866b3610],
4	européen	NNP	O	européen	nn	6	SENT_268	[p10l888t3540r1158b3610],
5	Georges	NNP	PERSON	Georges	nn	6	SENT_268	[p10l1184t3545r1414b3610],
6	Pompidou	NNP	PERSON	Pompidou	_	0	SENT_268	[p10l1436t3542r1745b3610],
7	,	,	O	,	_	0	SENT_268	[p10l1436t3542r1745b3610],
8	Paris	NNP	LOCATION	Paris	nn	10	SENT_268	[p10l1770t3543r1926b3605],
9	,	,	O	,	_	0	SENT_268	[p10l1770t3543r1926b3605],
10	France	NNP	LOCATION	France	appos	6	SENT_268	[p10l1951t3545r2146b3597],

1	Caroline	NNP	PERSON	Caroline	nn	2	SENT_269	[p10l1635t3720r1886b3774],
2	Moreau	NNP	PERSON	Moreau	_	0	SENT_269	[p10l1911t3723r2146b3774],

1	Marie-Anne	NNP	PERSON	Marie-Anne	nn	3	SENT_270	[p11l1579t24r1944b78],
2	Loriot	NNP	PERSON	Loriot	nn	3	SENT_270	[p11l1969t24r2148b78],
3	AP-HP	NNP	O	AP-HP	_	0	SENT_270	[p11l420t114r623b175],
4	,	,	O	,	_	0	SENT_270	[p11l420t114r623b175],
5	Hopital	NNP	O	Hopital	nn	8	SENT_270	[p11l648t110r866b180],
6	européen	NNP	O	européen	nn	8	SENT_270	[p11l888t110r1158b180],
7	Georges	NNP	PERSON	Georges	nn	8	SENT_270	[p11l1184t114r1414b180],
8	Pompidou	NNP	PERSON	Pompidou	appos	3	SENT_270	[p11l1436t111r1745b180],
9	,	,	O	,	_	0	SENT_270	[p11l1436t111r1745b180],
10	Paris	NNP	LOCATION	Paris	appos	3	SENT_270	[p11l1770t113r1926b175],
11	,	,	O	,	_	0	SENT_270	[p11l1770t113r1926b175],
12	France	NNP	LOCATION	France	nn	15	SENT_270	[p11l1951t115r2146b166],
13	Université	NNP	O	Université	nn	15	SENT_270	[p11l971t198r1265b254],
14	Paris	NNP	LOCATION	Paris	nn	15	SENT_270	[p11l1286t201r1430b254],
15	Descartes	NNP	LOCATION	Descartes	appos	3	SENT_270	[p11l1452t203r1745b262],
16	,	,	O	,	_	0	SENT_270	[p11l1452t203r1745b262],
17	Paris	NNP	LOCATION	Paris	appos	3	SENT_270	[p11l1770t201r1926b262],
18	,	,	O	,	_	0	SENT_270	[p11l1770t201r1926b262],
19	France	NNP	LOCATION	France	nn	22	SENT_270	[p11l1951t203r2146b254],
20	INSERM	NNP	O	INSERM	nn	22	SENT_270	[p11l427t289r665b341],
21	UMR	NNP	O	UMR	nn	22	SENT_270	[p11l688t290r828b341],
22	S	NN	O	s	appos	3	SENT_270	[p11l849t289r883b341],
23	775	CD	NUMBER	775	num	22	SENT_270	[p11l908t290r1025b349],
24	,	,	O	,	_	0	SENT_270	[p11l908t290r1025b349],
25	45	CD	NUMBER	45	appos	3	SENT_270	[p11l1050t289r1123b341],
26	rue	FW	O	rue	nn	27	SENT_270	[p11l1148t302r1242b341],
27	des	FW	O	des	dep	25	SENT_270	[p11l1266t287r1360b341],
28	Saints	NNP	PERSON	Saints	nn	29	SENT_270	[p11l1381t288r1558b341],
29	Peres	NNP	PERSON	Peres	dep	25	SENT_270	[p11l1580t285r1745b349],
30	,	,	O	,	_	0	SENT_270	[p11l1580t285r1745b349],
31	Paris	NNP	LOCATION	Paris	nn	33	SENT_270	[p11l1770t288r1926b349],
32	,	,	O	,	_	0	SENT_270	[p11l1770t288r1926b349],
33	France	NNP	LOCATION	France	appos	3	SENT_270	[p11l1951t290r2146b341],

1	Eric	NNP	PERSON	Eric	nn	3	SENT_271	[p11l1781t465r1895b518],
2	Durand	NNP	PERSON	Durand	nn	3	SENT_271	[p11l1919t464r2145b518],
3	AP-HP	NNP	O	AP-HP	_	0	SENT_271	[p11l420t555r623b616],
4	,	,	O	,	_	0	SENT_271	[p11l420t555r623b616],
5	Hopital	NNP	O	Hopital	nn	8	SENT_271	[p11l648t551r866b621],
6	européen	NNP	O	européen	nn	8	SENT_271	[p11l888t551r1158b621],
7	Georges	NNP	PERSON	Georges	nn	8	SENT_271	[p11l1184t555r1414b621],
8	Pompidou	NNP	PERSON	Pompidou	appos	3	SENT_271	[p11l1436t552r1745b621],
9	,	,	O	,	_	0	SENT_271	[p11l1436t552r1745b621],
10	Paris	NNP	LOCATION	Paris	appos	3	SENT_271	[p11l1770t554r1926b616],
11	,	,	O	,	_	0	SENT_271	[p11l1770t554r1926b616],
12	France	NNP	LOCATION	France	nn	15	SENT_271	[p11l1951t556r2146b607],
13	Université	NNP	O	Université	nn	15	SENT_271	[p11l971t639r1265b695],
14	Paris	NNP	LOCATION	Paris	nn	15	SENT_271	[p11l1286t642r1430b695],
15	Descartes	NNP	LOCATION	Descartes	appos	3	SENT_271	[p11l1452t644r1745b703],
16	,	,	O	,	_	0	SENT_271	[p11l1452t644r1745b703],
17	Paris	NNP	LOCATION	Paris	appos	3	SENT_271	[p11l1770t642r1926b703],
18	,	,	O	,	_	0	SENT_271	[p11l1770t642r1926b703],
19	France	NNP	LOCATION	France	nn	21	SENT_271	[p11l1951t644r2146b695],
20	INSERM	NNP	ORGANIZATION	INSERM	nn	21	SENT_271	[p11l7t731r241b782],
21	U	NNP	O	U	appos	3	SENT_271	[p11l256t731r300b782],
22	970	CD	NUMBER	970	num	21	SENT_271	[p11l312t731r432b790],
23	,	,	O	,	_	0	SENT_271	[p11l312t731r432b790],
24	Paris	NNP	ORGANIZATION	Paris	nn	27	SENT_271	[p11l448t729r589b782],
25	Centre	NNP	ORGANIZATION	Centre	nn	27	SENT_271	[p11l606t731r791b782],
26	de	IN	ORGANIZATION	de	amod	27	SENT_271	[p11l808t728r874b782],
27	Recherches	NNP	ORGANIZATION	Recherches	appos	3	SENT_271	[p11l888t728r1207b782],
28	Cardio-vasculaires	NNS	ORGANIZATION	cardio-vasculaire	dep	27	SENT_271	[p11l1225t728r1768b790],
29	,	,	O	,	_	0	SENT_271	[p11l1225t728r1768b790],
30	Paris	NNP	LOCATION	Paris	nn	32	SENT_271	[p11l1785t729r1936b790],
31	,	,	O	,	_	0	SENT_271	[p11l1785t729r1936b790],
32	France	NNP	LOCATION	France	appos	3	SENT_271	[p11l1955t731r2146b782],

1	Hubert	NNP	PERSON	Hubert	nn	4	SENT_272	[p11l1662t905r1872b959],
2	Van	NNP	PERSON	Van	nn	4	SENT_272	[p11l1889t908r2007b959],
3	Viet	NNP	PERSON	Viet	nn	4	SENT_272	[p11l2025t906r2148b959],
4	AP-HP	NNP	PERSON	AP-HP	_	0	SENT_272	[p11l469t995r668b1056],
5	,	,	O	,	_	0	SENT_272	[p11l469t995r668b1056],
6	Hopital	NNP	ORGANIZATION	Hopital	nn	9	SENT_272	[p11l690t992r904b1062],
7	européen	NNP	O	européen	nn	9	SENT_272	[p11l923t991r1188b1062],
8	Georges	NNP	PERSON	Georges	nn	9	SENT_272	[p11l1211t996r1436b1062],
9	Pompidou	NNP	PERSON	Pompidou	appos	4	SENT_272	[p11l1455t993r1759b1062],
10	,	,	O	,	_	0	SENT_272	[p11l1455t993r1759b1062],
11	Paris	NNP	LOCATION	Paris	appos	4	SENT_272	[p11l1781t994r1932b1057],
12	,	,	O	,	_	0	SENT_272	[p11l1781t994r1932b1057],
13	France	NNP	LOCATION	France	appos	4	SENT_272	[p11l1955t996r2146b1048],

1	Michel	NNP	PERSON	Michel	nn	3	SENT_273	[p11l1708t1171r1910b1226],
2	Desnos	NNP	PERSON	Desnos	nn	3	SENT_273	[p11l1932t1175r2145b1226],
3	AP-HP	NNP	O	AP-HP	_	0	SENT_273	[p11l469t1262r668b1323],
4	,	,	O	,	_	0	SENT_273	[p11l469t1262r668b1323],
5	Hopital	NNP	ORGANIZATION	Hopital	nn	8	SENT_273	[p11l690t1259r904b1328],
6	européen	NNP	O	européen	nn	8	SENT_273	[p11l923t1258r1188b1328],
7	Georges	NNP	PERSON	Georges	nn	8	SENT_273	[p11l1211t1263r1436b1328],
8	Pompidou	NNP	PERSON	Pompidou	appos	3	SENT_273	[p11l1455t1260r1759b1328],
9	,	,	O	,	_	0	SENT_273	[p11l1455t1260r1759b1328],
10	Paris	NNP	LOCATION	Paris	appos	3	SENT_273	[p11l1781t1261r1932b1323],
11	,	,	O	,	_	0	SENT_273	[p11l1781t1261r1932b1323],
12	France	NNP	LOCATION	France	nn	15	SENT_273	[p11l1955t1263r2146b1315],
13	Université	NNP	O	Université	nn	15	SENT_273	[p11l1007t1346r1293b1402],
14	Paris	NNP	LOCATION	Paris	nn	15	SENT_273	[p11l1312t1349r1452b1402],
15	Descartes	NNP	LOCATION	Descartes	appos	3	SENT_273	[p11l1472t1351r1759b1410],
16	,	,	O	,	_	0	SENT_273	[p11l1472t1351r1759b1410],
17	Paris	NNP	LOCATION	Paris	appos	3	SENT_273	[p11l1780t1349r1932b1410],
18	,	,	O	,	_	0	SENT_273	[p11l1780t1349r1932b1410],
19	France	NNP	LOCATION	France	nn	22	SENT_273	[p11l1955t1351r2146b1402],
20	INSERM	NNP	O	INSERM	nn	22	SENT_273	[p11l557t1438r790b1489],
21	UMR	NNP	O	UMR	nn	22	SENT_273	[p11l811t1438r950b1489],
22	S	NN	O	s	appos	3	SENT_273	[p11l968t1438r1001b1489],
23	633	CD	NUMBER	633	num	22	SENT_273	[p11l1022t1438r1139b1497],
24	,	,	O	,	_	0	SENT_273	[p11l1022t1438r1139b1497],
25	Faculté	NNP	PERSON	Faculté	nn	27	SENT_273	[p11l1161t1433r1367b1489],
26	de	IN	PERSON	de	amod	27	SENT_273	[p11l1387t1435r1453b1489],
27	Médecine	NNP	PERSON	Médecine	appos	3	SENT_273	[p11l1472t1433r1758b1497],
28	,	,	O	,	_	0	SENT_273	[p11l1472t1433r1758b1497],
29	Paris	NNP	LOCATION	Paris	appos	3	SENT_273	[p11l1780t1436r1932b1498],
30	,	,	O	,	_	0	SENT_273	[p11l1780t1436r1932b1498],
31	France	NNP	LOCATION	France	appos	3	SENT_273	[p11l1954t1438r2146b1489],

1	Pascale	NNP	PERSON	Pascale	nn	3	SENT_274	[p11l1639t1612r1853b1667],
2	Gaussem	NNP	PERSON	Gaussem	nn	3	SENT_274	[p11l1876t1615r2147b1667],
3	AP-HP	NNP	O	AP-HP	_	0	SENT_274	[p11l469t1703r668b1764],
4	,	,	O	,	_	0	SENT_274	[p11l469t1703r668b1764],
5	Hopital	NNP	O	Hopital	nn	8	SENT_274	[p11l690t1699r904b1769],
6	européen	NNP	O	européen	nn	8	SENT_274	[p11l923t1699r1188b1769],
7	Georges	NNP	PERSON	Georges	nn	8	SENT_274	[p11l1211t1703r1436b1769],
8	Pompidou	NNP	PERSON	Pompidou	appos	3	SENT_274	[p11l1455t1700r1759b1769],
9	,	,	O	,	_	0	SENT_274	[p11l1455t1700r1759b1769],
10	Paris	NNP	LOCATION	Paris	appos	3	SENT_274	[p11l1781t1702r1932b1764],
11	,	,	O	,	_	0	SENT_274	[p11l1781t1702r1932b1764],
12	France	NNP	LOCATION	France	nn	15	SENT_274	[p11l1955t1704r2146b1755],
13	Université	NNP	O	Université	nn	15	SENT_274	[p11l1007t1787r1293b1843],
14	Paris	NNP	LOCATION	Paris	nn	15	SENT_274	[p11l1312t1790r1452b1843],
15	Descartes	NNP	LOCATION	Descartes	appos	3	SENT_274	[p11l1472t1792r1759b1851],
16	,	,	O	,	_	0	SENT_274	[p11l1472t1792r1759b1851],
17	Paris	NNP	LOCATION	Paris	appos	3	SENT_274	[p11l1780t1790r1932b1851],
18	,	,	O	,	_	0	SENT_274	[p11l1780t1790r1932b1851],
19	France	NNP	LOCATION	France	nn	22	SENT_274	[p11l1955t1792r2146b1843],
20	INSERM	NNP	O	INSERM	nn	22	SENT_274	[p11l527t1878r761b1930],
21	UMR	NNP	O	UMR	nn	22	SENT_274	[p11l782t1879r919b1930],
22	S	NN	O	s	appos	3	SENT_274	[p11l938t1878r972b1930],
23	765	CD	NUMBER	765	num	22	SENT_274	[p11l995t1878r1109b1938],
24	,	,	O	,	_	0	SENT_274	[p11l995t1878r1109b1938],
25	Faculté	NNP	LOCATION	Faculté	nn	27	SENT_274	[p11l1131t1874r1337b1930],
26	de	IN	LOCATION	de	amod	27	SENT_274	[p11l1358t1876r1423b1930],
27	Pharmacie	NNP	LOCATION	Pharmacie	appos	3	SENT_274	[p11l1442t1876r1758b1938],
28	,	,	O	,	_	0	SENT_274	[p11l1442t1876r1758b1938],
29	Paris	NNP	LOCATION	Paris	appos	3	SENT_274	[p11l1780t1877r1932b1938],
30	,	,	O	,	_	0	SENT_274	[p11l1780t1877r1932b1938],
31	France	NNP	LOCATION	France	appos	3	SENT_274	[p11l1955t1879r2146b1930],
32	Corresponding	VBG	O	correspond	partmod	3	SENT_274	[p11l570t1963r1013b2032],
33	author	NN	O	author	dobj	32	SENT_274	[p11l1033t1963r1234b2018],
34	at	IN	O	at	prep	32	SENT_274	[p11l1253t1971r1325b2019],
35	:	:	O	:	_	0	SENT_274	[p11l1253t1971r1325b2019],
36	Université	NNP	ORGANIZATION	Université	nn	38	SENT_274	[p11l1351t1961r1659b2018],
37	Paris	NNP	ORGANIZATION	Paris	nn	38	SENT_274	[p11l1681t1964r1822b2018],
38	Descartes	NNP	ORGANIZATION	Descartes	dep	3	SENT_274	[p11l1845t1966r2145b2026],
39	,	,	O	,	_	0	SENT_274	[p11l1845t1966r2145b2026],
40	Faculté	NNP	PERSON	Faculté	nn	42	SENT_274	[p11l78t2050r289b2106],
41	de	IN	PERSON	de	amod	42	SENT_274	[p11l311t2051r382b2106],
42	Pharmacie	NNP	PERSON	Pharmacie	appos	38	SENT_274	[p11l403t2051r732b2114],
43	,	,	O	,	_	0	SENT_274	[p11l403t2051r732b2114],
44	INSERM	NNP	ORGANIZATION	INSERM	nn	46	SENT_274	[p11l754t2054r994b2106],
45	UMR	NNP	ORGANIZATION	UMR	nn	46	SENT_274	[p11l1015t2055r1165b2106],
46	S	NN	O	s	appos	38	SENT_274	[p11l1185t2054r1215b2106],
47	765	CD	NUMBER	765	num	46	SENT_274	[p11l1238t2054r1361b2114],
48	,	,	O	,	_	0	SENT_274	[p11l1238t2054r1361b2114],
49	Avenue	NNP	O	Avenue	nn	51	SENT_274	[p11l1382t2054r1609b2106],
50	de	IN	O	de	amod	51	SENT_274	[p11l1631t2051r1702b2106],
51	l'observatoire	NNP	O	l'observatoire	appos	38	SENT_274	[p11l1724t2051r2145b2114],
52	,	,	O	,	_	0	SENT_274	[p11l1724t2051r2145b2114],
53	75006	CD	NUMBER	75006	num	56	SENT_274	[p11l157t2141r342b2193],
54	Paris	NNP	LOCATION	Paris	nn	56	SENT_274	[p11l365t2139r521b2201],
55	,	,	O	,	_	0	SENT_274	[p11l365t2139r521b2201],
56	France	NNP	LOCATION	France	appos	38	SENT_274	[p11l543t2142r753b2193],
57	.	.	O	.	_	0	SENT_274	[p11l543t2142r753b2193],

1	Tel.	NNP	O	Tel.	_	0	SENT_275	[p11l773t2138r895b2193],
2	:	:	O	:	_	0	SENT_275	[p11l773t2138r895b2193],
3	+33	CD	NUMBER	+33	number	4	SENT_275	[p11l927t2141r1055b2196],
4	1	CD	NUMBER	1	dep	1	SENT_275	[p11l1084t2141r1107b2192],
5	56093936	CD	NUMBER	56093936	dep	4	SENT_275	[p11l1138t2141r1456b2201],
6	;	:	O	;	_	0	SENT_275	[p11l1138t2141r1456b2201],
7	fax	NN	O	fax	dep	1	SENT_275	[p11l1483t2138r1589b2193],
8	:	:	O	:	_	0	SENT_275	[p11l1483t2138r1589b2193],
9	+33	CD	NUMBER	+33	number	10	SENT_275	[p11l1620t2141r1749b2196],
10	1	CD	NUMBER	1	dep	7	SENT_275	[p11l1776t2141r1800b2192],
11	56093913	CD	NUMBER	56093913	dep	10	SENT_275	[p11l1831t2141r2145b2193],
12	.	.	O	.	_	0	SENT_275	[p11l1831t2141r2145b2193],

1	E	NN	O	e	nn	4	SENT_276	[p11l774t2227r964b2282],
2	—	CD	NUMBER	—	num	4	SENT_276	[p11l774t2227r964b2282],
3	mail	NN	O	mail	nn	4	SENT_276	[p11l774t2227r964b2282],
4	address	NN	O	address	_	0	SENT_276	[p11l984t2227r1220b2282],
5	:	:	O	:	_	0	SENT_276	[p11l984t2227r1220b2282],
6	pascale.gaussem@egp.aphp.fr	NN	O	pascale.gaussem@egp.aphp.fr	dep	4	SENT_276	[p11l1244t2227r2145b2295],
7	.	.	O	.	_	0	SENT_276	[p11l1244t2227r2145b2295],

1	8	CD	DATE	8	_	0	SENT_277	[p11l1581t2452r1613b2504],
2	September	NNP	DATE	September	dep	1	SENT_277	[p11l1640t2449r1972b2518],
3	2010	CD	DATE	2010	num	2	SENT_277	[p11l1994t2452r2146b2504],

